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ABSTRACT
Four distinct DNA ligase activities (I-IV) have been identified within 
mammalian cells. Evidence has indicated DNA ligase I to be central to lagging strand 
DNA replication, as well as being involved in DNA repair processes. It has also been 
reported that DNA ligase I is essential for cell viability. A patient with altered DNA 
ligase I displayed a phenotype similar to Bloom's Syndrome, being immunodeficient, 
growth retarded, and predisposed to cancer. Fibroblasts isolated from this patient 
(46BR) exhibited abnormal lagging strand DNA synthesis, and repair deficiency. 
Gene inactivation was the first step of a 'double replacement' strategy to introduce 
analogous mutations into the mouse DNA ligase I gene (Ligl). Using gene targeting 
in HPRT-deficient embryonic stem (ES) cells, the last 5 exons of the endogenous 
Ligl gene were replaced by an HPRT minigene, and subsequently DNA ligase I- 
deficient mice were produced.
Embryos lacking DNA ligase I developed normally to mid-term, when 
haematopoiesis usually switches to the foetal liver. Thereupon severe disruption to 
foetal liver erythropoiesis occurred, leading to acute anaemia and prenatal death. In 
vitro assays indicated that erythroid-committed progenitor cells were present in the 
liver, but in reduced numbers. Apart from the developing liver, organogenesis was 
not perceptibly affected and non-erythroid haematopoietic lineages were not reduced.
Injection of cell suspensions from single foetal livers were unable to rescue 
lethally-irradiated mice. However, injection of multiple livers into a single recipient 
was able to effect long term repopulation of the haematopoietic system. Animals 
rescued with cells lacking DNA ligase I displayed splenomegaly, anaemia coupled 
with reticulocytosis, and hypoplasia in all haematopoietic tissues.
Fibroblasts isolated from embryos lacking DNA ligase I displayed an abnormal 
profile of replication intermediates, but showed no increase in the level of sister 
chromatid exchanges. Northern and western analysis demonstrated that DNA ligase I 
expression was completely abrogated, but that expression of DNA ligases El and IV 
remained unaltered.
A second round of gene targeting in ES cells was used to introduce two 
flanking loxP sites into the endogenous Ligl locus, as the basis of a 'conditional 
knockout' strategy. Mice heterozygous for the 'floxed' Ligl allele were crossed with 
mice carrying a mammary-specific Cre recombinase transgene, and their offspring 
were analysed to assess the efficacy of Cre-mediated recombination in vivo. Deletion 
of the 'floxed1 Ligl allele was detected at high levels in the mammary gland of 
lactating females.
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Although DNA ligase I is required for normal development, we conclude that it 
is not essential for cell viability, or DNA replication, and the absence of DNA ligase I 
has no discernible consequence for most embryonic tissues. We propose that the 
phenotype observed reflects the particularly high replicative requirements during 
foetal liver erythropoiesis and in vivo haematopoietic repopulation. Exactly which 
other ligase activity replaces DNA ligase I still remains unclear, but a previously 
unsuspected redundancy must exist among the mammalian DNA ligases.
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In order for data to be faithfully preserved, the medium on which it its stored 
has to be stable, and genetic information is no different in this respect. DNA, the 
genetic material of almost all organisms, must be maintained in an informationally 
active form in spite of any molecular changes. Modification to the structure of DNA 
can arise spontaneously, from normal cellular processes, or as a result of the action of 
environmental agents. Whatever the cause, damage that remains unrepaired has the 
potential to alter the information encoded by the DNA, or result in the loss of 
information. Such changes can have a variety of consequences, but most will be 
deleterious to an organism's survival or reproductive capacity. In response to this, 
living organisms have evolved a number of mechanisms to maintain genomic stability.
As had been true for all areas of molecular biology, study of model prokaryotic 
organisms, such as Escherichia coli, provided a powerful tool for studying the cellular 
mechanisms involved in the repair or tolerance of DNA damage. However, whilst 
many pathways are conserved across evolutionary time, the eukaryotic organism is far 
more complex. Not only do eukaryotic cells contain far larger genomes and multiple 
chromosomes, but they also possess a higher order DNA structure not present in 
prokaryotes. Furthermore the development of multicellular organisation requires tight 
control of cell division and differentiation. Accumulation of DNA damage is known 
to disrupt and deregulate both of these processes. The challenge is therefore to 
understand how DNA repair and damage tolerance mechanisms act in the context of 
the mammalian system.
1.2 DNA repair mechanisms
DNA damage can be divided into two classes on the basis of origin. 
"Spontaneous" damage arises as the result of normal cellular processes such as DNA 
replication, while the "environmental" damage is produced by exogenous agents. The 
variety of spontaneous alterations and environmental damaging agents are reviewed in 
Friedberg , Walker and Siede 1995, but are summarised in Table 1.2.1 and Table 1.2.2 
respectively. It can be seen from these tables that the total number of different lesions 
is large. Rather than maintaining numerous repair pathways specific for individual 
damage products, eukaryotic cells have evolved a limited number of general 
mechanisms which are each able to deal with multiple types of lesion. Although 
thorough discussion of all cellular responses to DNA damage is beyond the scope of 


































































































































































































































































































































































































































































































































































































































1.2.1 Direct reversal of DNA damage
Mechanisms which involve enzyme-catalysed return of damaged DNA directly 
to its original state are the simplest example of DNA repair. The classic example of 
direct reversal is the monomerisation of cis-syn cyclobutane pyrimidine dimers caused 
by UV irradiation. Enzymatic photoreactivation by DNA photolyase has been 
extensively studied in E. coli, but there is no definitive evidence that such a 
mechanism exists in higher eukaryotes. Similarly the rejoining of single strand DNA 
breaks by DNA ligase has been observed in E. coli, but the relative importance of this 
mechanism is not certain in mammalian cells. Ligation requires free ends of duplex 
DNA with 3'OH and 5'P termini. In most cases radiation induced single strand breaks 
are accompanied by damage to strand ends, and processing by other enzymes has to 
occur before ligation.
Repair of alkylation damage by direct means has been observed in mammalian 
cells. O6-alkylguanine is a major product of the reaction between DNA and alkylating 
agents such as methylnitro-nitrosoguanidine (MNNG) and methyl-nitrosourea 
(MNU). O6-alkylguanine lesions are thought to be highly mutagenic, and are removed 
by O6-methylguanine transferase (O6-MGT). The methyl group is transferred from the 
DNA to a cysteine residue on the enzyme, forming S-methyl cysteine and resulting in 
permanent inactivation of the enzyme.
1.2.2 Base excision repair
The main strategy for correcting DNA lesions arising from spontaneous 
hydrolysis and attack by free radicals is base excision repair (BER) (reviewed by 
Lindahl 1995, and Lindahl, Karran and Wood 1997). The damaged base is recognised 
by a DNA glycosylase, which hydrolyses the glycosylic bond and releases the 
modified base, thereby generating an abasic site (see Figure 1.2.1). Thereafter the 
apurinic or apyrimidinic (AP) site is recognised by an AP endonuclease which 
hydrolyses the phosphodiester bond 5' of the AP site. Recent research has shown that 
subsequent processing can occur by either one of two possible pathways. It has been 
proposed that the majority of AP sites are filled by DNA polymerase p which adds 
one nucleotide to the 3' terminus and excises the 5'-terminal deoxyribose phosphate. 
The two termini are joined together by the a form of DNA ligase HI in a complex 
with XRCC1. Alternatively polymerase P (or polymerases 8 or E, and along with 
several accessory factors) can add several nucleotide residues, displacing the parental 
strand in the process. Subsequently the 'overhang' is removed by the structure-specific 
nuclease DNase IV/FEN1, and repair is completed by DNA ligase I.
21 
CHAPTER ONE: INTRODUCTION
Figure 1.2.1: Schematic representation of possible BER strategies
A model for base excision repair, adapted from Lindahl, Karran and Wood 
1997. The sugar-phosphate backbone of DNA is depicted by lines, while bases are 
represented by circles. Open circles indicate bases present prior to repair, and solid 















































































































































































































































































































1.2.3 Nucleotide excision repair
Nucleotide excision repair (NER) is the most flexible of the repair pathways as 
it can act on a wide variety of lesions. DNA damage is recognised by local distortion 
of the normal helical structure of DNA, and as such any alteration that causes 
distortion can potentially be repaired by this mechanism. Despite this broad 
specificity, the main function of NER is to remove photoproducts arising from 
exposure of cells to UV radiation (reviewed by Lindahl, Karran and Wood 1997).
Helix-altering lesions are recognised by a complex of XPA and RPA proteins. 
Thereafter the transcription factor TFHH is recruited. The helicase activity of TFIIH 
allows the region around the damage to be unwound ('opened up') in an ATP- 
dependent manner, whereupon the structure-specific nucleases ERCC1-XPF and XPG 
make dual incisions on the damaged strand. An oligonucleotide 24-32 residues long 
containing the damaged nucleotide is released, and repair synthesis occurs to fill the 
resulting gap. Finally the repair patch is ligated to the pre-existing strand by a DNA 
ligase (possibly DNA ligase I) (Figure 1.2.2).
The products of up to 30 genes could be involved in the pathway in mammalian 
cells (reviewed in Lehmann 1995), but a number of these do not seem to be required 
for the basic repair reaction. The precise role of each protein remains to be delineated, 
but some certainly act to refine the function of the basic NER machinery (Friedberg, 
Walker and Seide 1995, and references therein). The organisation of DNA into 
chromatin has been shown to impair NER efficiency, and it is probable that NER is 
linked to nucleosome rearrangement. It is known that the efficiency of NER varies 
across the genome. Repetitive DNA is repaired more slowly than the rest of the 
genome, and repair synthesis appears to localise preferentially to sites of DNA 
replication and transcription. Comparison of expressed genes to bulk genomic DNA 
revealed that actively transcribed sequences are repaired preferentially (transcription- 
dependent repair). Further examination showed that the coding strand of RNA 
polymerase H-transcribed genes was also repaired preferentially to the non-transcribed 
strand (transcription-coupled repair). The mechanism of strand-specific repair remains 
to be understood, but most probably is brought about through the involvement of 
TFIIH in both NER and RNA polymerase It-dependent transcription.
1.2.4 Mismatch repair
Although DNA polymerases possess a proof-reading activity, mispairing of 
bases during DNA replication (replication errors) still remains the main source of 
alterations arising from normal DNA metabolism. Repair of such mismatches in
23 
CHAPTER ONE: INTRODUCTION
Figure 1.2.2: Schematic representation of the basic NER reaction in mammalian 
cells
A model for nucleotide excision repair, adapted from Lindahl, Karran and Wood 
1997. The sugar-phosphate backbone of DNA is depicted by lines, while bases are 
represented by open circles. Open circles indicate bases present prior to repair, and 
solid circles bases introduced by the repair process. Proteins are shown as shaded 
objects. See text for details.
helix distorting defect
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Figure 1.23: Schematic representation of mismatch repair in human cells
A model for mismatch repair, adapted from Undahl, Karran and Wood 1997. 
The sugar-phosphate backbone of DNA is depicted by lines, while bases are 
represented by circles. Open circles indicate bases present prior to repair, and solid 
circles bases introduced by the repair process. Proteins are shown as shaded objects. 
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human cells is achieved via a mechanism which closely parallels that present in E. 
coli (reviewed in Lindahl 1994). Recognition of mismatches is carried out by 
heterodimers of three homologues of the E. coli MutS protein. The protein hMSH2 
can complex with either hMSH6(GTBP) or hMSH3 to form hMutScc and hMutSp 
respectively. hMutScc preferentially recognises single base mispairs, single base loops 
and two base loops in repeated sequences, while hMutSp favours binding to larger 
loops (three or four bases). The bound protein-DNA complexes then recruit hMutLcc 
(secondary recognition). hMutLoc is also a heterodimer, composed of two homologues 
of the E. coli MutL protein (hMLHl and hPMS2), and this complex acts as an adapter 
molecule to initiate repair. The details of this process remain unclear, but it involves 
excision of a long patch of DNA from the mismatched strand, resynthesis of the 
oligonucleotide and finally ligation (Figure 1.2.3).
1.2.5 DNA strand break repair
Double-strand breaks (DSBs) can be created by ionising radiation or during 
recombination reactions, and are lethal to eukaryotic cells. It has been calculated that a 
single double-strand break within its genome is sufficient to kill a yeast cell 
(Frankenberg et al. 1981). In order to repair DSBs, eukaryotic cells employ two 
mechanisms. Lower eukaryotes, including yeasts, preferentially repair broken ends by 
homologous recombination, whereas higher eukaryotes predominantly use processes 
that do not rely on homology (illegitimate/non-homologous end joining).
1.2.5.1 Homologous recombination
Homologous recombination in Saccharomyces cerevisiae is mediated by genes 
in the RAD52 epistasis group (RAD50, RAD51, RAD52, RAD53, RAD54) (Friedberg, 
Walker and Siede 1995). Evidence has accumulated for the functional conservation of 
the RAD52 pathway in mammals (Essers et al. 1997 and references therein). It is 
conceivable that one of the proposed models of DSB repair in E. coli will be 
applicable to mammalian cells. Single-stranded DNA from the damaged chromosome 
invades a homologous DNA duplex. Following initiation of strand exchange, DNA is 
synthesised from the damaged ends using the intact strands as templates. Thereupon 
the two Holliday junctions which have been formed are resolved by cleavage to 
separate the two duplexes. Depending on the orientation of the cleavage events, the 
resulting DNA molecules may or may not exchange flanking markers (crossing over).
1.2.5.2 Non-homologous end joining (NHEJ)
In addition to homologous recombination, DSBs can also be repaired by a 
second independent pathway, termed non-homologous end joining (NHEJ). Although
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it plays an auxiliary role in wild-type yeast cells, NHEJ is the predominant DSB repair 
mechanism in mammalian cells. Study of ionising radiation-sensitive cell lines has 
revealed that the repair of DSBs employs a number of proteins also involved in V(D)J 
recombination. V(D)J recombination is a site-specific recombination event which 
occurs in developing B lymphocytes. It is a programmed DNA rearrangement to 
generate a diverse repertoire of immunoglobulin genes from germline gene segments, 
and brings together variable (V), diversity (D) and joining (J) subexonic gene 
segments in various combinations. A similar mechanism is also believed to generate 
diversity in T-cell receptor (TCR) genes in T lymphocytes. The action of DNA 
dependent protein kinase (DNA-PK) is now known to be central to both V(D)J 
recombination and NHEJ (reviewed in Bogue and Roth 1996).
DNA-PK is a nuclear protein-serine/threonine kinase that is activated by 
binding to DNA ends (Jackson and Jeggo 1995 and references therein). It is a 
multiprotein complex comprising of a large catalytic subunit (DNA-PKcs) and a DNA 
binding subunit (Ku). Ku is itself a heterodimer of VOkDa and SOkDa proteins (Ku70 
and Ku80 respectively). Ku binds to DNA ends and recruits the catalytic subunit, 
which subsequently becomes enzymatically active.
The precise chain of molecular events following DNA-PK binding to DNA 
remains unclear. A number of possible mechanisms have been proposed for DNA-PK 
action (summarised in Weaver 1995). Binding of the protein to DNA ends apparently 
acts to protect termini from nucleolytic degradation and promotes end joining. It is 
possible that DNA-PK may play an active role in the recruitment of enzymes to the 
site of damage, phosphorylating, and thereby activating, repair proteins. The kinase 
activity may also inhibit the transcriptional machinery and control the cell cycle, 
cellular processes that might otherwise interfere with repair. Alternatively the protein 
may provide a structural framework to juxtapose DNA ends and hold them together 
while interacting with other components of the repair machinery. It was recently 
reported that Ku stimulates ligation by DNA ligases I, ffl, and IV, and that Ku acts as a 
'bridging' or 'alignment factor' between DNA molecules, stabilising intermolecular 
associations (Ramsden and Gellert 1998). Exactly which DNA ligase is involved will 
be discussed further in section 1.4.1.7, but existing evidence points towards DNA 
ligase IV.
1.3 Human diseases arising from genomic instability
Deficiency in the repair of DNA damage has been implicated in a disparate 
group of rare human diseases; ataxia telangiectasia, Bloom's syndrome, Cockayne's 
syndrome, Fanconi's anaemia, trichothiodystrophy, and xeroderma pigmentosum. All 
of these diseases are inherited in an autosomal recessive manner, and are characterised
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by hypersensitivity to one or more genotoxic agents, increased mutation rates and 
(with exception of CS and TTD) a predisposition to cancer (reviewed in Friedberg, 
Walker and Siede 1995). Although it is now known that not all of the genes 
implicated are directly involved in the repair of DNA damage, study of this group of 
diseases has been important for identifying those processes responsible for the 
maintenance of genomic stability.
1.3.1 Xeroderma pigmentosum, Cockayne's syndrome and trichothiodystrophy
Xeroderma pigmentosum (XP), Cockayne's syndrome (CS) and 
trichothiodystrophy (TTD) are three hereditary diseases with strikingly different 
clinical features. However, it was noted that both CS and TTD could be associated 
with XP. Investigation into the molecular basis of each disease has revealed the 
surprising finding that patients of all three diseases have defective NER. Information 
in this section comes from reviews by Lehmann 1995, Tanaka and Wood 1994 and 
Friedberg, Walker and Siede 1995 with references therein.
1.3.1.1 Xeroderma pigmentosum
XP patients display extreme sensitivity to sunlight. The skin freckles very easily, 
and areas of the skin exposed to solar radiation show an extremely high incidence of 
skin cancers (2000-fold increased compared to normal), with the average age of 
cancer diagnosis being 8 years. Other areas of the body exposed to the sun, such as the 
eyes and tongue, are also prone to neoplasia, and the rate of internal cancers is also 
increased.
The XP phenotype is caused by a defect in the NER mechanism, first shown by 
a substantially reduced rate of DNA synthesis outside S-phase (unscheduled DNA 
synthesis) in response to irradiation with ultraviolet light. As a consequence, cells 
from patients are unable to repair DNA lesions caused by UV radiation, and hence are 
prone to formation of chromosomal abnormalities and neoplastic transformation. 
Cells are also sensitive to killing by a wide range of other DNA damaging agents, but 
levels of sensitivity vary between patients. Complementation analysis by fusion of 
cultured cells confirmed that this variability was the result of heterogeneity at the 
molecular level. Seven complementation groups were identified, designated A to G 
(plus a "variant" form - typical clinical symptoms, but apparently with normal NER 
activity). Genes corresponding to most of these complementation groups have been 
cloned. However, some of these genes have proven to be genes previously identified 
from studies of rodent cell lines. Excision repair genes were cloned on the basis of 
their ability to complement the repair deficiency of 11 groups of UV-sensitive mutant
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cell lines, and hence the genes were designated excision repair cross-complementing 
(ERCC).
Table 1.3.1 summarises the current knowledge of the relationship between XP 
and ERCC genes, and the proposed function of each gene. Evidence suggests that in 
XP groups A to G the incision step of NER is defective, while XP variant cells are 
unable to tolerate UV damage during DNA replication but that the basic NER reaction 
functions normally.
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XP patients in the complementation groups B, D and G have occasionally 
presented with the additional clinical features of CS. CS is a multi-system disorder 
and patients show arrested growth and development, characteristically having sunken 
eyes and disproportionately long limbs. Other symptoms include sun-sensitivity and 
deafness, optic atrophy, and severe mental retardation. The average age of death is 12 
years.
Cultured CS cells are extremely sensitive to killing by UV irradiation, but 
measurements of NER activity proved to be normal. However, it has been shown that 
CS cells are deficient in transcription-dependent NER. Wild-type cells exhibit 
preferential repair of transcribed regions of the genome after UV-irradiation, but in 
CS cells both transcribed and non-transcribed regions are repaired at the same rate. 
Some CS cells are also defective in the transcription-coupled repair of the coding 
strand of transcribed genes. The result is that RNA synthesis is inhibited by UV 
irradiation for longer than normal.
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Using cell fusion techniques two CS genetic complementation groups were 
identified (designated CSA and CSB), although three additional groups are defined by 
overlap with XP (referred to as XP-B/CS, XP-D/CS, and XP-G/CS). The 
corresponding genes have been cloned, and both CSA and CSB proteins are thought 
to function as transcription factors which allow the coupling of repair to transcription 
by interaction with TH1H. In those cases where CS overlaps with XP, the primary 
mutations are within those XP genes that make up subunits of TFIIH and the XPG 
endonuclease.
1.3.1.3 Trichothiodystrophy
Trichothiodystrophy, or TTD, is the term coined to describe a syndrome of 
brittle sulphur-deficient hair, fish-like scales on the skin (ichthyosis), mental and 
physical retardation. However, photosensitivity is present in about half of TTD cases, 
and cells from these patients were found to be NER-deficient. In these cases it was 
found that the underlying molecular cause was mutation of either the XPB or XPD 
genes.
In order to explain how mutations in XPB and XPD can cause three different 
diseases a "transcription syndrome" hypothesis has been proposed. As components of 
the TFHH transcription factor, these genes play roles in both NER and RNA 
polymerase H-dependent transcription. Certain mutations inactivate just the NER 
function of the protein, resulting in typical XP. Other mutations inactivate the NER 
function and/or alter the efficiency of transcription, which specifically affects certain 
proteins whose synthesis is dependent on maximal transcription. Finally another class 
of mutations can prevent the coupling of transcription to repair.
1.3.2 Fanconi anaemia
Fanconi anaemia (FA) is a pleiotropic disease whose main characteristic is bone 
marrow failure (reviewed by Digweed and Sperling 1996). The clinical picture is, 
however, highly variable. Patients may be affected by any number of congenital 
deformities such as skeletal defects, microcephaly, and ear, heart, kidney, intestinal 
and hand abnormalities, but 25% of patients display no symptoms other than 
pancytopenia (depression of all types of blood cells). Bone marrow failure usually 
begins in the first few years of life, and can be accompanied by stunted growth, and 
learning disabilities. There is a marked predisposition to develop acute myeloid 
leukaemia and other solid tumours, which is apparently linked to an elevated level of 
spontaneous chromosomal breakage.
Levels of chromosome aberrations increase after treatment of cells with 
mitomycin. Whilst some evidence supports the hypothesis that FA is caused by
30 
CHAPTER ONE: INTRODUCTION
defective repair of DNA cross-links, other molecular changes have been observed in 
FA cells, and it has been proposed that the primary defect is in cell cycle control. 
Failure to arrest DNA replication following cross-link formation will ultimately result 
in the generation of chromatid breaks and chromosome damage. Cell fusion 
experiments indicated that there are 8 complementation groups, designated A to H, 
and genes corresponding to 3 of these have been cloned (FAA, FAC, and FAE) (On- 
line Mendelian Inheritance in Man 1997). However, the molecular mechanism by 
which the disease is manifested has remained elusive.
1.3.3 Ataxia telangiectasia
Interest in ataxia telangiectasia (AT) stems from the fact that the gene 
responsible may also be the single largest cause of breast cancer. AT affects up to one 
in 40,000 people, and is pleiotropic in nature (reviewed in Friedberg, Walker and 
Siede 1995). The most striking characteristic is cerebellar ataxia, resulting in a 
staggering gait, lack of co-ordination and progressive mental retardation, but 
telangiectasia (dilation of the small blood vessels in the eye and skin) also occurs. 
Immune dysfunction means that patients are exceptionally susceptible to infections, 
and this may also contribute to the high incidence of cancer observed. In most AT 
individuals neoplasia occurs in the lymphoreticular system before the age of 20, and it 
has been shown that this predisposition stems from problems cells experience in 
response to DNA damage.
The first indication of a DNA repair defect came from observation of the severe, 
sometimes fatal, response of AT patients to radiotherapy. Subsequently it was 
demonstrated that AT cells are sensitive to killing by ionising radiation, but cells 
exhibit a high number of chromosomal breaks even prior to irradiation. A number of 
cell cycle anomalies have been recorded in AT cell lines, including failure to arrest at 
the Gl-S or G2-M checkpoints after irradiation, and the lack of normal inhibition of 
DNA synthesis following irradiation accounts for the extreme radiosensitivity.
Five AT complementation groups were defined from cell fusion studies, 
designated AB, C, D, E and Vi. However, it was subsequently found that all AT 
patients have mutations in single gene, named ATM. Positional cloning of ATM was 
achieved in 1995, and analysis of the coding sequence immediately gave a clue to the 
function of the protein. ATM is a member of the PI3-kinase-related protein kinase 
superfamily (along with DNA-PK) and has protein kinase activity. It is believed that 
ATM acts as a damage sensor and checkpoint protein at the head of the p53 signal 
transduction pathway. In response to DNA damage, ATM phosphorylates cellular 





Bloom's syndrome (BS) was first recognised in 1954 by paediatrician Dr David 
Bloom following study of three patients (Bloom 1954.), and was described as 
"congenital telangiectatic erythema resembling lupus erythematosus in dwarfs" 
(Bloom 1966). Along with the initial report, Dr Bloom also initiated a registry of BS 
patients to collect clinical data about the disease. Since then approximately 170 cases 
have been reported world-wide, and the disease has been determined to have an 
autosomal recessive mode of inheritance (German 1969.) Although very rare in most 
populations (cases tending to arise from consanguineous unions), the incidence of the 
disease is higher in Japan and among the Ashkenazim, where 1 in 100 are 
heterozygous carriers.
1.3.4.1 The Bloom's syndrome phenotype
The clinical features of BS are reviewed in Passarge 1983, and German 1993. 
See also On-line Mendelian Inheritance in Man. All cases are similar in clinical 
appearance, and show complete penetrance and expressivity (German et al. 1994). 
The main characteristics are as follows:
i) Telangiectatic erythema. Dilation of the capillaries of the face produces a 
characteristic butterfly rash, visible from infancy.
ii) Skin photosensitivity. Exposure to sunlight results in hyperpigmentation and 
worsening of areas of erythema.
iii) Growth retardation. Growth is stunted from birth, meaning that adults are 
dwarfed, though with normal body proportions.
iv) Moderate to severe immunodeficiency. This leads to repeated bacterial 
infections during infancy and early childhood. Although the situation improves with 
age, patients tend go on to develop severe chronic lung disease as a result. Studies 
revealed the basis of the immunodeficiency to be an aberrant immunoglobulin serum 
profile, with low IgM concentrations, and mildly decreased IgG and IgA levels. The 
IgM deficiency apparently arises from dysfunction during the maturation of B cells, 
since although the percentage of cells bearing surface IgM is not reduced, numbers of 
IgM secreting cells are. Further explanation may come from the observation of 
preferential damage to IgM production by UVB irradiation. Peripheral blood 
mononuclear cells (B cells, T cells and monocytes) recover their proliferative 
response to pokeweed mitogen stimulation more slowly than normal after UVB 
irradiation (Ozawa et al. 1993). Patients also showed reduced reactivity to skin test 
antigens in vivo, and a low proliferative response by lymphocytes to mitogen 
stimulation in vitro. Reduced numbers of IgG bearing lymphocytes accounts for the
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lowered levels of IgG. In addition, natural killer cell activity is diminished, as is
helper T cell function (Steihm 1993).
v) Minor clinical conditions are common. Mild mental retardation, and
hypogonadism may be present (male BS patients all being sterile), and there is a
higher than normal incidence of diabetes among older patients.
vi) Elevated risk of cancer. BS patients show a predisposition to develop almost any
type of cancer at an earlier age than the rest of the population. On average, leukaemia
becomes manifest at 22 years, while solid tumours are detected at age 35 in surviving
patients, compared to the norms of 55 and 65 respectively. Despite modern medical
techniques, no BS patient has survived beyond 48 years of age (German 1993).
1.3.4.2 Molecular characteristics of Bloom's syndrome
At a cellular level, BS cells show a striking level of genomic instability. 
Between 5 and 15% of all metaphases looked at have more than one cytogenetic 
abnormality, and the numbers of micronuclei formed in vivo are increased. It is 
believed that the alterations observed arise as a result of an increase in the rate of 
exchanges between DNA strands in BS cells (somatic recombination). This can occur 
between homologous chromosomes at homologous sites to produce symmetrical 
quadriradials or telomeric associations. Other chromosomal defects, such as 
chromosomal translocations, are also increased. Alternatively reciprocal interchanges 
may occur between chromatids of one chromosome after DNA replication (exchange 
of two homologous DNA helices between sister chromatids during mitosis). These 
type of exchanges are known as sister chromatid exchanges (SCEs). The frequency of 
SCE formation is raised to a level 10-fold higher than normal (Chaganti, Schonberg, 
and German 1974).
A number of groups were able to demonstrate increased mutation and somatic 
recombination rates. Spontaneous 6-thioguanine resistance was shown to be raised 4- 
to 15-fold in fibroblasts (Warren et al 1981) and 8-fold in peripheral blood 
lymphocytes (Vijayalaxmi et al. 1983). Passage of Herpes simples virus-1 indicated 
that viral recombination was abnormal in Bloom's syndrome cells, and Langlois et al. 
found a 50- to 100-fold increase in NM blood group variant erythrocytes (Langlois et 
al 1989).
BS cells display sensitivity to some DNA damaging agents (Table 1.3.3). This 
observation, combined with the predisposition of patients to cancer, led to BS being 
designated a DNA repair deficiency. Exposure of cells to UV irradiation was 
accompanied by altered unscheduled DNA synthesis (UDS) and increased chain 
breakage, taken to indicate an abnormality in a postincision step of DNA excision 
repair, such as ligation (Willis et al 1987). Study of the in vivo joining ability, by
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transfection with linearized replicating shuttle vector plasmid, revealed that DNA end 
joining was reduced and error prone in BS cells (Riinger and Kraemer 1989). It was 
subsequently proposed that these defective ligation processes could be the cause of 
not only elevated mutation, and chromosome breakage levels, but also the impaired 
immune function found in Bloom's syndrome patients, since normal immunoglobulin 
gene processing involves the joining of DNA segments (Riinger and Kraemer 1989). 
A defect in ligation was also suggested by observation of a retarded rate of replication 
fork progression during semi-conservative DNA synthesis (Hand and German 1975). 
Furthermore, pulse labelling of replicating DNA with [ 3H]tritium revealed a novel 
class of 20kb intermediates, not seen in normal cells, to be present in BS cells (Lonn 
et al. 1990).
1.3.4.3 Genetic basis of Bloom's syndrome
Consistent with this data was the finding that the activity of DNA ligase I is 
reduced in BS cells. Immunoblotting showed enzyme levels to be normal (Chan and 
Becker 1988), but when purified, the enzyme proved to be unusually heat labile, or to 
form anomalous dimers (Willis and Lindahl 1987). However, when the human gene 
encoding DNA ligase I (L/G7) was cloned (Barnes et al. 1990), comparison of cDNA 
sequences revealed DNA ligase I from BS cells to contain no amino acid alterations. 
LIG1 cDNA from BS cells was able to rescue S. cerevisiae cdc9 mutants, and 
Northern blot analysis showed LIG1 message levels to be normal (Petrini, Huwiler 
and Weaver 1991). It was therefore concluded that Bloom's syndrome does not arise 
primarily from an alteration in the LIG1 gene.
Numerous investigations have revealed altered structure and/or activity levels of 
enzymes involved in DNA metabolism in BS cells. Nevertheless, all of these were 
ruled out as the primary BS defect because of their chromosomal location 
(summarised in Table 1.3.2). BS is represented by a single complementation group, 
cell fusion of BS cell lines from different ethnic backgrounds all failing to 
complement each other (Weksberg et al. 1988). McDaniel and Schultz used microcell- 
mediated chromosome transfer of human chromosomes to complement the SCE 
phenotype of BS cells, and thereby map the Bloom's syndrome locus (BLM) to 
chromosome 15ql4-qter (McDaniel and Schultz 1992).
The location was further refined by linkage analysis of polymorphic loci in the 
progeny of consanguineous marriages (homozygosity mapping). 25 out of 26 BS 
patients were homozygous for a tetranucleotide repeat in intron V of the proto- 
oncogene FES. FES had previously been mapped to 15q26.1 by fluorescence in situ 
hybridisation (FISH), and hence it was possible to also assign BLM to 15q26.1



































Summary of the chromosomal locations of the human genes whose products show 
alterations in BS cells. Gene symbol abbreviations: LIG1, DNA ligase I. LIG3, DNA 
ligase ffl. UNG, uracil DNA-glycosylase. TOPI, topoisomerase I. TOP2A, 
topoisomerase HA. TOP2B, topoisomerase LIB. MGMT, O6-methylguanine 
methyltransferase. AAG/MPG, 3-methyladenine DNA glycosylase. TYMS, thymidylate 
synthetase. SOD1, superoxide dismutase I. SOD2, superoxide dismutase E. SODS, 
superoxide dismutase ffl Chromosomal locations taken from On-line Mendelian 
Inheritance in Man 1997.__________________________________
(German et al. 1994). As shown in Table 1.3.2, none of the other genes map to this 
region.
Subsequently, mapping of BLM exploited a phenomenon that been observed in 
some BS lymphoblastoid cell lines (LCLs) (Ellis et al. 1995a). High SCE frequencies 
are unique to BS, and are routinely used to confirm clinical diagnoses. However, it 
had been noted that certain cell lines established from lymphoid cells of BS patients 
with non-consanguineous parents exhibited low SCE rates, representing a minor 
population of cells in vivo (mosaicism). It was hypothesised that this was caused by 
somatic intragenic recombination between different BLM alleles generating a 
functionally normal allele, thereby correcting the SCE phenotype. One consequence of 
this event would be that loci distal to BLM would become homozygous in low SCE
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cells while proximal loci would remain heterozygous. Analysis of 12 polymorphic 
markers around FES in LCLs from 11 patients displaying mosaicism narrowed the 
location of BLM to 250kb proximal of FES (Ellis el al. 1995b). There was only one 
non-repetitive single copy transcribed sequence within the region, and the identity of 
this novel gene as BLM was confirmed by the detection of mutations in a number of 
BS patients.
The BLM protein has a predicted molecular mass of 159kDa, and showed 
homology to the RecQ subfamily of DExH box-containing helicases. It has been 
suggested the BS phenotype arises from mutations which cause the loss of helicase 
activity, and that consequently BS cells have difficulty resolving specific DNA 
structures generated during replication (Ellis et al 1995b). It is hypothesised that an 
error-prone recombination process subsequently becomes activated, leading to 
excessive crossing over observed as SCEs and quadriradials. Theoretically an SCE 
has no consequence, but imprecise or unequal exchanges could lead to base 
substitutions, deletions, duplication or even breaks. This would account for the 
spontaneous mutability of BS cells, while somatic crossing over will also cause loss 
of heterozygosity, thereby promoting tumour formation (German 1993).
1.3.5 '46BR' patient
1.3.5.1 The '46BR' phenotype
The so called '46BR' patient was a young female with a number of clinical 
symptoms suggestive of Bloom's syndrome (Webster et al. 1992). At birth the patient 
was slightly underweight and anaemic. Normal developmental milestones were 
delayed, and growth was retarded, leading to an "elf-like" appearance. Although there 
was no mental retardation, secondary sexual characteristics did not develop. Repeated 
ear and chest infections occurred, leading to poor hearing and lung function. Exposure 
of the skin to sunlight caused hypersensitivity, and, at age 17, patches of telangiectasia 
appeared. Shortly after this, a liver lymphoma was diagnosed, but the patient died, 
aged 19, from pneumonia.
Thyroid, pituitary and adrenal function were normal, but immunodeficiency was 
noted. IgM levels were normal, but there was moderate IgG depression, and a 
deficiency of IgA and isohaemagglutinins. Erythrocyte, lymphocyte and neutrophil 
counts were normal, but T and B lymphocyte cells showed a poor proliferative 
response to mitogens in vitro. There were abnormally large numbers of macrocytes in 
the peripheral blood, but no anaemia. Bone marrow culture at age 17 revealed 
depressed red cell colony formation, at which point the patient was found to have
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become lymphopenic, with no lymphocyte proliferative response in vitro to 
phytohaemagglutinin or Ca2+ ionophore stimulation.
1.3.5.2 Cellular characteristics
Repeated attempts to establish a lymphoblastoid cell line by immortalisation 
with Epstein-Barr virus were unsuccessful, but skin fibroblasts, designated 46BR, 
were established in culture. These fibroblasts proved to be sensitive to a wide range of 
DNA damaging agents (Table 1.3.3), but particularly to monofunctional methylating 
agents. In contrast to BS, where numbers of SCEs are characteristically 10-fold 
higher, 46BR cells exhibited baseline levels only marginally higher than normal 
(Henderson et al. 1985). A single cell gel electrophoresis ('comet') assay has also been 
used on 46BR cells to analyse DNA breakage following treatment with DNA 
damaging agents. As expected from cell survival data, the number of breaks in 46BR 
cells was much higher than wild-type after UV irradiation, and these breaks persisted 
for a long time. Unexpectedly however, treatment with y radiation and agents to 
induce superoxide anion formation revealed no differences from wild-type cells 
(Nocentini 1995).
Because DNA lesions generated by ionising radiation, UV light, mitomycin C 
and alkylating agents are chemically unrelated, and corrected by different modes of 
excision repair , it was concluded that the underlying defect in 46BR could not lie 
within any one particular repair pathway. Rather, the deficiency must be at a step 
common to all pathways, such as polymerisation or ligation (Teo and Arlett 1982). 
More detailed study of replicative DNA synthesis, UDS, and daughter strand 
postreplicative repair following UV irradiation revealed no abnormality. Similarly the 
removal of 3-methyladenine after DMS treatment was normal. However, strand 
breaks persisted, as they did after UV irradiation (Squires and Johnson 1983). Given 
the fact that DNA polymerisation, as measured by UDS, was apparently normal, it 
was therefore concluded that the raised level of DNA strand breaks was the 
consequence of an alteration in the rate of ligation. Using the rate of gap sealing as a 
measure of ligase activity, it was thus calculated that normal cells ligate induced gaps 
3 times faster than 46BR.
Further support for this conclusion came from the effect of 3-aminobenzamide 
(3AB) on 46BR cells. 3AB is a specific inhibitor of poly(ADP-ribose) polymerase 
(PARP/PADPRP)1 . PARP is an abundant zinc-finger DNA binding nuclear protein 
which uses NAD+ as a precursor to synthesise chains of poly(ADP-ribose), and 
transfers them to a number of proteins, as well as to the enzyme itself. Activity is













































The response of cell strains from BS patients and the 46BR patient to DNA damaging 
agents, n indicates a wild-type response; +, sensitivity to killing by that agent; ND, not 
determined. Abbreviations: UV, ultraviolet radiation; y> gamma radiation; 4NQO, 
nitroquinoline oxide; DMS, dimethyl sulphate; MMS, methyl methanesulphonate; 
EMS, ethyl methanesulphonate; MNNG, A^methyl-Af-nitro-./V-nitrosoguanidine; 
MNU, Af-methyl-Af-nitrosourea; ENU, Af-ethyl-W-nitrosourea; AAF, 
acetylaminofluorine; Adapted from Teo et al. 1983 .___________________
dependent on DNA strand breaks, and although a number of nuclear functions 
have been ascribed to PARP, it appears to be a molecular sensor of DNA strand breaks 
(Masson et al. 1998 and references therein). In normal cells inhibition of PARP by 
SAB results in the accumulation of strand breaks, and increased cell death, following 
DNA damage. However, 46BR cells proved to be hypersensitive to the lethal effects 
of 3AB, even in the absence of any other agent (Lehmann et al. 1988).
Defective ligation in 46BR was demonstrated more directly by measuring the 
accumulation of replication intermediates. Okazaki fragments in mammalian cells are 
approximately 200nt in length, and exist only transiently before being incorporated 
into larger 10kb molecules, which are themselves subsequently united into high 
molecular weight DNA. Pulse labelling revealed that low molecular mass replication 
intermediates persist in 46BR cells, thereby indicating abnormally slow joining of 
Okazaki fragments (Lehmann et al 1988, Lonn et al. 1989, Prigent et al 1994,
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Mackenney, Bames and Lindahl 1997). Demonstration that the 46BR phenotype is a 
direct consequence of mutation of DNA ligase I came with the cloning of LIG1.
Initial suggestions as to the cause of the immunodeficiency of the 46BR patient 
centred upon the joining of gene segments during V(D)J recombination in developing 
lymphoid cells. Using 46BR fibroblasts transfected with RAG1 and RAG2 expression 
plasmids, the efficiency of V(D)J recombination on plasmid substrates was assayed 
Sequencing of the coding junctions and signal joints formed did not reveal changes in 
the fidelity or efficiency of V(D)J recombination in 46BR cells (Hsieh, Arlett and 
Lieber 1993, Petrini et al. 1994). It was thus concluded that the immunodeficiency 
observed was not simply due to failure of immunoglobulin and TCR gene 
rearrangement.
1.4 DNA ligases
DNA ligases catalyse the formation of phosphodiester bonds, sealing breaks in 
double-stranded DNA molecules. As such, DNA ligases are required for a variety of 
cellular processes, including DNA replication, excision repair and recombination. 
DNA ligase activity in eukaryotes was first described in rabbit tissues by Lindahl and 
Edelman in 1968 (Lindahl and Edelman 1968), and soon after it was shown that there 
are [at least] 2 different ligases in mammals (Soderhall and Lindahl 1973). There are 
now known to be at least four biochemically distinct DNA ligases present in 
mammalian cells, of which three have been cloned (Table 1.4.1) (reviewed by Lindahl 
and Barnes 1992, Lindahl et al. 1993, Tomkinson and Levin 1997). Figure 1.4.1 
depicts an alignment of the DNA ligases I, the two splice-variant forms of DNA ligase 










































































































































































































Figure 1.4.1: Schematic representation of DNA ligases I, IIIo, Hip, and IV
Alignment of the three cloned human DNA ligases based on conserved motifs. 
Adapted from Wei et al 1995 and Tomkinson and Levin 1997. The active site and 
conserved peptide motifs are represented by solid bars. Shaded box, N-terminal 
regulatory domain of DNA ligase I. Hatched box, alternatively spliced regions of 
DNA ligase HI. Predicted molecular masses are indicated. It was noted from 
alignment of the predicted amino acid sequences of the three DNA ligases that the 


















































































































1.4.1.1 Cloning and gene structure
Using oligonucleotides deduced from partial amino acid sequences of purified 
bovine DNA ligase I, and testing for the ability to complement a temperature sensitive 
DNA ligase mutant of Saccharomyces cerevisiae (cdc9), Barnes et al. were able to 
clone the LIG1 cDNA from a human cDNA library (Barnes et al. 1990). The cDNA 
was found to encode a 919aa (102kDa)u protein with 37% identity to the yeast Cdc9 
protein. Northern blot analysis revealed LIG1 to produce a single 3.2kb transcript, 
while hybridisation to a panel of rodent-human somatic cell hybrids retaining subsets 
of human chromosomes localised the gene to chromosome 19. Subsequently, 
Southern analysis of rodent-human somatic cell hybrids and FISH mapped LIG1 to 
19ql3.2-13.3 (Bames et al 1992a).
Analysis of gene structure revealed the human gene to consist of 28 exons (54 to 
173 bp in length) spanning 53kb (Noguiez et al. 1992). The first exon (-1) is 
untranslated, and utilises a GC dinucleotide instead of the usual GT at the donor 
splice site. The 400bp upstream of the translation initiation methionine was 
sequenced, and showed the promoter to have a high GC content, and no Goldberg- 
Hogness (TATA) or CCAAT boxes. Primer extension indicated that transcription 
initiation occurs at multiple sites, all of which is typical of a putative 'housekeeping' 
gene. In addition, four inverted SP1 binding sites were identified, along with a motif 
recognised by p53 protein-containing complexes, and a possible ATF binding site 
(Noguiez et al. 1992).
1.4.1.2 Expression pattern
DNA ligase I has been detected in all cell types looked at, even terminally 
differentiated neurones (Teraoka and Tsukada 1982), but a correlation has been 
demonstrated between LIG1 expression and the rate of cell proliferation. DNA ligase I 
is the major polynucleotide joining activity in proliferating cells, contributing 85% of 
the total activity in calf thymus (Tomkinson et al. 1990). There is an increase in DNA 
ligase I activity upon stimulation of quiescent cells (Elder and Rossignol 1990, 
Soderhall 1976). The increase is 100-fold in human lymphocytes stimulated by 
phytohaemagglutinin (with slight delay with respect to the onset of DNA synthesis), 
with levels remaining high thereafter. Correspondingly, when the human
" Estimates from western blotting give the size of the protein as around 125kDa. This difference is 
though to reflect reduced mobility arising from proline and phosphoserine-rich regions in the N- 
terminus of the protein (see Lindahl and Barnes 1992)
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premyelocytic leukaemia cell line HL-60 is induced to differentiate, L1G1 mRNA 
levels drop (Montecucco et al. 1992).
DNA ligase I activity is induced 15-fold in the regenerating rat liver (Chan and 
Becker 1985), and mRNA levels are considerably higher in proliferating cells, but 
drop when cells reach confluence or are starved (Montecucco et al. 1992). Following 
starvation, the basal mRNA level increases 12 hours after serum stimulation, reaching 
a plateau 6hr later (maximum expression coinciding with the first S-phase after serum 
stimulation), and remaining high even when S phase is completed. Because LIG1 
mRNA is stable regardless of state of cell, dropping only V5 after 3hrs incubation with 
transcription inhibitor actinomycin D, it was concluded that the elevation of mRNA 
levels are due to raised transcription rather than increased stability.
The expression pattern of LIG1 is similar to that of DNA polymerase oc. The 
pola gene, and other genes involved in DNA replication (e.g. tk, TOPIIA, PCNA) all 
encompass SP1, and ATF sites within their promoters, and lack TATA boxes (but do 
contain CCAAT boxes). Taken together these data suggest a role for DNA ligase I in 
replication. However, constitutive expression of DNA ligase I, even in resting cells, 
resembles the expression pattern of polymerase (3, a DNA polymerase known to 
participate in DNA repair (Montecucco et al. 1992). After UV-C irradiation of 
confluent fibroblasts, DNA ligase I activity and mRNA levels both increase 6-fold 
(Montecucco et al. 1995a). Induction is serum independent, and results in an increase 
in steady state mRNA proportional to the UV dose. However, expression is raised 
only after 24 hours, when UDS is no longer detectable and nucleotide excision repair 
(NER) can no longer be operating. Thus, if DNA ligase I has a role in NER, the basal 
cellular level must be sufficient to accomplish this. Since activation occurs at a lower 
UV dose in XP cells that show UV hypersensitivity (as a result of abnormal NER), it 
was proffered that DNA ligase I induction could be part of a response to damage not 
removed by NER. This proposed DNA repair system would be activated late after UV 
irradiation, as a consequence of unrepaired DNA damage, in a similar manner to the 
SOS response in E. coli. Given that p53 protein has been suggested to play a role as a 
checkpoint protein, inducing growth arrest in cells with DNA damage, it was 
hypothesised that p53 may play a role in the induction of the DNA ligase I gene 
(Montecucco et al. 1995a).
1.4.1.3 Protein localisation
Although it was reported that a substantial amount of DNA ligase I was present 
in the cytoplasmic fraction of preparations from calf thymus (Soderhall and Lindahl 
1975), recent evidence has indicated DNA ligase I to be localised to sites of DNA 
replication in the nucleus. Immunohistochemistry and immunofluorescence showed a
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punctate pattern of staining in the nuclei of S phase cells. When cells entered mitosis, 
breakdown of the nuclear membrane allows DNA ligase I to become distributed 
throughout the cell (Lasko, Tomkinson and Lindahl 1990). This was confirmed by 
other groups. Intranuclear immunofluorescence staining revealed DNA polymerase a 
and DNA ligase I to both localise to the same granular-like structures. At the Gl/S 
boundary these structures are distributed throughout nucleoplasm, whereas at the 
S/G2 boundary they are constrained adjacent to the nuclear envelope. In contrast 
polymerase (3 was distributed throughout nucleoplasm at all times (Li et al. 1993). 
Montecucco et al. found that in early S phase staining for DNA ligase I produced a 
fine, evenly distributed punctate pattern. By mid-S phase, dots became more 
concentrated round the nucleoli and nuclear periphery, while in late S phase 
homogeneous staining was seen. These changes closely paralleled alterations to the 
location of DNA replication (Montecucco et al. 1995b).
More recently, amino acid sequences which function to target the DNA ligase I 
to the nucleus and replication foci have been identified. Fusion of regions of DNA 
ligase I to a marker protein allowed visualisation of subcellular localisation by 
immunostaining. A 13 amino acid peptide (PKRRTARKQLPKR, 119-131 in DNA 
ligase I) was found to be required for targeting of the fusion protein to the nucleus. 
This nuclear localisation signal (NLS) is conserved between human and mouse 
protein, and when deleted, DNA ligase I does not enter the nucleus (Montecucco et al. 
1995b). Deletion of 115 amino acids upstream of the NLS allowed accumulation of 
the protein into the nucleus, but not punctate staining during S phase (Montecucco et 
al. 1995b). Deletion of only residues 2-6 has a similar effect, as does deletion of 1-11 
or 12-20, and fusion of the first 20aa to a fluorescent reporter protein will result in 
targeting to replication foci. Comparison of sequences between proteins involved in 
DNA replication has indicated that the motif responsible for the targeting of proteins 
to replication factories is composed of two boxes. Box 1 (1-11 in the DNA ligase I 
sequence) includes the sequence IxxFF, while Box 2 (12-20 in the DNA ligase I 
sequence) is rich in positively charged residues (Montecucco et al. 1998). Similar 
results were also achieved by Cardoso et al. (Cardoso et al 1997).
1.4.1.4 Enzyme activity
DNA ligase I catalyses the formation of phosphodiester bonds between adjacent 
DNA fragments by the same general mechanism delineated for T4 DNA ligase 
(Lehman 1974) (Figure 1.4.2). The enzyme requires Mg2+, and is activated by the 
cleavage of ATP to generate a covalent DNA ligase-AMP intermediate, with a lysine- 
adenylate phosphoamide bond. AMP is then transferred to the 5' terminus of a DNA 
interruption, forming a transient DNA-AMP complex. In the final step, un-adenylated
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Figure 1.4.2: The reaction mechanism of DNA ligase I
Ligase + ATP « * Ligase-AMP + PPi
Ligase-AMP + Nicked DNA «_ ' Nicked DNA-AMP + Ligase
Ligase 
Nicked DNA-AMP   * Sealed DNA + AMP
A representation of the reaction mechanism of DNA ligase I. Abbreviations: 
ATP, adenosine triphosphate, AMP, adenosine monophosphate. A hyphen (-) indicates 
a covalent link. Adapted from Lehman 1974.
DNA ligase I catalyses nucleophilic attack of the 3' OH group on the activated 5' 
phosphate to generate a phosphodiester bond. The crystal structure of DNA ligase 
from the bacteriophage T7 has been extrapolated to suggest that DNA ligase I also 
consist of two domains with a deep DNA binding cleft between, with an ATP-binding 
pocket present in domain 1 (Subramanya et al. 1996).
DNA ligase I efficiently joins both single and double strand breaks in DNA, 
including blunt ends, but is also active on the synthetic substrates oligo(dT)/poly 
(dA), and oligo(rA)/poly(dT) (Arrand et al 1986, Tomkinson et al 1991a). 
Examination of the efficiency of ligation of DNA nicks with mismatched termini 
indicated that DNA ligase I is severely inhibited by the presence of 3' mismatches, 
leading Husain et al. to conclude that the enzyme is more faithful than the other 
mammalian DNA ligases (Husain et al. 1995).
Recently it was reported that DNA ligase I can also seal 5'-monoribonucleotides 
into DNA, although with only 10% of the efficiency of sealing 
monodeoxyribonucleotides. During lagging strand DNA synthesis, cleavage of the 
RNA primer in Okazaki fragments by RNase HI leaves a single ribonucleotide 
attached to the 5' end of the downstream DNA fragment. This is normally removed by 
DNase IV/FEN-1, but these data indicate that it can alternatively be sealed onto the 
DNA molecule by DNA ligase I (Rumbaugh et al. 1997).
Human DNA ligase I has 84% homology to mouse DNA ligase I, and 
approximately 40% with Schizosaccharomyces pombe cdc!7+ and S. cerevisiae 
CDC9 gene products (Barnes et al 1990). However, identity is greatest within the C- 
terminus, the N-termini being poorly conserved. The ~28kDa amino-terminal region 
is highly susceptible to proteolysis in vitro, and, when removed, the remaining
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~74kDa polypeptide (encoded by exons 8 to 27) is still enzymatically active 
(Tomkinson et al 1990). The C-terminal 'catalytic domain' is also sufficient to 
complement the cdc9 mutation in S. cerevisiae and E. coli lig mutant (Barnes et al. 
1990, Kodama, Barnes and Lindahl 1991). Sequencing a radioactively labelled tryptic 
peptide-AMP complex (Tomkinson et al. 1991), determined that the adenylated lysine 
residue is encoded by exon 17, and located within the catalytic domain. It was also 
shown that the active site lysine is bracketed by hydrophobic amino acids on each side 
within a sequence (E-K-DG-R) common to ligases from many different organisms. 
Replacement of the lysine by another residue caused complete loss of enzyme activity 
(Kodama, Barnes and Lindahl 1991). Comparison of human DNA ligase I to ligases 
from vaccinia virus, S. cerevisiae and S. pombe identified an additional highly 
conserved sequence near the C-terminal of the catalytic domain (Smith, Chan and 
Kerr 1989). The 16 amino acid sequence (GISLRFPRFTRIREDK) has also been 
subsequently found to be present in DNA ligases El and IV (Wei et al. 1995), but is of 
unknown function.
Measurement of enzyme stability revealed DNA ligase I to have a half-life of 8 
hours (Lasko et al. 1990), suggesting that transcriptional and translational regulation 
may only occur over long periods. It has been proposed that acute regulation is instead 
effected by post-translational mechanisms (Prigent et al. 1992). DNA ligase I is a 
phosphoprotein, with phosphorylation being essential for the formation of enzyme 
intermediates. Although the amino acid sequence contains putative phosphorylation 
sites for casein kinase n (CKH), p34cdc2, protein kinases-A and -C, only CKH, a 
serine/threonine kinase present in nuclei and cytoplasm of proliferating cells, affects 
enzyme activity in vitro. Seven possible CKQ sites are present in the N-terminus of 
the human protein, although intriguingly the two 'strongest' candidates are absent 
from the murine enzyme (Savini et al. 1994, Jessop and Melton 1995). Nevertheless, 
a model for enzyme activation has been proposed; the primary translation product of 
DNA ligase I is enzymatically inactive due to the N-terminal "regulatory" domain 
interfering with intermediate formation. Post-translational modification, by 
phosphorylation of a serine residue in the N-terminal region, induces a conformational 
change, thereby relieving inhibition.
1.4.1.5 Interaction with other proteins
Further levels of control of enzyme activity may be achieved by interaction with 
other proteins. Yang et al. purified a 55-75kDa heat labile protein from HeLa cells 
that inhibits DNA ligase I (Yang, Becker and Chan 1993), while Kenne and 
Ljungquist isolated a heat stable protein from a BS cell line that stimulates DNA 
ligase I activity (Kenne and Ljunquist 1988). DNA ligase I activity in joining double
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strand breaks has been found to be dependent on the presence of another cellular 
protein, REP-1 (Fairman, Johnson and Thacker 1992). The roles of these proteins in 
controlling ligation activity have not yet been elucidated, but it has been shown that 
both Ku and PCNA modulate DNA ligase I activity.
Addition of Ku stimulates the activity of DNA ligases I, IQ, and IV in vitro, 
probably by acting as a 'bridging' or 'alignment factor' to stabilise intermolecular 
associations between DNA molecules (Ramsden and Gellert 1998). PCNA has been 
observed to inhibit the ligation activity of DNA ligase I in vitro (Jonsson, Hindges and 
Hubscher 1998). PCNA can interact with DNA ligase I via an 118aa region in the N- 
terminus of DNA ligase I (Levin et al 1997). Construction of PCNA deletion mutants 
enabled Jonsson, Hindges and Hubscher to identify a hydrophobic pocket on PCNA 
involved in the interaction with polymerase 5, RF-C, DNase FV/FEN1, p21 and DNA 
ligase I (Jonsson, Hindges and Hubscher 1998). Comparison of these proteins 
identified a PCNA binding motif at the very N-terminus of DNA ligase I (residues 2- 
9) which may interact with the hydrophobic pocket of PCNA. This region of DNA 
ligase I was also identified as necessary to target the protein to replication foci 
(Montecucco et al. 1998). Residues 1-20 are sufficient to effect targeting, and are also 
required for interaction with PCNA. Mutation of the two phenylalanines in this 
sequence (see section 1.4.1.3) removed PCNA binding, while a peptide of amino 
acids 1-23 was able to compete for binding to PCNA. Taken together these data 
suggest that DNA ligase I is targeted to the replication foci by binding to PCNA 
(Montecucco et al. 1998).
It has also been reported that DNA ligase I affects the activity of other proteins 
in vitro (Mossi, Ferrari and Hubscher 1998). Addition of DNA ligase I stimulated RF- 
C-dependent loading of PCNA onto DNA. RF-C independent DNA elongation by 
polymerase 8 was inhibited by addition of DNA ligase I, but it was demonstrated that 
this effect occurs through interaction with PCNA. Strand displacement by polymerase 
8 was also inhibited by DNA ligase I, the polymerase pausing after gap filling to allow 
ligation. Conversely polymerase E activity was stimulated by addition of DNA 
ligase I, and further stimulated by supplementation with PCNA. It was concluded that 
DNA ligase I influences pol 8 and e in different ways through PCNA, and that this 
may reflect different roles of the two polymerases in DNA replication and repair 
(Mossi, Ferrari and Hubscher 1998). The inhibitory effect of DNA ligase I on DNA 
polymerisation by polymerase 8 was also observed by Levin et al., and they suggested 
that DNA ligase I may only interact with PCNA after the release of polymerase 8 
(Levin et al. 1997).
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1.4.1.6 Function of DNA ligase I in DNA replication
A wealth of biochemical evidence has implicated DNA ligase I in lagging strand 
DNA synthesis. A 21S complex of enzymes known to participate in DNA synthesis 
was purified from HeLa cell homogenates (Malkas et al. 1990, Li, Goodchild and 
Baril 1994). Approximately 80% of the total ligase activity in HeLa extracts is 
associated with this 2IS complex, which is composed of approximately 30 
polypeptides, and functions to replicate SV40 in vitro. The observed ligase activity 
was affiliated with a ~125kDa protein that reacted with anti-DNA ligase I antibodies, 
and also had the catalytic properties of DNA ligase I (Li et al. 1993, Applegren et al. 
1995).
Wu et al. purified a 17S multiprotein complex from the murine mammary 
carcinoma cell line FM3A (Wu et al. 1994). This complex can replicate polyoma 
virus DNA in vitro, and is apparently independent of non-specific interactions with 
other cellular proteins. Proteins present include; polymerase a and 5, DNA primase, 
PCNA, DNA helicase, topoisomerases I and n, and DNA ligase I, all of which were 
proposed to be part of the 'core' of a multiprotein DNA replication complex.
Using a synthetic DNA substrate and purified calf proteins, the enzymatic 
reactions for Okazaki fragment processing, and completion of lagging strand DNA 
replication were reconstituted in vitro. Purified DNA ligase I was sufficient to 
complete the reaction (Turchi and Bambara 1993, Turchi et al. 1994). Similarly it was 
possible to replicate SV40 in vitro using only purified proteins (Waga, Bauer and 
Stillman 1994) : SV40 large tumour antigen (TAg), replication protein A (RPA), DNA 
topoisomerases I and n, DNA polymerase o/primase, replication factor C (RFC), 
proliferating cell nuclear antigen (PCNA), DNA polymerase 5, maturation factor I, 
and DNA ligase I. Partially purified DNA ligase HI was not able to substitute for 
DNA ligase I, while T4 ligase was only a partially effective replacement.
Mackenney, Barnes and Lindahl used in vitro SV40 replication to further 
investigate the role of DNA ligase I (Mackenney, Barnes and Lindahl 1996). When 
using cell extracts from 46BR cells to support viral replication they found that, in 
keeping with other published data, newly replicated DNA was predominantly present 
as small fragments. However, the fragments were apparently unstable, not being 
incorporated into high molecular weight DNA with time, but instead simply being 
lost. Supplementing 46BR extracts with full length DNA ligase I corrected the 
replication defect, but DNA ligase EQ and T4 DNA ligase did not. The catalytic 
domain of DNA ligase I (lacking the N-terminal domain) worked only when present 
in excess, suggesting that the N-terminal region is required for efficient lagging strand 
DNA replication. Moreover, an excess of the N-terminal domain was able to inhibit 
replication in extracts from wild-type cells. From this it was concluded that the N-
48 
CHAPTER ONE: INTRODUCTION
terminal region may be important in the interaction of DNA ligase I with other 
replication proteins (Mackenney, Barnes and Lindahl 1996).
1.4.1.7 Functions in DNA repair and recombination
Other than studies of cells from the 46BR patient, direct evidence of the roles of 
DNA ligase I in the repair of DNA damage is limited. Expression of DNA ligase I is 
induced by damaging agents, and a mammalian cell variant with raised resistance to 
SAB and DMS correlating to raised DNA ligase I activity has been documented 
(Murray et al. 1986). DNA ligase I has been reported to be present in a purified 
complex of proteins involved in NER (He and Ingles 1997), and has been used in the 
reconstitution of NER in vitro (Aboussekhra et al. 1995). Similarly DNA ligase I 
interacts with polymerase (3 within a multiprotein complex that catalyses the repair of 
a uracil-containing duplex DNA substrate by BER (Prasad et al. 1996), and the 
purified protein has been used in reconstitution of BER in vitro (Nicholl, Nealon and 
Kenney 1997) However, published data indicates the major BER pathway in 
mammalian cells to be DNA ligase IE-dependent (see sections 1.2.2 and 1.4.2).
Reconstitution of V(D)J recombination in a cell-free system suggested that 
DNA ligase I may be preferred in V(D)J recombination (Ramsden, Paull and Gellert 
1997). Recombination of artificial plasmid substrates by partially fractionated HeLa 
cell extract, RAG1 and RAG2 protein, and cofactors was assisted by further addition 
of purified DNA ligase I. Augmentation increased the diversity of coding joins 
formed, apparently by reducing the reliance on microhomologies between DNA ends, 
and also increased the efficiency and accuracy of signal joint formation. These effects 
were not observed on addition of either DNA ligases IQ or IV (Ramsden, Paull and 
Gellert 1997).
1.4.1.8 '46BR' mutations
Sequencing of cDNAs from the '46BR patient' revealed that she had two mis- 
sense mutations within the coding region of LlGl (Bames et al. 1992b). By cloning 
and sequencing individual cDNA PCR products, it was demonstrated that the two 
alterations were on different alleles. Both changes are CpG-»TpG transitions, 
possibly arising from inefficient repair after spontaneous hydrolytic deamination of 5- 
methylcytosine. One mutation (GAA »AAA) occurs within the active site of the 
enzyme, resulting in the glutamate at position 556 being modified to a lysine. This 
change produces an enzymatically inactive protein (Kodama, Barnes, and Lindahl 
1991). The other alteration (CGG-»TGG), inherited from the mother, is further 
towards the carboxy-terminus, and produces an Arg 771 »Trp change.
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46BR.1G1 is an SV40 transformed subline of 46BR (Webster et al. 1992). This 
cell line contains only cDNA sequences corresponding to the Arg771 >Trp allele, 
either as a result of mitotic recombination leading to homozygosity, or chromosome 
loss leading to hemizygosity. Purified DNA ligase I from 46BR.1G1 showed a 
tendency to aggregate into dimers (Lehmann et al. 1988) and while the enzyme retains 
normal DNA binding, and intermediate formation properties, the ability to generate a 
phosphodiester bond is impaired. Hence, the defect of the 46BR enzyme lies in the 
conversion of DNA-AMP into the ligated DNA product. The final catalytic step 
occurs at only 3-5% of normal rate, and, as a consequence, DNA ligase I accumulates 
as an activated adenylate form in vivo (Prigent et al. 1994). Additional proof that the 
defect in 46BR lies at the DNA ligase I locus, came with the correction of the EMS 
and 3AB sensitivity phenotype of 46BR.1G1 by transfection of wild type LIG1 
sequences (Somia, Jessop and Melton 1993).
Although there have been reports that DNA ligase activity is diminished in T- 
cell acute lymphoblastic leukaemia cells (Rusquet, Feon and David 1988), no other 
DNA ligase I-deficient individuals have been identified. The 46BR patient is the only 
documented case in which a DNA sequence alteration can be directly correlated with 
a deficiency in ligation activity. In this respect, she appears to be 'a distinct genetic 
entity', and the first example of an inherited mutation in a mammalian replication 
enzyme (Webster et al. 1992).
1.4.1.9 "DNA ligase I mediates essential functions in mammalian cells"
During the course of work for this thesis, another group reported the use of gene 
targeting in murine embryonic stem cells to inactivate Ligl (Petrini, Xiao and Weaver 
1995). Given the relevance to the work reported here, and the fact that strikingly 
different conclusions have been drawn from the two experiments, this paper will be 
described in detail. Further information on gene targeting is given in section 1.5.
Homologous recombination was used to introduce a partially disabled neo 
selectable marker gene into the endogenous mouse Ligl locus. The neo cassette 
replaced half of exon 17, and all of exons 18 and 19, in effect deleting sequences 
encoding the active site of the enzyme. This region had previously been demonstrated 
to be essential for enzyme activity (Kodama, Barnes and Lindahl 1991). ES cells 
heterozygous for the targeted allele were isolated, and used in an attempt to isolate ES 
cells homozygous for the targeted allele.
It has been demonstrated that it is possible to isolate ES cells homozygous for a 
targeted mutation by increasing the selection on cells heterozygous for a partially 
disabled selectable marker gene (Mortensen et al. 1992). Only those cells which have 
undergone a spontaneous gene conversion event to duplicate the marker gene (and
50 
CHAPTER ONE: INTRODUCTION
hence become homozygous) are able to survive elevated levels of selection. When ES 
cells heterozygous for the targeted Ligl allele were placed under high G418 selection, 
no viable clones arose. Nevertheless, it was found possible to isolate ES cells 
homozygous for the targeted allele if a LIG1 cDNA expression construct was 
introduced into heterozygous cells prior to increasing selection. It was thus concluded 
that cells homozygous for the targeted mutation were inviable, and that DNA ligase I 
must "mediate essential functions in mammalian cells".
It was further reported that certain mutant forms of human DNA ligase I were 
unable to rescue homozygous ES cells. In addition to wild-type LIG1, lig32B2 (an 
alternative splice variant of DNA ligase I isolated from a human tonsillar cDNA 
library lacking 30aa encoded by exon 2), and Iig231 (a 72kDa truncation mutant of 
DNA ligase I lacking the 231 N-terminal amino acids) were used. Although proteins 
produced from these two variant cDNAs had lower enzymatic activity (measured as 
16 and 18% of wild-type levels respectively), both were able to complement the S. 
cerevisiae cdc9 mutant. Nevertheless, it proved possible to only rescue homozygous 
ES cells with the lig32B2 construct. The truncated Iig231 cDNA lacked sequences 
coding for the 'regulatory1 N-terminal domain of the protein, and the failure of this 
construct to complement for DNA ligase I deficiency was taken to indicate that the N- 
terminus is required for function in vivo.
While cells rescued with the full length cDNA were indistinguishable from 
wild-type, cells rescued with the lig32B2 construct showed DNA replication and 
DNA repair defects. In this case, although cell cycle distribution was indistinguishable 
from the wild-type, cells displayed a marginal increase in the percentage of newly 
replicated DNA present as small molecules (i.e. delayed Okazaki fragment joining), 
and were sensitive to killing by 3AB. The differential effects on replication and repair 
functions were hypothesised to reflect different protein-protein interactions being 
mediated by different regions of the N-terminus.
1.4.2 DNA ligase III
DNA ligase HI was first identified during purification of DNA ligase n from 
calf thymus (Tomkinson et al 199la). This ligase has different substrate specificity, 
immunological and purification properties compared to both DNA ligases I and n (see 
Lindahl and Barnes 1992) and is a polypeptide of lOOkDa in size. Although in calf 
thymus DNA ligase HI only contributes 5-10% of the total DNA ligation activity, in 
SV40-transformed human fibroblasts DNA ligase HI contributes >85% of the high 
molecular weight DNA joining activity (Tomkinson, Starr and Schultz 1993). The 
enzyme is apparently not induced in proliferating cells (Elder and Rossignol 1990) 
and, unlike DNA ligase I, associates with condensed chromatin during metaphase of
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the cell cycle (Mackey et al. 1997) suggesting that it is not involved in DNA 
replication.
A possible role for DNA ligase IE in DNA repair was indicated by the isolation 
of a protein complex that repairs double stranded breaks and deletions by 
recombination (Jessberger et al 1993). The complex, deemed RC-1, contained at least 
five proteins including DNA polymerase (8). A 5'-3' exonuclease and a DNA ligase 
activity were also identified. The ligase activity had a number of characteristics of 
DNA ligase HI (although because this work was performed prior to the discovery of 
DNA ligase IV there remains the possibility that it was DNA ligase IV).
There is now a large accumulation of data indicating that DNA ligase HI is a 
central component ot the BER pathway. It was noted during the purification of DNA 
ligase El that it associated with a second smaller polypeptide. This protein proved to 
be XRCC1, the product of a gene already known to be involved in the repair of DNA 
base damage (Caldecott et al 1994). XRCC1 had originally been cloned on the basis 
of the ability to complement the elevated SCE phenotype and sensitivity to ionizing 
radiation and alkylating agents of a mutant rodent cell line (EM9) (Thompson et al. 
1990). Subsequent studies have shown that the activity of DNA ligase HI is 
diminished (Ljungquist et al. 1994), and levels of the XRCC1-DNA ligase IE 
complex are reduced in EM9 cells (Caldecott et al. 1995). With the discovery that the 
XRCC1-DNA ligase HI complex interacts with DNA polymerase (3 and PARP it was 
hypothesised that the four proteins act in a multiprotein complex in the detection of 
strand breaks and repair by BER (Caldecott et al. 1996, Masson et al. 1998). 
Although it has also been reported that DNA ligase I associates with pol (3, this 
apparently conflicting data can be explained by the presence of two alternative BER 
pathways (see section 1.2.2). The XRCC1-DNA ligase El complex functions solely in 
the single nucleotide insertion pathway, while DNA ligase I is active in the patch 
replacement (PCNA-dependent) pathway, EM9 cells only being deficient in the 
former (Cappelli et al. 1997).
1.4.2.1 Two isoforms of DNA ligase III
The DNA ligase IE cDNA was cloned from a Hela cell cDNA library on the 
basis of homology to other DNA ligases (Wei et al. 1995). All eukaryotic DNA 
ligases show partial sequence homology with DNA ligase I, particularly around the 
active site. Expressed sequence tags (ESTs) displaying homology to this motif were 
identified from database searches, and these used to clone full length cDNAs. The 
LIG3 cDNA contained an open reading frame of 2766bp, encoding a 922aa (103kDa) 
protein. The gene mapped to chromosome 17ql 1.2-12, and produced a 4.2kb 
transcript that was most abundant in testis, and thymus. Sequence analysis revealed
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that within the N-terminus of the protein was a zinc finger domain similar to 'nick 
sensors' identified in PARP (Wei et al 1995). When presented with a nicked DNA 
duplex, it was found that DNA ligase HI was indeed able to detect nicked DNA, 
thereby potentially acting to target the whole XRCC1/DNA ligase IQ/polymerase P 
BER complex to the site of damage (Caldecott et al. 1996).
Soon after isolation of the LIG3 cDNA by Lindahl and coworkers, another 
group reported isolation of a LIG3 cDNA clone from a testis cDNA library using 
degenerate PCR based on peptide sequences from purified bovine DNA ligase HI 
(Husain et al. 1995, Chen et al. 1995). Comparison of the testis cDNA with the HeLa 
cDNA sequence revealed a difference at the 3' end of the open reading frame, 
apparently arising from alternative splicing of the transcripts. The Hela cDNA (a) 
encoded a peptide of 103kDa, while the testicular form of the protein (P) was only 
lOOkDa. Mapping of the 3' end of the Lig3 locus showed that either one of two 
mutually exclusive final exons could be spliced onto the 3' end of the transcript. The a 
exon encodes 77aa, whereas the P exon codes only 17aa, thereby accounting for the 
protein size difference (Mackey et al. 1997), but also explaining the different 
characteristics of the P form to interact with XRCCl. It was determined that XRCCl 
binds to the C-terminal 148aa of DNA ligase ffla. The P isoform, which lacks most of 
this C-terminal region, does not interact with XRCCl, hence implying that only DNA 
ligase ma participates in BER.
Although DNA ligase ffla is constitutively expressed in all tissues, the P form is 
specific to the mature testis, and is expressed at much higher levels (Chen et al. 1995, 
Mackey et al. 1997). Examination of the localization of DNA ligase Hip expression 
within the germ cell showed that elevated expression is restricted to the pachytene 
spermatocytes, beginning in the latter stages of meiotic prophase and ending in the 
round spermatid stage. Indirect immunofluorescence with anti-DNA ligase IQ 
antibodies illustrated that the protein associates with condensed chromatin 
incorporated into synaptonemal complexes. It was thus proposed that DNA ligase Hip 
may function specifically in meiotic recombination (Mackey et al. 1997).
1.4.3 DNA ligase IV
During the EST database search for human DNA ligase cDNAs, a third DNA 
ligase was identified. Surprisingly this proved not to encode DNA ligase n. A full 
length cDNA clone from a prostate library contained an open reading frame of 
2532bp, encoding a 844aa (96kDa) protein. The gene mapped to chromosome 13q33- 
34, and produced a 4kb transcript that was most abundant in testis, thymus and 
prostate. In addition to the presence of ligase-characteristic motifs, and homology to 
the catalytic domains of other DNA ligases, the protein was demonstrated to have the
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ability to form an enzyme-AMP complex and to act on an oligo(polydT)/poly(dA 
substrate). It was thus concluded that this gene encodes a novel, previously 
unidentified, DNA ligase (DNA ligase IV) (Wei et al 1994).
Alignment of the three cloned DNA ligases on the basis of positions of 
conserved motifs (Figure 1.4.1) revealed that DNA ligase IV has an extended C- 
terminal region. Within this region two BRCA1 C-terminus (BRCT) modules have 
been identified. BRCT modules are autonomous folding units of 90-100aa, first 
described in BRCA1 but widespread in DNA-damage responsive and checkpoint 
proteins, that are involved in protein-protein interactions (Callebaut and Mornon 
1997). It was therefore hypothesised that DNA ligase IV may be complexed with 
other proteins, and indeed the behaviour of the DNA ligase IV protein during 
purification procedures indicated that this was true (Robins and Lindahl 1996).
Other than genes encoding components of DNA-PK, one other gene has been 
directly implicated in V(D)J recombination and DSB repair: XRCC4. XRCC4 was 
isolated on the basis of complementation of defective V(D)J recombination and DSB 
repair in a mutant cell line. The XRCC4 protein has no homology to any other known 
protein, but has been shown to interact with, and stimulate activity of, DNA ligase IV 
(Grawunder et al. 1997, Critchlow, Bowater and Jackson 1997). It has been proposed 
that and XRCC4-DNA ligase IV complex carries out the final ligation steps of both 
processes (Grawunder et al. 1997). This hypothesis is supported by demonstration that 
the S. cerevisiae homologue of DNA ligase IV is directly involved in the NHEJ 
pathway (Wilson, Grawunder and Lieber 1997, Teo and Jackson 1997, Schar et al. 
1997, Ramos et al. 1997). Following the completion of the yeast genome sequencing 
project, database searches identified a second putative DNA ligase in yeast. This gene 
is not essential, and deletion confers no apparent growth phenotype, or sensitivity to 
DNA damaging agents. Nevertheless, reduced non-homologous end joining was 
observed in plasmid joining assays, and was accompanied by sensitivity to y radiation 
when the RAD52 pathway was also inactivated, indicating that DNA ligase IV 
functions in Ku-mediated repair of double strand breaks. Mutants sporulated less 
efficiently, and diploid cells were observed to be delayed in prophase I of meiosis, 
from which it was suggested that the protein may also play a role in specific 
recombination processes (Schar et al. 1997).
1.4.4 Other reported mammalian DNA ligase activities
1.4.4.1 DNA ligase II
A second DNA ligase was identified when it was discovered that two DNA 
ligase activities from calf thymus are separable by hydroxyapatite chromatography
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and gel filtration (Soderhall and Lindahl 1973b). Western blotting with an antibody 
specific for calf thymus DNA ligase n indicated that this enzyme consisted of a single 
68kDa polypeptide (Teraoka and Tsukada 1986) while other workers estimated its size 
as 67kDa (Yang et al 1990) or 72kDa (Tomkinson et al 1991a).
Like DNA ligase I, DNA ligase E is a nuclear enzyme (Soderhall and Lindahl 
1975), but the two are immunologically and qualitatively distinct (Soderhall and 
Lindahl 1975, Soderhall and Lindahl 1973b, Arrand et al 1986, Tomkinson et al 
199la). Levels of DNA ligase n were reported to be maximal in the liver, and 
although increases in the level of DNA ligase n have been observed in response to 
DNA damage, the enzyme was apparently not induced in response to cell proliferation 
(Wang et al 1994 and references therein).
However, it now appears that DNA ligase n is not derived from a novel gene. 
Rather it seems certain that DNA ligase n is somehow derived from DNA ligase IE 
(Husain et al. 1995). Database search strategies which were used to clone cDNAs 
encoding DNA ligases HI and IV failed to identify any ESTs corresponding to DNA 
ligase n (Wei et al. 1995). Purification of DNA ligases n and HI followed by 
proteolytic mapping, and amino acid sequencing suggested that both enzymes are 
encoded by the same gene (Roberts, Nash and Lindahl 1994, Wang et al. 1994, 
Husain et al. 1995). 10 identical peptide sequences (136aa) were obtained from DNA 
ligases n and ffl, and all other peptide sequences from DNA ligase n could be aligned 
with the predicted amino acid sequence of LIG3. It was therefore concluded that DNA 
ligase n and HI are encoded by the same gene, with DNA ligase n being an N- 
terminal truncated form of DNA ligase ffl. Exactly how DNA ligase n is derived is 
still to be determined. The N-terminus of DNA ligase n is resistant to Edman 
degradation, indicating the protein to be a primary translation product, and it has not 
been possible to convert purified DNA ligase IQ to DNA ligase n in vitro. However, 
alternatively spliced LIG3 transcripts have not been observed in tissues where DNA 
ligase n is a predominant enzyme product (Husain et al. 1995).
1.4.4.2 DNA ligase V
A DNA ligase activity was identified during purification of proteins involved in 
double strand break repair in human cells (Fairman, Johnson and Thacker 1992). 
Further purification determined activity to be associated with 44kDa protein which 
was adenylated in the presence of DNA breaks. This protein, designated DNA ligase 
V, could ligate double strand breaks with a similar efficiency to DNA ligase I, but had 




In order to assay for the ability to repair chromosomal DSBs, joining of plasmid 
substrates by nuclear extracts from human cells was measured. Components of the 
end joining activity identified were purified further, but the ligase activity identified 
did not correspond to DNA ligases I, n or HI. This non-homologous recombination 
(NHR) ligase could oligomerise monomer substrates and required both Mg2+ and ATP. 
The protein did not cross-react with anti-DNA ligase I antisera, had purification 
characteristics dissimilar to DNA ligase n and ffl, and enzymatic activity was 
stimulated by another component of the end joining activity (HPP-1) (Derbyshire et 
al. 1994). There does remain the possibility that NHR ligase corresponds to DNA 
ligase IV which had not been discovered at that time.
1.4.4.4 Mitochondrial DNA ligase
There are only two published reports of mitochondrial DNA ligases. Levin and 
Zimmerman identified a DNA ligase activity in rat liver mitochondria, but the enzyme 
responsible was not characterised (Levin and Zimmerman 1976). However, recently 
the purification of a DNA ligase from Xenopus laevis mitochondria has been detailed. 
Ligase activity was detected in a crude mitochondrial fraction, and further purification 
of the protein determined that the enzyme had different properties to the one known 
Xenopus ligase. Antibodies raised against a DNA ligase Hi-specific peptide detected 
both human DNA ligase HI and the purified mitochondrial ligase, suggesting that it is 
a homologue of DNA ligase IE.
1.5 Gene targeting
A number of animal diseases which mimic human conditions have been 
identified either arising spontaneously in animal populations or from random 
mutagenesis screens. However, factors such as time, cost and complexity constrain 
large scale screening of higher eukaryotes, so that until recently these 'animal models' 
have been too sparse to play a significant role in mammalian genetic studies. This 
problem has now been eliminated by the advent of gene targeting, whereby it is now 
possible to generate mice with defined genomic alterations (reviewed by Melton 1994, 
and Moore and Melton 1997). Numbers of gene targeted mice are growing rapidly and 
it has been estimated that by the year 2001, 3000 strains will be available (Simpson et 
al 1997).
Gene targeting can be defined as "homologous recombination between 
chromosomal DNA sequences and newly introduced exogenous sequences, enabling 
the transfer of any desired alteration into the genome of a cell" (Capecchi 1989). 
Upon introduction of a targeting vector bearing DNA homologous to a gene of
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interest, homologous recombination may initiate exchange of DNA sequences 
between the vector and the genomic locus. Formerly it was possible only to delete or 
"knock-out" genes, however a growing number of targeted alterations are now 
possible. Such alterations include conditional gene deletion (Gu et al. 1993), subtle 
alterations (e.g. single base pair changes, Moore et al. 1995) and targeted 
chromosomal translocations (Smith et al. 1995).
When DNA is introduced into cells it can have a number of possible fates, 
including nucleolytic degradation, random integration and homologous recombination 
with genomic DNA (for a review see Bollag, Waldman and Liskay, 1989). The 
limiting factor in gene targeting in higher eukaryotes is the marked preference for 
random integration of targeting vectors over homologous recombination. As noted in 
section 1.2.5, it is probable that gene targeting occurs through a /?AD52-like 
recombination pathway (Essers et al. 1997), but homologous recombination 
mechanisms play only a minor role in higher eukaryotes compared to non- 
homologous end joining events. The ratio of random integration to homologous 
recombination events in mouse cells has been estimated at 1000:1 (Thomas and 
Capecchi, 1987).
In order to maximise the chances of identification and retrieval of targeted 
clones, gene targeting is performed with large numbers of cells, and utilising selection 
strategies which enrich for rare homologous recombination events. The most widely 
used selection scheme is the positive-negative strategy (Mansour, Thomas and 
Capecchi, 1988). Since both the transfection frequency of cells is relatively low, a 
positive selection scheme is required to select for cells which have integrated the 
targeting vector. The most common positive selection scheme in use is the bacterial 
neomycin phosphotransferase gene (neo) used in combination with G418, but a 
scheme based on the use of an HPRT minigene in combination with HAT selection 
has also been used successfully (Reid et al. 1990, Selfridge et al. 1992).
Positive selection schemes select both for cells which have undergone the 
desired gene targeting events and those which have undergone random integration 
events. It is therefore necessary to use a negative selection step to enrich for 
homologous recombinants. Selection against non-homologous recombinants with 
replacement vectors is achieved by introduction of negative selectable markers, such 
as the herpes simplex virus thymidine kinase gene (HSV-ffc), at the termini of regions 
of homology (see Figure 1.5.1).
1.5.1 Production of "knockout" mice
Whilst gene targeting can be used to manipulate the genome of cells in culture, 
use of embryonic stem (ES) cells makes it additionally possible to transmit targeted
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alterations to the mouse germline (Figure 1.5.2). ES cells are derived from the inner 
cell mass of 3.5 day mouse blastocysts and contribute to all cell lineages in the 
developing embryo (pluripotency). Moreover they retain this potential even after 
prolonged culture in vitro (Evans and Kaufman, 1981). Once gene targeting has been 
performed, the ES cells are injected into a blastocyst stage embryo, which is re- 
implanted into the uterus of a pseudopregnant foster female. Because ES cells are 
pluripotent, they can subsequently contribute to all tissues of the developing mouse, 
resulting in the production of 'chimaeric' animals. Providing the injected ES cells 
carry coat colour alleles different from that of the recipient embryo, any chimaeras can 
be identified by virtue of having a coat of mixed colours. Where injected ES cells 
contribute to the germ line, chimaeras will be able to pass markers derived from 
injected cells to their progeny (also identifiable on the basis of coat colour). Thus by 
carrying out gene targeting in ES cells and then using these cells for blastocyst 
injections, it is possible to produce mice carrying a defined genomic alteration 
(Thompson et al 1989).
1.5.1.1 Gene targeting in HM-1, an HPRT deficient mouse ES line
The male embryonic stem cell line HM-1 is an HPRT (hypoxanthine-guanine 
phosphoribosyltransferase HPRT; IMP pyrophosphate phosphoribosyltransferase; EC 
2.4.2.8) deficient male ES cell line which can contribute to the mouse germline with 
high frequency (Magin et al. 1992b). HM-1 cells have undergone spontaneous 
deletion of approximately 10kb of sequence 5' of the HPRT locus, resulting in loss of 
HPRT expression (Thompson et al. 1989). Because HPRT is X-linked, and male ES 
cells are hemizygous for this gene, loss of function of the one HPRT allele gives rise 
to HPRT-deficient cells.
HPRT catalyses an early step of the purine salvage pathway in mammals. In 
humans loss of HPRT function results in Lesch Nyhan disease (Lesch and Nyhan, 
1964), but HPRT activity is non-essential in cell lines in vitro (provided that the main 
purine synthesis pathway is functional). It is possible to select for HPRT activity in 
vitro with medium supplemented with hypoxanthine, aminopterin and thymidine 
(HAT). Aminopterin is an inhibitor of de novo synthesis of purines and pyrimidines. 
Only when HPRT activity is present can cells bypass the aminopterin-induced 
metabolic block by utilising hypoxanthine and thymidine in the purine and pyrimidine 
salvage pathways respectively. Hence by incorporating HPRT minigenes into gene 
targeting vectors as selectable markers, HPRT-deficient ES cells can be used to 
produce "knockout" mice (Selfridge et al. 1992). Figure 1.5.1 and 1.5.2 outline a 
typical gene targeting strategy employed in HM-1 ES cells.
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Figure 1.5.1: A gene targeting strategy employed in HM-1 ES cells
A positive-negative selection procedure used in HPRT-deficient cells to enrich 
for homologous recombination events. Schematic representation of 13.5kb at the 3' 
end of the wild-type mouse DNA ligase I locus, linear targeting vector, and gene 
structure following a) homologous recombination or b) random integration. Boxes, 
exons (numbered according to the human convention); thick lines, Ligl introns or 
flanking regions; thin lines, plasmid vector DNA. Solid boxes and lines, regions of 
Ligl replaced by targeting; stippled box, HPRT minigene; hatched box, Herpes 
simplex virus thymidine kinase (HSV-ffc) cassette.
The targeting vector consist of 5* and 3' flanking sequence homologous with the 
target locus, an HPRT minigene, and an HSV-tk cassette outwith the region of 
homology (plus plasmid vector DNA). The HPRT minigene has the dual role of 
replacing essential exons within the target gene, and functions as a positive selectable 
marker for stable transfectants.
a) Replacement gene targeting vectors integrate following a double reciprocal 
recombination event resulting in the complete replacement of a region of the target 
locus with vector sequence. Negative selection against non-homologous recombinants 
is used to enrich for homologous recombinants. This is achieved by placing an HSV- 
tk negative-selectable marker outside the region of vector homology with the target 
gene. Regions at the vector termini which are not homologous to the target gene will 
be excluded from the final structure of the correctly targeted locus. This renders the 
cells resistant to the toxic viral thymidine kinase substrate gancyclovir and HAT 
selection.
b) The majority of random integrants will be stably transfected with the 
whole vector including the HSV-tk marker as well as the HPRT minigene. As a 
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Figure 1.5.2: Generation of mice from gene targeted embryonic stem cells
Schematic representation of the procedure to generate mice heterozygous for a 
targeted alteration. Adapted from Moore 1997.
ES cells can be genetically modified in vitro, then introduced into blastocysts 
and, following embryo transfer and successful implantation, can generate germline 
chimeras. Coat and eye colour markers aid the identification of ES cell contribution to 
chimeras and to germline pups.
For autosomal loci, only 50% of germline pups carry targeted alleles because ES 
cells are usually heterozygous for targeted alterations. Germline transmission of 
129/Ola HM-l-ES cell derived gametes is determined by the transmission of 129/Ola 
coat and eye colour markers (Selfridge et al., 1992): 129/Ola are homozygous for the 
white bellied agouti allele (Aw) and the chinchilla allele (cf/l) at the albino locus which 
results in a light brown coat colour. 129/Ola are also homozygous for the recessive 
allele, pink-eyed dilute (p) and have pink eyes.
When used in conjunction with recipient blastocysts which differ from 129/Ola 
at these loci, it is possible to determine the contribution of ES derived tissue in 
chimeras. For example, introduction of 129/Ola ES cells into Balb/c recipient 
blastocysts (Balb/c mice have a white coat and pink eyes: c/c, P/P, A/A) results in 
white mice (blastocyst coat colour) and chimaeric, 129/Ola derived tissue, shows up 
against this coat colour as light brown. Following test crosses between chimeras and 
inbred 129/Ola mice, the transmission of ES gametes from germline chimeras is 
indicated by a chinchilla coat and pink eyes in progeny. The targeted allele of a gene 
will be transmitted to 50% of the offspring, and these germline pups will be 
heterozygous for that allele. Non-germline pups have a grey coat and black eyes as 
































































































































1.5.2 Double replacement gene targeting
In many cases, mutations that are the root of a human disease do not disrupt 
gene expression completely. It is therefore more desirable to be able to make subtle 
alterations to a gene. To this end, a method of 'double replacement1 gene targeting has 
been developed to exploit the ability to select both for and against the presence of 
HPRT (Stacey et al. 1994, Melton 1997). This method was first suggested by Reid et 
al. (Reid et al. 1990). An initial round of gene targeting is used to introduce an HPRT 
selectable marker into the desired locus, enabling a "knockout" allele to be generated 
if required. Subsequently, a second round of gene targeting is initiated. The second 
step employs a replacement vector consisting of sequence homologous to the target 
gene sufficient to reconstruct the disrupted allele, but bearing an engineered mutation. 
Homologous recombination between the "knockout" allele and the second step 
targeting vector results in the replacement of the selectable marker by sequences 
bearing the engineered mutation (Figure 1.5.3). It is possible to enrich those cells 
which have homologously recombined with the alteration vector by selecting for the 
loss of the HPRT minigene. Selection against HPRT activity in vitro is achieved by 
supplementing culture media with the cytotoxic base analogue 6-thioguanine.
1.5.3 Cre/ZojcP-mediated gene targeting
The ability to modify the mouse genome has been further extended by the use of 
site-specific recombinases in conjunction with homologous recombination. The 
strategy most commonly used exploits the loxP/Cre recombinase system from the 
bacteriophage PI (reviewed by Kiihn and Schwenk 1997). Cre is a site-specific DNA 
recombinase which recognises a 34bp target sequence (loxP site) (Kilby, Snaith and 
Murray 1993). Cre-mediated recombination between two loxP sites results in the 
reciprocal exchange of DNA flanking the two sites, but the products formed by the 
recombination reaction will depend on the location and orientation of the two loxP
sites.
When two loxP sites are in the same orientation on the same DNA molecule, 
recombination will excise the intervening DNA segment as a circular molecule, 
leaving a single loxP site on each reaction product. By flanking a gene of interest with 
two loxP sites (termed 'floxing'), it is thus possible to excise the genomic locus, and 
hence delete the gene by Cre-mediated recombination. Conversely, if the recognition 
sites are in the opposite orientation, inversion of the intervening region will occur. 
Intermolecular recombination between loxP sites on different DNA molecules can 
also take place. By selecting for the desired recombinant products it has proved 
possible to produce site directed chromosomal translocations (Smith et al 1995),
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inversions and duplications (Ramfrez-Solis, Liu and Bradley 1995). Further 
refinement has allowed site directed mutagenesis (Torres et al. 1996), gene insertion 
("knock-in") (Kitamoto et al. 1996) and large chromosomal deletions (Li et al. 1996). 
In each of these strategies, modification of the genome involves two steps; 
introduction of the loxP sites into the genome followed by Cre-mediated 
recombination. Whilst it is possible to carry out both of these steps in ES cells prior to 
blastocyst injection, because recombination efficiency is high it is possible to carry 
out the Cre-mediated recombination step in vivo. Cre recombinase is not dependent on 
cofactors, and so Cre-mediated recombination between two loxP sites requires only 
expression of the protein. Control of Cre expression can thus be used to limit 
recombination to a particular tissue, cell lineage, or timepoint (termed conditional 
gene targeting). One way of doing this is to cross mice harbouring a 'floxed' gene to a 
strain of transgenic mice expressing Cre under the control of a tissue-specific 
promoter. The 'floxed' gene will only be deleted in those cells expressing Cre, and 
hence other tissues will be unaffected. Conditional gene targeting therefore offers the 
potential to permit analysis of gene knockouts that are otherwise lethal.
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Figure 1.5.3: Introduction of subtle alterations by double replacement gene 
targeting
A two step 'double replacement' strategy for the introduction of a subtle 
alteration into an endogenous gene. Schematic representation of the 3' end of the wild- 
type mouse DNA ligase I locus, the Tcnockout' Ligl allele, linear second step targeting 
vector, and gene structure following homologous recombination. Boxes, exons; thick 
lines, Ligl introns or flanking regions; thin lines, plasmid vector DNA. Solid boxes 
and lines, regions of Ligl replaced by targeting; stippled box, HPRT minigene; 
asterisk, engineered mutation.
The second step targeting vector consists of Ligl sequences sufficient to 
reconstruct the disrupted locus, but bearing an engineered mutation. Following a 
double reciprocal recombination event between regions of homology between the 
"knockout" allele and the introduced vector, the HPRT minigene will be lost. 
Selection against the HPRT minigene with 6-thioguanine is sufficient to enrich for 
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1.6 Project Aim
A number of distinct DNA ligase activities have been identified within 
mammalian cells, and three of these have been cloned (DNA ligases I, ffl, and IV). 
Various lines of evidence have indicated DNA ligase I to be involved in DNA 
replication, repair and recombination processes. As a result it was suggested that 
DNA ligase I is essential for cell viability, and it has been reported to be impossible to 
isolate cells lacking the enzyme.
One patient ('46BR' patient) has been identified with reduced DNA ligase I 
activity correlating to missense mutations within the protein coding sequence. This 
individual displayed a phenotype similar to Bloom's Syndrome, being 
immunodeficient, growth retarded, and predisposed to cancer. Fibroblasts exhibited 
abnormal lagging strand DNA synthesis and repair deficiency. Despite extensive 
screening, no other DNA ligase I-deficient individuals have been identified. Further 
study of the roles of DNA ligase I within the mammalian system would therefore be 
greatly facilitated by an experimental model of DNA ligase I-deficiency.
The work described in this thesis is part of an ongoing project to produce a 
mouse model of the '46BR' patient by gene targeting. Gene inactivation was the first 
step of a 'double replacement' strategy to introduce analogous mutations into the 
mouse DNA ligase I gene (Ligl). Utilising established techniques, the 3' end of the 
endogenous Ligl gene was replaced with an HPRT minigene, and this alteration 
transferred into the mouse germline. I report here investigation of the developmental 
and molecular consequences of targeting of Ligl. In addition, efforts to modify Ligl 






CHAPTER TWO: MATERIALS AND METHODS
2.1 Materials
2.1.1 Suppliers of equipment, laboratory reagents and consumables
Amersham International pic, Lincoln Place, Green End, Aylesbury, Buckinghamshire, 
HP20 2TP
Becton Dickinson Labware, Becton Dickinson and Company, Franklin Lakes, NJ,
USA 87417-1886
BDH Ltd., Burnfield Avenue, Thornliebank, Glasgow, G46 7TP
Biogenesis Ltd., 7 New Fields, Stinsford Road, Poole, England, BH17 ONF
Bio-Rad Laboratories Ltd., Bio-Rad House, Maylands Avenue, Hemmel Hempstead,
Hertfordshire, HP2 7TD
Boehringer Mannheim UK Ltd., Bell Lane, Lewes, East Sussex, BN7 1LG
The Boots Company pic, 1 Thane Road West, Nottingham NG2 3AA
Caltag Ltd., 1849 Old Bayshore Highway, Suite 200, Burlingame, CA 94010
Canberra Packard, Brook House, 14 Station Road, Pangbourne, Berkshire, RG8 7DT
Coulter Electronics Ltd., Northwell Drive, Luton, Bedfordshire, LU3 3RH
Difco Laboratories, PO Box 14B, Central Avenue, West Molesey, Surrey, KT8 2SE
Du Pont (UK) Ltd., Diagnostics and Biotechnology Systems, NEN Products,
Wedgwood Way, Stevenage, Hertfordshire, SG1 4QN
Fisher Scientific UK Ltd., and Fisons Scientific Equipment, Bishop Meadow Road,
Loughborough, Leicestershire, LEU ORG
Forma Scientific, Life Sciences International (UK) Ltd., Unit 5, The Ringway Centre,
Edison Road, Basingstoke, Hampshire, RG21 6YH
Gibco BRL Life Technologies Ltd., PO Box 35, Trident House, Renfrew Road,
Paisley, Renfrewshire, PA3 4EF
Hoefer, 654 Minnesota Street, San Francisco, CA 94107, USA
Hybaid Ltd., Life Sciences International (UK) Ltd., Unit 5, The Ringway Centre,
Edison Road, Basingstoke, Hampshire, RG21 6YH
ICN Biomedicals Ltd., Thame Park Business Centre, Wenman Road, Thame,
Oxfordshire, OX9 3XA
Millipore (UK) Ltd., The Boulevard, Blackmore Lane, Watford, Hertfordshire, WD1
8YW
Molecular Dynamics Ltd., 5 Beech House, Chiltern Court, Asheridge Road, Chesham,
Buckinghamshire, HP5 2PX
National Diagnostics, 305 Patton Drive, Atlanta, Georgia 30336, USA
New England Biolabs (UK) Ltd., 67 Knowl Piece, Wilbury Way, Hitchin,
Hertfordshire, SG4 OTY
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New England Nuclear Life Science Products, 549 Albany Street, Boston, MA 02118, 
USA
Oswel DNA Service, Lab 5005, Medical and Biological Sciences Building, University
of Southampton, Boldrewood, Bassett Crescent East, Southampton, SO 16 7PX
Packard Instrument Company, 800 Research Parkway, Meriden, CT 06450, USA
Perkin Elmer Applied Biosystems, Warrington, WA1 4SR
Pharmacia Biotech, 23 Grosvenor Road, St. Albans, Hertfordshire, AL1 3AW
Pharmingen, 10975 Torreyana Road, San Diego, CA 92121, USA
Pierce, PO Box 117, Rockford, Illinois 61105, USA
Promega UK Ltd., Delta House, Chilworth Research Centre, Southampton SO 16 7NS
Qiagen Ltd., Unit 1 Tillingbourne Court, Dorking Business Park, Station Road,
Dorking, Surrey, RH4 1HJ
Scotlab Ltd., Kirkshaws Road, Coatbridge, Strathclyde, ML5 SAD
Sigma-Aldrich Company Ltd., Fancy Road, Poole, Dorset, BH17 7NH
Stratagene Ltd., 140 Cambridge Innovation Centre, Cambridge Science Park, Milton
Road, Cambridge, CB4 4GF
2.1.1.1 Laboratory reagents
BDH Ltd.: dimethyldichlorosilane, DPX mountant, hydrochloric acid, Sarkosyl NL30,
xylene, xylene cyanol.
Boehringer Mannheim UK Ltd.: deoxyribonucleotides, proteinase K.
The Boots Company pic: nail varnish, skimmed milk powder.
Difco Laboratories: agar, bacto-tryptone, bacto-yeast extract.
Fisher Scientific UK Ltd/Fisons Scientific Equipment: 3M blotting paper, boric acid,
butanol, calcium chloride, citric acid, disodium hydrogen orthophosphate, disodium
hydrogen orthophosphate, EDTA, filter paper, glacial acetic acid, hydroxyquinolin,
isoamyl alcohol, isopropanol, potassium dihydrogen orthophosphate, sodium acetate,
sodium chloride, sodium citrate, sodium hydroxide, sodium dihydrogen
orthophosphate, potassium acetate, trichloroacetic acid.
Gibco BRL Life Technologies Ltd.: lOObp DNA marker ladder, agarose, formamide,
guanidine hydrochloride, Hind ffl digested A DNA marker ladder, phenol, Tris, low
melting point agarose, urea.
ICN Biomedicals Ltd.: Dulbecco's PBS tablets.
Millipore (UK) Ltd.: disposable sterile filters, Immobilon P.
National Diagnostics: ecoscint A.
New England Biolabs (UK) Ltd.: prestained broad range molecular weight marker
proteins, 3X reducing SDS sample buffer.
New England Nuclear Life Science Products: Genescreen Plus.
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Pierce: BCA* protein assay reagents A and B.
Promega (UK) Ltd.: BCIP, NBT, oligo dT, random hexamers, rRNasin.
Qiagen Ltd.: tip 500 columns.
Scotlab Ltd.: acrylamide/bis-acrylamide solutions.
Sigma-Aldrich Company Ltd.: ammonium persulphate, bovine serum albumin,
bromophenol blue, dextran sulphate, DTT, ethidium bromide, ficoll, formaldehyde,
Giemsa stain, glycerol, glycine, Harris eosin Y alcoholic solution, Harris eosin Y
aqueous solution, Harris hematoxylin solution, herring sperm DNA, Hoechst 33258,
IPTG, mineral oil, MOPS, new methylene blue, NP-40, parafilm M, PMSF, Ponceau
S solution, sodium bicarbonate, TEMED, thymidine, Triton X-100, Tween 20, X-Gal.
2.1.1.2 DNA/RNA modifying enzymes
Boehringer Mannheim UK Ltd.: Klenow polymerase, M-MuLV reverse transcriptase,
restriction endonucleases.
Gibco BRL Life Technologies Ltd.: bacterial alkaline phosphatase, restriction
endonucleases, T4 DNA kinase, Taq DNA polymerase.
New England Biolabs (UK) Ltd.: restriction endonucleases, T4 DNA ligase.
2.1.1.3 Mammalian cell culture reagents
Becton Dickinson Labware: plasticware.
Boehringer Mannheim UK Ltd.: colcemid.
Difco Laboratories: trypsin.
Gibco BRL Life Technologies Ltd.: foetal calf serum, Glasgow's Modified Eagle
Medium (BHK21), horse serum, L-glutamine, new-born calf serum, non-essential
amino acids, sodium bicarbonate, sodium pyruvate.
Sigma-Aldrich Company Ltd.: (3-mercaptoethanol, ES cell trypsin.
2.1.1.4 Radioactive reagents
Amersham International pic.: Redivue [a-32P]-dCTP (-3000 Ci/mmole, lOmCi/ml), 
[methyl-3H]-thymidine (25 Ci/mmole, ImCi/ml).
2.1.1.5 Antibiotics
Sigma-Aldrich Company Ltd.: ampicillin, penicillin G, streptomycin.
2.1.1.6 Antisera
Caltag Ltd.: Anti-mouse IgM F(ab')2 PE-conjugated affinity purified goat IgG, anti- 
mouse CD4 PE-conjugated rat monoclonal IgG2a (clone CT-CD4), anti-mouse CD8a 
FITC-conjugated rat monoclonal IgG2a (clone CT-CD8a), anti-mouse B220 PE-
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conjugated rat monoclonal IgG2a (clone RA3-6B2), anti-mouse G(p FTTC-conjugated 
rat monoclonal IgG2b (clone RB6-8C5).
Pharmingen: Anti-mouse T200 PE-conjugated rat monoclonal IgG2b (clone 30F 
11.1), anti-mouse TCRotp FTTC-conjugated hamster monoclonal IgG (clone H57- 
597), anti-mouse TER 119 FITC-conjugated rat monoclonal IgG2b (clone TER-119), 
anti-mouse H-2Kd FITC-conjugated rat monoclonal IgG2a (clone SF1-1.1), anti- 
mouse H-2Kb PE-conjugated rat monoclonal IgG.
Promega UK Ltd.: Anti-rabbit IgG alkaline phosphatase-conjugated mouse 
monoclonal IgG
Sigma-Aldrich Company Ltd.: Anti-mouse CD5 FITC-conjugated rat monoclonal IgG 
(clone 53-7.3).
Antisera raised against DNA ligases I, ffl, and IV were kindly provided by Dr. Tomas 
Lindahl and co-workers. TL5 is a rabbit polyclonal antibody raised against purified 
full length bovine DNA ligase I, and TL6 is a rabbit polyclonal antibody raised 
against a conserved peptide present in the C-terminus of DNA ligase I (Tomkinson et 
al. 1990). TL18 is a rabbit polyclonal antibody raised against a peptide in the C- 
terminus of human DNA ligase IV, whilst TL25 is an affinity purified rabbit 
polyclonal antibody raised against recombinant full length human DNA ligase IE (T. 
Lindahl, personal communication).
2.1.1.7 Oligonucleotides
All oligonucleotides were synthesised by the Oswel DNA service. The 
sequences of all primers used are given in Table 2.1.1.
2.1.2 Media
2.1.2.1 Bacterial media
Luria Broth (LB): 1% (w/v) bacto-tryptone, 0.5% (w/v) bacto-yeast extract, and 0.5%
(w/v) NaCl, adjusted to pH 7.2 with NaOH.
Luria Agar: 1.5% agar, 1% (w/v) bacto-tryptone, 0.5% (w/v) bacto-yeast extract, and
0.5% (w/v) NaCl, adjusted to pH 7.2 with NaOH.
Terrific Broth (TB): 1.2% (w/v) bacto-tryptone, 2.4% (w/v) bacto-yeast extract, 0.4%
(v/v) glycerol, 170mM potassium dihydrogen orthophosphate, and 72mM dipotassium
hydrogen orthophosphate.
When required, ampicillin was added immediately prior to use, to a final 
concentration of 100/zg/ml.
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2.1.2.2 Mammalian tissue culture media
Glasgow's Modified Eagles Medium (GMEM) (McPherson, 1962, with 
modifications by W. House, Medical Research Council Institute of Virology, 
University of Glasgow, 1964) was used as the base culture medium for mouse and 
human fibroblast cell lines, ES cells, and haematopoietic cells.
Freezing medium for long term storage of cells consisted of the appropriate 
supplemented culture medium with additional DMSO and PCS to final concentrations 
of 10% (v/v) and 20% (v/v) respectively.
Bottom agarose was prepared by addition of equal volumes of 2X alpha medium 
and molten 1.2% (w/v) agarose. The mixture was equilibrated to 42°C before VIQ 
volume of L929 and V40 volume of API factors were added. L929 and API were a 
gift from G. Graham (Beatson Institute, Glasgow) to J. D. Ansell.
Top agarose was prepared by addition of equal volumes of 2X alpha medium 
and molten 1.2% (w/v) agarose.
Methylcellulose medium was prepared by mixing equal volumes of 2X alpha 
medium with 18% (w/v) methylcellulose, and supplemented with growth factors 
required for erythroid differentiation (Ing/ml interleukin-3, and 2units/ml 
erythropoietin).
ES cell culture medium: O.lmM p-mercaptoethanol, 5% (v/v) foetal calf serum
(PCS), 5% (v/v) new-born calf serum (NCS), IX non-essential amino acids, ImM
sodium pyruvate, leukaemia inhibitory factor, in GMEM.
Fibroblast culture medium: 10% (v/v) PCS, IX non-essential amino acids, 25U/ml
penicillin, ImM sodium pyruvate, 25/ig/ml streptomycin, in GMEM.
Serum free fibroblast culture medium: IX non-essential amino acids, 25U/ml
penicillin, ImM sodium pyruvate, 25/xg/ml streptomycin, in GMEM.
2X alpha medium: 50% (v/v) horse serum, 2mM L-glutamine, 0.45% (w/v) sodium
bicarbonate, ImM sodium pyruvate in GMEM.
Lymphocyte proliferation medium: 10% (v/v) PCS, IX non-essential amino acids,
25U/ml penicillin, ImM sodium pyruvate, 25jUg/ml streptomycin, in GMEM.
2.1.3 Bacterial strains
The E. coli strain DH5a was used for the propagation and purification of all 
plasmids. DH5cx has the genotype supE44, ^lacU169 (0 80lacZ^M15), hsdR17, 
RecAl, endAl, gyrA96, thi-1, and was first described by Hanahan 1983.
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2.1.4 Mammalian cell lines
The human fibroblast cell lines and mouse ES cell lines utilised are outlined in 
Table 2.1.2.
2.1.5 Plasmids and cloning vectors
The plasmids and cloning vector employed are described in Table 2.1.3.
2.1.6 Buffers
alkaline phosphatase buffer: lOOmM Tris-HCl pH 9.5, lOOmM NaCl, 5mM MgCl2
alkaline running buffer: 50mM NaOH, ImM EDTA
6X alkaline sample buffer: 300mM NaOH, 6mM EDTA, 18% (w/v) Ficoll (Type
400), 0.15% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanol FF
bacterial alkaline phosphatase buffer: 530mM Tris-HCl pH 7.5, 95mM MgCl2 , 50mM
DTT
CA: 24 parts chloroform, 1 part isoamyl alcohol
citrate saline: 0.6% (w/v) sodium citrate, 0.72% (w/v) sodium chloride
Coomassie stain: 0.025% (w/v) Coomassie blue R-250, 40% (v/v) methanol, 7% (v/v)
glacial acetic acid
Coomassie destain: 40% (v/v) methanol, 7% (v/v) glacial acetic acid
denaturation buffer: 0.5M NaOH, 1.5M NaCl
electroblotting buffer: 48mM Tris-HCl, 39mM glycine, 20% (v/v) methanol, pH 9.2
electroporation buffer: 21mM HEPES, 5mM D-glucose, 8mM Na2HPO4, 5mM KC1,
140mM NaCl
eosin: 75% (v/v) Hams' eosin Y aqueous solution, 25% (v/v) Hams' eosin Y
alcoholic solution, 0.5% (v/v) glacial acetic acid
FACS PBS: 0.1% BSA, 0.1% sodium azide in PBS
formalin: 10% (v/v) formaldehyde in phosphate buffered saline
formamide sample buffer: 2.3X MOPS, 50% deionized formamide, 11%
formaldehyde
gel fix: 0.6% (w/v) trichloroacetic acid, 20% (v/v) methanol, 7% (v/v) ethanol
Giemsa stain: 5% (v/v) Giemsa's stain improved R66 solution in phosphate buffer pH
6.8
guanidine hydrochloride: 6M GnHCl, lOmM DTT, 25mM EDTA
haematoxylin: 4.6% (v/v) glacial acetic acid in Harris hematoxylin solution
Hoechst stain: 5/ig/ml Hoechst 33258 stain in phosphate buffer pH 6.8
10X kinase buffer: 50mM Tris-HCl pH 7.5, lOOmM MgCl2 , lOOmM DTT, lOmM
ATP, 0.5/ig/ml BSA
L buffer: 0.1M EDTA, 0.01M Tris-HCl pH 8.0,0.02M NaCl
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10X T4 DNA ligase buffer: 200mM Tris-HCl pH 7.6, 75mM MgCl2, 50mM DTT,
250/Ag/ml BSA, 5mM ATP
2X lysis buffer: lOOmM Tris-HCl pH 8.3, 250mM NaCl, 2% NP-40, 4mM EDTA,
200mM Na2HPO4, 2mM PMSF
10X MOPS: 200mM 3-(AT-morpholino) propane-sulphonic acid (MOPS), 50mM
sodium acetate, lOmM EDTA, pH 7.0
neutralising buffer: 3M NaCl, 0.5M Tris-HCl, pH 7.0
Northern blot stripping solution: 0.01% (w/v) SDS, 0.01X SSC
oligo labelling buffer: 50jiil solution A, 125/xl solution B, 75/xl solution C
Solution A: 1.25M Tris-HCl pH 8.0, 0.125M MgCl2 , 25mM 6-mercaptoethanol, 
0.5mM each of dGTP, dATP and dTTP.
Solution B: 2M HEPES buffer adjusted to pH 6.6 with NaOH.
Solution C: Random hexadeoxyribonucleotides OD260nm=90 units/ml in TE 
PI: 50mM Tris-HCl pH 8.0, lOmM EDTA, 100jng/ml RNase A 
PE: 20mM NaOH, 1% (w/v) SDS 
PHI: 2.55M potassium acetate pH 4.8
PCA: 25 parts redistilled phenol, 24 parts chloroform, 1 part isoamyl alcohol 
10X PCR: 50mM KC1, 1.5mM MgCl2, lOmM Tris-HCl pH 8.3, 0.01% (w/v) gelatin, 
0.45% (v/v) Triton X-100, 0.45% (v/v) Tween 20 
phosphate buffer pH 6.8: 49mM Na2HPO4, 51mM NaH2PO4 
phosphate buffer pH 8.0: 95mM Na2HPO4, 5mM NaH2PO4 
phosphate buffered saline (PBS): 8mM K2HPO4 , 1.5mM KH2PO4, 150mM NaCl 
QBT: 750mM NaCl pH 7.0, 50mM MOPS, 15% (v/v) ethanol, 0.15% (v/v) Triton X- 
100
QC: 1M NaCl pH 7.0, 50mM MOPS, 15% (v/v) ethanol 
QF: 1.25M NaCl pH 8.2, 50mM MOPS, 15% (v/v) ethanol 
new methylene blue: 1% (w/v) new methylene blue in citrate saline 
3X reducing SDS sample buffer: 187mM Tris-HCl pH 6.8, 6% (w/v) SDS, 30% (v/v) 
glycerol, 0.03% phenol red, 125mM DTT
RNA solution: 0.1M Tris-HCl pH 8.9, 0.1M NaCl, ImM EDTA, 1% (w/v) SDS 
10X RT buffer: 500mM Tris-HCl pH 8.3, 60mM MgCl2 , 400mM KC1, lOmM DTT 
5X sample buffer: 20% (v/v) glycerol, lOOmM EDTA, 0.1% (w/v) bromophenol blue 
Scott's tap water: 1% (w/v) potassium hydrogen carbonate, 10% (w/v) magnesium
sulphate
SDS-PAGE running buffer: 250mM Tris-HCl, 1.92M glycine, 2% (w/v) SDS
sequencing sample buffer: 0.3% (w/v) bromophenol blue, 0.3% (w/v) xylene cyanol
FF, lOmM EDTA pH 7.5, 97.5% (v/v) deionised formamide
20X SSC: 3M NaCl, 0.3M tri-sodium citrate, pH 7.0
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Southern blot stripping solution: 1% (w/v) SDS, 0. IX SSC
10X TBE: 0.9M Tris-HCl, 0.9M boric acid, 20mM EDTA
tail buffer: 300M sodium acetate, lOmM Tris-HCl, ImM EDTA, 1% (w/v) SDS
TEST: 50mM Tris-HCl pH 7.5, 150mM NaCl, 0.05% (v/v) Tween 20
TE buffer: lOmM Tris-HCl, ImM EDTA, pH 8.0




Animals were maintained according to established animal care guidelines 
(Poole 1989), and all procedures subject to Home Office licence under the Animals 
(Scientific Procedures) Act 1986. Briefly, mice were kept under a 12 hour light/12 
hour dark cycle, with standard mouse chow and tap water ad libitum. At 4 weeks of 
age young animals were weaned into single sex cages, 1cm of distal tail tissue 
removed for genotyping, and ears marked to permit identification.
For timed matings, individually housed male stud mice were presented with 2-4 
sexually mature females overnight. The morning after, females were checked for the 
presence of a copulation plug in the vagina, the day on which a vaginal plug was 
found being designated as E0.5.
2.2.1.2 Collection of tissue samples
Peripheral blood was obtained from anaesthetised mice by bleeding from the 
eye orbit through heparinized capillary tubes. Haematocrit values were determined by 
plugging one end of a full capillary tube and centrifuging at l,500rpm for 5 minutes. 
The length of the pellet of packed red cells was measured and expressed as a 
percentage of the total length of the sample within the capillary. For reticulocyte 
staining and genomic DNA preparation, two drops of whole blood were collected into 
a microfuge tube. To produce blood smears, one drop was placed onto a clean 
microscope slide, thinly spread across the surface using a coverslip, and allowed to air
dry.
To isolate the white cell fraction for FACScan analysis, 15 drops were collected 
into lOmls of PBS. Cells were pelleted by centrifugation at l,300rpm for 6 minutes, 
the supernatant discarded, and 9mls of water added to lyse the red cells. After 10 
seconds 1ml of 10X PBS was added to arrest lysis, and the remaining cells pelleted by 
centrifugation at l,300rpm for 6 minutes. The supernatant was aspirated, the white
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cell pellet resuspended in lOmls of PBS, then spun down again, and finally 
resuspended in 200/>tl of FACS PBS.
Other tissues were dissected from mice killed by cervical dislocation. Cells were 
collected from the peritoneal cavity by repeated flushing with a large volume of PBS 
and centrifugation of the eluate at l,300rpm for 6 minutes. Bone marrow was 
collected from the femur. Surrounding muscle was stripped away, and the bone 
severed at either end as close to the knee and pelvis as possible. The cells in the 
marrow cavity were flushed out with 1ml of PBS using a syringe and 23G needle, and 
then pelleted by brief centrifugation at l,000rpm. Tissues for RNA preparation were 
snap frozen, and stored at -70°C, whilst samples to be analysed by FACScan were 
teased apart in a small volume of FACS PBS, and a single cell suspension created by 
successive passage through a 25G needle.
2.2.1.3 Dissection of conceptuses
Plugged females were killed on the required day of embryonic development, and 
the uteri were dissected out of the body cavity. The muscle layer of the uterus was 
removed, along with the Reichert's membrane and placenta, to leave the embryo and 
visceral yolk sac.
The yolk sac was removed for genomic DNA preparation, and embryonic 
peripheral blood obtained from the umbilical vessels. lOju.1 blood samples were 
diluted in 1ml of PBS to prevent clotting. Embryos were treated in a number of 
possible ways:
a) photographed under a Zeiss photomicroscope using Kodak film (100 ASA).
b) fixed whole in formalin for histologic analysis.
c) snap frozen, and stored at -70°C for RNA and protein preparation.
d) foetal liver isolated for injection into lethally irradiated recipients, or colony 
forming assays
e) foetal liver and thymic rudiment isolated for FACS analysis.
f) incubated in trypsin and disaggregated for embryonic fibroblast isolation.
Alternatively, if the yolk sacs were to be analysed, the embryo carcass was used 
for genomic DNA preparation.
2.2.1.4 Rescue of lethally-irradiated animals with foetal liver cells
Embryos were isolated from plugged females at E13.5 of development. The 
embryonic yolk sacs were removed for rapid sexing of the embryos by male-specific 
PCR. Foetal livers were dissected out into 400/d of sterile PBS supplemented with 
foetal calf serum to a final concentration of 2% (v/v), and stored on ice until the sex of 
each embryo had been determined. Single cell suspensions were then derived from
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foetal livers by snipping with scissors and passage through a 25G needle three times. 
A lOjLtl sample of each cell suspension was taken for a cell count, and the remainder 
injected into lethally-irradiated recipients.
Strain 129/Ola or 129/CBA Fl mice were used as recipients of foetal liver cell 
suspensions. Female mice aged 6 to 8 weeks were exposed to 10.5 Gy of y radiation. 
Foetal liver single cell suspensions were subsequently injected into the recipients' tail 
vein, and the animals ear marked for identification. In most cases suspensions from 
single livers were injected into single recipients. Alternatively suspensions from 
multiple embryos were injected into a single recipient, in which case suspensions 
were mixed, the cells pelleted by brief centrifugation at 1,000 rpm, and resuspended 
in 400/il of sterile PBS prior to injection. As a negative control for survival following 
irradiation, a small number of irradiated animals received no injection of cells. All 
animals received neomycin in their drinking water for the first week following 
irradiation, and their weight was monitored daily.
Blood samples were taken from those animals which survived five weeks. 
Further samples were taken two weeks later. Two months after irradiation, surviving 
animals were killed, and haematopoietic tissues removed for analysis.
2.2.2 Bacterial culture
2.2.2.1 Growth of E. coli
Cells were grown at 37°C either in suspension in LB or TB with shaking, or on 
the surface of Luria agar plates. Cells grown on Luria agar plates supplemented with 
ampicillin were incubated at 30°C to prevent growth of satellite colonies.
2.2.2.2 Storage of E. coli
For short term storage (4 to 6 weeks) bacteria were streaked onto Luria agar 
plates, and stored at 4°C. For longer term storage, 900jul of a fresh culture, grown 
overnight in LB, was mixed with 100/xl DMSO, and frozen at -70°C. Cells were 
recovered by scraping the surface of the frozen culture with a sterile inoculating loop 
and streaking onto a Luria agar plate.
2.2.2.3 Transformation of E. coli
Bacteria were transformed with plasmid DNA by the method of Mandel and 
Riga (1970) with modifications by Dagert and Ehrlich (1974). 0.5ml of an overnight 
culture of E. coli was added to 50ml of LB supplemented with MgCl2 to a final 
concentration of 20mM. Cells were grown with vigorous shaking at 37°C until the 
ODeoOnm of me suspension equalled 0.2, and the cells were in log phase growth. The 
cells were chilled on ice for 5 minutes, and then spun down at l,500rpm for 15
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minutes at 4°C. The pellet was gently resuspended in 20ml ice-cold transformation 
buffer, incubated for 30 minutes on ice, subsequently re-pelleted at l,500rpm for 15 
minutes at 4°C, and finally resuspended in 2ml ice-cold transformation buffer. The 
suspension of competent cells was then incubated on ice for a minimum of 2 hours 
prior to use.
Approximately lOng of plasmid DNA in a volume of 5-10/xl was added to 
lOOjul of competent cells, which were then incubated on ice for 30 minutes. Following 
heat shock at 37°C for 5 minutes, 400/d of warm LB was added, and the mixture 
incubated at 37°C for 1 hour to allow expression of antibiotic resistance. Thereafter, 
the cells were spread onto Luria agar plates with ampicillin selection, and incubated 
overnight at 30°C.
Where appropriate, 30/d of 2% (w/v in dimethylformamide) X-Gal and 20/il of 
lOOmM IPTG were also spread over the surface of the plate to enable blue-white 
colour selection of colonies containing recombinant plasmids.
2.2.3 Mammalian cell culture
2.2.3.1 Growth of embryonic stem cells
HM-1, a feeder independent line of murine ES cells (Magin et al. 1992b) were 
maintained in supplemented GMEM at 37°C in a 5% CO2 atmosphere in a humidified 
tissue culture incubator (Forma Scientific). Cells were prompted to adhere to flasks 
and dishes by coating the plastic surfaces with 0.1% (v/v) gelatin.
To passage cells, the medium was aspirated, the bottom of the flask or dish 
rinsed with l-2mls of trypsin, then a further l-2mls of trypsin added and incubated at 
37°C until the cells had become detached. Thereupon 5 volumes of medium were 
added, the cell suspension transferred to a sterile 50ml tube, and cells pelleted by 5 
minutes centrifugation at l,300rpm. The supernatant was discarded, and the cells 
resuspended in an appropriate volume of medium, and an aliquot transferred into a 
tissue culture flask.
For long term storage, cells were kept in liquid nitrogen. Cultures to be frozen 
were trypsinised, spun down, the supernatant removed, and cells resuspended in ice 
cold freezing medium. 1ml aliquots were placed at -20°C for 2 hours, then transferred 
to -70°C overnight, before removal into liquid nitrogen. Frozen aliquots were thawed 
rapidly at 37°C and diluted in 9mls of medium, before being pelleted by 
centrifugation at l,300rpm for 5 minutes. The supernatant was discarded, the cells 
resuspended in an appropriate volume of medium, and transferred into a flask.
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2.2.3.2 Electroporation
In order to achieve transient expression of cloned DNA sequences in ES cells, a 
circular expression vector was introduced by electroporation Cells to be 
electroporated were trypsinized, pelleted by centrifugation, and 2.0X107 cells were 
resuspended in 0.8ml of electroporation buffer. The suspension was mixed with 
200jLig of plasmid DNA in lOOptl sterile distilled water, and transferred into an 
electroporation cuvette (0.4cm electrode, Bio-Rad). The cuvette was slotted into a 
Gene Pulser (Bio-Rad), and the cells pulsed at 900V, 3/iFd capacitance. After 10 
minutes incubation at room temperature, the cells were added to 20mls supplemented 
GMEM and transferred to a flask. The pool of cells were allowed to grow for 48 
hours, whereupon the process was repeated.
2.2.3.3 Growth of mammalian fibroblasts
Human and mouse fibroblasts were maintained, passaged and stored in the 
manner outlined in section 2.2.3.1, except that plasticware was not gelatinised prior to 
use.
2.2.3.4 Isolation of mouse embryonic fibroblast strains
Primary fibroblasts were isolated from E12.5 embryos. Following dissection, 
embryos were incubated in 0.5ml trypsin for 30 minutes at 37°C. 15mls of medium 
were added, the embryo mechanically disaggregated with a pipette, and cells plated 
out into 90mm dishes. In order to derive established fibroblast cell lines, primary 
fibroblast cultures were passaged until cells lost growth potential and underwent 
"crisis". Thereupon the medium was changed periodically until an immortalised cell 
line emerged.
2.2.3.5 Pulse labelling of DNA replication intermediates
Newly synthesised DNA was labelled by incorporation of [methyl-3H]- 
thymidine. Fibroblasts were plated out into 30mm dishes in supplemented GMEM so 
that cultures were about 80% confluent 48 hours later. Dishes were rinsed twice with 
warm serum free GMEM, and then incubated at 37°C for 10 minutes in 2mls of warm 
serum free GMEM supplemented with [methyl-3H]-thymidine to a final concentration 
of 2jLtCi/ml. The medium was aspirated, and the dishes rinsed with ice cold PBS to 
stop DNA replication. A further 1ml of ice cold PBS was added and the cells 
harvested by scraping, whereupon they were transferred to a microfuge tube and 
pelleted by brief centrifugation. The supernatant was removed and the pellet 
resuspend in 20jnl of ice cold L buffer. 60/il of molten 1.5% (w/v) low melting point 
agarose was added to the suspension, mixed, and left to set on ice for 5 minutes.
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Alternatively, cells were chased with unlabelled thymidine after being pulsed. 
Following 10 minutes incubation with [methyl-3H]-thymidine, the medium was 
aspirated, and the dishes rinsed with warm supplemented GMEM plus 2mM 
thymidine. A further 2mls warm supplemented GMEM plus 2mM thymidine was 
added and the dishes incubated at 37°C for the required chase period (2, 5, 10, 15, or 
30 minutes). Subsequently, the dishes were rinsed with ice cold PBS and processed as 
above.
2.2.3.6 CFU-A assay
Numbers of primitive pluripotent haematopoietic progenitors in the foetal liver 
were estimated by an in vitro colony forming assay (Lorimore et al. 1990). 1X105 
cells from foetal liver single cell suspensions were mixed with 1ml of molten top 
agarose equilibrated to 37°C. The mixture was transferred to 30mm dishes into which 
1ml of bottom agarose had already been distributed, and allowed to set. Dishes were 
incubated at 37°C in a humidified atmosphere of 10% CO2 , 5% O2 in nitrogen for 11 
days, whereupon colony numbers and sizes were scored.
2.2.3.7 BFU-E assay
Numbers of erythroid burst forming units in the foetal liver were estimated from 
an in vitro methylcellulose colony forming assay (Freshney 1994). 1.5X105 cells from 
foetal liver single cell suspensions were mixed with 2mls of methylcellulose medium 
in 30mm dishes, and incubated at 37°C in a humidified atmosphere of 10% CO2 , 5% 
O2 in nitrogen. Colony numbers and sizes were scored after 8 days.
2.2.3.8 Lymphocyte proliferation assays
The ability of B and T lymphocytes to proliferate in response to mitogens was 
measured by incorporation of [methyl-3H]-thymidine as an indicator of total cell 
numbers. Cells from haematopoietic tissue were resuspended in supplemented 
GMEM to a concentration of 5X106 cells per ml. 100/>tl aliquots were distributed into 
round bottomed 96 well microtitre plates, and to each well a further 100/xl of 
supplemented GMEM plus mitogen was added. The mitogens employed were 
lipopolysaccharide (LPS), phytohaemagglutinin (PHA), Staphlococcus enterotoxin B 
(SEB). Plates were incubated at 37°C in a 5% CO2 atmosphere in a humidified tissue 
culture incubator for 72 hours, after which period 20/d of GMEM supplemented with 
5jLtCi/ml [methyl-3H]-thymidine was added, to a final concentration of l^iCi per well. 
Following incubation for a further 18 hours, the plates were harvested and assayed for 
3H incorporation using a filtermate system (Canberra Packard). Briefly, cells from 
each well were transferred onto GF/C membrane, which was washed and then dried
81 
CHAPTER TWO: MATERIALS AND METHODS
prior to detection of bound 3H by scintillation. A measure of the ability of 
lymphocytes to proliferate in response to mitogens was derived by comparing the 
amount of radiolabel incorporated in mitogen-stimulated samples with the level 
incorporated into control samples that had not received mitogen.
2.2.4 Nucleic acid procedures 
2.2.4.1 Nucleic acid isolation
2.2.4.1.1 Small-scale preparation of plasmid DNA
A modification of the method described by Ish-Horowicz and Burke (1981) was 
used to prepare amounts of plasmid DNA up to 10/ig. Bacteria were grown overnight 
at 37°C in 5ml LB or TB supplemented with ampicillin to a final concentration of 
50/jg/ml. 1.5ml of the culture was transferred to a microfuge tube, and the cells 
pelleted by centrifugation for 5 minutes. The pellet was resuspended in 100/il of 
solution PI, and the cells lysed by addition of 200/xl of solution P2 with 5 minutes 
incubation on ice. 150jul of cold solution P3 was added, with gentle mixing, and the 
tube incubated on ice for a further 15 minutes. Precipitated chromosomal DNA, SDS 
and protein were sedimented by centrifugation for 10 minutes in a microcentrifuge, 
and the supernatant, containing the plasmid DNA, removed to a fresh tube. The 
supernatant was centrifuged again for a further 10 minutes to remove residual debris, 
and then plasmid DNA was precipitated by addition of 1ml cold ethanol. Following 
10 minutes centrifugation, the nucleic acid pellet was washed twice with 70% (v/v) 
ethanol, vacuum dried, resuspended in 50jul sterile distilled water and stored at -20°C.
2.2.4.1.2 Large-scale preparation of plasmid DNA
For preparation of larger amounts of plasmid DNA, up to 500/xg, a column 
purification method was employed. Bacteria were grown for 24 hours at 37°C in 50ml 
of TB supplemented with ampicillin to a final concentration of 100jLtg/ml. Cells were 
pelleted by spinning at 4,000rpm for 20 minutes at 4°C. The pellet was resuspended in 
10ml of solution PI supplemented with RNase to a final concentration of 0.5jng/ml, 
and the cells lysed by addition of 10ml of solution P2 with 5 minutes incubation at 
room temperature. 10ml of cold solution P3 was added, with gentle mixing, and the 
tube incubated on ice for a further 20 minutes. Precipitated chromosomal DNA, SDS 
and protein were sedimented by centrifugation at 16,000rpm for 10 minutes at 4°C. 
The supernatant was removed promptly, filtered and applied to a Qiagen-tip 500 
column (Qiagen), previously equilibrated with 10ml of QBT buffer. After washing 
twice with 30ml QC buffer, the plasmid DNA was eluted from the column with 15ml 
QF buffer. 12ml of isopropanol was added to precipitate the DNA, which was then
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spun down at 10,000rpm for 10 minutes at 4°C. The DNA pellet was resuspended in 
400/il of sterile distilled water, prior to transfer into an microfuge tube, whereupon the 
DNA was reprecipitated with 40/d of P3 and 1ml of cold absolute ethanol. Following 
10 minutes centrifugation, the nucleic acid pellet was washed twice with 70% (v/v) 
ethanol, vacuum dried, resuspended in 200/d sterile distilled water and stored at - 
20°C.
2.2.4.1.3 Preparation of mammalian genomic DNA
DNA was prepared from mouse tail samples, embryonic yolk sacs, whole blood, 
tissue samples, ES cells and fibroblasts by the same method. Cultured cells were 
harvested by scraping in ice cold PBS, and pelleted by centrifugation at l,300rpm for 
5 minutes. Cell pellets and tissue samples were digested overnight at 37°C in TOOjul 
tail buffer supplemented with proteinase K to a final concentration of 280jug/ml. The 
supernatant was extracted twice with 700/xl PC A and vigorous shaking, and 
subsequently once with 700/il CA to remove traces of phenol. Thereupon the DNA 
was precipitated for 10 minutes at room temperature by addition of 25/xl 3.0M sodium 
acetate pH 5.0 and 700/>tl of isopropanol. Following 10 minutes centrifugation, the 
nucleic acid pellet was washed twice with 70% (v/v) ethanol, vacuum dried, 
resuspended in 200/xl sterile distilled water and stored either at 4°C in the short term 
or at -20°C for longer periods.
2.2.4.1.4 Preparation of RNA from mammalian cells
RNA was prepared using a modification of the methods described by Strohman 
et al. (1977) and MacDonald et al. (1987). Cultured cells were harvested by scraping 
in ice cold PBS, and pelleted by centrifugation at l,300rpm for 5 minutes. The cells 
were resuspended in 5mls of guanidine hydrochloride, transferred to a glass 
homogenizer and macerated prior to being transferred into a centrifuge tube. Frozen 
embryo and tissue samples were homogenized in lOmls guanidine hydrochloride with 
an Ultra-Turrax T25 homogenizer (IKA-Laboratechnik). l l^ volume of 3M potassium 
acetate, pH 5.0 and V2 volume of cold absolute ethanol were added to the 
homogenate, mixed, and the solution left at -20°C for at least 4 hours to precipitate the 
RNA. The RNA was pelleted by centrifugation at 12,000rpm for 20 minutes at 4°C, 
the supernatant discarded, and then the RNA re-precipitated twice more under the 
same conditions. The resulting pellet was suspended in 3ml of RNA solution. An 
equal volume of PCA was added and the sample extracted by vigorous shaking for 10 
minutes, followed by centrifugation at 4,000rpm for 10 minutes. RNA was 
precipitated from the aqueous layer by addition of V5 volume of 3M sodium acetate, 
pH 5.0 and 2 volumes of cold absolute ethanol. The RNA was left to precipitate for 4
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hours at -20°C and then pelleted by spinning at 12,000rpm for 20 minutes at 4°C. The 
pellet was resuspended in 0.5ml sterile distilled water, transferred to an microfuge 
tube, and reprecipitated by addition of VIQ volume 3M sodium acetate, pH 5.0, 2 
volumes cold absolute ethanol and incubation at -70°C for 15 minutes. The nucleic 
acids were pelleted by centrifugation for 10 minutes in a microcentrifuge, washed 
twice with 70% (v/v) ethanol, dried, resuspended in 50jul of sterile distilled water and 
stored at -70°C.
2.2.4.1.5 Processing of agarose plugs
Cells which had been embedded in agarose plugs were processed by an 
adaptation of the method outlined in Sambrook et al. (1989). L buffer was 
supplemented with sarkosyl NL30 and proteinase K to final concentrations of 2% 
(v/v) and 400/xg/ml respectively. 1ml of this mixture was added to the tube containing 
the plug and allowed to soak at 4°C for 2 hours. The tube was then transferred to 
37°C for 24 to 48 hours, after which time the plug was removed into 5mls of cold L 
buffer, and stored at 4°C.
2.2.4.1.6 Quantification of nucleic acids
2.2.4.1.6.1 Estimation of DNA concentration
DNA samples were diluted in 1ml of distilled water and the absorbency at 260 
and 280nm measured in a spectrophotometer (Perkin-Elmer, Lambda 15, UV/VIS 
Spectrophotometer). Double stranded DNA of concentration 50/>tg/ml has an 
OD260nm = 1-0. The ratio OD260nm/OD280nm gives an estimate of nucleic acid purity. 
For DNA, a value of around 1.8 indicates that the preparation is not significantly 
contaminated with protein or phenol..
2.2A.I.6.2 Estimation of RNA concentration
RNA concentrations were measured as for DNA. OD260nm =1-0 represents an 




The DNA to be purified was made up to a volume of at least 100/il with IX 
THE, 0.2M NaCl. 1/xl of glycogen was added to act as a carrier, and thereby increase 
the amount of DNA ultimately recovered. An equal volume of redistilled phenol 
equilibrated in Tris-HCl pH 8.0 was added, the mixture vortexed until an emulsion
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was formed, then spun down in a microfuge for 5 minutes. The aqueous phase was 
removed into a fresh tube, and lOOjLtl of butanol added to remove traces of phenol. 
The mixture was vortexed, then spun down for 1 minute and subsequently the butanol 
layer discarded. VIQ volume 3M sodium acetate pH 5.0 and 2 l /2 volumes of cold 
absolute ethanol were added, and the DNA precipitated at -70°C for 20 minutes. 
Following 10 minutes centrifugation, the nucleic acid pellet was washed twice with 
70% (v/v) ethanol, vacuum dried, and resuspended in 10/il sterile distilled water.
2.2.4.2.2 Restriction of DNA with endonucleases
DNA was digested with 5 units of the desired endonuclease per /xg of DNA, 
using buffer and temperature conditions recommended by the manufacturer. For 
double digests involving enzymes with different buffer requirements, reactions were 
either carried out under intermediate buffer conditions, or DNA was digested in two 
sequential steps separated by a DNA purification procedure. Reactions were halted by 
addition of 5X sample buffer or by heating at 65°C for 10 minutes.
2.2.4.2.3 Dephosphorylation
Bacterial alkaline phosphatase (BAP) removes 5' phosphates from DNA and 
RNA by hydrolysis. It was used to dephosphorylate linearized plasmid vectors, prior 
to insert ligation, thereby preventing vector recircularization and hence increasing the 
frequency of recombinant plasmids produced. Approximately Ing of DNA, in 90jLil of 
sterile distilled water, was mixed with lOjitl of 10X BAP buffer and 66 units of BAP. 
The reaction mix was incubated for one hour at 65°C, following which the DNA was 
purified to remove all traces of the enzyme.
2.2.4.2.4 Phosphorylation of PCR products and ligation
In order to facilitate the cloning of PCR products it was necessary to 
phosphorylate their 5' termini by means of a kinase reaction. Reactions were 
performed on gel purified PCR products in lOjul volumes containing 1/zl 10X kinase 
buffer, and l^il of T4 DNA kinase. Following incubation at 37°C for lV2 hours, a 
further IJLI! of 10X kinase buffer was added, along with linearized plasmid vector 
DNA and 2 units of T4 DNA ligase. The total volume was made up to 20jul with 
sterile distilled water, and the ligation reaction incubated overnight at 15°C, after 
which it was used to transform competent E. coli.
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2.2.4.3 Electrophoresis of nucleic acids
2.2.4.3.1 Electrophoresis of DNA in agarose gels
DNA fragments were separated on 0.8-2% (w/v) electrophoresis grade agarose 
gels containing 0.5/jg/ml ethidium bromide and IX TBE. DNA samples were mixed 
with V5 volume of 5X sample buffer prior to loading. Electrophoresis was carried out 
horizontally at l-5V/cm in a IX TBE buffer system. Hind El digested bacteriophage X 
DNA marker ladder and a lOObp DNA ladder were used as size markers. After 
electrophoresis, DNA was visualised by ultra-violet illumination.
2.2.4.3.2 Recovery of DNA from agarose gels
If DNA was to be recovered from agarose gels, low melting point agarose was 
used, and the desired section of gel excised following electrophoresis. An equal 
volume of IX TBE, 0.2M NaCl was added, and the gel melted at 65°C. 1/d of 
glycogen was added to act as a carrier, and increase the proportion of DNA ultimately 
recovered. Next, an equal volume of redistilled phenol equilibrated in Tris-HCl pH 
8.0 was added, the mixture vortexed until an emulsion was formed, then spun down in 
a microfuge for 5 minutes. The aqueous phase was removed into a fresh tube, and 
100/>il of butanol added to remove traces of phenol. The mixture was vortexed, then 
spun down for 1 minute and subsequently the butanol layer discarded. VIQ volume 3M 
sodium acetate pH 5.0 and 2l/2 volumes of cold absolute ethanol were added, and the 
DNA precipitated at -70°C for 20 minutes. Following 10 minutes centrifugation, the 
nucleic acid pellet was washed twice with 70% (v/v) ethanol, vacuum dried, and 
resuspended in lOjLtl sterile distilled water.
2.2.4.3.3 Electrophoresis of DNA in denaturing alkaline agarose gels
Single-stranded DNA replication intermediates were separated on 1% (w/v) 
electrophoresis grade agarose gels containing 50mM NaCl, 50mM NaOH, and ImM 
EDTA, according to the method outlined in Sambrook et al. (1989). Agarose plugs 
were soaked in 40/d 6X alkaline loading buffer at 37°C for 90 minutes to denature the 
DNA. Plugs and buffer were transferred into wells cut in the alkaline gel, which were 
then sealed with molten agarose prior to submersion of the gel in alkaline running 
buffer. Electrophoresis was carried out horizontally at 2V/cm in a 50mM NaOH, ImM 
EDTA buffer system for 6 hours. Hind HI digested bacteriophage X DNA marker 
ladder and a lOObp DNA ladder were used as size markers. After electrophoresis, the 
gels were neutralised by soaking in neutralisation buffer for 1 hour, and following a 
further 1 hour incubation in 0.5/ig/ml ethidium bromide solution, DNA was visualised
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by ultra-violet illumination. For subsequent detection of 3H by scintillation, the gel 
was sliced into chunks of approximately 1cm3 volume.
2.2.4.3.4 Electrophoresis of DNA in polyacrylamide gels
For enhanced resolution of DNA fragments, electrophoresis was carried out in a 
0.2mm thick 6% (w/v) polyacrylamide gel using a Sequi-Gen sequencing cell (Bio- 
Rad). Gels were made up of 50% (w/v) of urea, 6% (w/v) acrylamide/0.3% (w/v) bis- 
acrylamide in IX TBE buffer, and polymerised by addition of ammonium persulphate 
and TEMED to final concentrations of 0.1% (w/v) and 0.04% (v/v) respectively.
DNA samples were prepared for loading by addition of Vs volume of 
sequencing sample buffer, and heated to 80°C for 2 minutes. Gels were run in a IX 
TBE buffer system at SOW, at a temperature of 55°C to give maximal resolution. After 
electrophoresis, gels were laid on filter paper, covered with cling film and dried for 
two hours at 80°C under vacuum. Ladders of radiolabelled bands were visualised by 
autoradiography.
2.2.4.3.5 Recovery of DNA from polyacrylamide gels
DNA was purified from polyacrylamide gels by a modification of the 'crush and 
soak' method outlined in Sambrook et al. (1989). The relevant band was cut from the 
gel and transferred to an microfuge tube, whereupon it was crushed against the side of 
the tube. 2 volumes of elution buffer was added, and the tube incubated at 37°C 
overnight with shaking. Polyacrylamide debris was removed by centrifugation for 1 
minute, and then passing the supernatant through a large pipette tip packed with a 
Whatman GF/C filter. The DNA was precipitated by addition of 2 volumes of cold 
absolute ethanol and incubation on ice for 30 minutes. Following 10 minutes 
centrifugation, the nucleic acid pellet was resuspended in 200/xl of sterile distilled 
water, and reprecipitated by addition of Vio volume 3M sodium acetate pH 5.0 and 
2 l/2 volumes of cold absolute ethanol. After 20 minutes incubation at -70°C, the DNA 
was pelleted by 10 minutes centrifugation, washed twice with 70% (v/v) ethanol, 
vacuum dried, and resuspended in lO/xl sterile distilled water.
2.2.4.3.6 Electrophoresis of RNA in agarose gels
RNA samples were separated on denaturing 1% (w/v) agarose gels containing 
0.5/ig/ml ethidium bromide, IX MOPS and 0.66M formaldehyde. 20/*g of total RNA 
in 20/il of sterile distilled water was added to an equal volume of formamide sample 
buffer and V4 volume of 5X sample buffer. Samples were heated for 5 minutes at 65°C 
and snap chilled on ice immediately prior to loading. Electrophoresis was carried out 
in a IX MOPS buffer system at 2.5V/cm for 3-4 hours.
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2.2.4.4 Transfer of nucleic acids from agarose gels to membranes
2.2.4.4.1 DNA transfer (Southern blotting)
This procedure was originally developed by Southern (1975) and modified by 
Smith and Summers (1980). For Southern analysis of genomic DNA, 10/xg of DNA 
was cut with an appropriate restriction enzyme, and the resulting fragments were 
separated by agarose gel electrophoresis. Similarly, for quantification of PCR 
reactions, products also separated on a 1% agarose gel. The gel was soaked in 
denaturation buffer for 30 minutes preceding DNA transfer onto Genescreen Plus 
nylon membrane (New England Nuclear) by capillary action using denaturation buffer 
as the transfer medium (Reed and Mann 1985). A wick made of wet blotting paper 
was placed on a platform, with both ends of the blotting paper immersed in denaturing 
buffer in a reservoir underneath the platform. The gel was laid on top of the wick, 
bordered with cling film. A sheet of nylon membrane (previously equilibrated in 
denaturing buffer) was placed on top, overlaid by three sheets of moistened blotting 
paper and a stack of dry paper towels. A weighted glass plate was put on top of the 
paper towels. Transfer was allowed to proceed for 12-24 hours, after which time the 
membrane was neutralised for 30 minutes in neutralising buffer, and air dried.
2.2.4.4.2 RNA transfer (northern blotting)
Following electrophoresis the gel was soaked for two 20 minute periods in 10X 
SSC. Transfer was as for DNA, except that 10X SSC was used as the transfer 
medium. When transfer was complete, the membrane was rinsed in 2X SSC and 
baked for 2 hours at 80°C under a vacuum.
2.2.4.5 Nucleic acid hybridisation
2.2.4.5.1 Labelling DNA by random priming with hexadeoxyribonucleotide 
primers
Radioactively labelled DNA was obtained using the randomly primed DNA 
labelling method (Feinberg and Vogelstein 1983). This method is based on the 
hybridisation of a mixture of hexanucleotides to the DNA, and allows small amounts 
of DNA to be labelled to high specific activities. Many sequence combinations are 
represented in the hexanucleotide primer mixture, which leads to binding of primer to 
template in a statistical manner. The complementary strand is synthesised from the 3' 
hydroxyl termini of the hexanucleotide primers using Klenow polymerase, 
simultaneously incorporating radiolabelled dCTP into the newly synthesised DNA 
strand.
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DNA fragments to be labelled were purified from agarose gels. Approximately 
5ng of DNA dissolved in 32/il of sterile distilled water was denatured by boiling for 5 
minutes, followed by incubation at 37°C for 10 minutes. 10/d of oligo labelling 
buffer, 20/zg of BSA, 50/>iCi of a-32P-dCTP and 2 units of Klenow polymerase were 
added, and the mixture incubated overnight at room temperature. 4.5mg of sonicated 
herring sperm DNA was added to the probe, which was then denatured prior to 
hybridisation by boiling for 5min.
2.2.4.5.2 Hybridisation
Membranes onto which DNA had been transferred were blocked by incubation 
in 30ml of 6X SSC, 1% (w/v) SDS, and 10% (w/v) dextran sulphate with 3.5mg of 
denatured sonicated herring sperm DNA for two hours at 65°C in a hybridisation oven 
(Hybaid Ltd.). Hybridisation was performed by addition of denatured radiolabelled 
probe to the prehybridisation mixture, and incubation for a further 12-24 hours at 
65°C. Membranes to which RNA was bound were treated identically, except that 
incubations were performed at 60°C.
Following hybridisation, non-specifically bound DNA molecules were removed 
by washing. The membrane was first immersed in 2X SSC at room temperature for 5 
minutes with agitation, and then twice in 2X SSC, 1% (w/v) SDS for 30 minutes at 
either 65°C or 60°C. Finally the membrane was rinsed in 0.1X SSC for 10 minutes at 
room temperature, and sealed in a plastic bag to prevent drying out. Radioactive DNA 
molecules bound to the membrane were then visualised by autoradiography or 
phosphorimagery. If a high background to signal ratio was observed, the membrane 
was rewashed in more stringent conditions of IX SSC, 1% (w/v) SDS for 15 minutes 
at 65°C or 60°C.
2.2.4.5.3 Stripping probes from filters
Radiolabelled DNA probes hybridised to nucleic acids immobilised on nylon 
were removed by the method described in the manual supplied with Genescreen Plus 
membranes. Southern filters were boiled three times for 10 minutes in 0.1X SSC, 1% 
(w/v) SDS. Northern filters were washed five times for 3 minutes in hot 0.1X SSC, 
0.01% (w/v) SDS. Filters could then be dried and hybridisation repeated as above.
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2.2.4.6 Detection of radioactivity
2.2.4.6.1 Autoradiography
Autoradiography was performed using Cronex (Du Pont) X-ray film in a 
cassette with intensifying screens (Cronex Lightning Plus, Du Pont). Cassettes were 
stored at -70°C during exposure to slow the reversal of activated bromide crystals to 
their stable form and give an enhanced signal.
2.2.4.6.2 Phosphorimagery
Phosphorimagery was performed using a storage phosphor screen (Molecular 
Dynamics). After exposure of the screen, signals were visualised through a Molecular 
Dynamics phosphorimager, and analysed with ImageQuant software.
2.2.4.6.3 Scintillation of agarose gel pieces
1cm3 chunks of gel were transferred into scintillation vials containing l.Smls of 
0.1M HC1, and left for 1 hour. The agarose in each vial was melted by heating in a 
microwave at 600W for 40 seconds, and subsequently lOmls of Ecoscint A scintillant 
was added with vigorous shaking to form an even emulsion. A Tri-Carb 2100TR 
liquid scintillation analyser (Packard Instrument Company) was used to detect 3H 
disintegration by scintillation.
2.2.4.7 DNA sequencing
2.2.4.7.1 Dye terminator cycle sequencing
DNA sequencing was performed using an ABI PRISM dye terminator cycle 
sequencing reaction ready kit (Perkin-Elmer Corporation), on an Omnigene thermal 
cycler (Hybaid Ltd.) and extension products separated on an ABI PRISM 377 DNA 
sequencer (Perkin-Elmer Corporation).
Approximately 0.4/>ig of double stranded DNA template was mixed with 
3.2pmoles of an appropriate oligonucleotide primer and 8/d of terminator ready 
reaction mix in a final volume of 20jnl. The mixture was overlaid with a drop of 
mineral oil, and subjected to thermal cycling as follows: 96°C for 30 seconds, 50°C 
for 15 seconds, 60°C for 4 minutes, repeated for 25 cycles.
Extension products were purified away from unincorporated terminators by 
addition of 2.0/il 3M sodium acetate pH 4.8, 50/il absolute ethanol, and incubation on 
ice for 10 minutes followed by 15 minutes centrifugation. The resulting pellet was 
washed with 70% (v/v) ethanol, vacuum dried, and stored dry at 4°C prior to 
electrophoresis.
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2.2.4.7.2 Sequence analysis
Sequence analysis was carried out on a UNIX mainframe computer using the 
Genetics Computer Group (GCG) package of programs, version 9 (Genetics 
Computer Group 1996). Alignment of nucleotide sequences was performed using the 
Bestfit, Lineup, and Pileup programs, while nucleotide and protein database searches 
were carried out using Fasta and Blast functions.
2.2.4.8 Amplification of DNA by the polymerase chain reaction
All PCR reactions were carried out in 50/xl volumes in IX PCR buffer 
supplemented with EDTA and dNTPs, to a final concentration of 0.4mM and O.lmM 
respectively, and 2.5 units of Tag DNA polymerase. Approximately lOOng of DNA 
was used per reaction, along with Ing of each primer. Cycle conditions varied for 
different primers pairs, but denaturation was generally carried out at 94°C for 1 
minute, followed by 1 minute at an appropriate annealing temperature, and synthesis 
at 72°C for 1 to 2 minutes. 35-40 cycles were carried out for all genotyping PCR 
reactions. All experiments were carried out using an Omnigene thermal cycler 
(Hybaid Ltd.).
2.2.4.8.1 PCR genotyping
In order to determine the genotype of an individual, PCR reactions were 
performed on genomic DNA samples from tail or yolk sac. The sex of embryos was 
also determined by this method. Cycle conditions employed for different primer pairs 
are outlined in Table 2.2.1. 20jnl of each reaction was subjected to agarose gel 
electrophoresis, and products visualised by ultra-violet illumination.
2.2.4.8.2 Quantitative PCR
Quantitative PCR was performed in a manner similar to genotyping PCR 
reactions, except that only 20 cycles were performed. Cycle conditions employed for 
different primer pairs are described in Table 2.2.2. Ligl deleted and Ligl targeted (B) 
PCR products were each amplified as part of duplex reactions, with an independent 
reaction acting as a control for the initial amount of DNA. The Ligl deleted product 
was amplified along with a product from the wild-type mouse Ercc-1 gene, whilst the 
Ligl targeted (B) product was amplified with a product from the wild-type mouse 
Prn-p gene. The male-specific reaction was run in parallel with the wild-type mouse 
Ercc-1 reaction, although the two reactions had to be performed separately. PCR 
products were separated by agarose gel electrophoresis, transferred onto nylon 
membrane, and hybridised to 32P-labelled probes specific for the two PCR products. 
Levels of bound radiolabel were analysed by phosphorimagery, and the ratio of the
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two signals calculated. In order to estimate the percentage of an allele present in each 
sample, calculated ratios were compared against a standard curve. The standard curve 
was produced by spiking varying amounts of DNA positive for a particular allele into 
a wild-type DNA sample, and subjecting to PCR quantification in parallel to 
experimental samples.
2.2.4.8.3 Rapid screening using the polymerase chain reaction
In order to rapidly screen colonies of cultured mammalian cells, a PCR-based 
strategy that bypassed the need for DNA purification was employed (McMahon and 
Bradley 1990). When colonies were picked from dishes to be transferred into 
multiwell plates, half of each colony (circa 1,000 cells) was transferred into a 1.5ml 
microfuge tube. The cells were pelleted for by centrifugation for 30s, and the medium 
removed using a pipette. The pellet was resuspended in 40/xl IX PCR buffer to which 
proteinase K had been added to a final concentration of O.lmg/ml, and incubated at 
65°C for two hours. The proteinase K was inactivated by heating at 90°C for 15 
minutes, and 10/>tl of sample used as a template for PCR.
Rapid sexing of embryos was also achieved by a modification of this protocol. 
The embryonic yolk sac was digested by incubation at 65°C for 15 minutes in 200jul 
IX PCR buffer supplemented with proteinase K to a final concentration of Img/ml. 
The proteinase K was inactivated by heating at 90°C for 15 minutes, and lOjitl used in 
male-specific PCR reactions.
2.2.4.8.4 RT-PCR
Reverse transcription was performed on 10-20/ig of total RNA. Samples were 
made up to a volume of lO/il with sterile distilled water, heated to 70°C for 2 minutes 
to denature the RNA, then snap cooled on ice. Reactions were carried out at 43°C for 
1 hour in IX RT buffer supplemented with 0.5/il of rRNasin, dNTPs to a final 
concentration of 1.25mM, 0.1 jug of random hexamers, 25jng of oligo dT, and 30 units 
of reverse transcriptase. A second round of reverse transcription was then carried out. 
The mixture was heated to 75°C for 1 minute, snap cooled on ice, and an additional 
0.5/-11 of rRNasin and 30 units of reverse transcriptase added. After incubation at 43°C 
for a further 1 hour, the mixture was diluted with 200jiil of TE, and stored at 4°C.
Specific cDNA sequences were amplified by PCR, under the buffer conditions 
outlined in section 2.2.4.8, using 10/zl of the reverse transcription reaction product as 
a template. Cycle conditions employed for different primer pairs are outlined in Table 
2.2.3. 20/11 of each reaction was subjected to agarose gel electrophoresis, and products 
visualised by ultra-violet illumination. To amplify rare cDNA sequences, nested sets 
of primers were used in two sequential rounds of PCR. 5jLtl of the initial reaction was
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seeded into a second PCR reaction employng a pair of internal primers which bound 
within the region amplified by the first reaction.
2.2.4.8.5 Low stringency RT-PCR using sequence specific primers
Reverse transcription was performed as described in section 2.2.4.8.4, and 10/zl 
of the reverse transcription reaction product was used as a template for PCR reactions. 
Buffer conditions were as outlined in section 2.2.4.8, except that 0.5^Ci a-32P-dCTP 
was additionally included in each reaction. The cycle conditions employed were 
identical for each pair of primers: 30 seconds at 94°C, 1 minute at 42°C, 1 minute at 
72°C, 35 cycles. Details of the primer combinations tried are given in Table 5.5.1.
PCR reaction products were precipitated by addition of Vio volume 3M sodium 
acetate pH 5.0 and 2 l/2 volumes of cold absolute ethanol, and incubation at -70°C for 
20 minutes. Following 10 minutes centrifugation, the nucleic acid pellet was washed 
twice with 70% (v/v) ethanol, vacuum dried, and resuspended in lOjul sterile distilled 
water. Samples were then separated by electrophoresis through polyacrylamide gels.
Once differentially expressed bands had been identified, one further 
polyacrylamide gel was run, and exposed to autoradiography film whilst still wet. The 
desired bands were excised, and DNA purified by the 'crush and soak' method. In 
order to obtain sufficient quantities of DNA to clone, 1/xl of each purified fragment 
was subsequently reamplified by PCR. The same primer combination was used as 
employed in the initial amplification, but under higher stringency conditions: 30 
seconds at 94°C, 1 minute at 50°C, 1 minute at 72°C, 35 cycles.
2.2.5 Protein procedures
2.2.5.1 Protein isolation
Whole cell protein extracts were prepared from fibroblasts and embryos by a 
method adapted from Prigent et al. 1994. Cell pellets were incubated for 30 minutes 
on ice in an equal volume of 2X lysis buffer. Frozen embryos were homogenized 
briefly in an equal volume of 2X lysis buffer and then incubated for 30 minutes on ice. 
The lysate was centrifuged at 8,000rpm at 4°C for 15 minutes, and the supernatant 
removed into a fresh microfuge tube. Glycerol was added to a final concentration of 
30%, and the extract stored at -20°C.
2.2.5.2 Quantification of proteins
Protein concentrations were assayed using BCA* protein assay reagents 
according to manufacturers instructions. 1 volume of reagent A was mixed with 50 
volumes of reagent B, and 2mls of the mixture added to 100/il of the sample to be 
assayed. After incubation at 37°C for 30 minutes, the absorbency of the solution at
95 
CHAPTER TWO: MATERIALS AND METHODS
562nm was measured by spectrophotometry. The concentration of protein was then 
estimated by comparison with the absorbencies of a range of standards of known 
concentration.
2.2.5.3 Electrophoresis of proteins
Proteins were separated by electrophoresis through 8% SDS-polyaery 1 amide 
gels according to the method of Laemmli 1970, using an SE250 Mighty Small H slab 
gel electrophoresis unit (Hoefer). Gels consisted of a 5% stacking gel upon an 8% 
separating gel. The separating gel was poured first and was composed of 375mM Tris- 
HC1 pH 8.8, 0.1% (w/v) SDS, 7.8% (w/v) acrylamide/0.3% (w/v) bis-acrylamide 
polymerised by addition of ammonium persulphate and TEMED to final 
concentrations of 0.1% (w/v) and 0.06% (v/v) respectively. The stacking gel was 
composed of 125mM Tris-HCl pH 6.8, 0.1% (w/v) SDS, 4.9% (w/v) acrylamide/0.2% 
(w/v) bis-acrylamide polymerised by addition of ammonium persulphate and TEMED 
to final concentrations of 0.1% (w/v) and 0.1% (v/v) respectively.
Protein samples were mixed with ! /2 volume of 3X reducing SDS sample buffer 
and heated to 90°C for 5 minutes prior to loading. Prestained broad range protein 
markers were used as molecular weight markers, and were prepared analogously. 
Electrophoresis was carried out vertically at 10mA in a SDS-PAGE running buffer 
system for 2 hours or until the dye front reached the end of the gel.
Gels were either blotted onto nylon membranes or stained. Staining was 
achieved by immersing the gel in a large volume of Coomassie stain for 1 hour, and 
then in Coomassie destain overnight. Gels were subsequently laid on filter paper, 
covered with cling film and dried for two hours at 80°C under vacuum.
2.2.5.4 Transfer of proteins from polyacrylamide gels to membranes (western 
blotting)
Proteins were transferred from gels onto Immobilon P nylon membrane by 
electroblotting using a Trans-Blot SD semi-dry transfer cell (Bio-Rad). The gel and 
membrane were equilibrated in electroblotting buffer for 15 minutes. A piece of 
blotting paper, soaked in transfer buffer, was placed on the bottom electrode plate of 
the unit. On top of this was laid the nylon membrane sheet, the gel, and a second piece 
of blotting paper soaked in transfer buffer. The other electrode plate was positioned on 
top to complete the circuit, and proteins were transferred at 15V for 1 hour. In order to 
confirm that complete transfer had occurred, the membrane was immersed in Ponceau 
S solution for 1 minute, after which the colouration was washed off by rinsing in 
TEST.
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2.2.5.5 Detection of blotted proteins with antibodies
Membranes carrying transferred proteins were blocked overnight in 5% (w/v) 
skimmed milk powder in TEST at 4°C with shaking. After briefly rinsing in TEST, 
the membrane was incubated with primary antibody diluted in TEST for 1 hour at 
room temperature with shaking. The four antisera employed for western blotting were 
TL5, TL6, TL18, and TL25, all of which were raised in rabbits, and which were used 
at Aooo, /soo» /iooo> and VSQO dilutions respectively. The membrane was then washed 
three times for 5 minutes in TEST, following which it was incubated with an anti- 
rabbit IgG alkaline phosphatase-conjugated mouse IgG monoclonal antibody. The 
membrane was again washed three times for 5 minutes in TEST, before being 
immersed in alkaline phosphatase colour substrate solution. This consisted of alkaline 
phosphatase buffer supplemented with NET and BCIP to final concentrations of 
330/zg/ml and 167/ig/ml respectively. Colour was allowed to develop in the dark 
without agitation until the signal was of the required intensity, whereupon the reaction 
was stopped by rinsing with copious amounts of water.
2.2.6 Staining of cells and tissue sections 
2.2.6.1 Peripheral blood samples
2.2.6.1.1 Giemsa staining of dry samples
Embryonic peripheral blood cells were distributed onto the surface of a 
microscope slide using a cytospinner. 200/xl aliquots of diluted samples were spun at 
TOOrpm for 5 minutes, and the resulting slides allowed to air dry.
Air-dried cytospin slides and adult blood smears were fixed by brief immersion 
in absolute methanol. The slides were rinsed with copious amounts of water, and 
again left to air dry, before being bathed in Giemsa stain for 10 minutes. After rinsing 
in water, the slides were left to air dry. Permanent preservation was achieved using 
DPX mounting medium, and a coverslip.
2.2.6.1.2 Vital staining of reticulocytes
Reticulocytes were distinguished from mature erythrocytes by staining of wet 
preparations with new methylene blue. 2 to 4 volumes of 1% new methylene blue 
were added to fresh blood samples, and incubated at 37°C for 20 minutes. One drop 
of the mixture was spotted onto the middle of a clean microscope slide, and a 
coverslip positioned over the liquid. The edges of the coverslip were sealed with a 
thin layer of nail varnish to prevent evaporation, and the wet preparation examined 
under a microscope and photographed.
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2.2.6.2 Tissue histology
Embryos were fixed in formalin, embedded in paraffin and sectioned at 
onto microscope slides. Sections were stained with haematoxylin and eosin by a 
modification of Harris' method whereby a 1% acid alcohol wash is omitted. Slides 
were immersed in xylene for 5 minutes, then dipped into absolute ethanol for 20 
seconds, 95% ethanol for 20 seconds, and 70% ethanol for 20 seconds. After rinsing 
in water, the slides were stained with haematoxylin for 10 minutes, and rinsed again. 
Immersion in Scott's tap water for 30 seconds, was followed by another rinse in water, 
and then staining in eosin for 5 minutes. After one final rinse, the sections were 
dehydrated by sequential passage through 70% ethanol for 10 seconds, 95% ethanol 
for 10 seconds, and ultimately absolute ethanol for 10 seconds. Following immersion 
in absolute alcohol, the slides were cleared by dipping in xylene, and then left to air 
dry. Permanent preservation was achieved using DPX mounting medium, and a 
coverslip. Photography was performed under a Zeiss photomicroscope using Kodak 
slide film (200 ASA).
2.2.6.3 Fluorescence activated cell scanning
Fluorescence activated cell scanning (FACScanning) was used to identify 
individual cells by detection of expressed cell surface markers. FACScanning was 
performed by direct staining of single cell suspensions from haematopoietic tissues. 
Cells numbers were electronically counted (Coulter counter ZM with Channelyzer 
256, Coulter Electronics), and all samples diluted to a concentration of 1X107 cells/ml 
with FACS PBS. 100/il aliquots (approximately 1X106 cells) were distributed into 
round bottomed 96-well microtitre plates, and 20/il of an optimal dilution of the 
desired fluorochrome-linked antibody added to each. After incubation at 4°C for 30 
minutes, the volume of liquid in each well was made up to 200jLtl with FACS PBS. 
The cells were pelleted by centrifugation at SOOrpm for 30 seconds, the supernatant 
thrown off, and the cells resuspended in 200jLtl of FACS PBS. This washing procedure 
was repeated once more to remove all unbound antibody, before the cells were finally 
resuspended in 200/zl of FACS PBS, and transferred to 3ml FACS tubes.
For each sample, 25,000 to 50,000 cells were acquired using a Becton 
Dickinson FACScan, and the resulting data subsequently analysed using Lysis n 
software. FACScan analysis is based on the use of laser light (488nm wavelength) to 
excite fluorochrome molecules, which subsequently emit light of a longer wavelength. 
Two different fluorochromes were employed, each with different peak emission 
wavelengths: fluorescein isothiocyanate (FTTC) (550nm, "green"), and phycoerythrin 
(PE) (630nm, "orange"). By linking the fluorochromes to antibodies raised against cell 
surface molecules, it is possible to attach the fluorochrome to the surface of cells. Cell
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suspensions pass into the FACScanner under pressure, such that a stream of single 
cells pass through a beam of laser light. Cells to which fluorochrome-conjugated 
antibody is bound will fluoresce strongly, and the emitted light is detected by the 
FACScan. Using a combination of different fluorochrome-conjugated antibodies 
specific for different cell surface marker molecules it was possible to identify which 
markers were expressed on the surface of an individual cell, and hence to determinate 
the phenotypic identity of that cell.
Cells passing through the beam of laser light will also scatter that beam. Light 
which strikes the surface of the cell and deviates very little ("forward scatter") is used 
to measure cell size. Light which passes through the cell will be refracted and emerge 
at a different angle ("side scatter"), and is used as an indicator of internal cell 
complexity. The FACScan identifies and records the different parameters of each cell 
that passes through the laser beam.
Mature erythrocytes and dead cells were distinguished from live nucleated cells 
on the basis of their small size, and were excluded from data acquisition. Unstained 
cells can fluoresce even though no antibody is bound (autofluorescence). However, 
because the intensity of autofluorescence is weaker than emissions from bound 
fluorochromes it was possible to differentiate between the two signals. To this end, 
unstained samples were always included as a measure of the level of 
autofluorescence. It was hence possible to exclude autofluorescing cells from final 
analyses by only including data points above a determined fluorescence threshold.
Optimal dilutions of the fluorochrome-linked antibodies were deduced by 
staining cells suspensions from an appropriate control tissue. The tissue was 
processed as described, incubated with serial dilutions of the antibody, washed, and 
subjected to FACScan analysis. From the results, the optimal dilution was determined 
that gave maximal sensitivity of detection with minimal background fluorescence.
2.2.6 A Sister chromatid exchange rate assay
The number of exchanges between sister chromatids occurring during mitosis 
was assessed by differential staining of sister chromatids, using a modified 
fluorescence plus Giemsa technique after Perry and Wolff 1974, with modifications by 
Goto et al. 1978. Conditions were optimised for the study of mouse embryonic 
fibroblasts.
2.2.6A.I BrdU labelling of newly synthesised DNA
Fibroblasts were plated into 60mm dishes in supplemented GMEM plus BrdU 
to a final concentration of 10/iM, and grown at 37°C for 36-96 hours. The precise 
length of incubation time depended on the cell strain or line used, but had to be
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sufficient for two rounds of DNA replication to occur. Dishes were kept in the dark to 
prevent light-induced chromosome breakage.
2.2.6.4.2 Metaphase chromosome preparation
Next, colcemid was added to a final concentration of 0.135/>tM, and the dishes 
incubated at 37°C for an additional 4 hours. Cells were detached from the dishes 
using trypsin, pelleted by centrifugation at l,000rpm for 5 minutes, and the 
supernatant poured off. The cells were gently resuspended in 5mls of hypotonic KCI 
solution and incubated at 37°C for 15 minutes. After being pelleted by spinning at 
1,000 rpm for 5 minutes, the cells were gently resuspended in 5mls of Carnoy 
fixative. Following incubation at room temperature for 20 minutes, the cells were 
again pelleted, resuspend in 5mls of Carnoy fixative, and incubated at room 
temperature for 20 minutes as before. Finally, the suspension was centrifuged again, 
the cells resuspended in O.Smls of Carnoy fixative, and then dropped onto a clean 
microscope slide. The slides were left to air dry before staining.
2.2.6.4.3 Differential staining of sister chromatids
Slides were immersed in Hoechst stain for 15 minutes at room temperature, 
rinsed in phosphate buffer pH 8.0, then mounted in phosphate buffer pH 8.0. Nail 
varnish was used to temporarily fix a coverslip onto the slide and prevent evaporation 
of the buffer. Spreads were exposed to a "blacklight" (18W Blacklight blue special 
fluorescent lamp, Philips. Peak emission: 365nm) at a distance of 5cm for 30 minutes 
at 55°C. The coverslip was removed, and the slide incubated in 2X SSC for 2 hours at 
65°C. Subsequently, the slide was rinsed in phosphate buffer pH 6.8, and stained for 
30 minutes in Giemsa stain. After rinsing in water, and air drying, slides were 
mounted with DPX mounting agent under a coverslip. Ultimately, metaphase spreads 
were photographed, and the number of sister chromatid exchanges counted. 
Photography was performed with a Zeiss photomicroscope using Kodak Technical 
Pan film (25 ASA) and a green filter to enhance contrast.
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One human patient has been identified with reduced DNA ligase I enzyme 
activity correlating to missense mutations within the protein coding sequence. Gene 
inactivation was the first step of a 'double replacement' strategy to introduce 
analogous mutations into the mouse DNA ligase I gene. Utilising positive-negative 
selection in the HPRT-deficient ES cell line HM-1, exons 23 to 27 of Ligl were 
replaced with an HPRT minigene. Targeted ES cells were injected into host Balb/c 
blastocysts. The resulting germ line chimaeras were outbred with Balb/c mice to 
produce mice heterozygous for the targeted allele (Jessop 1995, Bentley et al. 1996). 
Heterozygotes were phenotypically normal. This suggested that a single active allele 
of DNA ligase I is sufficient for all cellular requirements, and was consistent with the 
recessive nature of DNA ligase I-deficiency in humans. However, when interbred, no 
pups homozygous for the targeted allele were found. It was thus concluded that the 
absence of DNA ligase I is developmentally lethal. This chapter describes the 
phenotype of embryos homozygous for the targeted Ligl allele, and work to 
characterise the developmental defect arising from the absence of DNA ligase I.
This work was carried out in association with Jim Selfridge, Kay Samuel, 
Helen Taylor, Nicholas Hole and John Ansell and published in Nature Genetics (13: 
489-491). A reprint of the paper is included at the rear of this thesis. Kay Samuel 
carried out all FACScan cell acquisition procedures.
3.1 PCR genotyping of embryos
In order to identify which embryos carried the targeted Ligl allele, genotyping 
PCR reactions were carried out on genomic DNA prepared from embryonic yolk sacs. 
Two reactions were carried out on each sample: one specific for the targeted Ligl 
allele, and one specific for the wild-type Ligl allele.
The PCR reaction used to screen for the presence of the targeted allele was the 
same reaction that had been initially used to screen ES cell colonies following gene 
targeting, and which had subsequently been used to follow the allele during breeding. 
One primer (262W) was specific for the 3' end of the HPRT minigene, and the other 
(G1022) specific for the 3' flanking region of the Ligl gene. This second primer was 
specific for endogenous sequence outwith the targeted region, and consequently, only 
the correctly targeted allele could give rise to a 1.8kb PCR product (Figure 3.1.1).
A second PCR reaction was used to screen for the presence of the wild-type 
allele. One primer (N2469) was specific for exon 22 of the Ligl gene, and the other 
(M5176) specific for exon 23. Because exon 23 is replaced by the HPRT minigene 
during targeting, the targeted allele will not give a product with this primer pair. 
Hence, the 1.5kb product from this reaction is diagnostic of the wild-type allele 
(Figure 3.1.1).
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Figure 3.1.1: Schematic representation of the Ligl gene targeting strategy
Schematic representation of 13.9kb at the 3' end of the wild-type mouse DNA 
ligase I locus, targeting vector and gene structure following homologous 
recombination. Recombination occurs between the wild-type Ligl allele and the two 
regions of Ligl homology contained within the targeting vector (MLTV). The result is 
that a region of the endogenous DNA ligase I gene, containing the last five exons, is 
replaced with an HPRT minigene. In correctly targeted cells, no other part of the 
vector should be inserted into the genome, and therefore the thymidine kinase gene is 
lost along with other vector sequences. The targeted gene lacks the final five exons, 
but still retains 3' flanking sequences
Drawn to scale: 1cm = 2kb. Solid boxes indicate exons (numbered according to 
the human convention); hatched box, HPRT minigene (PGK-HPRT); stippled box, 
Herpes simplex virus thymidine kinase (PGK-ffc) cassette; thin lines, Ligl introns or 
flanking regions; thick line, plasmid vector DNA. Arrows indicate the positions at 
which PCR primer pairs used for genotyping bind. BairiHl restriction sites are marked 





















































































































































































































































Figure 3.1.2: PCR genotyping reaction products
The products of PCR genotyping reactions for the wild-type and targeted Ligl 
alleles. Genomic DNA prepared from ES cells, embryo yolk sacs and isolated 
fibroblast lines was used as a template for PCR reactions carried out using primer 
pairs N2469+M5176, and 262W+G1022, and the products separated by agarose gel 
electrophoresis. The 1.8kb product indicated by an arrow is specific for the targeted 
allele, whilst the 1.5kb product indicated by an asterisk is specific for the wild-type 
allele. Samples used were as follows: HM-1, wild-type ES cell line; #53, HM- 
\ILigllPGK-HPRT #53 ES cell clone; +/+, +/-, and -/- representative midgestation 
embryos; PFL10T, PFL13T, and PF20T, embryonic fibroblast lines (see Chapter 5). 
























































































By performing PCR assays for both the wild-type and targeted Ligl alleles, it 
was possible to determine the genotype of each embryo. Wild-type mice (+/+), 
homozygous for the wild-type allele, gave a signal only from the wild-type Ligl 
reaction. Those embryos homozygous for the targeted allele (-/-) would only produce 
a positive result from the targeted Ligl reaction, whilst heterozygotes, carrying both 
alleles, were positive for both reactions (+/-). Figure 3.1.2 shows the results of PCR 
genotyping analysis performed on samples of the three different genotypes.
3.2 DNA ligase I is not essential for cell viability
In order to define the stage of embryonic development at which the absence of 
DNA ligase I resulted in lethality, embryos ranging from day 10.5 to day 16.5 
postcoitum (E10.5-E16.5) were collected from matings between heterozygous mice, 
and genotyped. Contrary to expectation, embryos homozygous for the targeted Ligl 
allele were observed most of the way through development (Table 3.3.1).
Live embryos of the three genotypes were obtained in the expected ratios at
^E10.5 [% 2 = 0.74 (NS)], indicating that there was no significant loss of any one 
genotype before day 10 of development. Furthermore, there was no significant loss of 
any genotype between El 1.5 and El5.5. Even at day 15 of development numbers of 
live embryos of the three genotypes did not depart significantly from the expected 
ratios [%22 = 3.8 (NS)]. However, whilst the majority of -/- embryos survived up to 
E15.5, all nine -/- embryos isolated at E16.5 were dead, as determined by the absence 
of a detectable foetal heartbeat.
Heterozygous embryos were indistinguishable from mice homozygous for the 
wild-type allele, and throughout the investigations reported in this thesis no 
differences were observed between +/- and +/+ samples. Hence, heterozygotes were 
regarded as 'wild-type', and, unless otherwise stated, the category 'wild-type' includes 
data from heterozygous samples.
3.3 Phenotype of -/- embryos
At E10.5 -/- embryos were visually indistinguishable from their wild-type and 
heterozygous siblings. Examination of embryonic carcasses revealed no detectable 
abnormalities or differences from wild-type, and no significant abnormalities were 
observed in the yolk sac of -/- embryos (data not shown).
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Embryos were isolated from matings between heterozygous mice and genomic DNA 
prepared from the embryonic yolk sacs for PCR genotyping. Ligl genotypes were 
determined as indicated in section 3.1. To determine if the ratios of the three 
genotypes deviated significantly from the expected Mendelian ratios, chi-squared tests 
were carried out. Calculated values were compared against a table of %2 distribution to 
determine the level of significance.____________________________
However, at El 1.5 all -/- embryos were paler in colour and slightly smaller than 
normal (Figure 3.3.la). As development proceeded, these differences became 
exacerbated. By day 15 of development -/- embryos displayed a strikingly abnormal 
phenotype (Figure 3.3.Ic and e), having a pallid appearance, and being smaller than 
their wild-type siblings.
Although small, -/- embryos appeared grossly normal (Figure 3.3.1e). 
Histological examination confirmed that, with the exception of the developing liver, 
organogenesis was not perceptibly affected (data not shown). The embryonic liver, 
appeared disproportionately reduced in size when compared to controls.
The pallor observed indicated severe anaemia, and this was further supported by 
the observation of reduced numbers of circulating red blood cells (erythrocytes) 
visible in the yolk sac blood vessels of -/- embryos. Cell counts performed on samples 
of blood taken from embryos between El 1.5 and E15.5 revealed a dramatic reduction 
in density of cells in the peripheral circulation of -/- embryos (Table 3.3.2). By the 
sixteenth day, concentrations of cells in samples from -/- embryos was down to 4% of 
those in age-matched controls. Assuming the total volume of plasma to be similar in 
both genotypes, there were therefore significantly fewer total erythrocytes in the 
peripheral circulation of -/- embryos at E15.5.
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Blood samples were taken from the peripheral circulation of wild-type and -/- 
embryos between El 1.5 and E15.5 and diluted into PBS. Cell numbers were counted 
using a haemocytometer, and the concentration of cells per millilitre of blood 
calculated. All values are expressed as cell concentrations per ml of blood, and are the 
mean values derived from at least three independent samples (± standard error). The 
density of -/- cells was also expressed as a percentage of the age-matched control.
3.3.1 Foetal liver erythropoiesis is severely disrupted
In the mouse embryo, blood cell production (haematopoiesis) begins in the yolk 
sac at day 7 of development, but is limited to the production of primitive, nucleated 
erythrocytes. Shortly afterwards haematopoietic stem cells (HSCs) from the AGM 
region colonise the foetal liver (Medvinsky et al. 1996), and haematopoiesis is 
initiated, with a concurrent decline in yolk sac erythropoiesis. The result is that at 
E10.5 the focus of erythropoiesis in the developing embryo shifts from the yolk sac to 
the foetal liver. From El 1.5 onwards, the liver is the major site of erythropoiesis, and 
remains so until birth, during which period erythroid cells can comprise up to 70% of 
the total liver mass (Metcalf and Moore 1971).
Livers from mid-gestation -/- embryos were disproportionately reduced in size, 
and contained consistently fewer total cells (Table 3.3.3). Differences in total cell 
numbers between wild-type and -/- livers increased over the course of development, 
so that by E15.5 -/- livers contained less than a third of the wild-type value. At this 
stage sections through the developing liver also appeared radically different. 
Normally, cells of the erythroid lineage cluster into 'blood forming islands', which 
could be identified in cross-sections through wild-type livers (Figure 3.3.2a). E15.5 -/- 
livers contained far fewer identifiable erythroid cells, with no discernible blood 
forming islands, giving an overall appearance of acellularity (Figure 3.3.2b). 
Nevertheless, liver hepatocytes appeared normal, as did megakaryoctes.
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Figure 33.1: External morphology of mid-gestation embryos
Comparison of the phenotype of -/- embryos with age-matched wild-type 
embryos. Embryos were isolated from matings between heterozygous mice and 
photographed prior to PCR genotyping.
a) Morphology of wild-type (left) and -/- (right) siblings at El 1.5. The -/- 
embryo was paler and slightly smaller than its sibling.
b, c) Morphology of wild-type (b) and -/- (c) conceptuses at E15.5 before 
dissection of embryos from the yolk sac, and placenta. -/- conceptuses exhibited a 
profound pallor, and reduced numbers of red blood cells were visible in the yolk sac 
blood vessels.
d, e) Morphology of wild-type (d) and -/- (e) embryos at E15.5 after dissection 
from the yolk sac. The -/- embryos were pale, smaller than their wild-type siblings, 
and the liver was disproportionately reduced in size, but were otherwise 
developmentally normal.
(q
Figure 3.3.2: Foetal liver histology
Histology of livers from wild-type and -/- El5.5 embryos. Embryos were fixed 
in formalin, sectioned, and then stained with haematoxylin and eosin. The wild-type 
liver contained numerous islands of erythropoietic cells (bracketed), and 
megakaryocytes (asterisked). The -/- liver lacked extensive cellularization and 
contained no readily identifiable erythropoietic islands. There was no evidence of 
increased apoptosis, hepatocytes appeared normal, and megakaryocytes (asterisked) 
were present in normal numbers (D. Harrison, data not shown).
&£££$*@a
&4iHC&i!ft
Figure 3.33: Incidence of nucleated erythrocytes in the embryonic circulation
The percentage of nucleated erythrocytes in wild-type and -/- embryonic blood. 
Cytospin preparations were made from blood samples from the peripheral circulation 
of wild-type and -/- embryos between El 1.5 and E16.5, and stained with Giemsa. The 
numbers of nucleated cells were scored, and this expressed as the percentage of total 
cells. The percentage was then plotted against developmental age for both -/- and 
wild-type samples. For each point, a minimum of 500 cells from at least two separate 
embryos were scored. Error bars indicate the standard deviation at each sample point. 
• , wild-type; ^ , -/-.
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Figure 3.3.4: Cytospin preparations of embryonic peripheral blood
Cytospin preparations of embryonic blood samples were made from wild-type 
and -/- El5.5 embryos, and stained with Giemsa. Blood from wild-type embryos 
consists predominantly of mature, enucleated liver-derived erythrocytes, although a 
few residual nucleated yolk sac-derived erythrocytes were present. In contrast, 
samples from -/- embryos displayed an elevated ratio of nucleated to enucleated 
erythrocytes. Those enucleated cells present display poikilocytosis and anisocytosis, 
with microcytes (arrowhead) and macrocytes (arrow) evident.
r«
Haematopoiesis in the foetal liver is distinct from that occurring in the yolk sac 
in several ways; blood cell production is not limited to erythropoiesis, the erythrocytes 
do not mature in a synchronous manner, and production is responsive to stimulation 
by erythropoietin. However, the most visible difference is the production of mature, 
enucleated erythrocytes as opposed to nucleated erythrocytes. As development 
proceeds and erythropoiesis shifts from the yolk sac to the foetal liver, there is a 
resulting change in the proportion of nucleated cells in the peripheral blood.
Emergence of the anaemia phenotype correlated very closely with the shift of 
the major site of haematopoiesis from the yolk sac to the foetal liver. Therefore, in 
order to investigate the nature of the anaemia further, we examined the peripheral 
blood from embryos derived from heterozygous matings at days 11 to 16 of 
development. Examination of cytospin preparations revealed a deficiency of mature 
enucleated erythrocytes in -/- embryos. The percentage of nucleated erythrocytes in 
the peripheral circulation of wild-type embryos showed a decrease characteristic of 
the shift in erythropoiesis from the yolk sac to the foetal liver. However, samples from
-/- embryos did not show the normal decrease, and the percentage of nucleated 
erythrocytes remained high even until E15.5 (Figure 3.3.3). The high percentage of 
nucleated cells could be seen clearly in blood samples from El5.5 embryos stained 
with a Romanowsky stain (Figure 3.3.4). Wild-type blood consisted predominantly of 
mature, enucleated liver-derived erythrocytes, although a few residual nucleated yolk 
sac-derived erythrocytes were present. In contrast, samples from -/- embryos were 
predominantly composed of nucleated cells, with very few enucleated erythrocytes. 
Many of those enucleated cells present also displayed abnormal features. There was 
variability in shape (poikilocytosis) and size (anisocytosis), with microcytes 
(erythrocytes smaller than normal) and macrocytes (erythrocytes larger than normal) 
evident. Some red cells were also observed to include nuclear remnants in the form of 
Howell-Jolly bodies.
These results demonstrated a severe disruption to foetal liver erythropoiesis, 
resulting in severe anaemia. Because erythrocytes are crucial to transport of oxygen 
around the body, acute anaemia will result in reduced oxygen supply to respiring 
tissues (hypoxia). In the absence of any other visible abnormalities it is postulated that
-/- embryos die as a result of hypoxia secondary to the anaemia.
3.3.2 Numbers of haematopoietic progenitors in the foetal liver are reduced
The observed disruption to foetal liver erythropoiesis in -/- embryos could have 
been due to a number of factors, including failure of HSCs to migrate efficiently to the 
liver. To test for the presence of haematopoietic precursors in the foetal liver, we
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performed an in vitro colony-forming assay. Single-cell suspensions from -/- and wild- 
type livers were plated under growth conditions optimised for primitive multipotent 
(CFU-A) haematopoietic progenitors. Colonies were formed by suspensions from -/- 
livers (Table 3.3.3), indicating that haematopoietic progenitor cells were present. At 
El 1.5, numbers of total cells and multipotent progenitors in -/- foetal livers were not 
significantly reduced. However, as development proceeded, both total cell numbers 
and numbers of CFU-A progenitors were significantly reduced in -/- embryos 
compared to age-matched controls. At E13.5 there were approximately 3-fold fewer 
total cells and 4-fold fewer CFU-A progenitors, and by E15.5 these differences had 
increased with 4-fold fewer total cells and 5-fold fewer CFU-A progenitors in -/- 
livers. Qualitative scoring at each developmental stage also revealed CFU-A colonies 
derived from -/- livers to be smaller on average than wild-type colonies, although cell 
morphology appeared normal (data not shown).
3.3.3 Numbers of erythroid progenitors in the foetal liver are reduced
To test for the presence of erythroid precursors in the foetal liver, we performed 
another in vitro colony-forming assay. Single-cell suspensions from -/- and wild-type 
E13.5 livers were plated under growth conditions optimised for erythroid (BFU-E) 
progenitors. BFU-E colonies were formed by suspensions from -/- livers (Table 3.3.4), 
indicating that cells committed to erythroid differentiation were present. However, 
significantly reduced numbers of colonies were formed from -/- embryos compared to 
age-matched controls, there being approximately 3-fold fewer BFU-E progenitors in - 
/- livers. Qualitative scoring again revealed colonies derived from -/- livers to be 
smaller on average than wild-type colonies, although cell morphology once more 
appeared normal (data not shown).
3.3.4 Non-erythroid haematopoietic lineages are not diminished
Although numbers of pluripotent progenitors were depleted in -/- livers, 
numbers of megakaryocytes observed in histology sections were not reduced. Hence it 
was possible that, despite a drop in the number of CFU-A progenitors, numbers of 
terminally differentiated non-erythroid haematopoietic cells were not diminished. To 
this end samples from El5.5 foetal livers were subjected to FACScan analysis using 
fluorochrome-conjugated antibodies raised against T200, B220, IgM, IgD, CD3, CD4, 
CDS, TCRccp, G(|), and Ter-119 cell surface markers. Each molecule is expressed by a 
defined subset of haematopoietic cells, and it is thus possible to categorise any cell by 
the combination of cell surface markers which it expresses. Cell suspensions from 
wild-type and -/- foetal livers were incubated with combinations of fluorochrome- 
conjugated antibodies raised against the different markers. After washing to remove
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unbound antibodies, samples were analysed by FACScan. However, the presence of 
large numbers of erythroid cells in foetal liver samples (especially wild-type samples) 
resulted in high levels of autofluorescence and non-specific binding of antibodies. 
This precluded analysis of small populations of terminally differentiated cells. Only 
populations positive for the either B220 or T200 markers were present in sufficient 
numbers to be analysed. B220 is expressed on all cells committed to the B lymphoid 
lineage, while T200, which is equivalent to CD45 in humans, is present on all non- 
erythroid haematopoietic cells. In each case, an electronic gate was used to isolate the 
population of positive staining cells from unstained. The number of cells within this 
gate was expressed as a percentage of the total sample, and was also used to estimate 
the total number of positive cells per foetal liver (Table 3.3.5).
Percentages of T200- and B220-positive cells in samples from -/- livers were 
higher than in the corresponding wild-type samples. However, when differences in the 
total cell count per foetal liver were taken into account, the total numbers of T200- 
positive non-erythroid haematopoietic cells and B220-positive B lineage cells were 
approximately normal. These data suggest that, in contrast to the erythroid lineage, 
members of non-erythroid lineages were relatively unaffected by the lack of DNA 
ligase I.













Estimates of the numbers of erythroid committed progenitors in wild-type and -/- 
El3.5 foetal livers. Cell suspensions were produced from wild-type and -/- foetal 
livers at E13.5, and the number of single cells counted. Equal numbers of single cells 
(cell equivalents) were plated out in conditions optimised for the proliferation and 
differentiation of erythroid progenitors. Numbers of colonies were scored after 8 days, 
and the total number of burst forming units per foetal liver calculated. All numbers 
are expressed per foetal liver, and are the mean values derived from at least three 
independent samples (± standard error). As a qualitative assessment of colony size, 
the number of 'large 1 (++) colonies was scored, and expressed as a ratio to the number 
of 'normal' (+) colonies. Statistical comparisons of the sample means were carried out 
using the Student's t-test (two tailed). Calculated values were compared against a table 
of the distribution of t to determine the levels of significance (P).
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Estimates of the numbers of non-erythroid (T200+ve) and B lineage (B220+ve) cells 
per El5.5 foetal liver. Single cell suspensions were produced from wild-type and -/- 
foetal livers and subjected to FACScan analysis. Samples were stained either with a 
PE-conjugated rat monoclonal antibody raised against the mouse cell surface marker 
T200, or with a PE-conjugated rat monoclonal antibody raised against mouse B220 
cell surface marker. For each sample 25,000 to 50,000 cells were analysed. The 
percentages of cells stained positive in each sample were multiplied by the total 
number of cells per foetal liver to estimate the total numbers of cells expressing T200 
or B220 in the whole foetal liver. Figures represent mean values from at least three 
independent samples (± standard error).
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CHAPTER FOUR:
RESCUE OF LETHALLY-IRRADIATED 
RECIPIENTS WITH HAEMATOPOIETIC CELLS
FROM -/- EMBRYOS
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Embryos lacking DNA ligase I developed normally to mid-term. Thereupon 
disruption to foetal liver erythropoiesis resulted in acute anaemia and prenatal death. 
Haematopoietic progenitor cells were present, as were cells committed to the 
erythroid lineage, but there was a deficiency of terminally differentiated erythrocytes. 
To determine whether this problem arose from a specific block in erythropoiesis we 
employed in vivo repopulation analysis.
A controlled dose of gamma (y) radiation ablates the haematopoietic system of 
adult mice. Without further treatment, the mice will die approximately 14 days after 
irradiation. However, it is possible to rescue lethally-irradiated mice by introduction 
of haematopoietic stem cells (HSCs). HSCs are, by definition, able to differentiate 
into any one of the 8 haematopoietic lineages and hence are able to repopulate the 
haematopoietic system of irradiated mice. Furthermore, by looking at the 
contribution of donor-derived cells to the haematopoietic system of rescued mice it is 
possible to study haematopoietic differentiation in an adult environment. Using foetal 
livers from Ligl -I- embryos as a source of HSCs, it would thus be possible to 
investigate the effects of the absence of DNA ligase I on mature haematopoietic cells, 
and determine whether the embryonic phenotype observed was due to an intrinsic 
defect in haematopoietic development.
This chapter describes efforts to rescue lethally-irradiated mice by injection of 
cell suspensions from DNA ligase I-deficient foetal livers, and characterisation of the 
surviving animals. Work was carried out in collaboration with Kay Samuel, Martin 
Waterfall and John Ansell. Kay Samuel performed all eye bleeding and y-irradiation 
procedures, and, together with Martin Waterfall, assisted FACScan analysis. 
Elements of this work have been published in Nature Genetics (13: 489-491), a 
reprint of which is included at the rear of this thesis.
4.1 Foetal liver cell suspensions from single Ligl -I- embryos were unable to 
rescue lethally-irradiated mice
Cell suspensions were produced from livers of E13.5 embryos, and injected 
intravenously into y-irradiated recipients. Donor embryos were isolated from timed 
matings between heterozygotes from either an outbred stock, where 129/Ola founder 
chimaeras had been crossed to strain Balb/c females and the offspring interbred, or 
from an inbred strain where the mutation was maintained on a 129/Ola background. 
In each case individual recipients received cells from a single donor liver (liver 
equivalents). In total, suspensions from wild-type livers were injected into 13 
recipients, and seven mice received cells from -/- embryos. Five irradiated animals 
received no donor cells, and hence acted as negative or irradiation controls. After one 
month 85% of the animals which had received wild-type cells remained alive, but
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none of the recipients of liver suspensions from -/- embryos survived (Table 4.1.1). 
Thus liver equivalent numbers of -/- cells were unable to rescue lethally-irradiated 
mice, indicating that disruption to foetal liver erythropoiesis is not simply the 
consequence of an inappropriate foetal hepatic microenvironment.
























Numbers of y-irradiated mice surviving after injection of foetal liver cell suspensions. 
Single cell suspensions were produced from individual wild-type and -/- E13.5 livers, 
and injected into the tail vein of mice exposed to 10.5 Gy of y radiation. Cell 
suspensions from inbred donors were injected into strain 129/Ola recipients, while 
suspensions from outbred donors were injected into 129/CBA Fl recipients. Because 
numbers of inbred -/- embryos were limited, the majority of data (10/13 wild-type 
and 5/7 -/- recipients) is derived from outbred donors. There was no apparent 
difference between inbred and outbred results. Numbers of mice surviving after 4 
weeks were recorded. All irradiated but uninjected control mice died within 3 weeks.
4.2 H-2K haplotype analysis of heterozygous mice
Although liver equivalent cell numbers from -/- embryos were unable to rescue 
lethally-irradiated mice, it was hypothesised that cell equivalent numbers would be 
able to effect rescue. Undertaking such an experiment required injection of cell 
suspensions from multiple -/- livers into a single recipient. However, because of the 
problems associated with breeding inbred 129/Ola mice it proved impossible to 
generate the large numbers of mice demanded. It was therefore necessary to employ 
outbred donors, and immunologically compatible recipients. Outbred donor 
heterozygote stocks had a heterogeneous heritage, being a mix of 129/Ola and Balb/c 
of uncertain proportions. A preliminary experiment utilising 129/Ola X Balb/c Fl 
mice as recipients unfortunately did not produce the expected number of survivors; 
only 3 out of 8 recipients of wild-type cells, and 1 out of 3 recipients of -/- cells 
survived four weeks (data not shown). The reason for this failure is discussed further
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in Chapter 7. In order to avoid this problem and maximise survival, we determined to 
use either inbred 129/Ola or Balb/c mice as recipients.
Rejection of tissue transplants between mouse strains is controlled 
predominantly by cell surface antigens encoded by the major histocompatability 
complex locus (termed H-2 in mice). The K gene within the H-2 locus has a number 
of different possible alleles, and Balb/c strain mice possess the "d" allele, while 
129/Ola mice carry the "b" allele. The outbred heterozygote stock population would 
therefore be comprised of mice of bb, dd and bd genotypes. To ascertain which mice 
were homozygous for one or other of the alleles, and which could hence be mated to 
produce only bb or dd offspring, we undertook H-2K haplotype analysis of the 
heterozygous stock mice.
Haplotyping was performed by FACScanning. H-2K encodes an MHC class I 
molecule expressed on the surface of most cells, and cells expressing this antigen 
will be recognised by antibodies raised against the H-2K gene product. Blood 
samples were taken from adult mice under anaesthetic, the red blood cells lysed, and 
the remaining white cell fraction collected. Cells were incubated with an FTTC- 
conjugated antibody raised against the H-2Kb cell surface molecule and a PE- 
conjugated antibody raised against the H-2Kd product. After washing to remove 
unbound antibodies, samples were examined for "green" and "orange" fluorescence 
by FACScan analysis. Mice homozygous for the b allele only express that allele, so 
cells will only bind antibodies against the H-2Kb product, and will fluoresce green. 
Similarly, samples from mice homozygous for the d allele will only bind the orange 
fluorescent anti-H-2Kd antibodies. Heterozygous mice express both alleles, and 
hence cells stain both green and orange. In this manner it was possible to infer the H- 
2K genotype of each mouse.
In total 12 male and 37 female Ligl +/- mice were typed on the basis of H2K 
expression. 2 males and 6 females were positive for expression of both b and d 
alleles, and were therefore bd heterozygotes. The remainder of the animals (10 
malesand 31 females) proved to be b haplotype, and thus homozygous for the H-2K b 
allele.
None of the animals tested were d haplotype. This asymmetric distribution of 
genotypes within the population was presumed to arise from a 'founder effect'. The 
stock population was derived from a small number of progenitor animals. 129/Ola 
founder chimaeras were crossed to strain Balb/c females, and offspring carrying the 
targeted Ligl allele interbred. Subsequent generations were produced by selection 
and successive interbreeding of Ligl +/- mice (although without a defined inbreeding 
strategy), which could readily have given rise to the distribution observed. Linkage 
between the H-2 locus and Ligl was ruled out because the former is located on
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chromosome 17, whilst the latter maps to chromosome 7 (Mouse Genome Database 
1997).
4.3 Liver suspensions from multiple Ligl -I- embryos were able to rescue 
lethally-irradiated mice
The 10 males and 31 females found to be homozygous for the H-2Kb allele 
were set up in timed matings. Plugged females were killed 13 days later and embryos 
isolated as donors for in vivo repopulation analysis. All embryos were theoretically 
homozygous for the H-2Kb allele, and thus immunologically compatible with the use 
of strain 129/Ola mice as recipients (b haplotype). Ligl -I- embryos were 
differentiated from wild-type embryos on the basis of visible anaemia.
Foetal livers were dissected into sterile PBS supplemented with PCS and stored 
on ice, while embryonic yolk sacs were used for rapid sexing of embryos by PCR. 
The yolk sacs were digested in IX PCR buffer supplemented with proteinase K, then 
the enzyme heat inactivated, and a small sample used as a template for the male- 
specific PCR reaction. The male-specific PCR reaction amplifies part of the coding 
sequence of the Zfy-1 gene (Kunieda et al. 1992), which is located on the Y 
chromosome, and hence only samples from male embryos should give a product. 
PCR sexing revealed 16 out of 31 embryos to be male (data not shown).
When the sexes of embryos had been determined, stored foetal livers were 
disaggregated to produce single cell suspensions, and cell counts were performed. 
The single cell suspensions were injected intravenously into y-irradiated female 
129/Ola recipients. In total, wild-type cells were injected into 9 recipients, and 5 mice 
received cells from -/- embryos. In the case of the former, each recipient received 
cells from single donors, with preference for cells from male embryos. Cell 
suspensions from trios of same sex -/- livers were amalgamated for injection into 
individual recipients, so that approximately equal number of cells were injected for 
both genotypes (cell equivalents). 6 irradiated animals received no donor cells. In 
addition one irradiated mouse received cells from both wild-type and -/- embryos. 
Details of donor samples and the ultimate fate of the recipients are summarised in 
Table 4.3.1.
The mass of each mouse was monitored daily (Figure 4.3.1). All irradiation 
control mice died within two weeks, preceded by a drop in bodyweight. Two out of 
nine recipients of wild-type cells survived for at least 10 weeks, as did two out of five 
recipients of -/- cells. In addition, the one mouse which had received cells from both 
wild-type and -/- embryos also survived. All recipients which died did so 
concomitantly with the irradiation controls, indicating that the cause of death was 
failure of the introduced HSCs to repopulate the recipient haematopoietic system.
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Table 4 J.I: Summary of donor and recipient data
Summary of data from y-irradiated mice injected with foetal liver cell suspensions. 
El3.5 embryos were isolated from heterozygote timed matings. The embryonic yolk 
sac was used for rapid sexing by PCR, and subsequently genomic DNA prepared for 
Ligl PCR genotyping. The foetal livers were disaggregated in sterile PBS 
supplemented with PCS, and numbers of single cells in suspensions counted. 
Approximately 1X108 cells were injected into the tail vein of wild-type female 
129/Ola mice exposed to 10.5 Gy of y radiation. Samples of the same sex from -/- 
embryos were amalgamated to equalise numbers (cell equivalents). Male samples 
were employed preferentially. Mice were subsequently monitored daily. All irradiated 
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Figure 4.3.1: Bodyweight profile of recipients following irradiation
Bodyweights of y-irradiated mice injected with foetal liver cell suspensions. 
Recipients were weighed daily as an indicator of general health, and the results 
expressed as a percentage of the initial mass of each animal. Percentage bodyweight 
was then plotted against length of time elapsed since irradiation, measured in days. 
Lines terminate where the subject died. Daily monitoring of the surviving animals 
ceased after 50 days.
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After an initial drop, the bodyweights of all surviving animals recovered to their 
original levels and were stable. These animals were outwardly healthy, and showed 
no symptoms of graft versus host disease (data not shown). Thus Ligl -I- HSCs 
were able to rescue lethally-irradiated mice, and to effect long-term haematopoietic 
repopulation when present in sufficient numbers.
Peripheral blood samples were taken from all surviving recipient mice five and 
seven weeks after irradiation for FACScan, red blood cell staining and genomic DNA 
preparation. At 10 weeks two mice (DB6 LOR1 and DB2 LORO) were killed 
for detailed analysis of the haematopoietic tissues. Peripheral blood was sampled, 
cells flushed from the peritoneal cavity, and the spleen, thymus, bone marrow, 
peripheral and mesenteric lymph nodes dissected. Single cell suspensions were 
prepared from each tissue, cell counts performed, and then samples processed for 
DNA preparation, FACScan analysis and mitogen stimulation. Two weeks later (12 
weeks following irradiation) animals DB6 LORO and DB2 L1RO were subject to the 
same treatment. The remaining animal DBS L1RO, which had received a mixture of 
wild-type and -/- cells, was killed at a later date, and tissue samples taken for DNA 
preparation.
4.4 Ligl -I- cells were able to contribute to all haematopoietic tissues
In order to prove that cells in the haematopoietic tissues of rescued animals are 
derived from donor cells, it was necessary to be able to differentiate between cells of 
different origins. Typically this is achieved using isozyme markers, but given the 
mixed background of the donor embryos, it was not possible in this situation. Instead 
we were forced to use a PCR-based strategy to follow donor cells.
Because the recipients were all female, it was possible to use the presence of a 
Y chromosome as an indicator of donor-derived material. The male-specific PCR 
reaction which amplified part of the coding sequence of the Y chromosome-specific 
Zfy-1 gene, had originally been used to sex the donor embryos. By performing the 
same PCR reaction on DNA prepared from haematopoietic tissues of the rescued 
mice, it was possible to detect the presence of donor-derived cells (data not shown).
Although preference had been given to male donor material, in order to 
increase the size of the experiment, female samples had also been used. To be able to 
study these animals as well, we employed an additional PCR marker. By definition, - 
/- donor samples carried two copies of the targeted Ligl allele per cell, whilst +/- 
samples carried one. Wild-type recipient mice only possessed wild-type Ligl alleles. 
Therefore, it was also possible to use the presence of the targeted Ligl allele as a 
marker for donor-derived material. A PCR assay specific for the targeted Ligl allele 
had been used to screen for targeting events in ES cells, track the passage of the allele
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in breeding populations, and genotype embryos. Performing the Ligl targeted PCR 
reaction on DNA from rescued mice, it was possible to confirm the presence of 
donor-derived cells (data not shown).
In order to quantify the levels of donor contribution to haematopoietic tissues 
we performed quantitative PCR on genomic DNA samples from the rescued animals. 
Quantitative PCR using the male-specific PCR reaction had previously been carried 
out by H. Taylor and N. Hole (N. Hole, personal communication), and we followed 
their protocol, using a reaction specific for the wild-type mouse Ercc-1 gene as an 
independent control for the initial amount of DNA. 20 cycles of PCR were carried 
out under conditions appropriate to the primer pairs used. Products were separated by 
agarose gel electrophoresis, transferred onto nylon membrane, and hybridised to a- 
32P-labelled probes specific for the two PCR products. Levels of radiolabel bound to 
each PCR product were analysed by phosphorimagery, and the ratio of the two 
signals calculated.
A standard curve was produced by spiking varying amounts of genomic DNA 
from a male animal into a female DNA sample, and subjecting to PCR quantitation 
in parallel to the experimental samples. The ratios between the two signals were 
calculated and plotted against the percentage 'maleness' of the standard samples. In 
order to estimate the percentage of male cells present in each unknown sample, 
experimental signal ratios were compared against this standard curve.
Quantitative PCR using a reaction specific for the targeted Ligl allele proved 
more complicated than initially anticipated. The original reaction specific for the 
targeted allele was unsuitable for the purposes of quantification, and it was 
consequently necessary to design an alternative PCR assay. Details of the new 
reaction [Ligl targeted (B)] are given in section 4.5. Quantitative PCR was carried 
out as above, except that the Ligl targeted (B) product was amplified as part of a 
duplex reaction with a pair of primers specific for the wild-type mouse Prn-p gene 
acting as an independent control for the initial amount of DNA. The standard curve 
was produced by spiking varying amounts of genomic DNA from a -/- embryo into a 
wild-type DNA sample.
The standard curve was produced from a positive control with two copies of 
the targeted Ligl allele per cell, but heterozygous cells only have a single copy of the 
allele. To compensate for this difference, calculated percentages from the animal 
rescued with a Ligl +/- sample (DB6 LOR1) were multiplied twofold to give more 
accurate estimates of the contribution donor cells made to haematopoietic tissues.
By combining results of PCR quantification of the two markers it was possible 
to estimate the contribution donor-derived cells made to the haematopoietic system 
of rescued recipients (Table 4.4.1). Donor specific markers were detected in all
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Table 4.4.1: Estimates of donor contribution to haematopoietic tissues of 
rescued animals
Recipient Tissue
Peripheral Blood (4 weeks)
Peripheral Blood (6 weeks)




























Levels of donor contribution to the haematopoietic tissues of y-irradiated mice 
rescued with foetal liver cell suspensions. Genomic DNA was prepared from the 
haematopoietic tissues of the four irradiated mice repopulated with wild-type and -/- 
cells. PCR reactions for donor cell markers were carried out in a quantitative manner 
to approximate the proportion of cells in each sample that were derived from injected 
cells. Figures represent the mean values from pairs of animals rescued with cells of 
each genotype [individual mean value of each animal sampled], and take into account 
differences in the number of targeted Ligl alleles between samples.__________
haematopoietic tissues of all recipients. Significant levels were detected in all tissues 
from animals rescued with wild-type cells. Donor-derived cells were also detected 
in all haematopoietic tissues from animals rescued with -/- cells, with exception of 
the peritoneal cavity sample, which also failed to give a signal from the control Prn-p 
wild-type PCR reaction. Apart from the bone marrow and spleen, the contributions of 
-/- cells to repopulated tissues were lower than the equivalent wild-type control
values.
The animal that had received both wild-type and -/- cells (DB5 L1RO) was also 
analysed by quantitative PCR to assess the contribution of donor cells to 
haematopoietic tissues. Because male +/+ and female -/- donor cells had been 
injected into a female recipient, it proved possible to differentiate between cells of 
the three different origins. Cells of -/- donor origin could not be detected in 
peripheral blood samples even though high levels of wild-type donor cells were 
present. Similarly other haematopoietic tissues displayed virtually no contribution
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from -/- cells, although a low level (9.8% ±2.0) was detected in the spleen (data not 
shown).
4.5 An alternative PCR genotyping assay
Alternative PCR genotyping assays for both wild-type and targeted Ligl alleles 
were designed to utilise a common primer specific for the 3' flanking region of the 
Ligl gene (V2014) (C. McEwan, D. W. Melton, unpublished data). This primer could 
be used in conjunction either with a primer specific for exon 27 of the Ligl gene 
(V0727), or with a primer specific for the 3' end of the HPRT minigene (262W). The 
former pair (V2014+V0727) produced a 0.3kb product diagnostic of the wild-type 
allele, while the latter pair (V2014+262W) was used to identify the targeted Ligl 
allele (Figure 4.5.1). Because exon 27 is replaced during targeting, the targeted allele 
will not give a product from the wild-type reaction. Similarly only the targeted Ligl 
allele would give rise to a 0.6kb product from the targeted reaction. Although both 
reactions could be performed independently, the two were found to work under 
identical cycle parameters, and could be carried out as a duplex without appreciable 
bias towards either product. In other words, the two reactions could be carried out in 
a single tube, with both wild-type and targeted products produced in a manner 
seemingly independent of one another. This enabled Ligl PCR genotyping to be 
performed as a single reaction involving the three primers (V2014+V0727+262W). 
Furthermore both reactions were highly sensitive and robust, functioning on 
extremely small amounts of initial template DNA even under suboptimal conditions 
(data not shown). In order to differentiate the alternative genotyping assays from the 
original PCR reactions, the new reactions were designated Ligl wild-type (B), and 
Ligl targeted (B).
4.6 Animals rescued with Ligl -I- cells displayed anaemia coupled with 
macrocytosis and reticulocytosis
Although all surviving animals were outwardly healthy and bodyweights were 
stable, when blood samples were taken at 4 weeks following irradiation it was noted 
that animals rescued with -/- cells were anaemic. Measurements of haematocrit 
values (the volume of packed cells per unit of blood) of wild-type control animals 
were within the normal range (42-50%). However, haematocrits from animals 
rescued with -/- cells were significantly lower at each sample point ( Table 4.6.1), 
indicating the number of red cells present in the peripheral blood of these animals to 
be lower than normal.
The severity of anaemia displayed by the recipients of -/- cells also proved to 
be variable. Whereas the haematocrits of the two control animals were stable up to
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Figure 4.5.1: Schematic representation of the Ligl gene targeting strategy
Schematic representation of 13.9kb at the 3* end of the wild-type mouse DNA 
ligase I locus, targeting vector and gene structure following homologous 
recombination. Drawn to scale: 1cm = 2kb. Solid boxes indicate exons (numbered 
according to the human convention); hatched box, HPRT minigene (PGK-HPRT)\ 
stippled box, Herpes simplex virus thymidine kinase (PGK-ffc) cassette; thin lines, 
Ligl introns or flanking regions; thick line, plasmid vector DNA. Arrows indicate the 









































































































The percentage of packed cells in blood samples from y-irradiated mice rescued with 
foetal liver cell suspensions. Blood samples from the peripheral circulation of the 
four irradiated mice repopulated with wild-type and -/- cells were centrifuged, and 
the volume of the resulting packed cell pellet expressed as a percentage of the total 
volume of each sample. Figures represent the mean values from pairs of animals 
rescued with cells of each genotype [individual mean value of each animal sampled].
10/12 weeks, haematocrits from the animals rescued with -/- cells dropped with 
successive sampling. Measured values across the 8 week period ranged from 
29.4% down to 15.9%, and mouse DB2 LORO was always more anaemic than DB2 
L1RO (data not shown). Whether this effect was an artefact of the sampling 
procedure, or truly reflected an underlying decline in erythrocyte production with 
time is unclear. Nevertheless, the results suggested that erythropoiesis was not 
occurring normally in mice rescued with -/- cells.
Examination of blood samples revealed that the anaemia was accompanied by 
macrocytosis and reticulocytosis. Blood samples were spread across the surface of a 
microscope slide, allowed to dry, then fixed and stained with Giemsa. The mean 
corpuscular volume of enucleated red cells (as indicated by cellular diameter) was 
greater in samples taken from mice rescued with -/- donor cells compared to wild- 
type controls. Although some ovalocytes (oval erythrocytes) and polychromatic 
macrocytes (erythroid cells larger than normal tending to stain intensely) were 
observed, red cell morphology was not otherwise abnormal.
When vital staining of wet blood samples was performed to distinguish 
reticulocytes from mature erythrocytes, a marked difference was observed. 
Reticulocytes are erythrocytes that have been released into the circulation before the 
maturation process has been completed. Unlike mature erythrocytes, the cytoplasm of 
reticulocytes still contains ribosomal RNA, which will stain with new methylene blue 
to give a stippled or reticular pattern. Samples from irradiated animals rescued with 
wild-type cells contained a low level of reticulocytes, but animals rescued with -/- 
cells displayed elevated numbers (Figure 4.6.1). Most reticulocytes displayed limited 
basophilia, but some early reticulocytes, containing large amounts of
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Figure 4.6.1: Blood from animals repopulated with -/- cells displayed an elevated 
level of reticulocytes
Staining for the presence of reticulocytes in blood samples from y-irradiated 
mice rescued with foetal liver cell suspensions. Blood samples from the peripheral 
circulation of irradiated mice repopulated with wild-type (a) and -/- (b) cells were 
stained with new methylene blue. Blood from wild-type controls consisted 
predominantly of mature, evenly stained erythrocytes. A small number of basophilic 
staining reticulocytes were present (arrow). In contrast, samples from animals 
repopulated with -/- cells displayed a high percentage of basophilic staining 
reticulocytes (arrowhead). Also present were early "stress" reticulocytes containing 
inclusions of reticulin (asterisk). The average diameter of erythrocytes in samples 





















reticulin, were observed. These cells are known to produce polychromatic staining 
with Romanowsky stains, thereby accounting for the polychromatic macrocytes or 
"stress reticulocytes" observed after Giemsa staining. These data indicated that in 
animals repopulated with -/- cells a high proportion of erythrocytes were being 
released into the circulation prematurely.
The severity of reticulocytosis was found to correlate to the severity of the 
anaemia observed. The level of reticulocytosis was quantified by scoring the number 
of reticulocytes as a percentage of the total number of cells. Samples with 
haematocrit values at the lowest end of the range observed (<20%) exhibited a high 
percentage of reticulocytes. Samples with haematocrit values at the upper end of the 
range (>25%) contained fewer reticulocytes, although still above the level in control 
samples (data not shown). Therefore, as the total number of erythrocytes in the blood 
of mice rescued with -/- cells decreased, the proportion of reticulocytes increased.
4.7 Animals rescued with Ligl -/- cells displayed splenomegaly but hypoplasia 
of other haematopoietic tissues
When repopulated animals were killed 10 or 12 weeks after irradiation it was 
observed that the spleens of recipients of -/- cells were enlarged compared to those 
mice which had received wild-type cells (splenomegaly). This was reflected by an 
increase in the average mass of the spleen (± standard deviation): Wild-type; 
100.5mg (±16.5), -/-; 327.0mg (±55.0). When single cell suspensions were prepared, 
the number of cells in spleens from animals rescued with -/- cells was also increased 
compared to wild-type controls (Table 4.7.1). However, reduced numbers of cells 
were recovered from all other haematopoietic tissues of animals repopulated with -/- 
cells compared to controls (hypoplasia). The hypoplasia was most severe in the bone 
marrow, where the number of single cells recovered was approximately 5-fold lower. 
This was also accompanied by a difference in visual appearance. Bone marrow from 
animals rescued with wild-type cells was dark red in colour, but marrow from 
animals rescued with -/- cells was pale pink, suggesting reduced numbers of 
haemoglobinised cells.
Because the percentage contribution made by donor cells to each 
haematopoietic tissue had been calculated (Table 4.4.1), it was subsequently possible 
to estimate the number of cells of donor origin in each tissue (Table 4.7.1). With 
exception of the spleen, the number of donor-derived cells in the haematopoietic 
tissues of mice rescued with -/- cells was reduced compared to wild-type cells. The 
extent to which estimated cell numbers were reduced varied between tissues, but 
total numbers were lower even when the percentage donor contribution was higher
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(e.g. bone marrow). As noted previously, the spleen of animals rescued with -/- cells 
displayed hyperplasia. In this case, the level of donor contribution was equivalent to 
controls and hence estimation of the number of donor-derived cells gave a figure 
double the control value.
The general reduction in cell numbers in the haematopoietic tissues of rescued 
mice indicated that -/- HSCs were deficient in some aspect of haematopoietic cell 
production. To determine whether this defect affected all 8 mature haematopoietic 
cell lineages or was limited to particular cell types, we analysed haematopoietic 
tissues from the four rescued mice by FACScan. Single cell suspensions from the 
haematopoietic tissues of mice rescued with wild-type and -/- cells were incubated 
with combinations of fluorochrome-conjugated antibodies raised against T200, B220, 
IgM, IgD, CDS, CD4, CDS, TCRa(3, G(|>, and Ter-119 cell surface markers. Each 
molecule is expressed by a defined subset of haematopoietic cells, although not 
necessarily in a mutually exclusive manner. The correlation of markers to cell lineage 
is as follows: B220 is expressed on all cells committed to the B lymphoid lineage, 
whilst IgM and IgD are present only on those mature B lymphocytes which have 
undergone V(D)J recombination. CD4 and CDS are found on the surface of 
thymocytes, and the TCRap molecule on those thymocytes which have undergone 
rearrangement of the T cell receptor gene. Ter-119 is a marker of erythroid lineage 
cells, and G(|) expressed only on granulocytes. Antibodies raised against CDS will 
bind to both T cells and a subset of B cells. T200, which is equivalent to CD45 in 
humans, is present on all non-erythroid haematopoietic cells. It is thus possible to 
categorise any cell by the combination of cell surface markers which it expresses.
After washing to remove unbound antibodies, samples were analysed by 
FACScanning. In each case, electronic gates were used to subdivide populations of 
cells on the basis of size and complexity, and to differentiate numbers of positively 
stained cells from autofluorescent signals (e.g. Figure 4.7.2). The number of stained 
cells was expressed as a percentage of the total sample, which was then used to 
estimate the total number of positive cells within the whole tissue (Table 4.7.2).
Whilst accurate interpretation of the data was difficult because of small sample 
sizes and high variability in estimated cell numbers, certain trends could be 
identified. The total numbers of cells positive for all non-erythroid markers were 
reduced in mice rescued with -/- cells (calculated mean values between 25 and 56% 
of wild-type controls), and numbers of T200+ve haematopoietic cells were generally 
reduced in all haematopoietic tissues (Table 4.7.2a). These data suggested that the 
haematopoietic deficiciency causing the hypoplasia affected all non-erythroid 
haematopoietic cell types in all tissues.
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Although mice rescued with -/- cells were anaemic, the total number of cells 
positive for the erythroid marker Ter-119 was increased (Table 4.7.2J). Large 
numbers of Ter-119+ cells were present in the spleen. Given that numbers of all other 
haematopoietic cell types were reduced compared to wild-type, it is probable that the 
splenomegaly observed was a direct result of the increase in erythroid cell numbers. 
Increased Ter-119+ cell numbers were also noted in peripheral blood samples, 
peripheral lymph nodes, and thymi. However, because of the relatively small 
numbers of cells involved, the variability in estimated numbers, and the high 
potential for contamination of the tissues samples with peripheral blood, no 
inferences were made.
Examination of the FACScan plots revealed that staining profiles of samples 
from mice rescued with -/- cells were similar to, and in many cases indistinguishable 
from, wild-type controls (data not shown). Ratios between single and double positive 
cells were also apparently normal in the majority of cases. Only when total numbers 
of cells per tissue were calculated did a difference emerge between wild-type and -/- 
samples. It was therefore concluded that those haematopoietic cells present had 
seemingly matured normally, just in fewer numbers.
However, whilst all haematopoietic cells were depleted, there did also appear to 
be quantitative differences between the mature lineages. B lymphocytes (as 
represented by B220, IgD, and IgM+ve cells) were less well represented than T cells 
(CD4, CDS, and TCRa(3+ve cells), and other granulocytic white cells (G((>+ve) (Table 
4.7.2, and data not shown). Although there were tissue specific variations, this 
disparity was particularly apparent in samples of peripheral blood (Figure 4.7.2). 
Very few circulating IgD+IgM+ cells were present in the sample from the animal 
repopulated with -/- cells compared to the wild-type control (Figure 4.7.2b). By 
contrast the populations of CD4+ and CD8+ cells are almost normal (Figure 4.7.2c). 
The difference is further highlighted by staining for TCRa|3 and CDS markers. The 
CD3+TCR«P+ T cell population was present in samples of both genotypes, but 
CD3+TCRocp- cells (i.e. B cells) were practically absent in samples from mice 
repopulated with -/- cells. Similarly the relative proportions of B220+ and G<j)+ cells 
were altered in a number of tissues (data not shown). Whereas total B cell numbers 
were markedly reduced, granulocyte numbers approached, and even exceeded, wild- 
type values (Table 4.7.2b and i).
To draw further conclusions about the abililty DNA ligase I-deficient cells to 
function normally, it was necessary to determine whether the lymphocytes observed 
by FACScan analysis were able to respond to mitogens. To this end we carried out in 
vitro proliferation assays. Single cell suspensions from haematopoietic tissues were 
incubated in the presence of [methyl-3H]-thymidine and mitogens to stimulate B and
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T lymphocyte proliferation. By measuring amount of radiolabel incorporated it was 
possible to determine the relative numbers of cells with and without stimulation, and 
hence to gauge the ability of lymphocytes to proliferate in response to mitogens. We 
found that samples from all four rescued mice were able to proliferate in response to 
mitogens in vitro (data not shown). To determine the origins of these proliferating 
cells, quantitative PCR reactions specific for donor cell markers were carried out on 
stimulated samples (data not shown). Whilst significant numbers of donor cells were 
present in stimulated samples from mice rescued with wild-type cells (39-94%), we 
were unable to detect significant levels of donor markers cells in corresponding 
samples from mice rescued with -/- cells (0-15%). It was thus concluded that, in the 
latter case, proliferating lymphocytes were of recipient origin, and as such not DNA 
ligase I-deficient. Whether these results were due to the absence of terminally 
differentiated -/- cells from haematopoietic tissue samples, or because -/- cells 
present could not proliferate in response to mitogens, could not be determined.
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Table 4.7.2: Estimates of haematopoietic cell numbers in rescued mice by 
FACScan analysis
Estimates of the numbers of cell surface marker-positive cells in the haematopoietic 
tissues of y-irradiated mice rescued with foetal liver cells. Single cell suspensions 
were produced from the haematopoietic tissues and peripheral blood of the four long- 
term repopulated mice, and cell counts performed. Cell suspensions were subjected to 
FACScan analysis using fluorochrome-conjugated antibodies raised against T200 (a), 
B220 (b), IgM (c), IgD (d), CDS (e), CD4 (0, CDS (g), TCRcc|3 (h), Gc|> (i), and Ter- 
119 (j) cell surface markers. For each sample 10,000 cells were analysed. The 
percentages of cells stained positive in each tissue sample (inclusive of double-stained 
cells) were multiplied by the total number of cells in that tissue to estimate the total 
numbers of cells expressing that marker. Where multiple electronic gates were 
employed, numbers quoted are the sum of the estimates from the different gates. 
Figures represent the mean values from pairs of animals rescued with cells of each 
genotype (± standard error). The numbers of -/- cells were also expressed as 
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Table 4.7.2: Estimates of haematopoietic cell numbers in rescued mice by 
FACScan analysis (continued)





















































































CHAPTER FOUR: RESCUE OF LETHALLY-IRRADIATED RECIPIENTS
Figure 4.7.2: FACScan analysis of peripheral blood from rescued animals
FACScan data plots of cell staining profiles of peripheral blood samples from 
mice rescued with wild-type and -/- cells. Erythrocytes were lysed and the remaining 
white cell fraction collected from the peripheral blood of the four long-term 
repopulated mice, and cell counts performed. Cell suspensions were subjected to 
FACScan analysis using pairs of fluorochrome-conjugated antibodies raised against 
(b) IgM and IgD, (c) CD4 and CDS, (d), CD3 and TCRa(3, (e) T200 and Ter-119, (f 
and g) B220 and G<j> cell surface markers. Panel a shows an unstained control sample. 
For each sample 10,000 cells were analysed. Panels a, b, c, d, e and f show events 
contained within electronic gate Rl, while panel g shows cells falling within region 
R3. The relative locations of electronic gates subdividing populations of cells on the 
basis of size (forward scatter) and internal complexity (side scatter) are depicted in 
panel h. Gate Rl was positioned to encompass the normal lymphocyte population, 
while R3 was intended to capture those cells with greater internal complexity e.g. 
granulocytes and actively proliferating lymphocytes. Gates R2, R4 and R5 were set in 
order to provide information on those populations of cells which were not contained 
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Embryos homozygous for the targeted Ligl allele displayed severe anaemia 
due to disruption of foetal liver erythropoiesis. The phenotype cosegregated with 
inheritance of two copies of the targeted allele, and showed complete penetrance. In 
addition, an independently derived line of Ligl targeted mice displayed a phenotype 
identical to that described in Chapter 3 (D. W. Melton, unpublished data). Taken 
together these data suggested that the observed phenotype was a result of DNA ligase 
I-deficiency. This chapter details further analysis to prove that samples PCR 
genotyped as being homozygous for the targeted allele lacked DNA ligase I.
A fibroblast cell line (46BR.1G1) derived from a patient with reduced DNA 
ligase I activity displayed abnormal lagging strand DNA synthesis. DNA ligase I had 
also been reported to be altered in cells from Bloom's Syndrome patients. These cells 
exhibited changes in the profile of replication intermediates, and high rates of SCEs. 
This chapter also describes investigation of lagging strand DNA replication and SCE 
rates in fibroblasts derived from -/- embryos. Furthermore, the effect of DNA ligase 
I-deficiency on the levels of other DNA ligases is reported, along with a pilot 
experiment to identify changes in expression of other genes.
5.1 Production of immortalised fibroblast lines
To facilitate investigation of the properties of cells lacking DNA ligase I, 
fibroblast cell lines were established from -/- embryos. Primary fibroblasts were 
isolated from El 1.5 embryos and passaged until cells lost growth potential and 
underwent "crisis". Thereupon the medium was changed periodically until 
immortalised cell lines emerged. Two lines established proved to be homozygous for 
the targeted Ligl/PGK-HPRT allele (designated PFL10T and PFL13T), whilst a third 
wild-type line (PF20T) had been previously derived by the same method. All three 
lines were apparently capable of being propagated indefinitely (A.-M. Ketchen and 
D. W. Melton, unpublished data).
5.2 Confirmation of the structure of the targeted Ligl/PGK-HPRT allele
The PCR reaction product specific for the targeted allele was designed to be 
amplified only when homologous recombination had inserted an HPRT minigene 
into the endogenous Ligl locus. However, generation of a PCR product did not 
guarantee that the locus had been targeted in precisely the desired manner, as 
targeting events can often be accompanied by other DNA rearrangements. In order to 
confirm that the correct homologous recombination event had occurred, Southern 
blot analysis was performed.
Southern analysis had been carried out on the original targeted heterozygous 
ES cell clone prior to injection into blastocysts (Jessop 1995), but interpretation of
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the banding pattern was complicated by the presence of a wild-type allele in addition 
to the targeted Ligl/PGK-HPRT allele. Using EcoRl and //mdffl restriction digests, 
targeting was marked only by alterations in relative band intensities.
To confirm that the targeted Ligl/PGK-HPRT allele did indeed have the 
predicted structure, and to verify the PCR genotyping of embryos, Southern blot 
analysis was carried out on genomic DNA samples representative of the three 
different Ligl genotypes (Figure 5.2.1). The results are summarised in Table 5.2.1, 
and the structures of the wild-type and targeted Ligl/PGK-HPRT alleles are shown in 
Figure 5.2.2 and Figure 5.2.3, along with predicted DNA fragments arising from 
restriction digestion. Those fragments highlighted in bold contain exons of the gene, 
and should thus be detected by hybridisation to a cDNA probe. The 13.9kb EcoRl 
genomic region corresponding to the 3' end of the wild-type allele contains four 
BamHl fragments that include exons (>4.2, 1.3, 1.0 and 3.7kb respectively). 
Replacement of exons 22 to 27 by an HPRT minigene deletes the 1.3, 1.0 and 3.7kb 
fragments, but also results in the extension of the >4.2kb fragment to >7.9kb. Thus 
targeting should result in the disappearance of the >4.2, 1.3, 1.0, and 3.7kb 
fragments, and the appearance of a novel >7.9kb band.
When wild-type genomic DNA (HM-1, +/+ embryo, and PF20T) was digested 
with BamHl, and subject to Southern blotting using a cDNA probe corresponding to 
exons 8 to 27 of the Ligl gene, six bands were detected (1.0, 1.3, 1.9, 3.6, 3.9, and 
9.4kb). Previous work had shown that the 3.6 and 1.9kb bands were derived from 
regions of the Ligl locus unaffected by targeting, and that the wild-type 9.4kb band 
corresponded to the predicted >4.2kb band (Jessop 1995). In samples heterozygous 
for the targeted allele (#53, +/- embryo), a novel 13.1kb fragment was observed and 
the 9.4, 3.9, 1.3 and 1.0kb bands were reduced in intensity compared to the 3.6 and
T* T1.9kb bands. Lanes corresponding to -/- samples (-/- embryo, PFL10 , and PFL13 ) 
exhibited only 3 bands: 13.1, 3.6 and 1.9kb. The 9.4, 3.9, 1.3 and 1.0kb fragments 
were all completely absent. Therefore the pattern of restriction fragments observed 
changed in the expected manner after targeting, and was entirely consistent with the 
proposed structure of the targeted allele. It was also concluded that Southern blot 
analysis corroborated the Ligl genotypes determined by PCR analysis.
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Figure 5.2.1: Southern blot analysis of samples representative of the different 
Ligl genotypes
Confirmation of the structure of the targeted Ligl/PGK-HPRT allele and PCR 
genotyping by Southern analysis. Genomic DNA was prepared from the original ES 
cell line (HM-1), one ES cell clone heterozygous for the Ligl/PGK-HPRT targeted 
allele (#53), E13.5 embryos of the three Ligl genotypes, the two immortalised 
fibroblast lines homozygous for the targeted Ligl/PGK-HPRT allele (PFL10T, 
PFL13T), and a wild-type fibroblast line (PF20T). DNA was then digested with 
flamffl, electrophoresed through an agarose gel, blotted onto nylon membrane and 
probed with a 2.1kb BamWEcoRI fragment of the Ligl cDNA, corresponding to 
exons 8 to 27. Ligl genotypes of the different samples, derived by PCR, are shown, 






















Figure 5.2.2: Restriction maps of the wild-type Ligl allele
Predicted restriction map of the 3' end of the wild-type Ligl allele. The wild- 
type map was based on restriction mapping and Southern hybridisation data from 
Jessop 1995, sequences of subcloned genomic fragments, and the sizes of certain PCR 
products (D. W. Melton, unpublished data). The locations of exons 25 and 26 are not 
certain beyond that neither are present within the 1.3kb Kpnl fragment, and at least 
one must lie within the 1.0kb BamHl fragment. However, because exon 26 is known 
to lie only 140bp upstream of exon 27 in humans, it has been provisionally assigned 
to the 0.6kb KpnMSstl fragment.
Drawn to scale: 1cm = 2kb. Black boxes indicate exons; lines, introns or 
flanking DNA. Restriction sites of BamHl, EcoRl, Hindm, Kpnl and Sstl are 
indicated, along with the arrangement of resulting restriction fragments for each 
individual enzyme. Sizes are given in kb. Fragments (and associated sizes) which 
contain exons, and hence will be detected on Southern blots probed with Ligl cDNA, 
are in bold.
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Figure 5.2.3: Restriction map of the targeted Ugl/PGK-HPRT allele
Predicted restriction map of the 3' end of the targeted Ligl/PGK-HPRT allele. 
The map was based on the known structures of the wild-type allele and MLTV gene 
targeting vector (Jessop 1995). Drawn to scale: 1cm = 2kb. Black boxes indicate 
exons; lines, introns or flanking DNA; hatched box,HPRT minigene. Restriction sites 
of fia/nffl, EcoRI, tfwdffl, Kpnl and Sstl are indicated, along with the arrangement of 
resulting restriction fragments for each individual enzyme. Sizes are given in kb. 
Fragments (and associated sizes) which contain exons, and hence will be detected on 























































































































































































































Table 5.2.1: Summary of the predicted BamHl restriction fragments from wild- 































Predicted and actual BamHl restriction fragments arising from the 3' end of the 
mouse DNA ligase I locus when probed with a 2.1kb BamWEcoRI fragment of the 
Ligl cDNA. Fragment sizes in brackets are those arising from parts of the gene 
outwith the 13.9kb EcoRl fragment used in the targeting experiments. Fragments 
marked with an asterisk are those which were present at a reduced intensity 
compared to +/+ samples._________________________________
5.3 Expression from the targeted Ligl/PGK-HPRT allele is abolished
The effect that a targeted alteration has on gene expression can vary between 
loci. Commonly insertion of a marker gene results in production of a fusion transcript 
and subsequently a truncated or fusion protein. Introduction of the HPRT marker into 
the Ligl locus is accompanied by deletion of exons 23 to 27 which should have 
effectively disrupted the integrity of the gene. However, to ascertain the nature of any 
product expressed from the targeted Ligl/PGK-HPRT allele, northern and western 
analysis was carried out.
Total RNA was isolated from the same representative panel of samples as 
employed for Southern analysis. ES cell and fibroblast cell cultures were passaged 
one day prior to harvesting to ensure that cells were actively dividing. The RNA was 
separated by electrophoresis, blotted onto nylon membrane, then hybridised to a Ligl 
cDNA probe (Figure 5.3.1). The 3.2kb Ligl transcript was readily detected in wild- 
type samples (HM-1, +/+ embryo, and PF20T). Samples heterozygous for the targeted 
allele (#53, +/- embryo) displayed a single band of the same size as the wild-type 
product but of reduced intensity. This was consistent with expression only from the
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single wild-type allele and not from the targeted allele. No bands of any size were
__ _____ rrv rr*observed in lanes corresponding to -/- samples (-/- embryo, PFL10 , and PFL13 ), 
suggesting that no stable transcripts were produced from the targeted allele. Although 
Figure 5.3.1 shows the result achieved using a Ligl cDNA probe corresponding to 
exons 8 to 27, an identical result was achieved using a probe for exons -1 to 7 (data 
not shown)
Western blot analysis was then performed on a representative panel of embryos 
and fibroblast cell lines. Whole cell protein extracts were prepared by brief 
homogenisation of tissue or cell pellets in protein lysis buffer. Proteins were 
separated on the basis of size by SDS-PAGE, blotted onto nylon membrane, and 
probed with antibodies raised against purified bovine DNA ligase I (Figure 5.3.2). A 
band of ~125kDa corresponding to DNA ligase I was detected in wild-type samples. 
The protein was present at reduced levels in +/- samples, while -/- lanes contained no 
detectable DNA ligase I. Because the anti-DNA ligase I antisera employed 
predominantly recognised epitopes located in the N-terminus of the protein (D. 
Bames, ICRF Clare Hall, personal communication) any truncated peptides should be 
detected. However, no DNA ligase I-derived peptide of any size was detected in 
samples from -/- embryos or fibroblasts. Visual inspection of bands arising from non­ 
specific crossreactivity did not reveal any other of these 'background' bands to be 
upregulated in +/- or -/- samples compared to wild-type.
Figure 5.3.2b shows western analysis of varying amounts of protein extract 
from a wild-type embryo spiked into a -/- embryo sample. As little as 1% of the 
amount of DNA ligase I normally present in wild-type embryos could be detected by 
western analysis. It was therefore reasonable to suppose that any significant level of 
DNA ligase I or DNA ligase I-derived peptides would have been detected. Thus we 
were unable to detect either mRNA or protein expression from the targeted Ligl 
allele. We therefore concluded that expression from the targeted allele was abrogated, 
and that DNA ligase I was absent from -/- embryos.
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Figure 53.1: Absence of detectable expression from the targeted Ligl/PGK- 
HPRTsMele
Northern blot analysis of samples representative of the different Ligl genotypes. 
Total RNA was prepared from the original ES cell line (HM-1), one ES cell clone 
heterozygous for the targeted Ligl/PGK-HPRT allele (#53), E13.5 embryos of the 
three Ligl genotypes, the two immortalised fibroblast lines homozygous for the 
targeted Ligl/PGK-HPRT allele (PFL107, PFL13T), and a wild-type fibroblast line 
(PF20T). Upper, RNA was electrophoresed through an agarose-formaldehyde gel, 
blotted onto nylon membrane and probed with a 2.1kb BamHI/EcoRI fragment of the 
Ligl cDNA, corresponding to exons 8 to 27. Positions of the 28S and 18S ribosomal 
RNA transcripts are indicated flanking the 3.2kb wild-type Ligl transcript. Ligl 
genotypes of the different samples are shown. Lower, ethidium bromide staining to 






















Figure 53.2: Absence of detectable DNA ligase I in -/- samples.
a) Western blot analysis of samples representative of the different Ligl 
genotypes. Total protein extracts were prepared from El3.5 embryos of the three Ligl 
genotypes, the two immortalised fibroblast lines homozygous for the targeted 
Ligl/PGK-HPRT allele (PFL107, PFL13T), and a wild-type fibroblast line (PF20T). 
Protein lysates were made by brief homogenisation of tissue or cell pellets in lysis 
buffer, and 100/ig loaded onto an 8% SDS-polyacrylamide gel. Separated proteins 
were blotted onto a nylon membrane, blocked in TEST plus 5% non-fat milk powder, 
and incubated with TL5 rabbit polyclonal antibody raised against purified bovine 
DNA ligase I. Detection of bound antibody was achieved using alkaline phosphatase- 
conjugated anti-rabbit IgG antibodies. Positions of protein molecular weight markers 
are indicated, as is the ~125kDa wild-type DNA ligase I protein. Ligl genotypes of 
the different samples are shown.
b) Western blot detection of varying amounts of DNA ligase I. Decreasing 
amounts of whole cell protein lysate prepared from a +/+ El3.5 embryo were spiked 
into a lysate from a -/- embryo. Details as above. In total 100/ig of protein extract was 


































5.4 DNA ligases III and IV in -/- embryos and fibroblasts
The viability of cells lacking DNA ligase I was unexpected given the wealth of 
data published on the involvement of the enzyme in lagging strand DNA replication. 
We hypothesised that for DNA replication to proceed, another ligase activity must 
compensate for the absence of DNA ligase I. Because DNA ligase I is far more 
abundant in actively dividing cells than any of the other DNA ligases, it would not be 
unreasonable to expect the levels of any complementing ligase to be increased. To 
test this hypothesis, we investigated the expression levels of the other known DNA 
ligases in samples lacking DNA ligase I.
5.4.1 Cloning of cDNA fragments of mouse DNA ligases III and IV
cDNAs encoding human DNA ligases HI and IV had previously been isolated 
(Wei et al. 1995), but there had been no reports of potential murine homologues. In 
order to clone fragments of mouse DNA ligase IE and IV cDNAs for use in northern 
blot analysis, RT-PCR was performed on mouse total RNA. The primers used were 
designed from the published human sequences (Database accession numbers: LIG3; 
X84740, LIG4; X83441), taking advantage of homology between the catalytic 
domains of all ATP-dependent DNA ligases (Figure 5.4.1).
To clone a fragment of DNA ligase HI cDNA, PCR primers were designed to 
bind a short distance upstream of (5* to) the enzyme active site (HLIG35 1), and a short 
distance downstream of (3' to) the conserved peptide (HLIG33 1). The binding sites of 
these primers were separated by 1.0kb on the human LIG3 cDNA. Northern analysis 
of the distribution of LIG3 mRNA had shown maximal expression in human testes 
(Wei et al. 1995). Total RNA isolated from mouse testes was reverse transcribed, and 
the reaction products employed as a template for PCR using the primer pair HLIG35' 
and HLIG33'. PCR products were separated by agarose gel electrophoresis, and a 
1.0kb fragment purified. The fragment was then cloned into the EcoRV restriction 
site of pBluescriptn SK+ (designated pMLIG3) and sequenced. The predicted amino 
acid sequence of the insert showed high homology to the amino acid sequence of 
human DNA ligase El (Figure 5.4.2). When the cloned product was used as a probe 
for northern blot analysis of a panel of wild-type adult mouse tissues, two transcripts 
were detected (Figure 5.4.3) The smaller band was approximately 3kb in size, while 
the second transcript detected was significantly larger, and corresponded to a size of 
about 6kb. Both transcripts were abundant in the testis, but expressed at considerably 
lower levels in all other tissues. The identity of the larger band, and the relationship 
between the two transcripts, is discussed further
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Figure 5.4.1: Schematic representation of DNA ligases I, III, and IV
Alignment of the three cloned human DNA ligases. Adapted from Wei el al. 
1995. The active site and conserved peptide motifs are represented by solid bars. 
Shaded box, N-terminal regulatory domain of DNA ligase I. Predicted molecular 
masses are indicated, as are the relative locations at which oligonucleotide primers 





























































































Figure 5.4.2: The amino acid sequence of the putative mouse DNA ligase III 
homologue cDNA fragment aligned with the published human DNA ligase III 
sequence.
The nucleotide sequence of the PCR product cloned in pMLJGS was translated 
and the predicted amino acid sequence aligned with that of human DNA ligase ffl 
using the Bestfit program from the Genetics Computer Group package, version 9 
(Genetics Computer Group 1996). Vertical lines indicate identical amino acid 
residues; two dots, a conservative substitution; one dot, a semi-conservative change. 
Numbers denote the location of residues within the published LIG3 amino acid 
sequence (Database accession number: X84740) (top), and the translated pMLJGS 
sequence (bottom). The relative locations at which oligonucleotide primers used in 
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611 FYGQGSKGGMMSIFLMGCYDPGSQKWCTVTKCAGGHDDATLARLQNELDM 660
IIIII.MIIMIIIIIIN lllllllMIIIIIMMIIMI II I 
201 FYGQGNKGGMMSIFLMGCYEPDSQKWCTVTKCAGGHDDATLARLQKELVM 250
• » • • •
661 VKISKDPSKIPSWLKVNKIYYPDFIVPDPKKAAVWEITGAEFSKSEAHTA 710







Figure 5.4.3: Lig3 expression is highest in testes
Northern blot analysis of Lig3 expression in a panel of wild-type mouse tissues. 
Upper, total RNA was prepared from a variety of adult tissues, electrophoresed 
through an agarose-formaldehyde gel, blotted onto nylon membrane and probed with 
a 1.0kb EcoRUHindm fragment of pMLIGS. Positions of the 28S and 18S ribosomal 
RNA transcripts are indicated, as are the two Lig3 transcripts (3.0 and ~6kb). Lower, 





















in Chapter 7, but the data were not inconsistent with the supposition that the 
cloned product was a fragment of the cDNA of the mouse homologue of DNA 
ligase HI.
To clone a fragment of DNA ligase IV cDNA, PCR primers were designed to 
bind a short distance upstream of the enzyme active site (HLIG45 1), and a short 
distance downstream of the conserved peptide (HLIG43 1). The binding sites of these 
primers were separated by 1.0kb on the human LIG4 cDNA sequence. Northern 
analysis of the distribution of LIG4 mRNA had shown highest levels of expression 
in testes and thymus (Wei et al. 1995). Thus, total RNA isolated from mouse thymus 
was reverse transcribed, and the reaction products employed as a template for PCR 
using the primer pair HLIG45' and HLIG43'. However, no product of the appropriate 
size was generated from this reaction. Therefore, in order to maximise the chances of 
amplifying a fragment of the Lig4 cDNA, a nested PCR strategy was employed. A 
second pair of primers was designed based on the human LIG4 cDNA sequence. The 
binding sites of these primers (LIG45 1 and LIG43') were separated by 0.75kb on the 
cDNA sequence, and both were within the 1.0kb region of the human cDNA defined 
by primers HLIG45'and HLIG43'. Primers HLIG45' and HLIG43' were employed in a 
PCR reaction on reverse transcribed mouse thymus RNA. 5/il of this reaction was 
then used to seed a second sequential PCR reaction, this time utilising primers 
LIG45' and LIG43'. The reaction products were separated by agarose gel 
electrophoresis, and a 0.75kb fragment purified. The PCR product was then cloned 
into the EcoRV restriction site of pBluescriptn SK+ (designated pMLIG4) and 
sequenced. The predicted amino acid sequence of the insert showed high homology 
to the amino acid sequence of human DNA ligase IV (Figure 5.4.4). When the cloned 
product was used as a probe for northern blot analysis of a panel of wild-type adult 
mouse tissues, a single 3kb transcript was detected (Figure 5.4.5) The transcript was 
abundant in the testes and thymus, but also expressed at lower levels in certain other 
tissues. These data were consistent with the cloned product being a fragment of the 
cDNA of the mouse homologue of DNA ligase IV.
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Figure 5.4.4: The amino acid sequence of the putative mouse DNA ligase IV 
homologue cDNA fragment aligned with the published human DNA ligase IV 
sequence.
The nucleotide sequence of the PCR product cloned in pMLIG4 was translated 
and the predicted amino acid sequence aligned with that of human DNA ligase IV 
using the Bestfit program from the Genetics Computer Group package, version 9 
(Genetics Computer Group 1996). Vertical lines indicate identical amino acid 
residues; two dots, a conservative substitution; one dot, a semi-conservative change. 
Numbers denote the location of residues within the published LIG4 amino acid 
sequence (Database accession number: X83441) (bottom), and the translated pMLIG4 
sequence (top). The relative locations at which oligonucleotide primers used in RT- 
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260 ILDGEMMAYNPNTQTFMQKGTKFDIKRMVEDSDLQTCYCVFDVLMVNNKK 309
• • * • •
51 PGAQTLRGGYEILCSIFTPIKGRTEIVQKIQAHTKEEWDALNDALDKRE 100
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151 GGMMSHFLCAVAETPPPGDRPSVFHTLCRVGSGYTMKELYDLGLKLAKYW 200
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Figure 5.4.5: Ug4 expression is highest in testes and thymus
Northern blot analysis of Lig4 expression in a panel of wild-type mouse tissues. 
Upper, total RNA was prepared from a variety of adult tissues, electrophoresed 
through an agarose-formaldehyde gel, blotted onto nylon membrane and probed with 
a 0.75kb EcoRJJHindni fragment of pMLIG4. Positions of the 28S and 18S ribosomal 
RNA transcripts are indicated flanking the ~3.0kb Lig4 transcript. Lower, ethidium 















5.4.2 Expression ofLigS and Lig4 is unaffected by the absence of DNA ligase I
Northern blot analysis was performed on RNA from a panel of embryos, ES 
cell, and fibroblast cultures, to assess levels of Lig3 and Lig4 expression in the 
context of altered Ligl expression. Total RNA from ES cell, embryo and fibroblast 
samples representative of the different Ligl genotypes was separated by 
electrophoresis, blotted onto nylon membrane, and then hybridised to cDNA 
fragments corresponding to either Lig3 or Lig4. Levels of the two transcripts were 
then assessed by phosphorimagery. Lig3 transcripts were detected at equal levels in 
all samples, regardless of Ligl genotype (Figure 5.4.6). Similarly, levels of Lig4 
expression remained unchanged following targeting of the Ligl locus (Figure 5.4.7).
5.4.3 Levels of DNA ligases III and IV are unaffected by the absence of DNA 
ligase I
Although the levels of Lig3 and Lig4 mRNA appeared unaffected by the 
absence of DNA ligase I, to confirm that protein levels were similarly unchanged, 
western blot analysis was performed on protein extracts. Whole cell lysates from a 
representative panel of embryos and fibroblast cell lines were separated by SDS- 
PAGE, and blotted onto nylon membrane. Blotted proteins were then incubated with 
antibodies raised against purified human DNA ligase HI (Figure 5.4.8) or with 
antibodies against DNA ligase IV (Figure 5.4.9). Despite being raised against human 
proteins, both antisera recognised the mouse homologues, without high levels of 
crossreactivity to proteins of other sizes. A band of ~100kDa corresponding to DNA 
ligase in was detected at equal levels in all samples, regardless of Ligl genotype. 
Similarly, a protein of ~100kDa corresponding to DNA ligase IV was detected in 
each lane at equivalent levels in wild-type, +/- and -/- samples. Thus we concluded 
that the absence of DNA ligase I did not result in alteration of the levels of either 
DNA ligase m or DNA ligase IV.
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Figure 5.4.6: Ug3 expression is unaltered by the absence of DNA ligase I
Northern blot analysis of LigS expression in samples representative of the 
different Ligl genotypes. Upper, total RNA was prepared from the original ES cell 
line (HM-1), one ES cell clone heterozygous for the targeted Ligl/PGK-HPRT allele 
(#53), E13.5 embryos of the three Ligl genotypes, the two immortalised fibroblast 
lines homozygous for the targeted Ligl/PGK-HPRT allele (PFL10T, PFL137), and a 
wild-type fibroblast line (PF20T). RNA was electrophoresed through an agarose- 
formaldehyde gel, blotted onto nylon membrane and probed with a 1.0kb 
EcoRI/Hwdffl fragment of pMLIG3. Positions of the 28S and 18S ribosomal RNA 
transcripts are indicated, as are the two LigS transcripts (3.0 and ~6kb). Lower, 
ethidium bromide staining to verify equal RNA loading.
Figure 5.4.7: Lig4 expression is unaltered by the absence of DNA ligase I
Northern blot analysis of Lig4 expression in samples representative of the 
different Ligl genotypes. Upper, total RNA was prepared from the original ES cell 
line (HM-1), one ES cell clone heterozygous for the targeted Ligl/PGK-HPRT allele 
(#53), El3.5 embryos of the three Ligl genotypes, the two immortalised fibroblast 
lines homozygous for the targeted Ligl/PGK-HPRT allele (PFL10T, PFL13T), and a 
wild-type fibroblast line (PF20T). RNA was electrophoresed through an agarose- 
formaldehyde gel, blotted onto nylon membrane and probed with a 0.75kb 
Ec0RI///mdin fragment of pMLIG4. Positions of the 28S and 18S ribosomal RNA 
transcripts are indicated flanking the ~3.0kb Lig4 transcript. Lower, ethidium bromide 

































Figure 5.4.8: The level of DNA ligase III is unaltered by the absence of DNA 
ligasel
Western blot analysis of DNA ligase ffl in samples representative of the 
different Ligl genotypes. Total protein extracts were prepared from E13.5 embryos of 
the three Ligl genotypes, the two immortalised fibroblast lines homozygous for the 
targeted Ligl/PGK-HPRT allele (PFL107, PFL137), and a wild-type fibroblast line 
(PF20T). Protein lysates were made by brief homogenisation of tissue or cell pellets in 
lysis buffer, and 100/zg loaded onto an 8% SDS-polyacrylamide gel. Separated 
proteins were blotted onto a nylon membrane, blocked in TEST plus 5% non-fat milk 
powder, and incubated with TL25 rabbit polyclonal antibody raised against 
recombinant full length human DNA ligase EL Detection of bound antibody was 
achieved using alkaline phosphatase-conjugated anti-rabbit IgG antibodies. Positions 
of protein molecular weight markers are indicated, as is the ~100kDa wild-type DNA 
ligase HI protein. Ligl genotypes of the different samples are shown.
Figure 5.4.9: The level of DNA ligase IV is unaltered by the absence of DNA 
ligase I
Western blot analysis of DNA ligase IV in samples representative of the 
different Ligl genotypes. Total protein extracts were prepared from E13.5 embryos of 
the three Ligl genotypes, the two immortalised fibroblast lines homozygous for the 
targeted Ligl/PGK-HPRT allele (PFL107, PFL13T), and a wild-type fibroblast line
T(PF20 ). Protein lysates were made by brief homogenisation of tissue or cell pellets in 
lysis buffer, and lOOjig loaded onto an 8% SDS-polyacrylamide gel. Separated 
proteins were blotted onto a nylon membrane, blocked in TEST plus 5% non-fat milk 
powder, and incubated with TL18 rabbit polyclonal antibody raised against a peptide 
in the C-terminus of human DNA ligase IV Detection of bound antibody was 
achieved using alkaline phosphatase-conjugated anti-rabbit IgG antibodies. Positions 
of protein molecular weight markers are indicated, as is the ~100kDa wild-type DNA 






































5.5 RT-PCR fingerprinting of DNA ligase I-deficient embryos.
mRNA differential display (DDRT-PCR) is an RT-PCR based technique that 
permits analysis of changes in gene expression between two or more samples (Liang 
and Pardee 1992). It allows identification and cloning of differentially expressed 
genes by arbitrary amplification and comparative display of transcripts. mRNA is 
reverse transcribed using an oligo-dT primer for first strand synthesis and a short 
arbitrary primer for second strand synthesis. Subsequently repeated PCR cycles are 
carried out under low stringency conditions with the same primers, and the multiple 
products separated on a polyacrylamide gel to produce a ladder of bands. Using a 
combination of different arbitrary primers it is possible to produce a series of patterns 
representative of all expressed genes. If mRNAs from two different sources are 
analysed in parallel, it is possible to identify and clone genes which are expressed at 
different levels. Two variations on this technique have been described: arbitrarily 
primed PCR (AP-PCR), which employs short arbitrary primers in both first and 
second strand synthesis, and RT-PCR fingerprinting. RT-PCR fingerprinting (Boehm 
1993) was designed to visualise differences in mRNA expression amongst multigene 
families, and has also been used successfully to identify novel members of known 
families. Degenerate oligonucleotide primers are designed to recognise regions 
known to be conserved amongst members of a gene family. mRNA is reverse 
transcribed using an oligo-dT primer for first strand synthesis, and subsequently 
repeated PCR cycles are carried out under low stringency conditions with the two 
specific primers. The PCR products are digested with a frequently cutting restriction 
enzyme such as HaeHl, and separated on a polyacrylamide gel to produce a ladder of 
bands. Individual bands correspond to the different members of the gene family, and 
it is possible to clone and identify differentially expressed bands as before.
Northern and western analysis of DNA ligases ffl and IV had shown that 
expression of these enzymes was not significantly altered in DNA ligase I-deficient 
samples. To examine the possibility that expression of a further (novel) DNA ligase 
may alternatively be upregulated, RT-PCR fingerprinting was attempted on RNA 
samples from +/+ and -/- midgestation embryos, using PCR primers based on the 
coding regions of Ligl, LIG3, and LIG4.
5.5.1 Low stringency RT-PCR fingerprinting using long sequence specific 
primers
Total RNA samples from El3.5 Ligl +/+ and -/- embryos were reverse 
transcribed under standard conditions. 3/il of each RT reaction was then used as a 
template for PCR under low stringency conditions. A small quantity of 32P labelled
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dCTP was included in each reaction to allow subsequent visualisation of the PCR 
products. A number of different combinations of PCR primer pairs were tried, a 
summary of which is given in Table 5.5.1. All were at least 21 bases in length, and 
had been initially used either for sequencing of the Ligl cDNA (Jessop 1995), 
genotyping PCR reactions, or to clone fragments of Lig3 and Lig4. The primer pairs 
employed were predicted to give products between 0.15 and 1.0kb from their 
respective gene specific templates.
The reaction products were precipitated and then resuspended in 20jul sterile 
distilled water. Half of the sample was separated on a polyacrylamide gel, whilst the 
remainder was digested with the restriction enzyme HaeTK, and then subjected to 
electrophoresis on a polyacrylamide gel. After drying, the gels were exposed to 
autoradiography film overnight.
Examination of the autoradiograph revealed the ladder of bands produced to be 
much more complex than anticipated. Even before HaeHl digestion, hundreds of 
distinct bands were visible in each track, and after digestion the complexity of the 
patterns increased (data not shown). Without full length cDNAs of Lig3 and Lig4 as 
positive controls, it proved impossible to determine which bands were derived from 
the three human DNA ligases. This unexpected complexity most probably arose as a 
result of the nature of the primers used. None of the primers had been designed for 
the purpose of RT-PCR fingerprinting. All were long sequence specific 
oligonucleotides not well suited for use as degenerate primers. Also, the predicted 
products amplified by many pairs were too large to be useful for this technique. 
Those few pairs that gave reasonably small products were invariably based on the 
Ligl cDNA sequence. Because of the relative abundance of Ligl expression in 
comparison to transcripts of the other two DNA ligases, these pairs exclusively 
amplified Ligl sequences. Hence, the attempt to carry out RT-PCR fingerprinting of 
the DNA ligase gene family was not wholly successful.
It was however noted that a few bands from certain primer pairs were of 
different intensity in different lanes. In most cases this manifested as the presence of 
a band in the +/+ sample which was absent from the -/- sample, and therefore 
attributable to targeted disruption of Ligl. However, some bands exhibited the 
reciprocal pattern, or were more intense in the -/- track. It was decided to investigate 
the origin of these fragments further.
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The different combinations of oligonucleotide primers tried for RT-PCR 
fingerprinting. Primer identifiers are given, along with an indication of the gene to 
which they were originally designed to bind. The predicted product sizes are based 
on binding locations within the respective cDNA sequences. The number of bands of 
greater intensity in -/- tracks compared to wild-type samples is also recorded. See text 
for details.
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Table 5.5.2: Summary of results from low stringency RT-PCR using long 
sequence specific primers
The 25 bands differing in intensity between +/+ and -/- samples in RT-PCR 
fingerprinting were used to probe northern blots of total RNA from midgestation 
embryos. Approximate sizes of the purified fragments are recorded, along with the 
estimations of the sizes of bands on the northern blots, and the origins of the signals 
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Undigested banding patterns were examined to identify those bands 
differentially expressed between the +/+ and -/- samples. Once differential bands 
were identified from dried gels, repeat PCR reactions were carried out, and the 
reactions separated as before, except that the gel was exposed to autoradiography 
film without being dried. Areas of the gel corresponding to bands of interest were 
excised, and the DNA fragments contained therein purified by the 'crush and soak' 
method, l/il of each purified fragment was then used to seed a further round of PCR 
in order to amplify the recovered DNA fragments. The primers employed were those 
that had been used in the initial round of low stringency PCR. For this amplification 
step higher stringency conditions were used.
Reamplified PCR reaction products were run out on a low melting point 
agarose gel, and the visible band (or bands) purified. Each recovered fragment was 
then used as a probe in a secondary screening procedure based on northern blot 
analysis. Total RNA samples from pairs of +/+ and -/- embryos were separated by 
formaldehyde-agarose gel electrophoresis, blotted onto nylon membrane, and 
hybridised to probes produced from the purified fragments. Autoradiography was 
used to identify those which corresponded to transcripts upregulated in -/- embryos. 
Results of this procedure, best described as 'low stringency RT-PCR using long, 
sequence specific primers', are summarised in Table 5.5.2
Of 25 fragments initially investigated, 5 did not give signals on northern blots, 
although in 4 of these cases the bands were under 0.2kb and the negative result 
probably stemmed from technical difficulties. 16 of the remaining 20 fragments 
picked up a very high molecular weight band (>15kb), either with or without 
hybridisation to smaller transcripts. This band was of greater intensity in the -/- 
sample, but its large size indicated the most likely source to be DNA contamination 
in the RNA preparations, and hence was ignored. Three fragments hybridised to 
ribosomal RNA, and nine detected transcripts that did not appear to be differentially 
expressed. However, three products, numbered #8, #10 and #23, did pick up 
transcripts which were more highly expressed in -/- RNA samples compared to wild- 
type. The sizes of the three transcripts were estimated as 0.5kb, 6kb and 2kb 
respectively.
Because none of the three fragments of interest detected only a single band, 
each probably consisted of more than one species of DNA molecule. Therefore 
before any further analysis could be conducted, it was necessary to isolate the 
individual fragments. To this end, the purified products from the second round of 
PCR were cloned into the EcoRV site of pBluescriptn SK+. In order to identify those 
plasmids containing fragments corresponding to differentially expressed transcripts, 
each clone was re-screened by northern analysis. The cloned sequence was excised
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from the plasmid vector by restriction digestion, and used to probe pairs of +/+ and - 
/- embryo RNA samples by northern blotting as before. Subsequently, clones which 
detected differentially expressed transcripts were sequenced, and these sequences 
then used to search nucleotide sequence databases.
5.5.2 Analysis of the three differentially expressed transcripts
5.5.2.1 0.5kb transcript (fragment #8)
Expression of the 0.5kb transcript was approximately 3-fold higher in -/- 
embryos compared to wild-type and heterozygous samples (Figure 5.5.2). No 
expression could be detected in ES cell or fibroblast samples, irrespective of Ligl 
genotype. The PCR fragment was produced from a reaction utilising two primers 
based on the L1G4 cDNA sequence (LIG45 1 and HLIG43'). When cloned and 
sequenced, the fragment proved to be 225bp in length, of which 176bp was non- 
primer derived (Figure 5.5.1). Analysis of this sequence revealed that it had 100% 
identity with a region of the murine intracellular calcium binding protein MRP14 
mRNA (Database accession number: M83219)111 . MRP14 transcripts are 0.5kb in size 
(Lagasse and Weissman 1992), closely matching the transcript observed on northern 
blots probed with the cloned PCR fragment. MRP14 is a member of the S100 family 
of proteins, most of which are involved in cellular differentiation or cell cycle 
progression. The protein complexes with another calcium binding protein MRP8 on 
the inside face of the cell membrane and on intermediate filaments. The precise 
function of MRP14 is still unclear, but it may be involved in intracellular signalling 
by modulating protein kinase function. However, irrespective of function, the protein 
is known to be expressed predominantly in granulocytes and monocytes of the 
haematopoietic system, and is linked to development of the myeloid lineage and 
activation during the inflammation response (Murao 1994).
5.5.2.2 2kb transcript (fragment #23)
Expression of the 2kb transcript was approximately 2-fold higher in -/- 
embryos compared to wild-type and heterozygous samples (Figure 5.5.4). No 
expression could be detected in samples from either ES cells or fibroblast lines, 
irrespective of Ligl genotype. The fragment was produced from a PCR reaction 
utilising two primers based on the mouse Ligl cDNA sequence (M5175 and N2468). 
When cloned and sequenced, the fragment was found to be 290bp, of which 246bp 
was non-primer derived (Figure 5.5.3). Analysis of this sequence revealed that it had
Hi Also called Calgranulin B or Cagb
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Figure 5.5.1: Sequence of fragment #8 aligned with the published mouse MRP14 
cDNA sequence.
The nucleotide sequence of fragment #8 was used to search the Genbank 
nucleotide sequence database through the Fasta program of the Genetics Computer 
Group package version 9 (Genetics Computer Group 1996). A matching sequence, 
corresponding to the murine intracellular calcium binding protein MRP14 cDNA, was 
retrieved. Numbers indicate the location of nucleotides within the published MRP14 
cDNA sequence (Database accession number: M83219) (top), and the sequence of 
clone p8Q (bottom). Vertical lines indicate identical nucleotides in the two sequences, 
and PCR primers sequences are marked.
LIG45'
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16 TTAGCCTTGAGCAAGAAGATGGCCAACAAAGCACCTTCTCAGATGGAGCG 65
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23 TGAC..CCTGGACGACCTAGAACAA 1
HLIG43'
Figure 5.5.2: Expression otMRP14 is upregulated in -/- embryos
Northern blot analysis of MRP14 expression in samples representative of the 
different Ligl genotypes. Upper, total RNA was prepared from the original ES cell 
line (HM-1), one ES cell clone heterozygous for the Ligl/PGK-HPRT targeted allele 
(#53), El3.5 embryos of the three Ligl genotypes, the two immortalised fibroblast 
lines homozygous for the targeted Ligl/PGK-HPRT allele (PFL10T, PFL13T), and a 
wild-type fibroblast line (PF20T). RNA was electrophoresed through an agarose- 
formaldehyde gel, blotted onto nylon membrane and probed with an EcoRVHimHn. 
fragment of p8Q. Positions of the 28S and 18S ribosomal RNA transcripts are 













































































































Figure 5.5.3: Sequence of fragment #23 aligned with the published mouse 
transferrin cDNA sequence.
The nucleotide sequence of fragment #23 was used to search the Genbank 
nucleotide sequence database through the Fasta program of the Genetics Computer 
Group package, version 9 (Genetics Computer Group 1996). A matching sequence, 
corresponding to the rat transferrin cDNA, was retrieved. Numbers indicate the 
location of nucleotides within the published transferrin cDNA sequence (Database 
accession number: D38380) (top), and the sequence of clone p23G (bottom). Vertical 
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305 CGCGGATCCGCTGAAGAAGGACTACCTTGAAAAGATTGTGAACGGAGAAG 256
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1241 CAGATGCCATGAGCTTGGATGGAGGTCATGCCTACATAGCAGGCCAGTGT 1290
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255 CGGACGCCATGACTTTGGATGGAGGACATGCCTACATTGCAGGCCAGTGT 206
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Figure 5.5.4: Expression of transferrin is upregulated in -/- embryos
Northern blot analysis of Trf expression in samples representative of the 
different Ligl genotypes. Upper, total RNA was prepared from the original ES cell 
line (HM-1), one ES cell clone heterozygous for the Ligl/PGK-HPRT targeted allele 
(#53), El3.5 embryos of the three Ligl genotypes, the two immortalised fibroblast 
lines homozygous for the targeted Ligl/PGK-HPRT allele (PFL107, PFL13T), and a 
wild-type fibroblast line (PF20T). RNA was electrophoresed through an agarose- 
formaldehyde gel, blotted onto nylon membrane and probed with an EcoRI/HindSl 
fragment of p23G. Positions of the 28S and 18S ribosomal RNA transcripts are 






















































100% identity with a stretch of sequence from a partial mouse transferrin cDNA 
(TV/), and 86%identity at the nucleotide level with a region of the rat transferrin 
mRNA (Database accession number: D38380). The rat Trf transcript is 2.3kb in size 
(Hosino, Hisayasu,and Shimada 1996), again matching the size of transcript observed 
on northern blots probed with the cloned PCR fragment. Transferrin is an iron 
transport protein whose expression is known to be stimulated by iron deficiency 
(Scriver 1995)).
5.5.2.3 6kb transcript (fragment #10)
Expression of the 6kb transcript was approximately 5-fold higher in -/- 
embryos compared to wild-type and heterozygous samples (Figure 5.5.5). Although 
no expression could be detected in ES cells or the wild-type fibroblast line PF20T, a 
significant level of expression was observed in one of the two DNA ligase I-deficient 
fibroblast lines (PFL10T). The PCR fragment was produced from a reaction 
employing one primer based on the LIG3 cDNA sequence (HLIG35 1) and one primer 
derived from the LIG4 cDNA sequence (LIG43 1). Two independent clones were 
obtained (plOE and pi OX), each containing around SOObp of non-vector sequence. 
However, when analysed, the two inserts were not identical. Homology only 
extended over half of the length of each clone (~400bp) (data not shown). Figure 
5.5.6 indicates the way in which the two sequences were apparently related. Each 
clone was a doublet of two unrelated 400bp sequences, but with only one of each 
doublet common to both clones. Both clones detected single transcripts of the same 
size on northern blots (data not shown). Thus it was assumed that the 400bp 
sequence common to both clones was the element which hybridised to the 6kb 
transcript, and hence the region of interest. The consensus sequence of this element is 
shown in Figure 5.5.7.
Nucleotide database searches with all of the sequences contained within clones 
plOE and plOX failed to reveal any significant homology to existing sequences. Blast 
searches for potential homology amongst translated amino acid sequences also failed 
to pick up any good candidate sequences. The closest match from these searches was 
to the P-type cation translocating ATPase from Plasmodium falciparum, but even in 
this case homology was limited (data not shown). It was therefore concluded that the 
fragment which hybridised to the ~6kb transcript was part of a transcript from a gene 
not in the sequence database.
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Figure 5.5.5: Expression of the transcript corresponding to fragment #10 is 
upregulated in -/- embryos and PFL10T fibroblasts
Northern blot analysis of "fragment #10" expression in samples representative 
of the different Ligl genotypes. Upper, total RNA was prepared from the original ES 
cell line (HM-1), one ES cell clone heterozygous for the Ligl/PGK-HPRT targeted 
allele (#53), E13.5 embryos of the three Ligl genotypes, the two immortalised 
fibroblast lines homozygous for the targeted Ligl/PGK-HPRT allele (PFL10T, 
PFL137), and a wild-type fibroblast line (PF20T). RNA was electrophoresed through 
an agarose-formaldehyde gel, blotted onto nylon membrane and probed with an 
EcoKUHindni fragment of plOE. Positions of the 28S and 18S ribosomal RNA 








































































Figure 5.5.6: Schematic representation of the relationship between clones 10E 
and 10X.
Nucleotide sequences of two independent clones of fragment #10 were aligned 
using the Lineup and Pileup programs on the Genetics Computer Group package, 
version 9 (Genetics Computer Group 1996), and the resulting alignment represented 
schematically. Sequences common between the two clones are depicted by filled 
boxes, other sequences by open and shaded boxes. Arrows indicate PCR primer 
sequences.
Figure 5.5.7: Consensus sequence of fragment 10.
Nucleotide sequences of clones 10E and 10X were aligned using Lineup and 
Pileup programs of the Genetics Computer Group package, version 9 (Genetics 
Computer Group 1996), and the consensus sequence of the common region produced 









1 ATGAAGAAAT GTCCCAATGG CATGTTTGCT GTGACTTTGC AGGACTCAGT
51 AAGCCAGTAG ATAAACATTA TTGTGTGATC TATGATTAGT AGTCTAACCA
101 TGACACAAGG CATTTGTATG CACTTCTGCT GGAGATGTGA TTCATTCTTG
151 GTTTACAAAT TCAAATTGTT CCTTCATTTT TGCTTTTTCC AAGAGTGAAA
201 CATCAACAAA TATTCATTAT TATACTAGTC CCCTTGCAGA TAATGTTATG
251 CCCTTGAGAT AGGTACCCAA TGCAAATTAA ATGAATGTAT AAAATTGGCT
301 GCACCTTG
LIG43'
5.6 Cells lacking DNA ligase I exhibited delayed joining of newly synthesised 
DNA replication intermediates into high molecular weight forms
Biochemical and genetic evidence has indicated DNA ligase I to be central to 
mammalian DNA replication. DNA ligase I expression and activity is induced upon 
cell proliferation. The protein has been isolated from mammalian replication 
complexes, and functions in the reconstitution of replication in vitro. Moreover, cells 
from the 46BR patient, with reduced DNA ligase I activity, exhibited defective 
joining of replication intermediates (Reviewed in Tomkinson and Levin 1997). Short 
nascent DNA chains (40-300 bases), termed Okazaki fragments, are formed during 
discontinuous 'lagging strand' DNA synthesis prior to incorporation into higher 
molecular weight strands. These replication intermediates are extremely transient in 
wild-type cells incubated at 37°C, and cannot be detected with pulse labelling periods 
over 1 minute. However, Okazaki-type fragments were detected in cells from the 
46BR patient, and these disappeared only after long chase times (Henderson et al 
1985, Lonn et al. 1989, Prigent et al. 1994). We were able to reproduce these 
observations using incorporation of radiolabelled deoxyribonucleotides to 
specifically label newly replicated DNA.
Exponentially proliferating cultures of immortalised fibroblast lines were pulse
•^ olabelled with [ H]-thymidine for 10 minutes. Alternatively cells were pulsed with H 
thymidine for 10 minutes followed by 2, 5, 10, 15, or 30 minutes incubation with an 
excess of unlabelled thymidine (chase). Cells were then harvested, embedded in 
agarose plugs, and lysed in situ, prior to incubation in alkaline conditions to denature 
the contained DNA. Thereupon single stranded DNA fragments were separated on 
the basis of size by electrophoresis through alkaline agarose gels. To detect the 
presence of 3H labelled DNA, gels were cut into defined slices which were assayed 
by scintillation. The numbers of radioactive counts detected in samples 
corresponding to the different ranges of DNA fragment size were expressed as a 
percentage of the total counts incorporated into DNA at that timepoint. Figure 5.6.1 
shows the percentage counts in the different fractions plotted against the chase time 
for four human and mouse fibroblast cell lines, while Figure 5.6.2 shows the 
cumulative percentage of counts in the four smallest fractions (DNA fragments under 
2.0kb size) plotted against chase time.
Following a 10 minute pulse, the majority of 3H radiolabel in wild-type human 
fibroblast cells (MRC5V1) was incorporated into DNA molecules over 23kb in size 
(Figure 5.6.la). Very little labelled thymidine was present in fragments under 2kb 
(Figure 5.6.2), and that which was present rapidly disappeared when chased with 
unlabelled thymidine. In contrast, labelled DNA from 46BR.1G1 cells was generally
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of a lower molecular weight, with less than 50% of the radiolabel in the heaviest 
fraction (Figure 5.6.15). Moreover, significant amounts of label could be detected in 
DNA fragments of less than 2kb size (Figure 5.6.2). Thus, as reported previously 
there was a delay in incorporation of replication intermediates into larger molecules 
in 46BR.1G1 cells. However, this delay was transient. After prolonged chase periods, 
very little 3H label remained in DNA fragments under 2kb, and the majority of 
radiolabelled DNA was at least 23kb in size.
__ rri
A wild-type mouse immortalised line (PF20 ) behaved in a manner very 
similar to its human counterpart in this assay. The majority of 3H radiolabel was 
incorporated into large DNA molecules after a 10 minute pulse, and only small 
amounts were present in smaller fractions (Figure 5.6.2). The fibroblast line lacking 
DNA ligase I (PFL13T) did not however display a normal distribution of nascent 
DNA molecules. Labelled DNA was of lower average molecular weight compared to 
the wild-type control, with less than 50% of the label in fractions over 23kb size 
(Figure 5.6. Id). Approximately 10% of 3H label was detected in DNA fragments 
under 2kb in size after a 10 minute pulse (Figure 5.6.2), indicating a delay in the 
joining of replication intermediates. Again this delay proved to be only transient, as 
after chase periods greater than 10 minutes, all of the label was to be found in 
molecules over 2kb.
__ ____ rrt
Although PFL13 fibroblasts displayed abnormal joining of replication 
intermediates, the profile observed was distinct from that seen in 46BR.1G1 cells. 
After a radioactive pulse, the average size of nascent DNA molecules was greater in 
PFL137 cells, with less radiolabel being located in small DNA fragments compared 
to 46BR.1G1 cells. However, these small intermediates were chased away at broadly 
similar rates in both 46BR.1G1 and PFL13T cell lines (Figure 5.6.2), and the rates of 
disappearance of small DNA fragments were similar across all size fractions (Figure 
5.6. Ib and d, and data not shown). Thus, whilst the initial rate of Okazaki-type
____ rpi
intermediate joining in PFL13 cells was apparently closer to normal parameters than 
in 46BR.1G1 cells, subsequent joining (or degradation) of these fragments apparently 
occurred at equivalent rates in both cell lines.
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Figure 5.6.1: Analysis of newly replicated DNA
Graphical representations of the size distribution of DNA fragments formed 
during DNA replication. MRC5V1 (a), 46BR.1G1 (b), PF20T (c) and PFL13T (d) cells 
were pulse labelled for 10 minutes with [3H]-thymidine. Alternatively cells were 
pulsed with [3H]-thymidine for 10 minutes followed by 2, 5, 10, 15, or 30 minutes 
chase with an excess of unlabelled thymidine. Cells were harvested, embedded in 
agarose plugs, and lysed in situ, prior to incubation in alkaline conditions. Thereupon 
single stranded DNA fragments were separated on the basis of size by electrophoresis 
through alkaline agarose gels. To detect the presence of 3H labelled DNA, gels were 
cut into defined slices which were assayed by scintillation. The numbers of 
radioactive counts detected in samples corresponding to the different ranges of DNA 
fragment size were expressed as a percentage of the total counts incorporated into 
DNA at that timepoint. These percentages were then plotted on a 3 dimensional bar 
chart against DNA fragment size and chase time. Each point represents the mean 
value from two independent experiments (error bars not shown for clarity). Increasing 



























Figure 5.6.2: The percentage of total radioactive counts in DNA fragments less 
than 2.0kb size.
A graphical representation of the persistence of small DNA fragments formed 
during replication over time. As indicated previously, MRC5V1, 46BR.1G1, PF20T 
and PFL13T cell lines were subjected to pulse-chase analysis. The sum percentages of 
radiolabel present within the four fractions under 2.0kb size were calculated at each 
timepoint for each cell line, and these percentages plotted as a function of chase time. 
Each point represents the mean of two independent experiments, error bars depicting 
the standard deviation at each sample point.
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5.7 Sister chromatid exchanges rates are normal in cells lacking DNA ligase I
One of the characteristics of Bloom's Syndrome is a high level of chromosomal 
instability and somatic recombination, characterised by reciprocal interchanges 
between homologous chromatids (sister-chromatid exchange, SCE) (reviewed in Ray 
and German 1983). Cells from BS patients exhibit 60-90 SCEs per metaphase, far in 
excess of the normal baseline of -10 SCE/metaphase. Although BS is not caused by 
mutations at the LIG1 locus, alterations in the activity and/or structure of DNA ligase 
I have been observed in BS cells (Willis and Lindahl 1987, Chan et al. 1987). 
Moreover, cells from the 46BR patient were hypersensitive to the induction of SCE 
by DNA damaging agents (Henderson et al. 1985). Because cells from Ligl -/- 
embryos showed an elevated level of chromosome instability (D. W. Melton 
unpublished data), we were interested to determine the levels of SCEs in these cells.
It is possible to differentiate between sister chromatids in metaphase 
chromosomes by employing a combination of 5-bromodeoxyuridine labelling and 
dye staining. As a result, numbers of exchanges occurring between the two 
chromatids can be quantified. The method we employed was based on the use of 
fluorescent dye combined with Giemsa stain to make permanent cytological 
preparations of differentially labelled chromatids (Perry and Wolff 1974, 
modifications by Goto et al. 1977) (see Figure 5.7.1 and Figure 5.7.2). Immortalised 
cell lines and primary cultures from mid-gestation embryos were allowed to 
incorporate the base analogue 5-bromodeoxyuridine (BrdU) for two rounds of DNA 
replication, whereupon colcemid was added to arrest the cell division in metaphase 
of mitosis. Cells were fixed and dropped onto microscope slides to spread the 
chromosomes, before being stained with Hoechst 33258 fluorescent dye. Sister 
chromatids stained in this way fluoresce differentially under UV illumination, but the 
dye is not photostable and the image fades rapidly. Finally, to produce a more 
permanent image, spreads were aged by exposure to 'blacklight' (UV-A) with heating, 
and thereafter incubated in hot 2X SSC. Thereafter, chromosomes were stained with 
Giemsa and permanently mounted. Differentially stained sister chromatids could then 
be visualised by light microscopy, and photographed for scoring of SCEs numbers.
Table 5.7.1 details the results of analysis of the numbers of sister chromatid 
exchanges in cultures of human and mouse fibroblasts. SCE numbers were expressed 
in terms of the number of exchanges per chromosome, and also the average number 
of SCE per metaphase. Because immortalised cell lines displayed variable numbers 
of chromosomes in each cell, it was assumed that each murine metaphase included 
the normal diploid complement of 40 chromosomes, and that each human cell had 
46.
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All wild-type samples whether human (MRC5V1) or mouse (PF20T, Ligl +/+) 
primary fibroblasts) displayed SCE rates consistent with previous studies (-10 SCEs 
per metaphase) (e.g. McDaniel and Schultz 1992). There also appeared to be no 
detectable difference between primary cultures and immortalised lines in this respect. 
Samples from -/- mouse embryos did not show any significant difference in the rate 
of SCE formation compared to wild-type (ANOVA F4>7 i= 1.42, P>0.05), and there 
was again no change following immortalisation. It was therefore concluded that the 
absence of DNA ligase I does not result in the elevation of SCE rates. An increased 
baseline level of SCEs had been noted previously in 46BR cells (Henderson et al. 
1985). Examination of 46BR.1G1 samples in this study also revealed a statistically 
significant increase in SCE formation (-20 SCEs/metaphase on average) compared 
to the control human cell line (Mann-Whitney U test: U=36.5, P<0.05).
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Cultures of immortalised human (MRC5V1,46BR.1G1) and mouse (PF20T, PFL137) 
fibroblasts and primary cultures from Ligl +/+ and -/- midgestation embryos were 
grown in BrdU-containing medium for sufficient time for two rounds of DNA 
replication to occur. Cells were arrested in metaphase by addition of colcemid, fixed 
and spread onto microscope slides. Chromosomes were then stained by incubation 
with Hoechst 33258, followed by exposure to a UV-A light source, incubation in 2X 
SSC and staining with Giemsa. Differentially stained metaphase chromosomes were 
examined by light microscopy and photographed using a green filter for maximal 
contrast between sister chromatids. Photographs were then visually scored for SCEs. 
The mean number of SCEs per chromosome scored was calculated for each sample 
(± standard error). Additionally, this value was expressed as the average number of 
SCEs per metaphase (± standard error), assuming that each cell contained a normal 
diploid complement of chromosomes (mouse; 2n = 40, human; 2n = 46).
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Figure 5.7.1: Schematic representation of sister chromatid differentiation by 
BrdU-dye staining techniques.
Adapted from Latt et al. 1983. Each oblong represents a single chromosome (or 
chromatid in a pair) composed of one double stranded DNA molecule. Circles 
represent centromeres. Cells are incubated with BrdU for two rounds of DNA 
replication. Semi-discontinuous DNA replication means the base analogue is 
incorporated only into daughter molecules. Hence after the second round of 
replication one chromatid will be composed entirely of BrdU containing DNA 
(bifilarly substituted), whilst the other chromatid is a hybrid of one parental strand and 
one BrdU containing strand (unifilarly substituted). The two sister chromatids will 
fluoresce differentially when stained with fluorescent dye such as Hoechst 33258 
during metaphase. The unifilarly substituted chromatid fluoresces more brightly than 
the bifilarly substituted sister chromatid. It is then possible to identify locations where 
reciprocal exchanges have occurred between two sister chromatids by examination of 
the differential staining pattern.
Figure 5.7.2: A differentially stained mouse metaphase
A photograph of a typical wild-type mouse fibroblast metaphase spread stained 
by the fluorescence plus Giemsa method. A primary culture from a wild-type mouse 
embryo was cultured, stained and photographed as detailed previously. One reciprocal 
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We have shown that DNA ligase I is required for normal development, and its 
absence results in death in utero. Prenatal lethality limits the scope of any 
investigation into the role of DNA ligase I in a whole animal system. Not only does it 
prevent study of the effects of DNA ligase I-deficiency on later developmental 
events, but also could conceal other consequences, such as predisposition to 
malignant transformation. It would therefore be desirable to be able to bypass the 
embryonic lethality, and to analyse DNA ligase I-deficient cells in an adult 
environment. Technical difficulties aside, in vivo haematopoietic repopulation of 
lethally-irradiated recipients had certain associated constraints, not least being study 
of only a restricted number of cell lineages. We therefore decided to pursue an 
alternative strategy for continued in vivo investigation.
Conditional gene targeting offers the potential to control the spatial and 
temporal boundaries of gene knockouts. The strategy makes use of the loxP/Cre 
recombinase system from the bacteriophage PI. Cre is a site-specific DNA 
recombinase which recognises a 34bp target sequence (loxP site) (Kilby, Snaith and 
Murray 1993). By flanking a gene of interest with two loxP sites (termed 'floxing'), it 
is subsequently possible to excise the intervening genomic locus (and hence delete 
the gene) via Cre-mediated recombination. Control of Cre expression can therefore 
be used to limit knockout of the 'floxed' gene to a particular tissue, cell lineage, or 
timepoint, and hence permit analysis of gene knockouts that are otherwise lethal 
(reviewed by Kiihn and Schwenk 1997).
This chapter describes the introduction of two loxP sites into the Ligl locus by 
means of a 'double replacement' gene targeting strategy. The resulting mice were 
crossed to a line carrying a Cre transgene, and analysis of Cre-mediated 
recombination at the Ligl locus in vivo is also detailed. Work was carried out in 
association with Carolanne McEwan, Anne-Marie Ketchen, Niki Redhead, Jim 
Selfridge, Caroline Holmes, Stefan Selbert, Dominic Rannie, Paula Louren?o, 
Christine Watson, and Alan Clarke and published in Transgenic Research (Selbert et 
al. 1998). A reprint of the paper is included at the rear of this thesis. Construction of 
the targeting vectors was done by Carolanne McEwan, and targeting ES cell culture 
performed by Anne-Marie Ketchen. Mice expressing Cre from a mammary-specific 
transgene were produced by Stefan Selbert, Dominic Rannie, Paula Lourenso, 
Christine Watson, and Alan Clarke. Genotyping of stock mice was carried out by 
Carolanne McEwan and Caroline Holmes. Southern blot analysis to quantify the 
levels of Cre-mediated recombination in mammary tissue samples was performed by 
Jim Selfridge.
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6.1 Double replacement gene targeting to introduce two loxP sites into Ligl
Double replacement gene targeting is a strategy for introducing subtle 
alterations into endogenous genes by means of two sequential rounds of gene 
targeting in ES cells (Reid et al. 1990). It is based around the use of HPRT selectable 
markers in the HPRT-deficient ES cell line HM-1, and is dependant on the ability to 
select both for and against HPRT expression (Stacey et al. 1994, Moore et al 1995). 
Although previously only employed to introduce point mutations, the method is 
equally suitable to engineer loxP sites into a genomic locus.
6.1.1 Retargeting the Ligl locus
The first step, inactivation of the Ligl locus by replacement of exons 23 to 27 
with an HPRT minigene, was carried out successfully and mice lacking DNA ligase I 
produced. However, when the second targeting step (replacement of the HPRT 
marker with an altered region of the target gene to reconstruct the locus) was 
attempted, the targeting frequency was much lower than anticipated (D. W. Melton, 
unpublished data). Subsequent analysis indicated that HPRT minigene expression 
had been lost, resulting in a high level of spontaneous 6-thioguanine resistance which 
precluded the isolation of second step targeted clones (Melton, Ketchen and Selfridge 
1997). In order to overcome this problem, it proved necessary to retarget the Ligl 
locus with a different HPRT minigene.
The original targeting vector (MLTV) included an HPRT minigene under the 
control of the constitutively expressed mouse phosphoglycerate kinase (PGK-l) 
promoter. The structure of this PGK-HPRT minigene was described in Magin et al. 
1992a, whilst construction of MLTV was outlined in Jessop 1995. The targeting 
strategy and structure of the original targeted Ligl locus (designated LigllPGK- 
HPRT) are depicted in Figure 3.1.1 (Chapter 3). An almost identical targeting 
strategy was employed to repeat targeting of the Ligl locus, the only difference being 
the use of minigene DWM110 as the selectable marker (D. W. Melton, unpublished 
data). DWM110 is an HPRT expression cassette under the control of part of the 
natural mouse HPRT promoter, and contains certain key transcription control 
elements (Magin et al. 1992a). The structure of the new targeted allele (designated 
L/g7/DWM110) is shown in Figure 6.1.1.
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Figure 6.1.1: Restriction map of the retargeted Ugl locus (Ugl/DWMllO)
Predicted restriction map of the 3' end of the targeted Ligl allele Lig7/DWM110 
based on the structures of the wild-type Ligl allele and Lig7/DWM110 targeting 
vector (data not shown). Drawn to scale: 1cm = 2kb. Black boxes indicate exons; 
lines, introns or flanking DNA, hatched box; HPRT minigene. Restriction sites of 
BarniK, £coRI, HindHl, Kpnl and Sstl are indicated, along with the arrangement of 
resulting restriction fragments for each individual enzyme. Sizes are given in kb. 
Fragments (and associated sizes) which contain exons, and hence will be detected on 
Southern blots probed with Ligl cDNA, are in bold.
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6.1.2 Second step gene targeting
A second step gene targeting vector was constructed for use in a second 
homologous recombination step to reconstruct a functional Ligl allele (C. McEwan, 
D. W. Melton, unpublished data). The targeting vector was introduced into an ES cell 
clone heterozygous for the new targeted Ligl allele (HM-l/L/g7/DWM110 #12). 
Selection for the loss of the HPRT marker was applied, using the purine analogue 6- 
thioguanine (6-TG), and those 6-TG resistant colonies arising were screened for the 
presence of a 'floxed' Ligl allele (denominated f) by PCR (A.-M. Ketchen, D. W. 
Melton, unpublished data. See Figure 6.1.2). 14 6-TG resistant colonies gave positive 
results from the PCR assay, and of these 8 were subsequently analysed further 
(designated HM-1/Ligl/loxP #7, 9, 41, 48, 58, 62, and 68). A schematic 
representation of the strategy used to produce the floxed Ligl allele is shown in 
Figure 6.1.2.
6.1.3 Confirmation of the structure of the floxed Ligl allele
The second step gene targeting vector used to reconstruct the Ligl allele was 
based around the same 13.9kb EcoRI genomic fragment that had been used in 
construction of the first step knockout vectors. The second step vector contained the 
whole 13.9kb EcoRI fragment, but with two loxP sites engineered into 55/1 sites 
within the genomic fragment. One site was located between exons 22 and 23, whilst 
the other was downstream of the final exon (27). Insertion of the two Cre recognition 
sequences during vector construction had resulted not only in the loss of the two SstI 
sites, but also the introduction of two novel restriction sites. The 5' loxP site was 
tagged with a HindlR site, while the downstream sequence was marked by the 
presence of an EcoRI site. The presence of these additional restriction enzyme 
cleavage sites thus permitted the floxed Ligl allele to be distinguished from the wild- 
type allele.
Figure 6.1.3 shows the predicted structure of the floxed Ligl allele arising after 
the second step gene targeting, along with predicted DNA fragments arising from 
digestion with BamHI, EcoRI, HindHl, Kpnl and Sstl restriction enzymes. Those 
fragments highlighted in bold contain exons of the Ligl gene and should thus 
hybridise to a Ligl cDNA probe and be detected on Southern blots. When the 8 ES 
cell clones were analysed by Southern blotting the pattern of fragments observed was 
consistent with the proposed structure of the floxed Ligl allele. It was thererfore 
concluded that all 8 clones had correctly undergone the desired homologous 
recombination event, and were heterozygous for the floxed allele (+/f). Analysis of 
two of the 8 clones is shown in Figure 6.2.4, and discussed further in section 6.2.4.
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Figure 6.1.2: Schematic representation of the double replacement gene targeting 
strategy to introduce loxP sites into the Ligl locus
Schematic representation of 13.9kb at the 3' end of the wild-type mouse DNA 
ligase I locus, targeted gene structure, and the structure of the reconstructed 'floxed' 
locus following second step gene targeting. In the first targeting step, the last 5 exons 
of the Ligl locus were replaced with an HPRT minigene by homologous 
recombination. A second homologous recombination step was subsequently used to 
reconstruct a functional allele, but with exons 23 to 27 flanked by two loxP sites
Drawn to scale: 1cm = 2kb. Solid boxes indicate exons (numbered according to 
the human convention); hatched box, HPRT minigene (DWM110); thin lines, Ligl 
introns or flanking regions; solid triangles, loxP sites. Arrows indicate the positions at 
which PCR primer pairs used for genotyping bind. BarnHl restriction sites are marked 



























































































































































































































Figure 6.13: Restriction map of the floxed Ligl locus
Predicted restriction map of the 3' end of the floxed Ligl allele based on the 
structures of the wild-type Ligl allele and second step targeting vector (data not 
shown). Drawn to scale: 1cm = 2kb. Black boxes indicate exons; lines, introns or 
flanking DNA; solid triangles, loxP sites. Restriction sites of BaniHI, EcoRl, #wdIQ, 
Kpnl and Sstl are indicated, along with the arrangement of resulting restriction 
fragments for each individual enzyme. The orientation of the loxP sites is indicated by 
the direction of the triangle, both loxP sites being in the same orientation. Sizes are 
given in kb. Fragments (and associated sizes) which contain exons, and hence will be 









































































6.1.4 Second step targeting restores expression to the floxed Ligl allele
Whilst second step targeting regenerated the 3' end of the Ligl locus, it 
remained possible that the engineered changes might disrupt expression or result in 
an altered transcript being produced. To determine whether expression from the 
floxed allele was comparable to the wild-type allele, northern blot analysis was 
carried out on ES cell clones heterozygous for the floxed Ligl allele (Figure 6.3.5). 
Total RNA was separated by electrophoresis, transferred onto nylon membrane, and 
probed with a Ligl cDNA probe. The wild-type Ligl transcript was easily detected in 
the wild-type ES cell line (HM-1), and present at reduced levels in the ES cell clone 
heterozygous for the knockout Ligl allele (#53). The samples heterozygous for the 
floxed Ligl allele (#58 and #68) displayed a single transcript of normal size, and the 
signal was of equal intensity compared to wild-type samples. Thus it was concluded 
that the reconstructed Ligl allele was transcriptionally functional, and that expression 
from the floxed allele was not detectably different from wild-type.
6.2 Conditional deletion of Ligl by Cre-mediated recombination
Cre-mediated recombination between the two loxP sites within the floxed Ligl 
allele has a number of consequences for the structure of the Ligl locus (Figure 6.2.1). 
Firstly, because the two loxP sites are arranged in the same orientation, 
recombination will result in excision of the intervening genomic region as a small 
circular DNA molecule. This molecule will lack elements necessary for maintenance 
and propagation within the cell, will be prone to nucleolytic degradation, and hence 
will subsequently be lost. Because exons 23 to 27 are contained within the region 
being excised, they will effectively be deleted by Cre-mediated recombination. Exons 
23 to 27 encode the terminal 175 amino acids of the DNA ligase I protein. It has been 
reported that removal of any more than 15 amino acids from the C-terminus of the 
protein abolishes enzymatic activity (Kodama et al. 1991). Deletion of the final 5 
exons should therefore disrupt gene function.
A second consequence of the recombination event is that previously 
unassociated regions will be brought into juxtaposition. Removal of the intervening 
sequences will bring exon 22 and the 3' flanking region into close proximity, in a 
manner unique to the deleted Ligl allele. We exploited this novel association to 
design a PCR assay specific for the deleted allele (denominated A).
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Figure 6.2.1: Schematic representation of the effect of Cre-mediated 
recombination on the floxed Ugl allele
Schematic representation of 13.9kb at the 3' end of the floxed mouse DNA 
ligase I locus, and the structure of the locus following Cre-mediated recombination 
between the two loxP sites. Cre-mediated recombination between the two loxP sites 
flanking exons 23 to 27 will result in excision of the intervening genomic region as a 
circular molecule (not shown), which will subsequently be lost from the cell. 
Consequently the last five exons of Ligl will effectively be deleted, and previously 
unassociated regions will be brought into juxtaposition.
Drawn to scale: 1cm = 2kb. Solid boxes indicate exons (numbered according to 
the human convention); thin lines, Ligl introns or flanking regions; solid triangles, 
loxP sites. Arrows indicate the positions at which PCR primer pairs used for 






























































































































6.2.1 PCR assay to detect the deleted Ligl allele
Oligonucleotide primers which bound within exon 22 (N2469) and the 3' flanking 
region of the Ligl gene downstream of exon 27 (V2014) were employed in a PCR 
reaction specific for the deleted allele. Prior to recombination, the distances between 
the two primer binding sites were too great for efficient amplification. Thus the wild- 
type and floxed alleles could not give a product from this reaction. Only after Cre- 
mediated recombination had excised the intervening region were the two primer 
binding sites close enough for a product to be amplified. Hence, the 0.5kb product 
spanning the Cre-induced join was diagnostic of the deleted Ligl allele. Figure 6.2.2 
shows the results of a screen for Cre-mediated recombination using the PCR assay to 
identify ES cell colonies containing the deleted Ligl allele.
6.2.2 Conditional deletion of Ligl in vitro by transient expression of Cre 
recombinase
To test whether Cre-mediated recombination could be induced between the two 
loxP sites in a genomic context, Cre recombinase was transiently expressed in ES 
cell clones carrying the floxed Ligl allele. The Cre expression vector pMC/CreN was 
electroporated into two ES clones heterozygous for the floxed allele (#58 and #68). 
In each case approximately 200/>ig of circular plasmid DNA was introduced into 
20X106
cells, which were then plated out as a single pool of cells in a large flask (denoted 
#58 1° and #68 1°). Two days later, samples of each pool were taken for genomic 
DNA preparation, after which a second round of electroporation was carried out on 
the remaining cells, again using 200jLtg of pMC/CreN. The cells were again plated out 
as pools (denoted #58 2° and #68 2°), allowed to proliferate for 2 days, and then 
samples taken for genomic DNA preparation.
Introduction of the circular pMC/CreN plasmid into ES cells should be 
sufficient to permit expression of Cre recombinase in a transient manner. The 
reported efficiency of the Cre-mediated recombination between loxP sites is very 
high. We therefore hypothesised that transient expression of Cre in ES cells carrying 
the floxed Ligl allele should be sufficient to induce Cre-mediated deletion of the 
allele, albeit at a low frequency. In order to detect such rare events, a PCR-based 
screening strategy was designed whereby generation of a PCR product specific for 
the deleted Ligl allele was employed as a marker of a recombination event (see 
section 6.2.1). DNA samples from pools of ES cells were screened for the presence 
of a Cre-mediated recombination event using this PCR reaction. Positive results were
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Figure 6.2.2 Screening for the deleted Ligl allele by PCR
The results of a screen of ES cell colonies for Cre-mediated recombination 
using a PCR reaction specific for the deleted Ligl allele. A Cre expression vector was 
introduced into ES cell clones carrying the floxed Ligl allele, and the surviving cells 
plated out at single cell density. ES cell colonies arising were picked and cells 
digested with proteinase K, before the lysates were used as templates for PCR. A PCR 
reaction specific for the deleted Ligl allele was carried out using the primer pair 
N2469+V2014. The products were separated by agarose gel electrophoresis, and the 
0.5kb product specific for the deleted allele is indicated by an arrow. Figures are the 
numerical identifiers of the colonies being screened, numbers 83 and 87 proving to be 




0.5kb product from 
deleted Ligl allele
obtained from all four of the ES cell pools transfected with the Cre expression 
plasmid (data not shown).
6.2.3 Isolation of ES cell clones heterozygous for the deleted Ligl allele
The PCR assay for Cre-mediated recombination of the floxed Ligl allele 
produced a 520bp product when tested on pools of Ligl +/f ES cells expressing Cre 
recombinase. In order to confirm that the positive result was due to the presence of a 
deleted Ligl allele within these cell populations, it was important to isolate an ES 
cell clone heterozygous for the deleted allele (+/A) from the pools.
Pools of cells from the second sequential round of electroporation (#58 2° and
#68 2°) were plated out at single cell density to allow colony formation. When 
colonies were sufficiently large, 96 were picked at random and screened for the 
presence of the deleted Ligl allele by PCR. Individual colonies were harvested by 
scraping and mechanically disaggregated in a small volume of medium. Thereupon 
one half of each cell suspension was deposited into a well of a multiwell plate for 
continued expansion of the colony, whilst the other half was used for the rapid colony 
screening procedure. Cells were pelleted by brief centrifugation and resuspended in 
IX PCR buffer plus proteinase K. After 2 hours digestion, the proteinase was 
inactivated by heating, whereupon a small aliquot was used in the PCR assay specific 
for the deleted Ligl allele. Out of 96 colonies screened in this manner, 3 produced 
positive signals (#69, 83, 87) (data not shown). Of these, the first was isolated from 
ES cell pool derived from clone IJM-l/Ligl/loxP #58, and hence was designated 
UM-l/Ligl/loxP #58/A69, while the latter two were isolated from HM-l/Ligl/loxP
#68, and hence were designated UM-l/Ligl/loxP #68/A83 and A87.
6.2.4 Confirmation of the structure of the deleted Ligl allele
Cre-mediated recombination between the two loxP sites within the floxed Ligl 
allele results in excision of the central loxP-flanked DNA segment as a circular 
molecule. The circular episome will not be replicated and is susceptible to 
degradation, and thus will ultimately be lost from the cell. Therefore, Cre-mediated 
recombination will effectively delete exons 23 to 27 from the endogenous floxed 
Ligl locus. Figure 6.2.3 shows the predicted structure of the deleted Ligl allele 
arising from Cre-mediated recombination of the floxed allele, along with the 
predicted DNA fragments arising from digestion with BamHl, EcoRl, HindHL, Kpnl 
and Sstl restriction enzymes. Those fragments highlighted in bold contain exons of 
the Ligl gene, and should thus hybridise to a Ligl cDNA probe and be detected by 
Southern blotting. The deleted allele contains a single 0.5kb HindUl fragment that 
includes an exon, whereas the floxed allele is composed of four exon containing
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fragments (0.5, 1.5, 1.6 and 4.3kb). Thus Cre-mediated deletion of the Ligl allele 
should result in the disappearance of the 1.5, 1.6, and 4.3kb fragments.
DNA was prepared from the original ES cell line (HM-1), a clone heterozygous 
for the targeted knockout allele (#53), two clones heterozygous for the floxed allele 
(#58 and #68), and the three clones which had given a positive result from the PCR 
reaction specific for the deleted allele (A69, A83 and A87). Following digestion with 
//mdin, the DNA was subjected to Southern blot analysis (Figure 6.2.4), results of 
which are summarised in Table 6.2.1. Using a Ligl cDNA fragment as a probe, 6 
bands were detected in wild-type and +/- samples (10.7, 4.3, 3.9, 2.0, 1.8, 1.6kb). 
Previous work had shown that 10.7, 3.9 and 1.8kb bands were derived from the 
central region of the Ligl gene and should thus be unaffected by targeting. The 
sample heterozygous for the first step targeted allele displayed an identical banding 
pattern, except that 4.3, 2.0 and 1.6kb bands were reduced in intensity, consistent 
with the structure of the LigllPGK-HPRT allele. Both lanes from HM-l/Ligl/loxP 
ES cell clones (#58 and #68) exhibited identical patterns of 7 bands (10.7, 4.3, 3.9, 
2.0, 1.8, 1.6, and 1.5kb). 6 bands were shared with +/+ and +/- samples, although the 
2.0kb band appeared less intense when compared to the 1.8kb reference band. The 
seventh band was a novel 1.5kb fragment.
The 13.9kb EcoRl genomic region corresponding to the 3' end of the wild-type 
allele contains 3 HindlR fragments that include exons (2.0, 1.6 and 4.3kb 
respectively). The reconstructed allele has an additional HindTH site within the 2.0kb 
fragment, hence dividing this fragment into two. Thus second step gene targeting 
should result in the disappearance of the 2.0kb fragment and appearance of two novel 
bands of 0.5 and 1.5kb, but leave both other wild-type bands (1.6 and 4.3kb) 
unchanged. Whilst an additional novel 0.5kb band had been predicted to arise from 
second step targeting, this fragment contained only a single exon (22) which had 
previously been observed to be difficult to detect by Southern blotting (Jessop 1995). 
Failure to detect this small fragment was hence regarded as a technical problem 
rather than a conflict with the predicted restriction map. Therefore, the pattern of 
fragments observed was not inconsistent with the proposed structure of the floxed 
Ligl allele.
The 1.5kb band detected in +/f samples was not present in lanes corresponding 
to clones A69 and A83. In these samples, six bands were observed in a wild-type 
pattern (10.7, 4.3, 3.9, 2.0, 1.8, 1.6kb), although the 4.3, 2.0 and 1.6kb fragments 
were reduced in intensity compared to wild-type samples. As previously noted, the 
predicted 0.5kb band arising as a result of reconstruction of the floxed allele, which 
should also be present in +/A samples, could not be detected. The pattern of 
fragments observed in samples A69 and A83 was therefore not inconsistent with the
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Table 6.2.1: Summary of the predicted Hindlll restriction fragments from wild- 








































Predicted and actual //mdlQ restriction fragments arising from the 3' end of the 
mouse DNA ligase I locus when probed with a 2.1kb BamWEcoRI fragment of the 
Ligl cDNA. Fragment sizes in brackets are those arising from parts of the gene 
outwith the 13.9kb EcoRl fragment used in the targeting experiments. Fragments 
marked with an asterisk are those which were present at a reduced intensity 
compared to +/+ samples.
proposed structure of the deleted allele. It was concluded that these two ES cell 
clones had correctly undergone Cre-mediated deletion of the floxed Ligl allele and 
were heterozygous for the deleted Ligl allele.
However, while the ES cell clone A87 had given a positive signal from the Ligl 
deleted PCR reaction, the pattern of fragments observed by Southern blotting was 
not consistent with this sample being heterozygous for the deleted Ligl allele. Seven 
fragments were present in the lane corresponding to A87 in Figure 6.2.4 (10.7, 4.3, 
3.9, 2.0, 1.8, 1.6, and 1.5kb), and in this respect closely resembled samples 
heterozygous for the floxed Ligl allele. However, the 1.5kb //mdffl fragment specific 
for the floxed allele did appear slightly reduced in intensity when compared to 
reference bands. The nature of the A87 sample is discussed further in chapter 7, but 
Southern blotting did not eliminate the possibility that a fraction of the cells from 
which the sample was derived had undergone Cre-mediated deletion of the floxed 
Ligl allele.
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Figure 6.2.3: Restriction map of the deleted Ligl locus
Predicted restriction map of the 3' end of the deleted Ligl allele based on the 
structure of the floxed Ligl allele. Drawn to scale: 1cm = 2kb. Black boxes indicate 
exons; lines, introns or flanking DNA; solid triangles, loxP sites. Restriction sites of 
ItaffiHI, EcoRI, //mdffi, Kpnl and 55/1 are indicated, along with the arrangement of 
resulting restriction fragments for each individual enzyme. Sizes are given in kb. 
Fragments (and associated sizes) which contain exons, and hence will be detected on 























































Figure 6.2.4: Southern blot analysis of ES cell clones positive for the Ligl deleted 
allele PCR assay
Confirmation of the structure of the deleted Ligl allele by Southern analysis. 
Genomic DNA was prepared from the original ES cell line (HM-1), one ES cell clone 
heterozygous for the targeted Ligl/PGK-HPRT allele (#53), 2 ES cell clones 
heterozygous for the floxed Ligl allele (HM-l/Ligl/loxP #58 and #68), and the 3 ES 
cell clones which had given positive results from PCR screening for the deleted Ligl 
allele (HM-l/Ligl/loxP #58/A69, HM-l/Ligl/loxP #68/A83 and A87). DNA was then 
digested with Hin<HK, electrophoresed through an agarose gel, blotted onto nylon 
membrane and probed with a 2.1kb BamHI/EcoRI fragment of the Ligl cDNA, 
corresponding to exons 8 to 27. Ligl genotypes of the different samples, derived by 












Ligl genotype +/+ +/- +/f +/f +/A +/A +/A
6.2.5 Expression from the deleted Ligl allele is abolished
Cre-mediated recombination of the floxed Ligl locus deletes the same five 
exons as are replaced by an HPRT minigene in the targeted LigllPGK-HPRT and 
L/g7/DWM110 alleles. There was no detectable expression from the targeted allele, 
but in order to determine the nature of any transcript produced by the deleted Ligl 
allele, northern blot analysis was carried out on samples heterozygous for the deleted 
allele (Figure 6.2.5). Total RNA was isolated from the same panel of ES cell samples 
that had been employed during Southern analysis of the structure of the deleted 
allele. After electrophoresis and transfer onto nylon membrane, the RNA was probed 
with a Ligl cDNA probe.
As discussed previously, second step gene targeting restores Ligl expression to 
wild-type levels in samples heterozygous for the floxed allele (section 6.3). A single 
transcript of wild-type size is present in samples heterozygous for the deleted Ligl 
allele (A69 and A83). However, the intensity of this band is reduced by 
approximately 50% compared to the wild-type sample, suggesting that no stable 
transcript is produced by the deleted allele. The absence of expression would thus 
indicate the deleted Ligl allele to be functionally equivalent to the targeted Ligl 
allele. The band in the lane corresponding to A87 appeared to be of equal intensity 
compared to +/+ and +/f samples.
6.3 Production of mice carrying the floxed Ligl allele and a Cre recombinase 
transgene
Following the confirmation that the floxed Ligl allele had the correct structure, 
was apparently functional, and that Cre-mediated recombination could be induced 
between the two loxP sites in vitro, +/f ES cells were used to produce mice carrying 
the floxed Ligl allele. A number of the +/f ES cell clones were injected into host 
blastocysts, and the resulting chimaeric males were mated with Balb/c females to 
produce mice heterozygous for the floxed allele. These animals were interbred to 
derive mice homozygous for the floxed Ligl allele (f/f). f/f mice developed normally 
to adulthood, were fertile, and to date no abnormalities have been observed in these 
mice. Furthermore, mice which were compound heterozygotes for the floxed and 
targeted Ligl alleles also developed apparently normally (J. Selfridge and D. W. 
Melton, unpublished data) These data confirmed that the floxed Ligl allele is 
functionally indistinguishable from the wild-type allele.
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Figure 6.2.5: Expression from the floxed Ligl allele is indistinguishable from 
wild-type transcript, and expression from the deleted Ligl allele is not detectable
Northern blot analysis of ES cell samples carrying the deleted Ligl allele. Total 
RNA was prepared from the original ES cell line (HM-1), one ES cell clone 
heterozygous for the targeted Ligl/PGK-HPRT allele (#53), 2 ES cell clones 
heterozygous for the floxed Ligl allele (#58 and #68), and the 3 ES cell clones which 
had given positive results from PCR screening for the deleted Ligl allele (A69, A83 
and A87). Upper, RNA was electrophoresed through an agarose-formaldehyde gel, 
blotted onto nylon membrane and probed with a 2.1kb BamHI/EcoRI fragment of the 
Ligl cDNA, corresponding to exons 8 to 27. Positions of the 28S and 18S ribosomal 
RNA transcripts are indicated flanking the 3.2kb wild-type Ligl transcript. Ligl 
genotypes of the different samples are shown. Lower, ethidium bromide staining to 




































































To test the ability of the floxed Ligl allele to undergo Cre-mediated 
recombination in vivo, we crossed f/f mice to transgenic mice expressing Cre 
recombinase under the control of the ovine (3-lactoglobulin (BLG) promoter (Selbert 
et al. 1998). BLG is the major milk protein in ruminants, but is not present in rodent 
milk. Previously it has been shown that the expression of transgenes under the 
control of the BLG promoter is largely position independent, and can be restricted 
exclusively to mammary secretory epithelial cells (Whitelaw et al. 1992). A BLG- 
Cre expression construct was used to produce a number of lines of transgenic mice. 
Two lines of mice (74 and 93), each carrying multiple copies of the transgene, had 
high levels Cre expression specific to the mammary gland of lactating females. 
Hemizygotes from both lines of BLG-Cre transgenic mice were mated to mice 
homozygous for the floxed Ligl allele, and female progeny positive for the Cre 
transgene and the floxed Ligl allele selected for further study.
6.3.1 Conditional deletion of Ligl in vivo was predominantly limited to 
lactating mammary tissue
Female mice heterozygous for the floxed Ligl allele and carrying the BLG-Cre 
transgene were mated to wild-type male mice. The females were subsequently killed 
at various time points during mammary gland development, and genomic DNA 
prepared from the mammary gland and a variety of other tissues. To assay for Cre- 
mediated deletion of the floxed Ligl allele in vivo, the PCR reaction specific for the 
deleted Ligl allele was carried out on genomic DNA samples from line 74 mice. The 
correct product was amplified in mammary and tail tissue samples from lactating 
females, but not any other tissue (data not shown). We therefore concluded that 
deletion of the floxed Ligl was occurring in vivo, and that this occurred in a spatially 
restricted manner.
6.3.1.1 PCR quantification
In order to estimate the level of Cre-mediated recombination occurring in the 
different tissues we performed quantitative PCR on genomic DNA samples. 
Quantitative PCR was carried out according to the same basic protocol outlined in 
chapter 4, but employing the PCR reaction specific for the deleted Ligl allele. The 
Ligl deleted product was amplified as part of a duplex reaction with a pair of primers 
specific for the wild-type mouse Ercc-1 gene. 20 cycles of PCR were carried out 
prior to agarose gel electrophoresis, transfer onto nylon membrane, and hybridisation 
to cc-32P-labelled probes specific for the two PCR products. Levels of radiolabel 
bound to each PCR product were analysed by phosphorimagery, and the ratio of the 
two signals calculated.
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A standard curve was produced by spiking varying amounts of genomic DNA 
from one of the ES cell clones heterozygous for the deleted Ligl allele (+/A) into a 
wild-type DNA sample, thereby creating a series of samples containing known 
percentages of the deleted allele. These standards were subjected to PCR quantitation 
in parallel to the experimental samples, and the ratio between the two signals plotted 
against the known percentage of the deleted Ligl allele to produce a standard curve. 
In order to estimate the percentage of cells in each tissue sample which had 
undergone Cre-mediated recombination, experimental signal ratios were compared 
against the standard curve. Figure 6.3.1 shows a typical standard curve produced.
We estimated the percentage of cells in each tissue sample which had 
undergone Cre-mediated recombination by means of quantitative PCR for the deleted 
Ligl allele (Table 6.3.1). Line 74 displayed very low levels of Cre-mediated 
recombination in all non-mammary tissues, the only exception being the sample 
taken from the tail tip. This sample had previously given a positive signal in a non- 
quantitative PCR assay for the deleted Ligl allele, and quantification revealed that 
approximately 1% of cells in this sample contained the deleted allele.
Levels of recombination in non-mammary tissues were slightly higher in line 
93. Although estimated figures were still below 1% in most tissues, they were over 
1% in samples from the salivary gland, skeletal muscle and skin. This suggested that 
ectopic expression of Cre was marginally higher in line 93 compared to line 74. 
However, data from both lines were in agreement with published data suggesting that 
BLG-driven transgene expression is largely position independent (Whitelaw et al. 
1992), and confirmed data indicating that expression of Cre recombinase was limited 
to the mammary gland (Selbert et al. 1998).
Using quantitative PCR on samples of mammary tissue taken from line 74 
mice at various time points during mammary gland development, we were able to 
determine the time course along which recombination occurred (Table 6.3.2). 
Samples from virgin mice displayed low levels of recombination in the mammary 
gland, with approximately 7% of cells containing the deleted Ligl allele. This level 
did not change significantly with age (data not shown), suggesting that the 
recombination events detected had arisen from a transient burst of Cre expression 
occurring during early development. Levels of the deleted allele in the mammary 
gland rose during pregnancy and birth, peaking about 10 days after birth. Cre- 
expression was thus tightly linked to the lactation status of the mammary gland, and 
this profile closely paralleled the published kinetics of BLG expression (Harris et al. 
1991). Between days 10 and 14 of lactation around 70 to 80% of cells in the 
mammary gland had undergone recombination. The proportion which had not
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Figure 6.3.1: A typical standard curve for PCR quantification of the deleted Ligl 
allele
Varying amounts of genomic DNA from the ES cell clone UM-l/Ligl/loxP 
#58/A69 was spiked into DNA from the wild-type ES cell line HM-1, thereby 
producing a series of standards containing known percentages of the deleted allele. 
These standards were used as templates for PCR reactions specific for the Ligl 
deleted allele using primers N2469+V2014. The product from the deleted allele was 
amplified as part of a duplex reaction with primers 033M+035M, which amplify the 
wild-type Ercc-1 gene. This second reaction was used as an independent control for 
the amount of input DNA. Products were separated by electrophoresis, blotted and 
hybridised to probes specific for the two PCR products. The relative levels of the two 
signals were quantified by phosphorimagery and the calculated ratios plotted against 
the known percentages of the deleted allele. Using this graph it was possible to derive 



















































































Levels of Cre-mediated recombination in a panel of tissues from two different BLG- 
Cre transgenic lines (74 and 93) were estimated by quantitative PCR for the deleted 
Ligl allele. The percentage deleted allele is an approximation of the proportion of 
cells in each tissue which contain the deleted allele.
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Levels of Cre-mediated recombination in mammary tissue of two different BLG-Cre 
transgenic lines (74 and 93) at different stages of development were estimated by 
quantitative PCR and Southern blotting. The percentage deleted allele is an 
approximation of the proportion of cells in the mammary gland that contain the 
deleted Ligl allele. Figures for quantitative PCR represent the average of at least 
three independent experiments for each timepoint (± standard deviation). N.D., not 
determined.________________________________________
undergone recombination (20-30%) most likely reflected non-epithelial cells 
present in the tissue samples. The BLG promoter will not be activated in fat cells, 
fibroblasts, lymphocytes etc.. These will therefore lack Cre expression, and hence not 
undergo recombination.
In addition, quantitative PCR was employed to estimate the frequency of cells 
containing the deleted Ligl allele in ES cell samples. Genomic DNA from the four 
pools of ES cells into which the Cre-expression plasmid pMC/CreN had been 
introduced (#58 1°, #58 2°, #68 l°and #68 2°) (see section 6.2) was analysed, along 
with the ES cell clone which had given a positive signal from the Ligl deleted PCR 
reaction but an incompatible banding pattern on Southern blots (HM-l/Ligl/loxP 
#68/A87). The calculated frequencies of cells containing the deleted Ligl allele are 
shown in Table 6.3.3. Estimates for pools #58 2° and #68 2° were close to 
frequencies calculated from colony screening (section 6.2.3, 2.1% and 4.2% 
respectively). Results for the HM-l/Ligl/loxP #68/A87 indicate that only 1/4 of cells 
contained the deleted allele.
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Levels of Cre-mediated recombination in ES cell samples were estimated by 
quantitative PCR. The percentage deleted allele is an approximation of the proportion 
of cells in each sample that contain the deleted Ligl allele. Figures for quantitative 
PCR represent the average of at least three independent experiments for each 
timepoint (± standard deviation).
6.3.1.2 Southern blotting
The reliability of quantitative PCR analysis to estimate levels of Cre-mediated 
recombination was confirmed independently by Southern analysis. Figure 6.3.2 
summarises the double replacement gene targeting strategy used to engineer two loxP 
sites into the 3' end of the endogenous Ligl locus, and the subsequent effect of Cre- 
mediated recombination on the floxed locus. The final 6 exons of the wild-type Ligl 
gene are located within a 13.9kb EcoRl fragment. The first round of homologous 
recombination, which replaced exons 23 to 27 with an HPRT minigene, also resulted 
in production of a novel 6.7kb fragment diagnostic of the Lr'g7/DWM110 targeted 
allele. A second gene targeting event was subsequently used to reconstruct a 
functional Ligl allele and introduce two loxP sites into locus. The presence of 
additional EcoRl restriction enzyme cleavage site tagged to the 3' loxP sequence 
permitted the floxed Ligl allele to be discriminated from the wild-type allele. 
Following EcoRl digestion, the floxed allele was marked by the presence of an 8.5kb 
restriction fragment on Southern blots. Subsequent Cre-mediated excision of exons 
23 to 27 from the genomic locus reduced the size of this EcoRl fragment to 3.5kb. 
Thus, the deleted Ligl allele could be identified by the presence of a unique 3.5kb 
EcoRl fragment on Southern blots. Hence, increasing levels of Cre-mediated deletion 
of the floxed Ligl allele should be reflected by disappearance of the 8.5kb band and 
the simultaneous appearance of the 3.5kb EcoRl fragment.
208
CHAPTER SIX: CONDITIONAL DELETION OF L/C/
Figure 6.3.2: Schematic representation of the strategies used to produce the 
deleted Ligl allele
Schematic representation of the 3' end of the wild-type mouse DNA ligase I 
locus, first step targeted locus, reconstructed 'floxed' locus, and the structure of the 
locus following Cre-mediated recombination between the two loxP sites. In the first 
targeting step, the last 5 exons of the Ligl locus were replaced with an HPRT 
minigene by homologous recombination. A second homologous recombination step 
was subsequently used to reconstruct a functional allele, but with exons 23 to 27 
flanked by two loxP sites. Cre-mediated recombination between the two loxP sites 
flanking exons 23 to 27 results in excision of the intervening genomic region, 
effectively deleting the last five exons of gene.
Drawn to scale. Solid boxes indicate exons (numbered according to the human 
convention); hatched box, HPRT minigene (DWM110); thin lines, Ligl introns or 
flanking regions; solid triangles, loxP sites. EcoRI restriction sites are marked by E, 






































































































































DNA was prepared from an ES cell clone heterozygous for the floxed allele 
(#58), an ES cell clone heterozygous for the deleted allele (A69) and mammary tissue 
samples from line 74 mice at various time points during mammary gland 
development. Following digestion with EcoRl, the DNA was subjected to Southern 
blot analysis (Figure 6.3.3). Using a Ligl cDNA fragment as a probe, 4 bands were 
detected in the +/f ES cell sample (13.9, 10.0, 8.5 and 5.2kb), and 4 bands in the +/A 
ES cell sample (13.9, 10.0, 5.2, and 3.5kb), as predicted from the known structures of 
the wild-type, floxed and deleted Ligl alleles. Samples from the mammary gland two 
virgin females displayed a pattern of bands almost identical to the +/f sample. A 
weak signal corresponding to a 3.5kb fragment could be detected one of the virgin 
samples, but not in the other. However, this fragment specific for the deleted Ligl 
allele was present at high levels in both samples from lactating females, and was 
accompanied by a marked reduction in the intensity of the signal from the 8.5kb 
fragment.
Phosphorimagery was then used to quantify the level of the 3.5kb fragment 
relative to the 5.2kb band. The 5.2kb fragment was common to all Ligl alleles, and 
hence acted as an independent control for the amount of DNA loaded in each sample. 
The calculated ratio of the two signals in each lane were compared against the ratio 
of signals in the +/A ES cell sample (known to have undergone recombination in 
100% of cells) to derive estimates of the fraction of cells in tissue samples which had 
undergone Cre-mediated recombination. The results of this analysis are shown in 
Table 6.3.2, and are in close agreement with those obtained by quantitative PCR. 
Thus Southern blotting provided independent confirmation that BLG-driven Cre 
expression results in conditional deletion of the floxed Ligl allele in a spatially and 
temporally controlled manner, being predominantly limited to the lactating mammary 
gland.
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Figure 6.3.3: Detection the deleted Ugl allele by Southern blotting
Southern blot analysis of Cre-mediated recombination in mammary tissues from 
BLG-Cre transgenic mice (line 74). Genomic DNA was prepared from one ES cell 
clone heterozygous for the floxed Ligl allele (HM-1/Ligl/loxP #58), one ES cell 
clone heterozygous for the deleted Ligl allele (HM-l/Ligl/loxP #58/A69), and 
mammary tissues from line 74 mice heterozygous for the floxed Ligl allele. The 
developmental status of each of the mammary samples was: lane 1; virgin 16 weeks 
old, lane 2; virgin 6 weeks old, lane 3; mother 14 days lactation, lane 4; mother 10 
days lactation. Lane 5 contains DNA from the +/f ES cell clone #58, while lane 6 
represents the +/A ES cell clone A69. DNA was then digested with EcoKL, 
electrophoresed through an agarose gel, blotted onto nylon membrane and probed 
with a 2.1kb BamHUEcoRl fragment of the Ligl cDNA, corresponding to exons 8 to 
27. The sizes of each hybridising fragment (in kb) are shown. Sizes in parentheses 
indicate fragments derived from the 5' and central region of the Ligl locus which are 
common to all four Ligl alleles. The 8.5 kb fragment specific for the floxed allele is 
indicated by an arrow, while the novel 3.5kb fragment generated by Cre-mediated 
recombination is marked by an asterisk. The sample in lane 4 was taken from a mouse 
that was a compound heterozygote for the targeted Ligl allele and the floxed Ligl 









In order for the genome to be successfully maintained and propagated, cells 
must be able to join DNA molecules. Enzyme-catalysed DNA joining (ligation) is 
therefore one of the basic activities required for cell viability. At least four 
biochemically distinct DNA ligase activities have been identified within mammalian 
cells, and the genes encoding three have been cloned (Barnes et al. 1990, Wei et al. 
1994). The three proteins are designated DNA ligase I, HI and IV, and of these, DNA 
ligase I is the most extensively studied.
As reviewed in chapter 1, published evidence implicates DNA ligase I in both 
DNA replication and DNA repair. A wealth of data supports the premise that DNA 
ligase I is central to lagging strand synthesis. The data can be summarised as follows:
• Gene expression and protein activity are both upregulated in proliferating cells
• The protein can be isolated from replication complexes, and has been proven to 
interact with PCNA
• The protein localises to replication foci in the nuclei of replicating cells
• Human cells with reduced DNA ligase I activity display an abnormal profile of 
replication intermediates
• The purified protein has been used to reconstitute DNA replication in vitro, and 
complements the replication disturbances of ligase-deficient humans, S. cerevisiae, 
and E. coli mutants
DNA ligase I is also thought to function in a number of DNA repair pathways:
• Gene expression and protein activity are upregulated upon UV irradiation
• The protein has been isolated from a complex of proteins involved in NER, and the 
purified protein has been used in reconstitution of NER in vitro
• The protein has been isolated from a complex of proteins involved in BER, and the 
purified protein has been used in reconstitution of BER in vitro
• Activity of the protein is stimulated by addition of Ku, and the purified protein has 
been used in the reconstitution of V(D)J recombination in vitro
• DNA ligase I-deficient human cells are sensitive to a wide variety of DNA 
damaging agents
Taken together, these data indicate that DNA ligase I functions in a number 
of cellular processes. It was consequently proposed that DNA ligase I is essential for 
mammalian cell viability:
"It is difficult to envisage that a cell can survive without the predominant
DNA ligase."
Hoeijmakers and Bootsma 1992
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Apparent proof of this hypothesis came in 1995 from work by Weaver and co- 
workers. They were unable to isolate cells lacking DNA ligase I in vitro, and from this 
concluded that DNA ligase carries out essential functions within mammalian cells 
(Petrini, Xiao and Weaver 1995).
Loss of function of a single LIG1 allele has no effect on phenotype (i.e. loss of 
function mutations are recessive to wild-type). A single functional DNA ligase I allele 
must be sufficient for all cellular processes. However, not all mutations will result in 
complete loss of function. The product of certain alleles may retain enough residual 
ligase activity to fulfil the cellular requirements, albeit in a reduced manner. Providing 
the protein also retains the ability to interact normally with other cellular proteins, 
compound heterozygotes of a loss-of-function allele and a partially functional allele 
could be viable. Nevertheless, the high requirement for DNA ligase activity in 
dividing cells places stringent requirements on the minimum level of activity 
sufficient for survival. Most mutants will fall below such a threshold, and will in 
effect resemble non-functional alleles. Only a limited subset of mutant alleles will 
thus be compatible with cellular viability. It has been hypothesised that the 46BR 
patient represents such an occurrence.
Given the presumed inviability of cells homozygous for complete loss-of- 
function alleles, it was rationalised that the only way to produce a viable experimental 
model of DNA ligase I-deficiency was to reproduce the 46BR mutations. Double 
replacement gene targeting is an ideal method by which to introduce analogous point 
mutations into the mouse genome. A two step scheme was devised to introduce the 
Arg771—>Trp change into exon 24 of the endogenous locus. The first step, 
introduction of an HPRT marker gene into the Ligl locus, had the additional 
advantage of deleting the last 5 exons of the gene, thereby creating a 'knockout' allele.
7.1 Embryos lacking DNA ligase I are viable
Using conventional techniques we were able to generate mice heterozygous for 
the knockout Ligl allele. These mice were phenotypically normal, but when interbred, 
no pups homozygous for the targeted allele were found. It was therefore concluded 
that DNA ligase I is essential for normal development. Contrary to expectation, when 
embryos were collected from heterozygote matings and genotyped, live embryos 
homozygous for the targeted mutation were found.
The PCR reactions used to follow the wild-type and targeted Ligl alleles, and to 
genotype embryos, were sensitive and robust. False negatives were not a problem 
under optimal reaction conditions (data not shown). Conversely, false positives were 
not observed from the targeted reaction. Providing care was taken to avoid 
contamination of yolk sac samples with maternally-derived tissue, false positives were
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also not observed from the wild-type reaction (data not shown). These assertions are 
corroborated by the ratios of embryo genotypes observed from heterozygote matings 
(e.g. E10.5, Table 3.3.1). No significant deviations from the expected mendelian ratios 
were observed in samples from early embryos. Similarly, Southern blotting of random 
embryos confirmed the genotypes determined by PCR. We therefore concluded that 
embryos genotyped as -/- by PCR were indeed homozygous for the targeted allele. 
Moreover, Southern blots of -/- samples were all consistent with the predicted pattern 
of restriction fragments produced from the targeted allele. We thus inferred that the 
targeted Ligl locus had indeed undergone the correct homologous recombination 
event, and exons 23 to 27 had been deleted.
In order to ascertain the nature of any mRNA produced from the targeted allele, 
northern analysis of Ligl expression was carried out. Transcript levels were reduced 
by approximately 50% in +/- samples compared to wild-type, and no signal could be 
detected in -/- embryos or cell lines. The lack of any kind of detectable transcript from 
the targeted allele was surprising given the targeting strategy employed. Replacement 
of exons 23 to 27 by a selectable marker cassette had been expected to result in the 
production of some sort of truncated or Ligl/HPRT fusion transcript (e.g. Porter et al. 
1995). The complete absence of detectable expression could have two possible 
explanations; rapid transcript degradation, or no transcription from the targeted allele.
In addition to replacing five exons, homologous recombination removed the 
polyadenylation signal. Addition of a poly-A tail is known to be essential for 
transcript stability (Jackson and Standard! 1990), and it had proved difficult to express 
Ligl cDNA clones truncated at the 3' end (Jessop 1995). It is therefore possible that 
Ligl transcripts lacking a poly-A tail might be unstable, and hence be rapidly 
degraded. Alternatively, transcription from the targeted Ligl locus may not occur. It 
has been shown that expression from the HPRT minigene within the targeted Ligl 
locus is highly unstable (Melton, Ketchen and Selfridge 1997). It was hypothesised 
that this might reflect an alteration to the locus associated with the targeting event 
itself, for example a change in chromatin structure. Deletion of a structural control 
element found within the 3' end of the Ligl locus could lead to transcriptional 
silencing of the region. Although such a switch might be limited to the Ligl locus 
only, alteration from an 'open' to a 'closed' chromatin structure would be likely to have 
longer range effects. It should thus be possible to test this alternate hypothesis by 
investigating whether transcription from other genes is affected by targeting. Other 
investigators have observed that insertion of a marker gene into a locus can alter 
expression of surrounding genes. These results were attributed to the nature of the 
selectable marker employed. The fact that expression from the deleted Ligl allele (A)
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was also abolished suggests that deletion of sequences is the crucial factor in this 
situation.
Whatever the cause, no transcription could be detected from the targeted Ligl 
allele by northern blot analysis. Similarly we were unable to detect any kind of Ligl- 
derived polypeptide in -/- samples by western blot analysis. Western analysis was 
performed using antibodies raised against purified bovine DNA ligase I, and also 
using antibodies raised against the C-terminal conserved peptide. Both produced 
identical results. Because were able to detect levels of DNA ligase I down to as little 
as 1% of normal, we were confident that any L/g7-derived proteins expressed in -/- 
samples would have been detected. No intact, truncated, or fusion protein of any size 
could be detected, and thus we concluded that expression from the targeted Ligl allele 
is abrogated, and that DNA ligase I is absent from -/- embryos.
Confirmation of this result was achieved using an assay for DNA ligase activity. 
All DNA ligases share the ability to form DNA ligase-AMP intermediates, and by 
using radioactively labelled ATP it is possible to visualise the adenylated products. 
When we carried out this assay on whole cell extracts from -/- embryos, no 
adenylation activity correlating to DNA ligase I was observed. No additional 
adenylated products were detected compared to the wild-type controls (data not 
shown). Whilst acknowledging the limited sensitivity of this technique, we concluded 
that there was no DNA ligase activity attributable to the targeted Ligl allele.
Lindahl and co-workers have suggested that survival of -/- embryos may arise as 
a consequence of low levels of a truncated Ligl -derived protein. They cite work by 
Subramanya et al. reporting that a single domain of bacteriophage T7 DNA ligase 
retains some enzymatic activity (Subramanya et al. 1996).
"The resulting truncated mRNA, which still encodes the active site of the 
enzyme was reported to be unstable. However, low levels of this mRNA 
might generate a large fragment of DNA ligase I, that by analogy with a 
homologous fragment of bacteriophage T7 DNA ligase, could have 
enough residual activity to allow survival of null embryos, at least until 
very rapid cellular proliferation is required during early erythropoiesis."
Mackenney, Barnes and Lindahl 1997
Extrapolating this result to the theoretical product of our targeted Ligl allele, 
Mackenney, Barnes and Lindahl suggested that low levels of a truncated DNA ligase I 
polypeptide may retain enough activity to permit cell survival during early 
development. The implication is that the targeted Ligl allele we have generated is not 
a true knockout allele, and it is this which allows -/- cells to survive. We would
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counter this argument by citing previous work carried out in the laboratory of Dr 
Lindahl. Kodama, Barnes and Lindahl expressed human DNA ligase I in E. coli, and 
used systematic mutagenesis to define the regions of the protein important for 
catalytic function. Engineered constructs were assayed for function by the ability to 
complement E. coli DNA ligase mutants, and the altered proteins were also assayed 
for DNA ligase activity by formation of adenylated intermediates in vitro. It was 
found that the majority of the catalytic domain was absolutely required for enzyme 
activity. Removal of more than 16aa from the C-terminus of the human DNA ligase I 
rendered the protein enzymatically inactive (Kodama, Barnes and Lindahl 1991). Our 
targeting strategy replaced exons 23 to 27, in effect deleting the final 175aa of the 
protein. Any protein produced from the targeted Ligl allele should therefore be 
catalytically inactive. Consequently, we believe that the model proposed by 
Mackenney, Barnes and Lindahl is invalid. Given the high levels of DNA ligase I 
activity normally found in proliferating cells, and the conspicuous absence of any 
detectable L/g7-derived protein in -/- cells, we find it inconceivable that an 
undetectable amount of a theoretical protein that should have no activity could meet 
the catalytic requirements of most proliferating cells.
Levin and Tomkinson have suggested that the viability of -/- embryos may 
alternatively be explained by developmental changes in DNA ligase expression (Levin 
and Tomkinson 1997). They propose that another DNA ligase complements for the 
absence of DNA ligase I during early development. The presence of DNA ligase I 
only becomes essential later in development, and it is at this point which -/- embryos 
die.
We have not addressed this hypothesis directly, but circumstantial evidence 
would suggest that this is not true. As with other cell types, ES cells proliferating in 
vitro contain high levels of Ligl expression, alluding to the presence of high levels of 
the protein in very early development. DNA ligases El and IV are expressed at much 
lower levels (data not shown). Studies of DNA ligase I expression have shown that 
DNA ligase I expression is switched on very soon after fertilisation of the egg 
(reviewed by Signoret and David 1986). Later in development, as cells differentiate, a 
switch between the forms of DNA ligase does occur. However, this leads to the 
replacement of Ligl by another DNA ligase rather than vice versa. Thus the available 
data indicates that DNA ligase I represents the predominant ligase activity in early 
eukaryotic development. Moreover, cells homozygous for the targeted allele are viable 
in non-embryonic environments. Fibroblast cell lines have been isolated from -/- 
embryos (chapter 5), and -/- cells were able to rescue lethally-irradiated mice and to 
repopulate the adult haematopoietic system (chapter 4). Recent data using Cre- 
mediated deletion of Ligl has also indicated that -/A cells lacking a functional Ligl
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allele can be generated in vivo. Taken together these data suggest that the viability of 
early -/- embryos cannot be explained simply in terms of a developmental changes in 
DNA ligase expression. Whether Ligl is required specifically for certain 
developmental events will be discussed further in section 7.4, but the fact that -/- 
embryos and cells can be isolated indicates that, contrary to expectations, DNA ligase 
I-deficient cells are viable in vivo. A previously unsuspected redundancy must 
therefore exist among the mammalian DNA ligases.
7.2 DNA ligase I is not essential for mammalian cell viability
Our data indicates that DNA ligase I-deficient cells are viable. This conflicts 
with conclusions drawn by Weaver and co-workers from studies of ES cells. Having 
carried out gene targeting of the Ligl locus in ES cells, Petrini, Xiao and Weaver were 
unable to isolate cells lacking DNA ligase I in vitro (Petrini, Xiao and Weaver 1995). 
This led to the conclusion that DNA ligase I is essential for cell viability. We believe 
that the contrast between this conclusion and our data arises mainly from an inherent 
difficulty in isolating ES cells homozygous for a disabling mutation in vitro. In order 
to enrich for cells which have undergone the desired recombination events, selection 
must be applied. Selection typically works by killing undesired cells via a toxic 
metabolite. Given the relative infrequency of targeting or gene conversion events, 
high levels of enrichment are required, and hence high selective pressures have to be 
applied. Whilst the desired cells will theoretically be resistant to killing, the drug may 
still affect the viability of these cells relative to non-selective conditions. It is thus not 
unfeasible that drug resistant cells with a pre-existing survival handicap will not be 
able to form colonies in culture when selection is applied. The handicap itself may not 
be lethal, and hence cells will be viable in vivo, but in the context of selection in low 
cell density conditions, cells may not proliferate. As a result, it would be impossible to 
isolate such cells in vitro. In support of this hypothesis, we cite data generated from 
targeting of the Ercc-1 locus. Production of ES cells homozygous for a knockout 
mutation at the Ercc-1 locus has not been achieved to date, even though Ercc-1- 
deficient mice were described in 1993 (McWhir et al. 1993, J. Selfridge and D.W. 
Melton, unpublished data).
The failure of Petrini, Xiao and Weaver to isolate cells homozygous for a 
targeted Ligl allele may also have been influenced by the targeting strategy they 
employed. They used an replacement gene targeting strategy to introduce a neo 
selectable marker cassette into the middle of exon 17. The cassette replaces half of 
exon 17 and all of exons 18 and 19, in effect deleting sequences encoding the active 
site of the protein. This region has previously been demonstrated to be essential for 
enzyme activity (Kodama, Barnes and Lindahl 1991), and thus any protein produced
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should be enzymatically inactive. However, while the product of the targeted allele 
would have no catalytic activity, we believe that an aberrant polypeptide is produced 
from the targeted allele, and that this affects normal cellular processes in a deleterious 
manner.
Given that the neo cassette was inserted directly into an exon, we would expect 
that some sort of truncated or fusion peptide would be produced by the targeted allele. 
Investigation of ES cells heterozygous for the targeted allele detected only the product 
of the wild-type allele. However, the "MoBN" Ligl cDNA fragment used in northern 
blot analysis corresponds only to exons 18 to 21 (depicted in Figure 7.2.1). The exons 
are downstream of the point of insertion of the neo module, and will therefore not 
detect a truncated or fusion transcript generated from the Ligl region 5' to the marker 
gene. Similarly, the antibody used for western analysis of cell extracts (F6F) was 
raised against a peptide close to the C-terminus of the wild-type protein (see Figure 
7.2.1). The antiserum will therefore not recognise Ligl -derived peptides lacking the 
C-terminus of the wild-type protein. Investigation carried out using these molecular 
probes would therefore not detect if a polypeptide was generated from the targeted 
allele. Thus the published data does not rule out the presence of a truncated, 
enzymatically inactive polypeptide derived from the targeted allele.
While Petrini, Xiao and Weaver state that ES cells heterozygous for the targeted 
allele were indistinguishable from wild-type controls, examination of the data may 
indicate otherwise. Heterozygous cells show a marginal increase in the percentage of 
newly replicated DNA present as small fragments, but also show increased sensitivity 
to killing by 3AB. One interpretation of these results might be that a polypeptide 
produced from the targeted Ligl allele interferes with cell function. Though 
catalytically inert, the peptide would still retain the N-terminal sequences known to be 
involved in protein-protein interactions. It is feasible that the polypeptide could 
interact with components of the replication and repair machinery, and thereby impair 
the normal functioning of these complexes. Disruption would be represented by 
decrease in the measurable replication and repair parameters. It is thus possible that 
the targeted allele may function as a dominant-negative mutation, and put cells at a 
survival disadvantage. Failure to isolate cells homozygous for the targeted mutation 
may hence occur because the targeting strategy significantly compromises cell 
viability.
Petrini, Xiao and Weaver reported that they were able to isolate ES cells 
homozygous for the targeted Ligl allele if they introduced a LIG1 cDNA construct. 
Cell lines rescued using a cDNA lacking 60 nucleotides from exon 2 were sensitive to
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Figure 7.2.1: Schematic representation of the Ligl cDNA
The relative locations of certain features within the Ligl cDNA are shown 
schematically. Numbers indicate locations within the coding sequence, which is 
numbered according to the published sequence (Jessop and Melton 1995). Information 
about the binding sites of cDNA probes NBA and MoBN are taken from Petrini, Xiao 




















































SAB, but only displayed minor perturbations in DNA replication. These data were 
interpreted as evidence that the missing region was important for interaction of DNA 
ligase I with repair proteins. Whilst this is a plausible explanation, if a truncated 
protein is being produced from the targeted allele, an alternative interpretation can be 
made. The apparent difference between the efficacy of replication and repair processes 
in these cells may actually reflect the effects of the inactive protein. Parallels can be 
drawn with 46BR cells. Although 46BR cells do display an altered profile of 
replication intermediates, they are hypersensitive to the effects of 3AB treatment. It is 
thus possible that an inactive or partially active form of DNA ligase I will have 
differential effects on the different cellular processes. Employing such cells as a 
system in which to test the effects of mutations on DNA ligase I protein function may 
thus not give unequivocal results. It would clearly be advantageous to express altered 
forms of DNA ligase I in cells devoid of any other form of the protein. In this respect, 
cells isolated from our -/- embryos, which can be proven not to contain any Ligl- 
derived polypeptide, would be a better model system in which to test the effects of 
mutations on protein function.
7.3 DNA ligase I is required for foetal liver erythropoiesis
The finding that embryos homozygous for the targeted Ligl allele are viable was 
unexpected. We demonstrated that expression from the targeted allele was abrogated, 
and that DNA ligase I was absent from -/- embryos. Furthermore, two completely 
independent strains of Ligl targeted mice displayed exactly identical phenotypes 
(chapter 3 and unpublished data). When second step gene targeting was used to 
reconstruct a functional Ligl allele, the resulting homozygous mice were 
phenotypically normal (J. Selfridge and D.W. Melton, unpublished data). We were 
thus able to rule out the possibility that the phenotype and molecular characteristics of 
-/- samples had arisen as a result of artifactual changes to the ES cell genome. We 
were certain that the phenotype observed is the result of targeted alteration of the Ligl 
locus.
Embryos lacking DNA ligase I developed normally until mid-term, and were 
indistinguishable from their wild-type counterparts until day 11.5 of development. 
Thereupon acute anaemia developed. At El 1.5, all -/- embryos were noted to be paler 
and smaller than normal. As development proceeded, the differences became 
exacerbated, so that by E15.5 the two genotypes were strikingly different. Appearance 
of the anaemia phenotype correlated very closely with developmental switch in the 
location of blood cell production (haematopoiesis).
The mature haematopoietic system comprises of eight mature cell lineages. All 
eight lineages are ultimately derived from a common pluripotent precursor or stem
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cell (HSC). These cells have two main characteristics; the capacity for apparently 
unlimited self-renewal, and the ability to differentiate into all haematopoietic lineages. 
HSCs are separated from the mature cells of the peripheral blood by a series of 
intermediates of increasingly limited developmental potential, the most restricted 
being committed to a single lineage and having limited capacity for self-renewal. 
Figure 7.3.1 shows a schematic representation of the genealogy of the different 
haematopoietic lineages.
While the bone marrow is the predominant focus of blood cell production in the 
adult, haematopoiesis is of a migratory nature during ontogeny (Figure 7.3.2). In the 
mouse embryo, blood forming islands develop in the yolk sac at E7. These arise from 
mesodermal cells (hemangioblasts) whose precursors originate from the primitive 
streak region of the blastoderm and migrate to a position in the yolk sac in contact 
with extraembryonic endoderm. By the time circulation is established between the 
yolk sac and embryo, the blood islands are connected by a network of capillaries, 
which evolve into 'erythropoietic sinusoids'. Yolk sac haematopoiesis is thus 
intravascular, and is predominantly limited to the production of primitive nucleated 
erythrocytes (lO^im diameter).
Recent work by Medvinsky and Dzierzak has identified a region within the body 
of the embryo also involved in early embryonic haematopoiesis (reviewed by 
Dzierzak and Medvinsky 1995). The aorta-genital ridge-mesonephros (AGM) region 
has been shown to contain haematopoietic progenitor cells between E8 and E10. The 
precise relationship between the AGM region, yolk sac, and liver remains to be 
delineated, but a limited number of HSCs migrate from either the AGM or yolk sac to 
colonise the foetal liver around day 9 of development.
At E9, the liver rudiment begins to form, and on the same day the first erythroid 
progenitor cells become visible within this structure. From El 1.5 onwards the liver is 
the major site of blood production in the developing embryo, and it remains so until 
shortly after birth. During this period, erythroid cells can comprise up to 70% of the 
total liver mass (Metcalf and Moore 1971). Haematopoiesis in the foetal liver is 
distinct from that occurring in the yolk sac in several ways: blood cell production is 
not limited to erythropoiesis, the erythrocytes do not mature in a synchronous manner, 
and production is responsive to stimulation by erythropoietin (Epo). However, the 
most visible difference is the production of mature enucleated erythrocytes (8/rni 
diameter). Thus, as development proceeds, and haematopoiesis switches from the yolk 




Figure 7.3.1: Schematic representation of the haematopoietic system
A depiction of the relationship of the eight mature haematopoietic cell lineages 
to progenitor cells. The lineages are identified on the basis of the terminally 
differentiated cell type they produce. For non-lymphoid lineages, the in vitro assays 
for committed precursor cells are indicated. The exact correlation between cells which 
produce colonies in the CFU-A assay and the multipotent progenitor cell remains 
unclear.
Figure 7.3.2: Schematic representation of the loci of haematopoiesis during 
mouse embryonic development
A depiction of the migration of haematopoiesis in the developing mouse 
embryo. Arrows indicate the possible migration pathways of HSCs from one organ to 
another, while numbers on the x-axis indicated the approximate timing of events 
during gestation. Question marks indicated the uncertain relationship between the 
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Examination of embryonic blood samples revealed a deficiency of mature 
enucleated erythrocytes in -/- embryos. The percentage of nucleated erythrocytes in 
the peripheral circulation did not show the normal decrease characteristic of the shift 
from the yolk sac to the foetal liver. Blood from wild-type embryos consisted 
predominantly of enucleated liver-derived erythrocytes. In contrast samples from -/- 
embryos displayed a high number of nucleated cells, and those enucleated cells 
present tended to be abnormal. It was hence concluded that foetal liver erythropoiesis 
was disrupted. Yolk sac haematopoiesis was, however, apparently normal. -/- embryos 
displayed no visible phenotype up until the switch to foetal liver haematopoiesis 
whereas mice deficient in yolk sac erythropoiesis die before Ell (e.g. GATA-2 
knockout mice, Tsai et al. 1994). Inspection of the peripheral blood and yolk sac 
histology of E10.5 embryos revealed no significant difference from wild-type.
In contrast, examination of livers from -/- embryos after El 1.5 revealed striking 
differences. Total cell numbers were reduced at El 1.5, and the reduction became more 
pronounced with time. El5.5 -/- livers lacked extensive cellularization and contained 
no readily identifiable erythroid islands. An in vitro BFU-E (blast forming unit- 
erythroid) colony forming assay was used to estimate numbers of erythroid-committed 
progenitors. Fewer colonies were formed from -/- livers compared to wild-type. 
Qualitative scoring also revealed BFU-E colonies derived from -/- livers to be smaller 
(i.e. they contained fewer cells), although cell morphology appeared normal. The 
presence of cells capable performing (almost) normally in this assay indicated that the 
anaemia phenotype was not the consequence of a complete block in erythroid 
differentiation. Instead the depleted numbers of BFU-E progenitors, and the reduced 
colony size were interpreted to be the result of restricted cell proliferation.
Hepatocyte and megakaryocyte lineages appeared normal in liver histology 
sections. Antibody staining for the cell surface marker T200 indicated that the total 
number of non-erythroid haematopoietic cells was normal in -/- livers. Similarly, 
numbers of B220-positive cells were not reduced. These data suggested that members 
of non-erythroid lineages were relatively unaffected. Thus we concluded that 
disruption caused by the lack of DNA ligase I was limited to the erythroid lineage.
The observed disruption to foetal liver erythropoiesis in -/- embryos could have 
had a number of causes. These included failure of HSCs to migrate to the liver, 
inability of the hepatic microenvironment to support erythropoiesis, or an intrinsic 
inability of DNA ligase I-deficient cells to complete erythroid differentiation. To 
quantify the numbers of haematopoietic progenitors within foetal livers, and to 
examine the capacity of these cells to differentiate, an in vitro assay was performed. 
Single cell suspensions from embryonic livers were plated out under conditions 
optimised for the proliferation and differentiation of primitive progenitors (CFU-A
224 
CHAPTER SEVEN: DISCUSSION
assay). Colonies were formed from -/- samples, and, at El 1.5, the total numbers per 
liver were not significantly different from wild-type. However, as development 
proceeded, numbers of CFU-A progenitors in -/- livers failed to increase by the same 
amount as wild-type controls. Furthermore, at each developmental stage investigated, 
qualitative scoring revealed colonies derived from -/- embryos to be smaller. Again 
cell morphology was apparently normal, from which it was concluded that the 
differences observed between -/- and wild-type samples could be explained by a 
quantitative defect in cell proliferation.
Considering all of these data, we were able to propose a model to explain the 
phenotype observed. Central to this model was the hypothesis that -/- cells were 
unable to proliferate as rapidly as wild-type cells. Measurements of the rate of cell 
division were made using primary fibroblasts isolated from mid-gestation embryos. It 
was possible to demonstrate that cells from -/- embryos divided slightly more slowly 
than wild-type cells (A.-M. Ketchen and D.W. Melton unpublished data). We believe 
that -/- cells are able to divide quickly enough to meet the requirements of early 
developmental events. However, -/- cells are apparently unable to meet the replicative 
demands of foetal liver erythropoiesis.
During initiation of haematopoiesis in the foetal liver, a limited number of 
HSCs migrated from the yolk sac. Upon reaching the foetal liver, they not only have 
to proliferate to produce a pool of stem cells, but also to generate large numbers of 
terminally differentiated erythrocytes. It is possible to give some indication of the high 
replicative requirements placed upon the stem cells using numerical data from the in 
vitro colony forming assays. At El 1.5 approximately 250 CFU-A progenitors can be 
detected in the wild-type foetal liver. At El5.5 approximately 6X107 total cells are 
present within the foetal liver. Taking the number of CFU-A progenitors to represent 
the number of HSCs present, and assuming that all 6X107 cells are members of 
haematopoietic lineages and derived from the original 250 stem cells, it is possible to 
calculate that 18 cell divisions are required to generate 6X107 cells from 250. Given 
that this proliferation takes place over 4 days, this equates to 4.5 cell divisions per day, 
or an average of one cell division every 5 hours 20 minutes. Even this crude 
calculation indicates the phenomenal rate of division to which cells are subject during 
foetal liver erythropoiesis. Any failure of -/- cells to match the required rate of cell 
division would preclude exponential proliferation. The normal geometric expansion 
of erythroid cells would thus be abbreviated and ultimately lead to fewer terminally 
erythrocytes. In terms of the calculation carried out above, extension of the length of 
the cell cycle from 5 hours 20 minutes to 6 hours would mean that 45,000,000 fewer 
cells would be generated after 5 days.
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The number of HSCs colonising the foetal liver rudiment is apparently normal 
in -/- embryos, as indicated by CFU-A numbers at E10.5). However, if the cells are 
not able to divide rapidly enough to meet the requirement for erythroid cells, the 
embryo will quickly become anaemic. There is a well defined homeostatic mechanism 
for maintaining numbers of red cells in the peripheral circulation. Anaemia stimulates 
the release of the growth factor erythropoietin. Epo stimulates erythroid precursors to 
differentiate and divide more rapidly, thereby increasing the numbers of erythrocytes 
released into the peripheral circulation. The most important parameter controlled by 
Epo regulation in vivo is the number of cell divisions in the CFU-E and erythroid cell 
stages (Pantel et al. 1990). However, if -/- cells are unable to divide more rapidly, then 
increased Epo production will have no effect on the numbers of circulating red blood 
cells. In the context of haematopoiesis in -/- embryos, the feedback system may even 
have a counterproductive effect. By forcing stem cells to differentiate to meet the 
demand for terminally differentiated erythrocytes, Epo may deplete the pool of stem 
cells. This would lead to fewer cells being subsequently available to proliferate and 
differentiate, thereby exacerbating the anaemia. Such a positive feedback loop could 
explain why the anaemia phenotype appears very rapidly between E10.5 and El 1.5. 
Because the embryonic tissues keep growing, the volume of the peripheral circulation 
keeps increasing, and so does the demand for large numbers of erythrocytes. Once the 
anaemia has become established, and there is no 'spare 1 proliferative capacity, the 
haematopoietic system will never be able to meet demand. As a result, the anaemia 
will become progressively worse.
Because the -/- embryos grew apparently normally until the onset of anaemia, 
we believe that growth retardation was secondary to the anaemia. The primary 
function of erythrocytes is to transport oxygen around the body. Chronic anaemia 
results in a drop in the oxygen concentration in the tissues (hypoxia), and because all 
cells require oxygen for respiration, under hypoxic conditions the embryonic tissues 
will not develop at a normal rate. Prolonged hypoxia will cause cell death, and 
ultimately will result in the death of the embryo.
Although erythroid cells predominate, haematopoiesis in the foetal liver is not 
limited to erythropoiesis. Data indicated the other haematopoietic cell lineages to be 
relatively unaffected by the absence of DNA ligase I. Reduced numbers of pluripotent 
progenitors were present, but it has been observed in other knockout mice strains that 
normal numbers of terminally differentiated haematopoietic cells can be present even 
when numbers of progenitors are reduced (e.g. Ohbo et al. 1996). Moreover, we 
believe that the results can be explained on the basis of known differences between 
erythroid differentiation and other haematopoietic lineages. It has been estimated that 
up to 15 cell divisions are required to generate a mature erythrocyte from a
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haematopoietic stem cell (Pantel et al. 1990). Non-erythroid lineages on the other 
hand only require 5-6 cell divisions. With the relatively small number of non- 
erythroid cells present in the foetal liver, the absence of direct regulation of non- 
erythroid cell numbers, and the dispensability of these cells during development, it is 
plausible that a limit on the maximum rate of cell division would not significantly 
disrupt prenatal development of non-erythroid haematopoietic lineages.
7.4 Lethally-irradiated mice could be rescued with -/- haematopoietic stem cells
Having devised a model to explain the specific disruption to foetal liver 
erythropoiesis caused by the absence of DNA ligase I, we are able to make a number 
of predictions. Central to the model is the conjecture that although the absence of 
DNA ligase I results in prenatal lethality, this arose as a secondary consequence of the 
anaemia. Furthermore, despite the observation that foetal liver erythropoiesis was 
disrupted, there is no specific block to erythroid differentiation. In other words we 
propose a quantitative rather that qualitative defect. Anaemia arises simply because 
cells are unable to proliferate rapidly enough to meet the requirements of the 
developing embryo. Because rapid erythrocyte production is essential for survival, 
inefficient foetal liver erythropoiesis results in lethality.
If there is no block to erythropoiesis per se, we hypothesised that -/- cells would 
be able to undergo normal erythropoiesis in a non-developmental context. This 
appeared to be true in vitro, but in order to test the idea in vivo, we employed radiation 
chimaeras. Adult mice whose haematopoietic system has been ablated by a controlled 
dose of Y radiation can be rescued by the introduction of HSCs to repopulate the 
haematopoietic system. One consequence of this procedure is that the haematopoietic 
system of rescued mice will be composed of cells derived from the donor HSCs. 
Using foetal livers as a source of HSCs, we attempted to rescue lethally-irradiated 
mice with cells lacking DNA ligase I.
Despite being able to prove that primitive pluripotent progenitors were present, 
suspensions from single -/- livers were unable to effect rescue. We therefore 
concluded that the observed disruption to foetal liver erythropoiesis was not simply a 
consequence of an inappropriate hepatic microenvironment. However, it was possible 
to rescue mice by injecting cell suspensions from multiple -/- livers into a single 
recipient, and long-term repopulation of the haematopoietic system was achieved.
Initial experiments using single foetal livers had achieved rescue with wild-type 
samples. However, subsequent procedures using multiple foetal livers carried out 
using Balb/c X 129/Ola Fl recipients failed to work even with wild-type samples. 
Experiments were carried out under identical conditions, apart from the strain of 
recipients used. Following irradiation, the body-weight profile of these animals
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dropped rapidly and did not recover. The majority of animals died (data not shown). 
We were unable to explain the failure of this experiment in terms other than 
incompatibility of donor and recipient. Fl recipients will be obligate heterozygotes for 
all loci which are not isogenic between the Balb/c and 129/Ola strains. Because donor 
embryos were an ill defined mix of 129/Ola and Balb/c strains, all should be 
immunologically compatible with Fl recipients. The failure of even wild-type 
samples to effect rescue was therefore puzzling. The only explanation we had for this 
(beyond technical problems) involved the hybrid histocompatibility locus (hh). The 
genetics are still poorly understood, but this locus is known to be outwith the MHC 
complex, and is expressed mainly on natural killer (NK) cells. The locus has the 
peculiar property of not being expressed in animals which are heterozygous at the 
locus, although homozygotes do express. Because Fl mice will be obligate 
heterozygotes but donor embryos could potentially be homozygotes, it is possible that 
the recipient haematopoietic cells remaining after irradiation could recognise the 
donor cells as foreign. An immune reaction would thus prevent repopulation and 
rescue. However, in view of the low survival of inbred recipients in the subsequent 
experiment, technical problems seem a more likely cause. The failure of wild-type 
liver suspensions to effect rescue even when donors and recipients were matched for 
major MHC compatibility could have been due to incompatibility of minor 
histocompatibility loci, but the body-weight profile suggested otherwise. After an 
initial drop, the body mass of mice which were rescued returned to normal, and 
remained stable. Those experimental animals which died, did so in parallel with 
irradiation controls. This suggested that donor cells were unable to effect rescue rather 
than rejection of the host tissue by injected donor cells (graft versus host disease, 
gvhd). We therefore concluded that the experiment was not successful because of a 
lack of donor cell viability, although the precise cause remained elusive.
Those recipients which were rescued, displayed donor markers in all 
haematopoietic tissues. FACScan analysis revealed the cellular profile of tissues from 
animals rescued with -/- cells to be indistinguishable from wild-type controls in most 
situations. However, whilst there was no extensive failure to contribute to any 
particular lineage or lineages, the numbers of cells in each haematopoietic tissue were 
reduced. Quantitative PCR data also indicated that the percentage of donor cells in 
each haematopoietic tissue were reduced compared to wild-type. When total 
differences in cell numbers were included, the calculated number of cells of donor 
origin were greatly reduced in animals rescued with -/- cells. Although the small 
sample size precluded meaningful statistical analyses of the data, the general trend 
towards reduced cell numbers was striking.
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In order to determine the origins of those mature cells present in the 
haematopoietic tissues of rescued animals, we employed a lymphocyte proliferation 
assay. Following mitogen stimulation of B and T lymphocytes in cell suspensions 
from haematopoietic tissues, PCR was again used to quantify the percentage of donor- 
derived cells. The reasoning behind this was that only mature lymphocytes proliferate 
in response to mitogen stimulation, and if a high percentage of these proliferating 
cells were of donor origin, it must follow that donor cells in haematopoietic tissues 
were terminally differentiated and capable of responding to stimulation. Whilst this 
proved to be true for wild-type samples, no significant donor-marker signal was 
observed in samples from mice rescued with -/- cells. Whether the failure of -/- cells 
to proliferate in these assays was due to the initial absence of mature cells, or a failure 
to respond to stimulation could not be determined from these data. It was thus not 
possible to determine if any of the cells which stained positive for mature cell surface 
markers by antibody staining were derived from -/- donor material.
Theoretically recipient haematopoietic cells should be mitotically inactive after 
irradiation, and thus incapable of dividing. However, it is acknowledged that a certain 
percentage of the haematopoietic system of rescued animals will be of recipient 
origin. It is possible for a small number of stem cells to effect repopulation of the 
haematopoietic system in a clonal manner (Micklem et al. 1989). Survival of even a 
few recipient HSCs could thus result in a significant proportion of the haematopoietic 
system of rescued mice being composed of host-derived cells. Therefore it is entirely 
feasible that the mature cells in the haematopoietic tissues of rescued animals 
observed by FACScan analysis were of recipient origin. These cells would be be wild- 
type with regards to DNA ligase I. Consequently, it was only possible to draw 
inferences about the properties of -/- cells from the cell populations which were absent 
from rescued recipients.
Data from mice rescued with -/- cells displayed a general trend towards reduced 
cell numbers in all haematopoietic lineages. This was consistent with the hypothesis 
that -/- cells are unable to proliferate as rapidly as wild-type cells. However, it 
appeared that the B cell lineage was underrepresented in comparison to T cells, and 
that in turn T cells were depleted compared to granulocytes. These results could be 
explained by a block to B cell (and T cell) differentiation, for example caused by a 
failure of -/- cells to undergo functional V(D)J recombination. Alternatively, -/- stem 
cells might preferentially differentiate rather than proliferate, and may even be biased 
towards differentiation into granulocytes. Both of these mechanisms would, if proven 
to be correct, implicate DNA ligase I in cellular processes beyond DNA replication.
The published data does lend tentative support to this hypothesis. It has been 
shown that single strand breaks present in resting peripheral blood lymphocytes are
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rapidly rejoined after PHA stimulation (Boulikas 1991 and references therein). During 
differentiation of HL-60 along the myeloid lineage, the number of single strand breaks 
increases, as also happens during induction of differentiation of primary avian 
myoblasts, murine erythroleukaemia cells, CFU-GM and during ageing. Inhibitors of 
PARP interfere with mitogen induced activation of human peripheral blood 
lymphocytes (Colon-Otero et al. 1987), and in addition, myeloid cell differentiation 
inducing protein (MGI-2) causes formation of single strand breaks in closed circular 
SV40. Exactly why DNA strand breaks affect differentiation is not clear, but one 
possibility involves the alteration of gene expression by relaxation of supercoiled 
domains in the genome. In DNA ligase I-deficient cells, the accumulation of strand 
breaks may result in a predisposition to differentiate rather than be maintained as stem 
cells, an effect that is only observed in the haematopoietic system where cell division 
rates are maximal. Alternatively, DNA structural changes may be involved more 
directly with the differentiation pathway taken by HSCs. From a study of PARP- 
mediated ligation, it was concluded that strand breakage is involved in the control of 
differentiation. During granulocyte-macrophage switching, monocytic differentiation 
is associated with the closure of existing breaks, while granulocytic differentiation 
involves creation of new disruptions (Kahn and Francis 1987). Analogously, UV 
treatment of lymphocytes has been shown to induce immunoglobulin class switching 
(Rosen and Klein 1983). A DNA ligase-deficiency might therefore bias differentiation 
towards or away from a particular pathway. Mice lacking the Rb protein display a 
phenotype similar to our DNA ligase I-deficient mice. It has been demonstrated that 
this is the result of differentiation of haematopoietic progenitor cells into certain non- 
erythroid cell types (Jacks et al. 1992). A similar mechanism could be acting in -/- 
embryos.
There is conflicting evidence as to which DNA ligase is involved in V(D)J 
recombination. Gellert and co-workers used DNA ligase I in reconstitution of V(D)J 
recombination in vitro, but 46BR cells exhibit normal V(D)J recombination. 
Additionally, DNA ligase IV has been shown to interact with, and be stimulated by, 
XRCC4, a protein required for both V(D)J recombination and double strand break 
repair. Failure of -/- cells to undergo V(D)J recombination would be strong evidence 
for the requirement of DNA ligase I in this process. Unfortunately, the data from 
rescued animals is inconclusive because it was not possible to determine the origins of 
those B cells observed in mice rescued with -/- cells. It should, however, be possible 
to address the question directly by differentiating stem cells from -/- livers in vitro. In 
vitro B cell differentiation would enable close examination of V(D)J recombination 
processes in cells lacking DNA ligase I.
230 
CHAPTER SEVEN: DISCUSSION
Whilst it is possible that the disparity between observed cell numbers in the 
different haematopoietic lineages of rescued mice was the result of specific 
disturbance to haematopoietic differentiation, a simpler explanation can be proposed. 
This suggestion involves the known kinetic demands of the repopulation process. 
Published data has indicated that all cells in the haematopoietic system of rescued 
mice may be derived from as few as 3 progenitors (Micklem et al. 1987). The stem 
cells involved are therefore under high proliferative pressure. Donor cells injected into 
the peripheral circulation of recipients initially home to the spleen, whereupon they 
proliferate to form colonies composed of erythroid and myeloid lineages. Thereafter 
other haematopoietic tissues become colonised, probably by migration of progenitor 
cells from the spleen. Because the development of lymphoid cells takes place only in 
certain locations (e.g. thymus and bone marrow), lymphoid cells are only generated 
once haematopoiesis has begun in these tissues. If secondary migration of progenitor 
cells from the spleen to other haematopoietic tissues does not occur, then mature 
lymphoid cells would not be generated, and would thus not be present in the 
peripheral circulation. If -/- cells do not proliferate sufficiently rapidly to completely 
fulfil the requirements of erythropoiesis, secondary migration of progenitors may not 
occur to the normal extent, and hence subsequent generation of mature lymphocytes 
may be abbreviated. Furthermore, Epo-mediated processes may cause bone marrow 
progenitors to preferentially differentiate into erythrocytes rather than B cells.
7.5 Types of anaemia
There are 3 basic cause of anaemia in humans; impaired red cell formation, lysis 
of red blood cells (haemolysis), and blood loss.
Impaired red cell formation can be caused by a number of mechanisms. These 
include metabolic disorders, toxic dyshaematopoiesis, bone marrow infiltration by 
malignant cells, impaired haemoglobin synthesis, and impaired DNA synthesis. In this 
last case, abnormal DNA synthesis typically arises from vitamin B12 or folate 
deficiency, or from drugs which inhibit DNA replication. In these situations, 
megaloblastic anaemia occurs. The features of megaloblastic anaemia include the 
presence of macrocytic erythrocytes in the peripheral circulation with profound 
variability of size and shape (anisocytosis and poikilocytosis). Inclusions are often 
observed within the erythrocytes (e.g. Howel-Jolley bodies, nuclear remnants), but 
few reticulocytes are seen.
Aplastic anaemia also arises from impaired red cell production. Fanconi's 
anaemia is a congenital aplastic anaemia, but similar symptoms can arise from bone 
marrow failure in adults. In each case, anaemia can be accompanied by macrocytosis 
with occasional nucleated cells, but there are reduced numbers of all haematopoietic
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cell types (pancytopenia) and bone marrow hypoplasia. The reticulocyte count is 
always low in aplastic anaemia.
Another form of aplasia is pure red cell aplasia. In this ill-defined group of 
diseases, there is isolated depletion of the erythroid lineage (rather than pancytopenia). 
Pure red cell aplasia can exist either as an acute condition or a chronic complaint. One 
example of a chronic red cell aplasia is Diamond-Blackfan anaemia (DBA). Work to 
date has suggested that DBA is caused by selective deficiency of erythroid 
progenitors, resulting in a failure to produce the normal number of erythrocytes after 
birth. Although splenomegaly is observed, reticulocyte numbers are again always low.
Haemolytic anaemias are caused by reduced red cell survival. There are a 
number of different types of haemolytic anaemias, but all have certain common 
features. Erythrocyte life-span is reduced, and to compensate there is an increased rate 
of red cell production. This is manifested as erythroid hyperplasia with high numbers 
of reticuloocytes in the peripheral circulation. In severe cases, nucleated erythrocytes 
may be released into the circulation, and red cells may display morphological 
abnormalities.
7.6 The anaemia phenotype of mice rescued with -/- cells displays characteristics 
of increased red cell turnover
The phenotype of -/- embryos matched the characteristics of megaloblastic 
anaemia, which was consistent with the hypothesis that the anaemia arose as a result 
of impaired DNA replication. The phenotype displayed by mice rescued with -/- cells, 
however, did not match any of the documented types of anaemia found in humans. 
Animals rescued with -/- cells were anaemic. The severity of this anaemia was 
variable, but where severe, was accompanied by pronounced reticulocytosis and 
macrocytosis. Whilst there was a shortage of circulating erythrocytes, the spleen 
contained large numbers of erythroid cells, of which a large proportion appeared to be 
DNA ligase I-deficient. The percentage of reticulocytes is always low in anaemia 
arising from impaired red cell formation, and hence the anaemia observed in mice 
rescued with -/- cells does not correspond to megaloblastic anaemia.
The phenotype also did not match exactly with red cell aplasia syndromes such 
as DBA. However, our interest in DBA was stimulated by publication of data 
mapping the DBA gene to a 1.8Mb region on human chromosome 19ql3.3 
(Gustavsson et al 1997). LIG1 maps to 19ql3.2-13.3, and given the anaemia 
phenotype of DNA ligase I-deficient mice, was thus a potential DBA candidate gene. 
However, we were unable to identify any changes to the L1G1 locus in DBA samples, 
and subsequent mapping of the disease locus proved that DBA is not congruent with 
L1G1 (S.E. Ball, personal communication).
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Reticulocytosis and erythroid hyperplasia are two characteristics of haemolytic 
anaemias arising as a consequence of increased red cell turnover. The fact that mice 
rescued with -/- cells displayed reticulocytosis and splenomegaly would suggest that 
red cell turnover was increased. The logical conclusion to be drawn from these data is 
that anaemia in -/- embryos and mice rescued with -/- cells arises because one of the 
final steps of erythroid differentiation is blocked. This would contradict the hypothesis 
that anaemia (and pancytopenia) was the result of a reduced rate of cell proliferation. 
Resolution of this conflict requires additional experiments to be carried out. The most 
obvious way to investigate this issue would be to carry out more detailed studies of 
erythroid differentiation of -/- cells in vitro (e.g. CFU-E assays carried out on foetal 
liver cell suspensions).
A specific disruption to erythroid differentiation would, however, not be easily 
reconciled with the pancytopenia observed, nor the variability in the degree of 
reticulocytosis. It remains possible that all the features observed in mice rescued with 
-/- cells may result from a reduced proliferative capacity. As outlined earlier, 
repopulation of the haematopoietic system is a dynamic process that involves rapid 
proliferation of stem cells. All sampling points we employed were after long term 
repopulation had been achieved, and thus only represented the final 'steady state'. It is 
possible that reticulocytosis may represent a secondary event arising from perturbation 
to the repopulation process.
The processes of repopulation and initiation of foetal liver erythropoiesis are 
similar in that both involve the proliferation and differentiation of a small number of 
HSCs to form a large population of terminally differentiated cells on a relatively short 
time-scale. The model devised to explain the disruption to foetal liver erythropoiesis 
in -/- embryos may thus be adapted to the repopulation of lethally-irradiated recipients 
with -/- cells. If -/- HSCs struggle to meet the initial proliferative demands, and fail to 
produce the normal number of differentiated cells, hypoplasia and anaemia would 
occur. Anaemia would result in Epo production, which in turn stimulates erythroid 
differentiation. As noted previously, this would have little effect on a system that was 
already operating to its full proliferative potential. In the absence of the required 
numbers of mature erythrocytes, immature erythroid cells could be prematurely 
released into the peripheral circulation, and reticulocytosis would occur. Reticulocytes 
are rapidly cleared from the peripheral circulation by the liver, and have a life-span of 
1-2 days, compared to 28 days for a mature erythrocyte. As a result, rapid clearance of 
these cells from the circulation would effectively mimic haemolytic events. A positive 
feedback loop would thus become established, anaemia forcing the release of 
reticulocytes, which are cleared rapidly, thereby exacerbating the anaemia. Providing 
sufficient numbers of stem cells are present to enable recipients to survive (and by
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definition rescued animals have to survive) then over the course of time, Epo 
stimulation of erythroid differentiation will expand numbers of erythroid lineage cells 
in the spleen, resulting in hyperplasia. Again the Epo response may diminish the pool 
of stem cells, precluding subsequent correction of the normal balance of 
haematopoietic lineages. Because the demand for erythroid cells in the adult mouse is 
static, given time, the anaemia should theoretically resolve. We did not observe 
resolution, and in fact the opposite occurred. However, given the repeated sampling 
which removed large volumes of blood, and the relatively short period prior to final 
sacrifice, this would not be inconsistent with the model presented.
7.7 DNA ligase I-deficient cells display an abnormal profile of replication 
intermediates
Whatever the precise nature of the disturbance to erythroid differentiation, there 
remains the fact that -/- cells are capable of cell division. It therefore follows that 
DNA replication must be occurring in the absence of DNA ligase I. This was highly 
unexpected given the wealth of data on the involvement of DNA ligase I in lagging 
strand DNA replication. In order to investigate the process of DNA replication in -/- 
cells, pulse-chase experiments were carried out. Radioactively labelled thymidine was 
introduced into cells for a short period of time. By separating DNA molecules on the 
basis of size, and using scintillation to detect the radiolabelled fragments, it proved 
possible to identify the newly replicated DNA.
Using pulse-chase labelling in human cells containing an altered form of DNA 
ligase I (46BR.1G1), we were able to demonstrate diminution of the average size of 
newly replicated DNA fragments. The 46BR.1G1 cells contained a raised proportion 
of small labelled fragments after the pulse procedure, though these small fragments 
were apparently incorporated into larger molecules with time. In this respect, these 
results were broadly similar to other studies of DNA replication carried out using 
46BR and 46BR.1G1 fibroblasts.
An immortalised fibroblast line derived from a -/- embryo exhibited a broadly 
similar replication defect to the 46BR.1G1 cells. There was a raised proportion of 
small labelled fragments after the pulse period and these were "chased away" with 
time. However, comparison between -/- cells and 46BR.1G1 revealed that the average 
fragment size was greater in -/- cells. Put another way, there were more small 
fragments in 46BR.1G1 cells. This would suggest that the initial joining of DNA 
fragments was more efficient in -/- cells. However, following the initial pulse period, 
fragments were chased away at broadly similar rates in both cell types. Whether any 
firm conclusions can be drawn from these results would be reliant on a more detailed 
study of the kinetics of the systems, but a number of general inferences can be made.
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The observation that DNA replication processes are disturbed in cells lacking 
DNA ligase I would be consistent with the hypothesis that -/- cells have a reduced 
proliferative capacity. Although the cell cycle was apparently unaffected by the 
absence of DNA ligase I (A.-M. Ketchen and D.W. Melton, unpublished data), the 
analysis would not detect subtle changes to timings of the cell cycle phases. Retarded 
joining of Okazaki fragments in -/- cells could therefore extend the time taken to 
complete S phase without the effect being noticeable by FACscan analysis of whole 
cell populations.
Satoh and Lindahl have presented a model to explain the hypersensitivity of 
46BR cells to 3AB in terms of the interaction of polyADPribose polymerase with 
DNA strand breaks (Lindahl et al. 1993). PARP binds tightly to breaks, and 
apparently prevents access of excision repair enzymes. Release occurs following 
automodification of PARP, since heavily autoribosylated PARP no longer binds 
effectively to DNA. SAB acts on PARP by inhibiting release of the molecule from 
DNA. Normally, PARP does not gain access to DNA strand interruptions during 
lagging strand synthesis, due to the protection of DNA termini by the replisome. 
Hence the effects of PARP on DNA joining is usually limited to BER of alkylation 
damage (PARP being known to associate with the BER complex of proteins). 46BR 
cells on the other hand, exhibit delayed joining of the Okazaki fragments, which may 
result in their escape from the replisome, and thereby become targets for PARP 
binding. In turn, this would delay conversion of the small intermediates into higher 
molecular weight forms, an effect greatly exacerbated by the presence of SAB, which 
would thus result in reduced cell viability. However, cells from -/- embryos are not 
sensitive to the effects of killing by SAB (A.-M. Ketchen and D.W. Melton, 
unpublished data). This implies that either the model proposed by Satoh and Lindahl 
is inappropriate, or that newly synthesised DNA fragments are processed in different 
ways in the two cell types.
It has already been noted that the initial numbers of small fragments are greater 
in 46BR.1G1 cells, but that subsequent joining occurs at broadly similar rates in 
46BR.1G1 and -/- cells. The assumption implicit in this interpretation is that the 
mechanisms by which the labelled fragments are generated, and subsequently 
processed, are identical in the two cell types, and that it is only the rates of reaction 
that are different.
It has been suggested that DNA ligase I is part of a 'core' multiprotein 
replication complex via interactions with PCNA. Nevertheless, data from Loor et al 
indicated that DNA ligase I may not be essential for the formation of replication 
complexes. Analysis of protein complexes which bound to PCNA failed to identify 
DNA ligase I as a component of complexes containing other replication proteins
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(Loor et al 1997). Our suggestion would be that replication complexes form and 
DNA polymerisation is carried out as normal in 46BR and -/- cells. Conflicting 
interpretations have been made from analyses of DNA replication in 46BR cells. 
Lehmann et al. found that incorporation of Okazaki fragments into high molecular 
weight forms occurred at a reduced rate (Lehmann et al. 1988). Prigent et al. 
determined that the initial rate of joining was normal, but that a percentage of small 
fragments remained unligated after prolonged chase periods (Prigent et al. 1994). Our 
data on 46BR cells was consistent with both models. In each case the assumption is 
that the defective DNA ligase I protein interacts with the replication complex in a 
normal manner. Joining of Okazaki fragments at the replication fork is carried out by 
DNA ligase I, albeit at a reduced rate. Subsequently unligated fragments are joined by 
the ligation activity of a repair pathway.
In cells lacking DNA ligase I, ligation during lagging strand synthesis cannot be 
carried out by DNA ligase I. The simplest explanation would be that another DNA 
ligase assumes the role of DNA ligase I within the replication complex. However, to 
date no other DNA ligase has been observed to participate in replication, and, at least 
I'w vitro, DNA ligases in and IV have been shown not to function (Waga, Bauer and 
Stillman 1994, Mackenney, Barnes and Lindahl 1997). Whether another DNA ligase 
acts to replace DNA ligase I directly in -/- cells remains to be determined. One 
potential way of doing this would be to isolate replication complexes from -/- cells. It 
would thus be possible to identify which, if any, other DNA ligase was present within 
the complex.
Alternatively, it is possible that all Okazaki fragments formed during lagging 
strand DNA synthesis in -/- cells are processed by a 'repair' mechanism not directly 
associated with the replication complex. It has been noted that single strand breaks 
generated during DNA replication are recombinogenic. The S. cerevisiae cdc9 DNA 
ligase mutant displays an increased mitotic recombination rate (Game, Johnston and 
von Borstel 1979). Recently Zou and Rothstein demonstrated that Holliday junction 
replication intermediates are increased in certain yeast replication mutants, including 
cdc9 (DNA ligase deficient) cells. They proposed that replication-related lesions are 
repaired by recombination via a Rad52-dependent pathway (Zou and Rothstein 1997). 
It is thus potentially possible that lesions arising from lagging strand DNA replication 
could be repaired by this, or other pathways, in the absence of DNA ligase I. Although 
speculative, different relative activities of 'replication' and 'repair'-mediated ligation 
between 46BR and -/- cells could explain the different profiles of replication 
intermediates observed.
Increased levels of mitotic recombination have already been observed in human 
cells containing aberrant DNA ligase I. Bloom's syndrome cells display high numbers
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of exchanges between sister chromatids (SCEs) and between homologous 
chromosomes. Elevated SCE levels have also been recorded in 46BR.1G1 cells 
following treatment with DNA damaging agents. We were therefore very interested to 
determine whether the frequency of SCEs was elevated in -/- cells. BS is now known 
to be caused by mutations within a helicase protein, and SCEs are thought to be a 
mechanism by which BS cells process abnormal structures formed during replication. 
46BR cells on the other hand are sensitive to a wide variety of DNA damaging agents, 
which has been presumed to indicate deficiency in a number of DNA repair pathways. 
It is therefore believed that induction of SCEs by treatment with DNA damaging 
agents represents a failure to repair lesions before entering S phase. Potentially 
therefore SCEs could be a marker for either perturbation of DNA replication, or 
inefficient repair of DNA damage.
Cells derived from -/- embryos did not display an elevated SCE frequency. No 
significant difference was observed between -/- samples and wild-type controls. These 
data indicate that perturbations in replication arising from the absence of DNA ligase I 
were not resolved by a mechanism that induced sister chromatid exchanges. 46BR 
cells had been observed to have a marginally raised baseline level of SCEs 
(Henderson et al. 1985), but this was not observed in -/- cells. When we carried out 
the assay on 46BR.1G1 cells, the numbers of SCEs observed were higher than 
reported elsewhere. Nevertheless we do not believe that this result was significant 
given the differences between the experiments. The disparity most likely stems from 
the use of primary fibroblasts, whereas we employed the SV40 immortalised 
46BR.1G1 line. Either the immortalisation process or the prolonged period of time 
spent in culture could have caused molecular changes which elevated the level of 
SCEs in 46BR.1G1 cells.
46BR cells were reported to be sensitive to the induction of SCEs by DNA 
damaging agents. Whether this is also true for -/- cells remains to be determined. The 
response of 46BR cells has been linked to the sensitivity of these cells to killing by 
DNA damaging agents. Studies by A.-M. Ketchen and D.W. Melton have indicated 
that -/- cell lines are not sensitive to a variety of DNA damaging agents. As such, it 
would be predicted that -/- cells would not show induction of the rate of SCE 
formation in response to DNA damage.
7.8 Molecular changes arising from the absence of DNA ligase I
DNA ligase I is the predominant DNA ligase activity in proliferating cells, and 
is thought to be central to lagging strand DNA replication. Because cells lacking DNA 
ligase I are nonetheless viable, some other gene product or pathway must assume the 
role of DNA ligase I in joining small replication intermediates into high molecular
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weight forms. The obvious candidate for this would be one of the other known DNA 
ligases. Because these other enzymes are poorly expressed in proliferating cells in 
comparison to DNA ligase I, it would not be unreasonable to expect expression of the 
complementing DNA ligase to be upregulated. To test whether DNA ligases HI or IV 
were upregulated in the absence of DNA ligase I, northern and western blot analysis 
was carried out.
In order to perform northern analysis, fragments of the mouse homologues of 
LIG3 and LIG4 were cloned by RT-PCR using primers based on the published human 
sequence. The fragment of the putative Lig3 cDNA cloned had a predicted amino acid 
sequence with high homology to the human protein. Furthermore, the fragment 
detected a transcript of the correct size (~4kb) which was highly expressed in testes. 
However, a ~6kb transcript was also detected by this probe, which also showed 
maximal expression in testes. Tomkinson and co-workers observed an identical 
phenomenon using a different region of the cDNA (Husain et al. 1996). It is therefore 
probable that the additional transcript was not an artefact, but instead represents a 
splicing intermediate.
The predicted amino acid sequence of the putative Lig4 cDNA fragment 
displayed homology with the published sequence of the human protein, and detected a 
fragment of the predicted size. The tissue distribution of this transcript correlated with 
published data on expression of LIG4, being most highly expressed in testes, thymus 
and bone marrow. The high levels observed in lymphoid tissues would lend credence 
to the supposition that DNA ligase IV is involved in V(D)J recombination.
In short, the properties of the cDNA fragments showed close agreement with 
data available for LIG3 and LIG4, and we were confident that we had cloned 
sequences from the mouse LigS and Lig4 homologues. The cloned fragments were 
thus used to probe RNA samples from embryos representative of the three genotypes 
and cell lines derived from mid-gestation embryos. There was no detectable change in 
levels of LigS or Lig4 transcripts in samples lacking DNA ligase I. Similarly, western 
blotting using antibodies specific for DNA ligases m and IV revealed no alterations to 
the respective protein levels in -/- samples. Furthermore, an in vitro assay for 
adenylation activity showed no detectable differences between wild-type and -/- 
samples (data not shown). We therefore concluded that targeted deletion of Ligl does 
not affect expression of either DNA ligase IE or DNA ligase IV. Whilst it is still 
theoretically possible that one (or both) of the two enzymes acts to complement for 
the absence of DNA ligase I, these data would suggest that the role is filled by some 
other enzyme.
Published evidence has suggested that there may be up to six distinct DNA 
ligase activities in mammalian cells. Biochemical strategies have been used to purify
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proteins designated as DNA ligase n, DNA ligase V, NHR ligase, and a mitochondria! 
DNA ligase. Little is known about any of these proteins, and in the case of DNA 
ligase V, NHR ligase and mitochondrial DNA ligase, references are limited to a single 
publication apiece. All putative DNA ligases have been shown to display DNA 
ligation activity. Whether any are actually derived from novel genes awaits cloning of 
the loci responsible. Without cloned cDNAs or reliable antisera against the proteins, it 
was impossible for us to investigate whether the absence of DNA ligase I affected 
expression of these other putative DNA ligases. The use of a functional assay, e.g. the 
ability to form adenylated intermediates, would have enabled us to investigate this 
possibility. However, when we carried out this assay on crude cell extracts, the 
sensitivity of the assay proved to be low. Without purification of the active proteins, it 
proved impossible to identify any differences in the levels of the known DNA ligases 
or to identify any novel adenylated products. This approach was therefore discounted 
as an option.
DNA ligases m and IV were both cloned on the basis of homology to DNA 
ligase I. Comparison of the protein sequences demonstrated that all known DNA 
ligases share certain common motifs, notably the active site and conserved C-terminal 
polypeptide. We attempted to exploit possible homology between DNA ligases in 
order to clone novel DNA ligases. The RT-PCR fingerprinting technique developed 
by Boehm had previously been used to clone novel members of the tyrosine 
phosphatase gene superfamily (Boehm 1993). Degenerate PCR primers are used to 
amplify the region between two conserved motifs. Thereupon the products are 
digested with frequently cutting restriction enzymes, and separated on a high 
resolution gel system. Divergence between homologous genes within the intervening 
region results in different family members generating different restriction patterns, 
from which it is possible to identify and clone previously unidentified members of the 
gene family.
Using PCR primers based on the sequences of DNA ligases I, El and IV under 
low stringency conditions, we found that large numbers of bands were produced even 
prior to restriction digestion. Without the appropriate cDNA controls it proved 
impossible to identify even the bands corresponding to the known DNA ligases. In 
this respect, the attempt to employ RNA fingerprinting was a failure. However, it was 
noted that patterns differed between wild-type and -/- samples. Cloning of those bands 
increased in intensity in -/- samples enabled us to identify two known genes and one 
previously unidentified gene whose expression was upregulated in mid-gestation -/-
embryos.
One of the genes we were able to identify encoded transferrin, a protein known 
to be upregulated in conditions of anaemia. This was not surprising given the anaemia
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phenotype of -/- embryos. The second identifiable transcript was a fragment of the 
MRP14 gene. MRP14 is known to be expressed during granulopoiesis, but why it 
should apparently be upregulated in -/- embryos remains unclear. It is possible that the 
increased level of transcript in -/- RNA samples compared to wild-type controls is 
merely an artefact. With far fewer erythroid cells present in the livers of -/- embryos, 
cell lineages present in normal numbers will represent a higher proportion of cells. It 
would thus follow that any lineage specific transcript not expressed in erythroid cells 
would appear to be 'upregulated' in -/- RNA samples. However, FACScan analysis of 
mice rescued with -/- cells does suggest that there is a disparity between numbers of 
cells in the different haematopoietic lineages. It is thus possible to speculate that the 
raised levels of MRP14 transcript observed actually represents an increase in the 
numbers of granulocytes in the livers of -/- embryos compared to wild-type controls. 
Given the consequent implication that non-erythroid haematopoietic cell lineages are 
differentially affected by the absence of DNA ligase I, the detection of MRP14 as a 
gene that is 'upregulated' may prove to be highly significant.
The third cloned fragment (#10) did not have homology to any sequence in the 
public databases. It therefore may represent a 'novel' gene of undetermined function. 
Although the transcript was not expressed in one -/- cell line, and we subsequently 
failed to detect expression in primary fibroblasts (data not shown), the fragment #10 
transcript was detected at high levels in one of the DNA ligase I-deficient cell lines. 
This raised the intriguing possibility that the gene may be involved in cellular 
processes directly affected by the lack of DNA ligase I. Further investigation is, 
however, required to clarify the matter.
Although not what was originally intended, the results achieved from this 
attempt to employ RNA fingerprinting do demonstrate the potential of the approach. It 
is possible that RNA fingerprinting could be made to work using specifically designed 
primers. However, this technique can only be employed to investigate the members of 
a defined gene family. The related technique of 'differential display' is far more 
versatile in that it permits analysis of the expression levels of all genes. It is highly 
sensitive, and can be used to identify quantitative differences in gene expression 
levels as well as simple qualitative changes. Furthermore, the technique is relatively 
cheap, and easy to perform, and thus represents an ideal method to screen for, and 
clone, genes whose expression is altered following gene targeting. The major 
limitation of this technique is that it only detects changes in gene transcription. It will 
not detect translational or post-translational control mechanisms, and identification of 
genes whose products might complement for the absence of DNA ligase I is therefore 
totally reliant on the assumption that transcriptional upregulation will occur.
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7.9 Cells lacking DNA ligase I are repair competent
In order to address the question of whether -/- cells are also repair deficient, -/- 
cell lines were challenged with a variety of different DNA damaging agents (A.-M. 
Ketchen and D.W. Melton, unpublished data). Results to date have indicated that -/- 
cells are not sensitive to the killing effects of any damaging agent. There are a number 
of potential explanations for these results.
DNA ligase I may not function in the pathway employed to repair the damage. 
For example, accumulating evidence points to DNA ligase IV, and not DNA ligase I, 
being involved in non-homologous double strand break repair. Alternatively, there 
may be two redundant repair pathways capable of repairing the damage lesion. In the 
case of BER, there are known to be two pathways which repair alkylated bases; 'short 
patch' (PCNA-independent) and 'long patch' (PCNA-dependent). While DNA ligase 
HI is involved in the former pathway, DNA ligase I is only thought to function in the 
latter, and hence the absence of the protein would not abolish repair of alkylation 
damage. It is possible that another DNA ligase may be able to fill the role of DNA 
ligase I. For example, it has been demonstrated that Ku can stimulate the activity of 
all three known DNA ligases, and so all may be able to function in Ku-mediated end 
joining. Redundancy is especially plausible if the final ligation step is not tightly 
associated with the initial lesion processing. Although NER and BER are thought to 
be carried out by multiprotein complexes, no such protein associations have been 
identified for the mismatch repair pathway. If free DNA ligase I protein carries out the 
final ligation step, then it would be feasible for another free DNA ligase to perform 
the same role equally well.
Although -/- cells are not sensitive to any exogenous DNA damaging agents, it 
has been shown that they do display a high level of genomic instability (D.W. Melton, 
unpublished data). Studies of metaphase cells demonstrated that there was a high 
variability in chromosome number, and the rate of micronucleus formation in vivo 
was also increased. As -/- cells are repair competent for all types of damaging agents, 
the implication is that either instability arises as a result of the replication defects 
observed, or that possibly DNA ligase I is required for a more general genome 
surveillance mechanism. Whichever is the case, Ligl -I- cells represent the first 
example of separation of genomic instability from sensitivity to DNA damaging 
agents.
7.10 Deletion of DNA ligase I in vivo
Whilst the ability to generate DNA ligase I-deficient mice demonstrated that 
DNA ligase I was not required for cell viability, the associated developmental lethality 
restricted the scope of investigation of the consequences of the absence of the protein
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in vivo. Studies of cell lines in vitro have contributed towards understanding the 
molecular changes involved, but a viable whole animal model would have far greater 
potential. In order to develop such a model, we chose to use the Cre/loxP 
recombination system. Cre recombinase mediates site-specific recombination between 
34bp sequences termed loxP sites. By flanking a gene of interest with two loxP sites, 
recombination will delete that gene when the Cre protein is expressed. Because Cre- 
mediated recombination is a highly efficient process, it is possible to carry out 
recombination in vivo without selection, and by limiting Cre expression to a defined 
cell lineage or timepoint, it is possible to perform gene knockout in a conditional 
manner.
We employed a double replacement gene targeting strategy to introduce loxP 
sites into the endogenous Ligl locus. Using ES cells heterozygous for the targeted 
Ligl knockout allele, we reconstructed a functional Ligl allele but with loxP sites 
flanking exon 23 and 27. Southern blotting confirmed that 8 ES cell clones identified 
by PCR had undergone the correct homologous recombination event. These clones 
were then used to produce mice heterozygous for the 'floxed' Ligl allele. 
Concurrently, we also used the ES cell clones to test Cre-mediated recombination of 
the floxed Ligl allele.
A PCR-based assay was devised to detect Cre-mediated recombination at the 
Ligl locus. This assay was used to screen ES cells into which a Cre-expression 
plasmid had been introduced. Three clones gave positive signals from this 
experiment, and Southern analysis confirmed that two had undergone Cre-mediated 
deletion of the last 5 exons of the floxed Ligl allele. The structure of the deleted Ligl 
allele determined by Southern blotting matched the predictions made from the known 
structure of the floxed allele. Northern blot analysis was also carried out on ES cell 
clones heterozygous for the floxed and deleted Ligl alleles. Samples heterozygous for 
the floxed allele were indistinguishable from wild-type samples. We thus concluded 
that the floxed allele was analogous to the wild-type allele, despite the engineered 
changes. Following Cre-mediated recombination, the level of Ligl transcript dropped 
by approximately 50%, suggesting that there was no expression from the deleted 
allele. The absence of expression is significant because it meant that the deleted allele 
is functionally equivalent to the targeted Ligl knockout allele. It should thus be 
possible to compare the properties of A/A, A/-, and -/- cells in the knowledge that no 
protein is produced from either allele.
The third ES cell clone which had given positive results from the PCR screen 
did not show an appreciably lower level of Ligl transcript signal compared to wild- 
type controls. Similarly, restriction patterns produced by Southern blotting did not 
show disappearance of the fragment specific for the floxed Ligl allele. When PCR
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quantification of the proportion of cells carrying the deleted allele was carried out, it 
was calculated that 75% of cells did not contain the deleted allele. The simplest 
explanation for this result was that during plating of cells at single-cell density a cell 
which had undergone Cre-mediated recombination remained attached to three cells 
which had not undergone recombination. The resulting ES cell colony would thus not 
be derived from a single cell, but would be a mixture of cells of different genotypes.
The ES cell clones heterozygous for the deleted allele were used to develop a 
quantitative PCR-based assay for the deleted Ligl allele. By spiking known amounts 
of DNA from samples heterozygous for the deleted allele into wild-type DNA, and 
then subjecting to PCR, a linear standard curve was produced. In this way it proved 
possible to quantify the level of Cre-mediated recombination which had occurred in 
other samples. Although the values calculated from this technique displayed a high 
variance, the validity of the data was confirmed independently by Southern blotting. 
Both PCR and Southern blotting gave results which were in close agreement.
The data from these in vitro studies gave us confidence that not only could Cre- 
mediated recombination occur between the two loxP sites at the Ligl locus, but that 
we were able to detect this event even at low levels. To investigate recombination in 
vivo, ES cells heterozygous for the floxed allele were used to produce mice 
heterozygous for the floxed allele. These mice were subsequently interbred to produce 
mice homozygous for the floxed Ligl allele (f/f). The f/f mice were phenotypically 
normal, indicating that the f allele was functionally equivalent to the wild-type allele. 
f/f mice were crossed to two lines of transgenic mice (74 and 93) which expressed Cre 
recombinase under the control of the beta lactoglobulin promoter (BLG). BLG is the 
major whey protein in ruminants, and the BLG promoter had previously been shown 
to direct expression of transgenes exclusively to the secretory epithelial cells of 
mammary tissue, where expression peaks at day 10 of lactation. Quantitative PCR and 
Southern analysis demonstrated that in one of the transgenic lines (74), Cre-mediated 
recombination occurred in 70-80% of the cells in the lactating mammary gland, while 
background recombination levels in non-mammary tissues were minimal. Very low 
recombination levels were observed in virgin mammary tissue, increasing throughout 
gestation and birth, to peak around day 10 of lactation. This pattern of Cre activity 
closely paralleled the published kinetics of BLG expression. We were thus able to 
conclude that the BLG-Cre construct specifies mammary-specific gene deletion, and 
that deletion is tightly controlled both spatially and temporally.
These results confirm other independent data on Cre expression from the BLG 
transgene in line 74 transgenic mice. However, they also provided valuable 
confirmation that high levels of Cre-mediated deletion of the Ligl allele can occur in 
vivo. This will hence facilitate investigation of the effects of the absence of DNA
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ligase I in an adult environment. By crossing mice carrying both the BLG-Cre 
transgene and the Ligl floxed allele to mice heterozygous for the targeted Ligl allele, 
it will be possible to produce f/- mice which undergo Cre-mediated deletion of Ligl in 
the lactating mammary gland. This should, in effect, produce A/- secretory epithelial 
cells lacking DNA ligase I. However, the availability of mice carrying a floxed Ligl 
allele offers wider potential than simple investigation of the effect of DNA ligase I- 
deficiency in the mammary gland. A wide range of conditional or inducible Ligl 
knockouts could be generated. By crossing the floxed Ligl allele with mice 
expressing Cre in different tissues, it will be possible to study the consequences of 
loss of DNA ligase I activity in other cell lineages. Given the phenotype of -/- 
embryos and mice rescued with -/- cells, the obvious starting point would be deletion 
of Ligl from specific haematopoietic cell lineages. This offers the immediate 
opportunity to resolve the current debate about the requirements of DNA ligase I for 
V(D)J recombination, and to determine whether the course of haematopoietic 
differentiation can be affected by the absence of DNA ligase I.
In short, the generation of mice carrying a floxed Ligl allele will allow the 
production of a number of different experimental mouse models of DNA ligase I- 
deficiency in the future. With these mice it should be possible to answer long-standing 
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DNA ligase I is required for fetal 
liver erythropoiesis but is not 
essential for mammalian cell 
viability
Barren J. Bentley1 , Jim Selfridge 1 , J. Kirsty Millar 1 - 3 , 
Kay Samuel2, Nicholas Hole2 , John D. Ansell2 
& David W. Melton 1
Four distinct DNA ligase activities (I-IV) have been 
identified within mammalian cells1 "3 . Evidence has 
indicated that DNA ligase I is central to DNA replica­ 
tion4"7 , as well as being involved in DNA repair 
processes8-9 . A patient with altered DNA ligase I dis­ 
played a phenotype similar to Bloom's syndrome, 
being immunodeficient, growth retarded and predis­ 
posed to cancer10 . Fibroblasts isolated from this 
patient (46BR) exhibited abnormal lagging strand syn­ 
thesis11 - 12 and repair deficiency13"15 . It has been 
reported that DNA ligase I is essential for cell viabili­ 
ty16 , but here we show that cells lacking DNA ligase I 
are in fact viable. Using gene targeting in embryonic 
stem (ES) cells, we have produced DNA ligase l-defi- 
cient mice. Embryos develop normally to mid-term, 
when haematopoiesis usually switches to the fetal 
liver. Thereupon acute anaemia develops, despite the 
presence of erythroid-committed progenitor cells in 
the liver. Thus DNA ligase I is required for normal 
development, but is not essential for replication. 
Hence a previously unsuspected redundancy must 
exist between mammalian DNA ligases.
One patient has been identified with reduced DNA lig­ 
ase I activity correlating to missense mutations within the 
protein coding sequence 12' 17 . Gene inactivation is the first 
step of a 'double replacement' strategy18 to introduce anal­ 
ogous mutations into the mouse DNA ligase I gene (Ligl). 
Utilizing positive-negative selection in the hypoxanthine 
phosphoribosyltransferase (HPRT)-deficient ES cell line 
HM-1 19, we replaced exons 23 to 27 of Ligl with an HPRT 
minigene (Fig. la). Targeted ES cells were injected into host 
blastocysts, and resulting germ line chimaeras outbred to 
produce mice heterozygous for the targeted allele (+/-). 
Heterozygotes were phenotypically normal, but when 
interbred, no pups homozygous for the altered allele (-/-) 
were found. From diis it was concluded that the absence of 
DNA ligase I is developmentally lethal.
To define the developmental defect, embryos ranging 
from day 10.5 to day 16.5 postcoitum (E10.5-E16.5) were 
collected from heterozygous matings and genoryped. Live 
embryos of the three genotypes were obtained in the 
expected ratios at E10.5 [« = 77, X2 2 = °- 74 (NS)], and 
there was no significant loss of any genotype between El 1.5 
and E15.5 [n = 167, %2 2 = 2.50 (NS)]. However, while the 
majority of-/- embryos remained alive at El5.5, all 6 iso­ 
lated at El 6.5 were dead.
To ascertain the nature of any mRNA or protein pro­ 
duced from the targeted Ligl allele, northern and western 
analysis was performed. No intact, truncated or fusion 
transcripts from the Ligl allele could be detected in -/- 
embryos using cDNA probes corresponding to either exons 
8 to 27 (Fig. 1 b) or exons -1 to 7 (data not shown). Similar­
ly, no peptide of any kind could be detected in protei 
extracts from -/- embryos when probed with antibodie 
raised against bovine DNA ligase I (Fig. Ic and data nc 
shown). We conclude that expression from the targete 
allele is abrogated and DNA ligase I is completely abser 
from -/- embryos.
At El0.5, -/- embryos were visually indistinguishabl 
from their wild-type and heterozygous siblings. Howevei 
at El 1.5 all -/- embryos were paler and smaller than nor 
mal (Fig. Id). By El5.5 this anaemia had become exacer 
bated (Fig. 2c). Although smaller, -/- embryos appeare< 
grossly normal (Fig. 2e). Histological examination con 
firmed that, with the exception of the developing livei 
organogenesis was not perceptibly affected (data no 
shown).
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Fig. 1 Targeted dis­ 
ruption of Lig1 in 
mouse embryonic 
stem cells, and 
expression of the 
wild-type allele. a, 
Schematic repre­ 
sentation of 13.5 kb 
at the 3' end of the 
wild-type mouse 
DMA ligase I locus, 
targeting vector 
and gene structure 
following homolo­ 
gous recombina­ 
tion. Boxes, exons 
(numbered accord­ 
ing to the human 
convention31 ); thick 
lines, Lig1 introns 
or flanking regions; 
thin lines, plasmid 
vector DMA. Solid 
boxes and lines, 
regions of L!g1 
replaced by target­ 
ing; stippled box, 
HPRT minigene; 
hatched box, Her­ 
pes simplex virus 
thymidine kinase 
(HSV-tfc) cassette. 
Arrows indicate the 
positions at which 
PCR primer pairs 
used for genotyp- 
ing bind. b, 
Absence of 
detectable expres­ 
sion from the tar­ 
geted Lig1 allele. 
Upper, northern 
analysis: original 
ES cell line (HM-1), 
one targeted ES 
cell clone (#53),
and E13.5 embryos of the three genotypes. Positions of the 28S 
and 18S ribosomal RNA transcripts are indicated flanking the 
3.2-kb wild-type Ligl transcript. The probe used in the figure 
was a 2.1-kb SamHI/EcoRI fragment of mouse DNA ligase I 
cDNA, corresponding to exons 8 to 27. Lower, ethidium bromide 
staining to verify equal RNA loading, c, Absence of detectable 
DNA ligase I in -/- embryos. Western blot on total protein 
extracts from E15.5 embryos. Positions of molecular weight 
markers are indicated, d. Embryonic expression from the wild- 
type Ligl locus. Upper, northern analysis on a wild-type panel of 
E10.5 embryo, E10.5 yolk sac, E13.5 embryo carcass minus 
liver, E13.5 embryonic liver and E15.5 yolk sac. Lower, ethidium 
bromide staining to verify equal RNA loading, e, Expression from 
the wild-type Ligl locus. Upper, northern analysis on a panel of 
tissues from wild-type adult mice. Lower, ethidium bromide 
staining to verify equal RNA loading.
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Fig. 2 Phenotype of -/- embryos, a, Mor­ 
phology of wild-type (left) and -/- (right) sib­ 
lings at E11.5. The -/- embryo is paler and 
smaller than its sibling, b-e, Morphology of 
wild-type (b and d) and -/- (c and e) 
embryos at E15.5 before (b, c) and after (d, 
e) dissection from the yolk sac. The -/- 
embryos are severely anaemic, smaller than 
their wild-type siblings, and the liver is dis­ 
proportionately reduced in size, but other­ 
wise developmentally normal, f, g, Histology 
of livers from wild-type (/) and -/- (g) E15.5 
embryos. The wild-type liver contains 
numerous islands of erythropoietic cells, and 
megakaryocytes (asterisked). The -/- liver 
lacks extensive cellularization and contains 
no readily identifiable erythropoietic islands, 
although there is no evidence of increased 
apoptosis. Hepatocytes appear normal and 
megakaryocytes (asterisked) are present in 
normal numbers, h, i, Cytospin preparations 
of peripheral blood from wild-type (h) and 
-/- (/) E15.5 embryos. Blood from wild-type 
embryos consists predominantly of mature, 
enucleated liver-derived erythrocytes, 
although a few residual nucleated yolk sac- 
derived erythrocytes are present. In contrast, 
samples from -/- embryos display an elevat­ 
ed ratio of nucleated to enucleated erythro­ 
cytes. Those enucleated cells present 
display poikilocytosis and anisocytosis, with micro- 
cytes (arrow) and macrocytes (arrowhead) evident.
production in the developing embryo, erythroid 
cells comprising up to 70% of the total liver 
mass20. Livers from -/- embryos contained no 
discernible erythropoietic islands, giving an 
overall appearance of acellularity (Fig. 2g). 
Hepatocytes appeared normal, as did megakary- 
octes.
Examination of embryonic blood cytospin 
preparations revealed a deficiency of mature 
enucleated erythrocytes in -/- embryos (Fig. 2i). 
The percentage of nucleated erythrocytes in the 
peripheral circulation did not show the normal 
decrease characteristic of the shift of 
haematopoiesis from the yolk sac to the fetal 
liver (Fig. 3). By E15.5 the total number of cells 
in the peripheral circulation of-/- embryos had 
dropped to approximately 5% of the wild-type 
value (data not shown). In the absence of any 
other visible abnormalities, we postulate that -/- 
embryos die as a result of hypoxia secondary to 
the anaemia.
To examine the differentiation capacity of 
haematopoietic precursors in vitro, single-cell 
suspensions from -/- and control fetal livers 
were plated under growth conditions optimized 
for either primitive multipotent (CFU-A) or 
erythroid (BFU-E) progenitors. Consistently 
fewer total cells were present in livers of -/- 
embryos, and numbers of both types of progeni­ 
tors were also reduced compared to controls 
(Table 1). Qualitative scoring also revealed both 
CFU-A and BFU-E colonies derived from -/- 
livers to be smaller, although cell morphology 
appeared normal (data not shown). Antibody 
staining for the cell surface marker T200 indicated that the 
total number of non-erythroid haematopoietic cells in -/- 
livers was normal (Table 1). Similarly, the numbers of 
B220-positive B lineage cells detected in -/- livers were not 
reduced at this stage (data not shown). These data suggest
that, in contrast to the erythroid lineage, members of non- 
erythroid lineages are relatively unaffected by the lack of 
DNA ligase I. However, liver suspensions from -/- 
embryos were unable to rescue lethally irradiated mice 
(Table 1), indicating the defect is not simply the conse­ 
quence of an inappropriate hepatic microenvironment.
We have shown that the absence of DNA ligase I has no 
discernible consequence for most tissues in the developing 
mouse embryo, the growth retardation observed after 
E10.5 probably arising as a consequence of the anaemia. 
No significant abnormality was observed in the yolk sac of 
-/- embryos at El0.5, and yolk sac erythropoiesis was 
apparently normal. The specific disruption of liver erythro­ 
poiesis alone may reflect the extremely high replicative 
pressure on this system, embryonic expression of DNA lig­ 
ase I being highest in E13.5 liver (Fig. Id). Failure of another 
DNA ligase to completely complement the absence of DNA 
ligase I would be likely to preclude exponential prolifera­ 
tion. The normal geometric expansion of erythroid cells 
would thus be abbreviated, resulting in fewer terminally 
differentiated erythrocytes and anaemia.
DNA ligase I was thought fundamental to lagging strand 
DNA synthesis. Expression is induced upon cell prolifera­ 
tion21"23 , being highest in embryos and rapidly dividing 
adult tissues such as spleen, testes and thymus (Fig. le). 
The protein has been isolated from replication complex­ 
es4'5, and can function in replication in vitro6'7 . As 46BR 
cells display abnormal replication intermediate pro­ 
files 11 ' 12 ' 14, a role in ligation of Okazaki fragments was pro­ 
posed. Inability to isolate ES cells lacking DNA ligase I in 
vitro, led Petrini et al. to conclude that the enzyme medi­ 
ates essential functions in mammalian cells 16. However, 
our data indicate that DNA ligase I-deficient cells are viable 
in vivo. We believe that this discrepancy stems mainly from 
an inherent difficulty in isolating ES cells homozygous for a 
disabling mutation in vitro. For example, we have 
described the production of Erccl deficient mice24 , but 
have been unable to produce ES cells homozygous for the 
Erccl mutation. These cells clearly exist in vivo, but cannot 
be isolated in vitro, presumably because they cannot sur­ 
vive the demanding selection conditions at low cell density.
Abnormal DNA ligase I activity has been documented in 
cells from Bloom's syndrome patients, and although LIG1 
is. not the Bloom's syndrome gene (BIM) 25 , interaction 
between the two gene products seems probable. Studies of 
DNA ligase I-deficient cells thus may help define the pro­ 
tein interactions occurring within the replication complex. 
Exactly which other ligase activity replaces DNA ligase I is 
unclear at present, but a previously unsuspected redundan­ 
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All cell numbers are expressed per fetal liver. Cell suspensions were produced by successive passage through 19G and 25G needles, and the number of single 
cells counted. Numbers of haematopoietic progenitors per isolated El 3.5 fetal liver (mean ± s.d.) were determined by standard assays29'30. Equal numbers of 
single cells (cell equivalents) were plated out in conditions optimized for the proliferation and differentiation of primitive progenitors (CFU-A assay), or erythroid 
differentiation (BFU-E assay), and colony numbers scored after 11 and 8 days respectively. Numbers of non-erythroid haematopoietic cells (mean ± s.d.) were 
determined by antibody staining. Cell suspensions from E15.5 fetal livers were stained with a PE-conjugated, rat monoclonal antibody raised against mouse 
CD45 (T200) (Clone 30F 11.1, Pharmingen). For each sample, 25,000 to 50,000 cells were analysed by FACScan, and numbers of T200 positive cells estimated. 
for in vivo repopulation analysis, suspensions from individual E13.5 livers (liver equivalents) were injected into the tail vein of strain 129 or 129/CBA F1 mice 
exposed to 10.5 Gy of y radiation. Numbers of mice surviving after 4 weeks were recorded. All irradiated but uninjected control mice died within 3 weeks.
Methods
Gene Targeting. A library of EcoRI-digested genomic DNA from 
the ES cell line E14TG2a was constructed in X EMBL4. Screening 
using full-length mouse DNA ligase I cDNA as a probe26, enabled a 
13.5-kb fragment, encompassing exons 22 to 27, to be isolated and 
subcloned into the EcoRI site of plasmid pUC8. Replacement of a 
4.9-kb Sstl and a 3.7-kb BamHI fragment produced a targeting vec­ 
tor (MLTV) in which an HPRT minigene is flanked by 3.3-kb (5 1 ) 
and 1.8-kb (3') regions homologous to Ligl, plus an HSV-f/c cassette 
outwith. MLTV was linearized by digestion with EcoRI, and intro­ 
duced into HM-1 ES cells by electroporation 19 . Transfected cells 
were enriched for targeting events by growth in HAT medium sup­ 
plemented with gancydovir. PCR screening and subsequent South­ 
ern blot analysis (data not shown) identified 2 out of 115 hprt+ tk- 
clones as having undergone the predicted homologous recombina­ 
tion event. Targeted ES cells were injected into host blastocysts, and 
one of the resulting chimaeric males was outbred with BALB/c, to 
produce mice heterozygous for the targeted allele.
Northern and western analysis. Total RNA was extracted from ES 
cell lines and tissues and subjected to northern analysis as 
described27. Protein lysates were made by brief homogenisation of 
tissue in lysis buffer (adapted from ref. 12), and 50 u,g loaded onto 
an 8% SDS-polyacrylamide gel. Proteins were blotted onto a nitro­ 
cellulose membrane, blocked in TBST plus 5% non-fat milk pow­ 
der, and incubated with rabbit polyclonal antibody raised against 
purified bovine DNA ligase I28 (kindly provided by T. Lindahl and
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D. Barnes), which predominantly recognizes epitopes in the N ter­ 
minus of the protein. Detection of bound antibody was achieved 
using alkaline phosphatase-conjugated anti-rabbit IgG antibodies.
Embryo analysis. Conceptuses were isolated from timed matings 
between +/- animals, the day on which a vaginal plug was found 
being designated as E0.5. Yolk sacs were used to prepare DNA for 
genotyping by PCR, while embryos were fixed in 4% phosphate 
buffered formaldehyde, embedded in paraffin and sectioned at 5 
u.m. Sections were stained with haematoxylin and eosin according 
to Harris' method. Embryonic blood obtained from the umbilical 
vessels was diluted in phosphate buffered saline plus 1% fetal calf 
serum and cytospun. Cells were fixed with methanol, and stained 
with Giemsa.
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Using the phage PI-derived Cre//oxP recombination system, we have developed a strategy for efficient mammary 
tissue specific inactivation of floxed genes. Transgenic mice were generated which express Cre DNA-recombinase 
under the control of the mammary gland specific promoter of the ovine beta-lactoglobulin (BLG) gene. To test the 
specificity of Cre mediated recombination, we crossed these mice to animals harbouring a floxed DNA ligase I 
allele. We show that the BLG-Cre construct specifies mammary specific gene deletion, and furthermore that it is 
temporally regulated, predominantly occurring during lactation. We fully characterised the extent of gene deletion 
in one line (line 74). In this strain the virgin gland is characterised by low levels (7%) of Cre mediated deletion, 
whereas 70-80% of cells within the lactating mammary gland have undergone recombination. Immunohisto- 
chemistry and indirect in situ PCR were used respectively to demonstrate that both Cre protein and Cre activity 
were evenly distributed throughout the population of secretory epithelial cells. The level of background 
recombination in non-mammary tissues was found to be s£l.l%, irrespective of mammary gland developmental 
status. Crossing the transgenic BLG-Cre strain described here to mice harbouring other floxed alleles will facilitate 
the functional analysis of those genes during differentiation and development of the mammary gland.
Keywords: beta lactoglobulin promoter; Cre recombinase; DNA ligase I; transgenics; mouse mammary gland
Introduction
The Crt-loxP recombination system has recently been 
shown to allow regulated gene deletion within mammalian 
cells (Kilby et al., 1993). The availability of such 
technology has greatly extended the scope of in vivo 
genetic manipulation, particularly where it has been used 
in conjunction with established gene targeting protocols. 
Using these approaches it is now possible to perform 
tissue-specific knock-outs (Gu et al., 1994), inducible
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EH8 9AG (Tel: +44 0131 650 2909; Fax: +44 0131 650 6528; Email:
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knock-outs (Kiihn et al., 1995), long targeted deletions (Li 
et al., 1996), site-directed mutagenesis (Torres et al., 
1996), gene-insertions (Kitamoto et al., 1996), site- 
directed chromosomal translocations (Smith et al., 1995) 
as well as inversions and duplications (Ramirez-Solis et 
al., 1995). The ability to generate temporally and/or 
spatially restricted gene alterations largely resolves two of 
the main problems associated with conventional gene 
'knock-outs', namely embryonic lethality and secondary 
effects of the targeting event, such as developmental 
compensation (Kilby et al., 1993).
The Cre-/o*P system is based on the PI bacteriophage 
Cre recombinase, which mediates site-specific recombi­ 
nation between 34 bp sequences referred to as lox? sites. 
When two lox? sites are placed in the same orientation 
on the same DNA molecule, Cre will mediate excision of
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the intervening DNA sequence. Conversely, inversion of 
the lox? flanked ('floxed') DNA occurs if the two loxP 
sites are in a head-to-head orientation (Chambers, 1994). 
Cre mediated recombination has been successfully 
employed in mammalian cells (Sauer et al., 1988) mice 
(Lakso et al., 1992), yeast (Sauer, 1987), bacteria 
(Maruyama et al., 1992) and plants (Dale et al., 1990). 
The system itself is not dependent on any cofac'tors but 
the outcome of conditional gene targeting is very heavily 
determined by the characteristics of the promotor used to 
drive Cre expression. Until now only a limited number of 
promotors have been used to successfully deliver tight 
expression of Cre. These include use of the Ick or CD 19 
promotors to generate T cell or B cell specific knock­ 
outs (Gu et al., 1994; Rickert et al., 1997), the CaMKII 
promotor to activate Cre specifically in the forebrain 
(Tsien et al., 1996) or the aP2 promotor to deliver 
adipose tissue expression (Barlow et al., 1997).
We have created transgenic mice which express Cre 
recombinase under the control of the ovine beta 
lactoglobulin promotor (BLG). In the past the BLG 
promotor has been successfully used to target transgenes 
efficiently and reliable to secretory epithelial cells of the 
mammary gland (Whitelaw et al., 1992; Farini et al., 
1995; Archibald et al., 1990; Clark et al., 1992). To test 
the specificity of Cre mediated recombination we crossed 
BLG-Cre expressing mice to animals harbouring a floxed 
DNA ligase I (Ligl) allele. Quantitative PCR and 
quantitative Southern analysis allowed us to fully assess 
the extent and specificity of the achieved recombination.
Materials and methods
Cre expression vector and generation of transgenic mice
The BLG-Cre construct is shown in Figure 1 and was 
developed as follows. A 2.5 kb Xho I fragment from 
plasmid pSP-PGK-Cre containing the Cre gene with a 
modified translation initiation codon and the mouse 
metallothionein I polyadenylation signal (Sauer et al., 
1990), was blunt-ended and ligated to the £coRV site of 
4.2 kb-BLG/SK+ plasmid (Whitelaw et al., 1992). The 
plasmid was linearized by Not I and was purified using a 
Qiagen purification kit prior to injection into pronuclei of 
fertilized eggs (CBA X C57Black6). Cre-transgenic mice 
were generated according to standard procedures and 
founder mice were detected by PCR using Cre primers 
(5 '-CCGGATCCCTA ATCGCC ATCTTCC AGC AGGC-3' 
and 5'-AAACGTTGATGCCGGTGAACG-3'). The result­ 
ing PCR product was 640 bp in size; its localization is
indicated in Fig. 1.
To determine the extent of recombination at the DNA 
ligase I floxed allele, doubly transgenic animals were 
generated by mating female mice carrying one floxed 
allele of the DNA ligase I gene to male mice positive for
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Cre recombinase. Both the transgene and the floxed allele 
segregated according to Mendelian ratios, and thus one 
mouse out of 16 littermates was Cre positive, carried one 
floxed Ligl allele and was female. The phenotype of 
these mice was normal at the gross level, with apparently 
normal mammary gland development and function as 
assessed by the ability to successfully complete a 
breeding cycle.
Immunoblotting
Mammary gland tissue (day 10 lactation) was homo­ 
genized in TEDABP (10 mM Tris/HCl, pH 7.8, 1 mM 
EGTA, 1 mM DTT, 0.02% NaN3 , 1 mM benzamidine, 
0.5 mM PMSF). Protein was determined according to the 
Bradford method using bovine serum albumin as a 
standard. SDS-PAGE was performed according to 
Laemmli et al. (1970), and Western blotting using the 
method of Towbin et al. (1979). Polyclonal anti Cre 
antibodies (Novagen, Madison, WI) were diluted 1:10,000 
in TBS. For detection of antibody binding the Amersham 
ECL detection system was used.
RNA preparation and RT-PCR
Total RNA was isolated from a range of tissues from 
lactating Cre mice using TRIZOL (GibcoBRL). One 
microgram of RNA was reverse transcribed using SUPER- 
SCRIPT-RT from Gibco BRL and oligo(dT)i 5 -primers 
(Boehringer Mannheim). An aliquot of 2 ul of the RT- 
reaction was used in a 50 |ol PCR reaction. 35 cycles were 
performed in the presence of three different pairs of 
primers. The pair of Cre primers mentioned above was 
used to amplify Cre mRNA and result in a PCR product 
of 640 bp. (3-actin primers were used as a positive control; 
the product appearing at a molecular size of 440 bp (5'- 
CGTAGATGGGCACAGTG-3' and 5'-CTCCGGCATG- 
TGCCAAAG-3'). As a control for DNA contamination 
BLG primers were used which amplify the BLG-promoter 
and give a PCR product of 250 bp (5'-CTTCTGGGGT- 
CTACCAGGA-3' and 5'-TCGTGCTTCTGAGCTCTG- 
CA-3'). The localization of the BLG primers is 
indicated in Fig. 1.
Quantitative PCR
Oligonucleotide primers N2469 (5'-CCTGTGAGGGCCT- 
GATGGTGAAGACCTTGG-3') and V2014 (5'-AGTGTT- 
CCCATGGCACAAGTGGCTGGAAGC-3') amplify a 
520 bp PCR product specific for the deleted Ligl allele. 
This was amplified as part of a duplex reaction with a pair 
of primers specific for the wild-type mouse ERCC1 gene 
(MeWhir et al., 1993) acting as an independent control for 
the initial amount of DNA. PCR was performed on tissue 
DNA samples under standard conditions. Cycle para­ 
meters: denaturation, 94 °C for 1 min; annealing, 70 °C for 
1 min; elongation, 72 °C for 1 min; 20 cycles. PCR 
products were separated by agarose gel electrophoresis.
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transferred onto nylon membrane, and hybridized to [a- 
32P]-labeled probes specific for the two PCR products. 
Transfer and hybridization conditions are described else­ 
where (Thompson et al., 1989). Levels of radiolabel 
bound to each PCR product were analyzed by phosphor- 
imager, and the ratio of the two signals calculated. In 
order to estimate the percentage of the deleted Ligl allele 
present in each tissue sample, calculated ratios were 
compared against a standard curve (see Fig. 4D). Primers 
V2014 and V0727 (5'-GTCAGATTCAGAACCAACA- 
AAG-3') were used in a control reaction on the wild 
type Ligl sequence to give a 310bp product.
Southern blotting
Genomic DNA was prepared and subjected to Southern 
analysis as described (Melton et a/., 1997). The source of 
the mouse DNA ligase I cDNA fragment used as a probe 
is described in Bentley et al. (1996).
Immunohistochemistry
Formalin fixed sections were deparaffinized in xylene, 
rehydrated in descending grades of alcohol to water and 
trypsinised for lOmin in 0.01% trypsin/0.1% CaCl2 . 
After washing the sections in Tris buffered saline (TBS) 
non-specific binding sites were blocked for 20 min with 
diluted rabbit serum (1:5 with TBS) and for 15 min with 
an avidin/biotin blocking Kit from Vector Lab. (no. SP- 
2001). Cre was detected by incubating the sections 
overnight in a 1:1000 dilution of polyclonal rabbit anti- 
Cre antibody (Novagen, Madison, WI). Sections were 
washed twice in TBS and incubated for 30 min with a 
biotinylated mouse anti-rabbit secondary antibody (Dako), 
washed twice in TBS and incubated with freshly prepared 
avidin-biotin alkaline phosphatase complex (Dako). The 
color reaction was allowed to progress for 20 min in 
complete darkness (Vector red, Alkaline Phosphatase 
Substrate Kit I). The sections were counterstained in 
haematoxylin and mounted in crystal mount.
Indirect in situ PCR
The Ligl probe (520 bp) detailed above was labeled using 
DIG-11-dUTP in a standard PCR reaction (primers N2014 
& V2469). The protocol comprised 35 cycles: 94 °C for 
1 min, 70 °C for 1 min and 72 °C for 1 min. Before using 
the labeled probe it was gel-purified using QiatexII 
extraction kit (Qiagen). The formalin fixed sections were 
deparaffinized in xylene and rehydrated in descending 
grades of alcohol to water. The following procedures were 
performed in a Hybaid PCR thermocycler. Tissue sections 
were permeabilized by incubation for 15 min at 37 °C in 
100 uJ of 10 u,g/ml Proteinase K (Boehringer Mannheim). 
The sections were washed four times in PBS and the in 
situ PCR was performed using the standard Cre PCR (see 
above) (GibcoBRL). Each section was incubated with 
100(0,1 of the following reaction mix: 7 ul 10 X buffer,
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2.1 (0,1 50 mM MgCb, 1.4 ul 10 mM dNTPs, 0.7 (ill primers 
(N2469 & V2014), 4.9 ul Taq/TaqStart antibodies (Clon- 
tech) and 53.9 ul water. The negative control did not 
include any primers. The in situ PCR was performed using 
25 cycles with the conditions detailed above. The sections 
were washed twice 5 min each in 2 X SSC at room 
temperature and twice in 2 X SSC at 37 °C. Slides were 
fixed for 15 min in 0.4% paraformaldehyde/PBS on ice. 
The slides were then washed for 5 min in PBS at room 
temperature, rinsed in water and incubated overnight in 
10 ul hybridization buffer: 20 ul 50 X Denhardt's, 100 ul 
dextran sulfate, 20 uJ denatured salmon sperm DNA, 
200 ul 20 X SSC, 100 ul TE, 1 ul 50 ng/ml DIG labeled 
DNA ligase I probe and 59 ul water. The hybridizing 
sections were incubated 6 min at 95 °C, 1 min on ice and 
then left at 42 °C overnight. Sections were washed three 
times in 2 X SSC at 20 °C and once in 0.1% SSC at 42 °C. 
For detection the slides were dipped briefly in buffer 1 
(100 mM Tris (pH 7.5), 150 mM NaCl, 2 mM MgCb), 
incubated in anti-DIG alkaline phosphatase conjugated 
antibody (Boehringer Mannheim), 1:500 diluted in buffer 
2 (buffer 1, 3% BSA) for 1 hour at room temperature. 
Non-bound antibodies were removed by two washes in 
buffer 1. For the color reaction the sections were 
equilibrated 5 min in buffer 3 (0.1 M Tris (pH 9.5), then 
20 ul NBT/BCIP color solution (Boehringer Mannheim) 
were added. The reaction took place for a few hours or 
overnight in a humid and dark chamber. The sections were 
rinsed in water and mounted in water soluble Crystal 
Mount (Biomeda, Foster City, CA, USA).
Results
Generation and characterization of BLG-Cre transgenic 
animals
We have generated several transgenic lines of mice which 
carry the bacteriophage PI Cre-DNA recombinase under 
the control of the sheep BLG promoter (BLG-Cre, Fig. 1). 
Transgenic mice were identified by PCR and Southern 
blot. Of 15 lines that scored positive for Cre DNA by 
Southern analysis, 5 showed Cre-protein expression in 
Western blot using polyclonal rabbit anti-Cre-antibodies 
(Novagen, Madison, WI). The copy number of the Cre 
transgene varied between 1 and 10 (data not shown) and in 
those lines with a single integration site (lines 27, 74 and 
93) approximately parallels the amount of detectable Cre 
protein as assessed by Western analysis (Fig. 2). Line 74 
showed the highest protein expression and an estimated 
copy number of 8, line 93 had an estimated copy number 
of 4 and line 27 had 3 copies. Lines 7 and 16 had multiple 
integration sites of the transgene. Tissue-specific expres­ 
sion of the Cre-transgene was analyzed by performing RT- 
PCR with RNA extracted from a variety of tissues (Fig. 
3). This analysis revealed mammary gland expression of
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Fig. 1. Structure of the Cre-transgene. Cre recombinase (striated 
box & spotted box) was cloned as an Xho I fragment of pSP-PGK- 
Cre into the Eco RV site of 4.2 kb-BLG/SK-f- plasmid. The start of 
translation is indicated by an arrow. The £coRV site is located in 
the first untranslated exon of the BLG gene (thick bar). The Cre 
recombinase fragment containing the polyadenylation signal 
contains 52 non-coding basepairs upstream of the ATG (spotted 
box). The small arrows indicate the location of two pairs of 
primers used to amplify BLG and Cre sequences by PCR.




Fig. 2. Western blot analysis of Cre expressing mice. 10 ug of 
mammary gland protein (day 10 lactation) was separated by SDS- 
PAGE, transferred onto nylon membrane and incubated with 
polyclonal anti Cre antibodies (Novagen, Madison, WI). Five of 
the lines showed Cre expression (7.19, 16.1, 27.1, 74.4 and 93.3) 
which is indicated by a positive immunoreaction at 38 kDa. Some 
of the probes also detected a smaller protein which may result 
from Cre degradation products.
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Fig. 3. RT-PCR analysis with RNA extracted from a variety of 
tissues from Cre transgenic mouse line 74.4. Primers within the 
Cre gene were used to amplify Cre mRNA which result in a PCR 
product of 640 bp. Cre mRNA can only be detected in mammary 
tissue (lane 1) and the non DNAse treated tail DNA (lane 10), 
which served as a positive control. Salivary gland (lane 2), liver 
(lane 3), heart (lane 4), kidney (lane 5), spleen (lane 6), small 
intestine (lane 7), pancreas (lane 8) and skeletal muscle (lane 9) 
were negative for Cre mRNA. PCR using |3-actin primers has been 
used as a positive control and appears at a molecular size of 
440 bp. As a control for DNA contamination BLG primers were 
used which amplify the BLG-promoter. Only the positive control 
shows the 250 bp product.
Cre in all the tested lines, and further that no ectopic 
expression was detected in the majority of these lines. Of 
the subset (3 lines) that did show expression outside the 
mammary gland, this was restricted to the salivary gland.
Cre activity is restricted to mammary tissue
To assess Cre activity, Cre expressing mice were mated to 
mice carrying a floxed target allele. In the study presented 
here we used the BLG-Cre strains showing the highest 
Cre-expression as assessed by Western blot and no ectopic 
Cre-mRNA as confirmed by RT-PCR (lines 74 and 93). As 
a target gene we used the DNA ligase I gene (Ligl) 
(Bentley et al., 1996), modified by homologous recombi­ 
nation so that it contains two loxP sites. Mice null for 
Lig I die during embryogenesis, as a result of disruption of 
foetal liver erythropoiesis (Bentley et al., 1996). A 
'double replacement' strategy was used to introduce two 
loxP sites into the endogenous locus (Fig. 4A). Female 
progeny positive for Cre (Cre+) with one floxed Ligl 
allele (flox/+) were selected for further study. Double 
transgenic females (Cre+/flox/+) were mated to wild 
type mice and the females were sacrificed at various time 
points during mammary gland development. DNA was 
extracted from a range of tissues and analyzed. A PCR- 
based approach was used to detect the Cre-mediated 
recombination event, and to quantify the level of 
recombination in each tissue (Fig. 4B-D). Cre mediated 
deletion of the floxed DNA ligase I allele was scored by 
amplification of a 520 bp PCR product using primers 
N2469 and V2014 (see Fig. 4A). This combination of 
primers gives a product only after recombination between 
the two loxP sites has excised the intervening genomic 
region. The distance between the two sites in the non- 
recombined allele is too great to allow amplification. As 
shown in Fig. 4B the 520 bp fragment specific for the 
deleted allele is amplified only in mammary tissue (10 
day lactation) and to a low extent in tail. A control 
reaction to assess the quality of the genomic DNA 
amplifies the non-recombined wildtype allele and gave a 
positive result for all samples (Fig. 4C).
Quantification of BLG-Cre mediated recombination
Performing quantitative PCR with the primers described 
above we estimate the amount of Cre mediated recombina­ 
tion in lactating mammary gland (line 74) to be 
approximately 70% whereas in all other tissues it was 
found to be ^1.1% (Table 1). The highest level of ectopic 
Cre mediated recombination was found in tail. In line 93, 
we observed 39% recombination in the lactating mammary 
gland and some background recombination in salivary 
gland (2%), skeletal muscle and skin (1.5%). A typical 
calibration curve, used to determine the level of Cre- 
mediated recombination, is shown in Fig. 4D. The results 
obtained from this analysis showed relatively large standard 
deviations, particularly at high levels of deletion. We
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therefore chose to use Southern analysis to independently 
measure the extent of Cre-mediated recombination (Fig. 
4E). The 3' end of the floxed Ligl allele is located on an 
8.5 kb Eco RI restriction fragment (see Fig. 4A). After Cre- 
mediated recombination this fragment is lost and replaced 
by a novel 3.5 kb fragment. This is illustrated for control 
$ cell lines in Fig. 4E before (lane 5) and after 
recombination (lane 6). For recombination ES cells have 
transiently been transfected with the Cre expression vector 
pSP-PGK-Cre. A mammary sample from a 6 week old 
virgin (lane 2) showed no evidence of the 3.5 kb fragment, 
while a low level of this fragment was present in a sample 
from a 16 week old virgin (lane 1). Mammary samples 
from two lactating females (lane 3, 14 days lactation; lane 
4, 10 days lactation) showed a marked reduction in the 
intensity of the 8.5 kb fragment and a high level of the 
3.5kb fragment. By using a phosphorimager to compare 
the intensity of the signal from the 3.5 kb fragment relative 
to a control (5.2 kb) fragment common to all Ligl alleles, 
the level of Cre-mediated recombination in the mammary 
samples could be compared to the 100% level in the 
recombined ES cell clone. This analysis gave the following 
levels of recombination: virgin 16 weeks, (Ligl+/flox) 
(lane 1), 15%; 14 days lactation, (Z,/gI+/flox) (lane 3), 
73%; 10 days lactation, (L/gI-/flox) (lane 4), 80%. The 
extent of reduction of the 8.5 kb band is not readily obvious 
in Fig. 4E as this photograph has purposely been over­ 
exposed to demonstrate the increase in the more weakly 
hybridizing 3.5 kb fragment. Phosphorimager analysis of 
the 8.5 kb band however confirms the reduction in intensity 
of this band. The additional 6.7 kb band in lane 4 results 
from the introduced Eco RI site present in the HPRT 
selectable marker of the targeted allele (see Fig. 4). 
Although these values are only based on a single blot, 
they are in good agreement with those obtained by 
quantitative PCR (see Table 1) and provide an important 
independent confirmation of the high level of Cre-mediated 
recombination in the lactating mammary gland, with a 
considerably lower level in the glands from virgin animals.
BLG-Cre mediated recombination during mammary gland 
development
We next used quantitative PCR analysis to establish the 
time course of recombination throughout mammary gland 
development. These studies were performed using line 74 
(Table 1). We found that in the virgin gland 7% of cells 
had recombined their floxed allele. At day 15 of gestation 
and at the time point of birth the level of recombination 
tad risen to between 20 and 30%. The highest percentage 
*as found at day 10 of lactation, where 69% of the floxed 
al 'ele had been deleted.
Localization of Cre-protein and Cre-activity
To assess the localization of Cre within mammary tissue
^e performed immunohistochemistry using polyclonal anti
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Cre antibodies (Novagen). Figure 5A shows that Cre 
protein was expressed in the vast majority of epithelial 
cells of the transgenic BLG-Cre strain (line 74) whilst 
corresponding cells of wild type mice were negative for 
Cre protein (Fig. 5B). Because some variability was 
observed in the staining pattern using the anti-Cre 
antibody, we also analyzed Cre activity by indirect in situ 
PCR using the primer combination N2469/V2014. This 
identified cells which had undergone Cre mediated 
recombination. Figure 5C shows that Cre positive nuclei 
were distributed throughout Cre positive mammary glands, 
but are absent from Cre negative control mice (Fig. 5D).
Discussion
The Cre-/ox based recombination system has the potential 
to become a powerful genetic tool, allowing the precise 
introduction of genetic alterations within a given time 
period and within a specific tissue of the animal. It 
therefore avoids many of the problems regularly arising 
from conventional knockout studies, in particular those 
associated with embryonic lethality. In this article we 
describe transgenic mice which utilize the ovine (3- 
lactoglobulin (BLG) promoter in combination with Cre 
recombinase. We show that this construct can be used to 
efficiently deliver gene deletion within the lactating 
mammary gland.
BLG is the major whey protein in ruminants. It is not 
present in rodent milk (AH et al., 1988). Various sizes of 
the BLG promoter, the smallest of which being 406 bp, 
have been shown to direct expression of transgenes 
exclusively to secretory epithelial cells of mammary 
tissue (Whitelaw et al., 1992), where expression peaks at 
about day 10 of lactation (Harris et al., 1991).
We utilised the BLG promoter sequence to generate 
transgenic mice carrying the bacteriophage PI Cre DNA 
recombinase driven by the sheep BLG promoter. As 
expected, Cre mRNA was restricted to the mammary 
gland (day 10 lactation) in the majority of the transgene 
positive lines. This finding is in agreement with 
published data suggesting that BLG expression is largely 
position independent (Whitelaw et al., 1992). Three lines 
showed ectopic expression in the salivary gland. Ectopic 
expression in the salivary gland has been previously 
reported in transgenic lines using the BLG promoter 
(Farini et al., 1995), and it has been speculated that this 
arises because these two tissues are developmentally 
related.
Cre activity was evaluated by crossing BLG-Cre 
positive lines (74 and 93) to mice carrying a floxed 
DNA ligase I gene. Quantitative PCR and Southern blot 
analysis show that in one of the lines (line 74) Cre 
mediated recombination of the floxed Lig\ allele occurs 
in 70-80% of lactating mammary gland with all other 
tissues exhibiting recombination levels ^I.IV Both
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Fig. 4. (A) Schematic representation of the strategies used to produce the floxed DNA ligase I allele and detect Cre-mediated 
recombination. The last 5 exons of the Ligl locus were replaced with an HPRT minigene by homologous recombination in HPRT-deficient 
ES cells (Bentley et al., 1996; McW)iir et al., 1993). A second homologous recombination step was subsequently used to reconstruct a 
functional allele, but with exons 23 to 27 flanked by two loxP sites (unpublished data). Cre-mediated recombination between the two loxP 
sites was detected by a PCR reaction specific for the deleted allele (Fig. 4B). Primer N2469 binds within exon 22, while primer V2014 
binds downstream of exon 27 and the adjacent loxP site. The wild-type and non-recombined floxed alleles do not give a product because 
the distances between the two primer binding sites are too great for efficient amplification. Only when Cre-mediated recombination has 
juxtaposed the primer binding sites can a 520 bp product be amplified. Solid boxes, exons (numbered according to convention); lines, Lig I 
introns or flanking regions; hatched box, HPRT minigene; solid triangles, loxP sites. Arrows indicate the positions at which PCR primers 
bind. £coRI restriction sites are marked by E and the sizes (in kb) of the £coRI restriction fragments diagnostic for the different Ligl 
allele structures are shown. (B) PCR-Assay for Cre-mediated DNA recombination in various tissues. DNA from thymus (lane 1), ovary 
(lane 2), mammary gland, day 10 lact. (lane 3), heart (lane 4), tail (lane 5), lung (lane 6), liver (lane 7), pancreas (lane 8), skin (lane 9), 
spleen (lane 10), small intestine (lane 11), large intestine (lane 12), kidney (lane 13), brain (lane 14) and salivary gland (lane 15) was used 
as a substrate for the target gene PCR assay. The primer combination V2014 and N2469 will only generate a PCR product (520 bp) if the 
Cre mediated recombination event brings the two binding sites into close proximity. (C) Primers V0727 and V2014 were used to amplify 
the wildtype Ligl sequence producing a 310bp product. The tissue samples are loaded in the same order as in K.g. 413.
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Fig.4. (D) A typical standard curve for PCR quantitation of the levels of Cre-mediated recombination of the floxed Ligl allele. Varying 
amounts of genomic DNA from an ES cell clone heterozygous for the deleted Ligl allele were spiked into wild-type DNA, thereby 
producing a series of samples containing known percentages of the deleted allele. These standards were then used as templates for PCR 
reactions specific for the deleted allele, as part of a duplex with an independent reaction acting as a control for the amount of input DNA. 
Products were separated by electrophoresis, blotted and hybridized to probes specific for the two PCR products. The relative levels of the 
two signals were quantified by phosphorimagery and the calculated ratios plotted against the known percentages of the deleted allele. Using 
this graph it was possible to derive estimates of the levels of Cre-mediated recombination in mammary DNA samples. (E) Southern blot 
analysis of the Lig[ locus before and after Cre-mediated recombination. Genomic DNA (10 u,g), prepared from mouse mammary tissue and 
mouse ES cells, was digested with EcoRl and subjected to Southern analysis using a 2.1 kb Bam Hl/Eco RI fragment of mouse DNA 
ligase 1 cDNA as a probe. The cDNA probe used hybridizes to exons 8-27 of the Ligl gene. Lanes 1-4: mammary tissue from line 74 
Cre transgenic mice heterozygous for the floxed Ligl allele (mice in lanes 1-3 are heterozygous floxed/wild-type; the mouse in lane 4 is 
heterozygous floxed/targeted Ligl allele). Lane 1, virgin 16 weeks old; lane 2, virgin 6 weeks old; lane 3, mother 14 days lactation, lane 
4, mother 10 days lactation. Lane 5, ES cell clone heterozygous for the floxed Ligl allele (heterozygous floxed/wild-type). Lane 6, ES cell 
clone heterozygous for the deleted Ligl allele (heterozygous deleted/wild-type). The sizes (in kb) of all the Ligl gene fragments 
hybridizing to the probe are indicated. Sizes in parentheses indicate fragments derived from the 5' and central region of the Ligl gene 
which are common to all four Ligl alleles and are not shown in panel a). The asterisk indicates the novel 3.5 kb fragment generated by 
Cre-mediated recombination. The arrow indicates the 8.5 kb fragment of the floxed allele which is lost after Cre-mediated recombination. 
The 3.5kb fragment only contains exon 22 and so hybridizes more weakly to the cDNA probe than the 8.5 kb fragment (containing exons 
22-27) which it replaces.
and Southern blot analysis gave results which 
in good agreement with each other, although the 
quantitative PCR proved to be quite sensitive to DNA 
quality, resulting in high standard deviations. The 
Pattern of Cre activity closely reflects the published 
Relics of BLG expression (Harris et al., 1991). Very 
low recombination levels were observed in the virgin 
mammary gland (7%), increasing throughout gestation 
tod birth (20-30%) and highest at about day 10 of 
Nation (70-80%). The amount of tissue which still 
c°ntains the non-recombined floxed allele (-20%) very 
reflects the population of non-epithelial stromal
cells (fat cells, fibroblasts and lymphocytes) which do 
not upregulate the BLG promoter and therefore lack 
Cre expression. However we cannot formally exclude 
the possibility that a small percentage of epithelial cells 
failed to undergo recombination. Such restriction of Cre 
expression to mammary epithelial cells is supported by 
the finding that anti-Cre antibodies only stained 
epithelial cells. Cre expression could be detected in 
the majority of epithelial cells, although the level of 
staining varied, which might reflect either staining 
artifacts or different expression levels of Cre within 
different cells. The occasional staimnu inside the lumen
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Table 1. Tissue-distribution of Cre-mediated recombination in two 
different Cre expressing mouse lines (74 and 93). Levels of 
recombination in Cre+/flox+ females were determined by 
quantitative PCR. The 'percentage deleted allele' reflects the 
proportion of cells which contain the deleted allele. Figures shown 
for the mammary gland samples represent at least three 
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of the alveoli probably results from the use of avidin 
to amplify the Cre-signal and represents cross reaction 
to milk protein; it is also apparent in Cre negative 
sections. To independently confirm Cre activity in the 
mammary gland, we used indirect in situ PCR to 
identify cells which had undergone recombination. This 
showed that Cre activity, as assessed by the presence of 
the recombined allele, was detectable in virtually every 
epithelial cell. Occasional negative nuclei were ob­ 
served, which we assume arise either because of failed 
recombination or because of technical failure of the 
PCR reaction (e.g. because the recombined allele is not 
present in that section of the nucleus). We have 
recently generated mice which are Cre positive, bear 
the floxed Ligl allele and also the null Ligl allele and 
we have initiated a study of mammary function in 
these mice. Preliminary data from these animals suggest 
that DNA ligase I deficiency retards mammary gland 
development.
Taken together, the data show that BLG driven Cre 
expression results in Cre mediated excision, which is 
tightly controlled both spatially and temporally. This is 
somewhat in contrast to a recently published study 
reporting the phenotypes of mice transgenic for Cre 
recombinase that are driven by the mammary gland 
promoters MMTV or WAP (Wagner et al., 1997). In 
this study, the MMTV-Cre construct did not show 
tissue specificity, and furthermore Cre was found to be 
expressed in the germline. The use of the WAP 
promoter did result in Cre expression in the mammary 
gland, however expression was also observed within 
the brain which is not without precedent as Gunzburg 
et al. (1991) have demonstrated high expression levels 
of WAP driven transgenes specifically in Bergman glia 
cells. Although WAP-Cre mice are clearly useful for 
the analysis of gene inactivation within the mammary 
gland, it remains possible that any phenotypic analysis 
will be complicated by the observed ectopic expres­ 
sion. Furthermore, no definitive data is given relating 
to the level of Cre activity in the WAP-Cre mice, and 
it therefore remains possible that the level and pattern 
of recombination is insufficient to result in detectable 
phenotypes in all 'floxed' strains of mice. This is a 
particularly relevant point for mammary specific 
transgenesis, as use of MMTV, WAP and even the 
BLG promoter has previously been shown to lead to 
mosaic expression within the mammary gland (Rollini 
et al., 1992; Robinson et al., 1995; Dobie et al., 
1996).
Based on the results presented here, we believe that 
this murine strain (line 74) will prove a valuable addition 
to the currently available tools for studying the genetic 
control of mammary biology, particularly for those genes 
where constitutive inactivation results in embryonic 
lethality.
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Fig. 5. Localization of Cre protein and Cre activity. Fig. 5A and C show formalin fixed mammary gland sections (day 10 lact.) of Cre 
expressing line 74, in B and D wild type mammary gland sections are shown. In A and B sections were incubated with 1:1000 dilution of 
polyclonal anti-Cre. In C and D indirect in situ PCR was used to amplify recombined DNA ligase I gene fragments. Sections were 
incubated with primer combination V2014 and N2469 to amplify the recombined Ligl allele and then probed with a DIG-labeled probe. 
After incubating the sections with alkaline phosphatase labeled anti-DIG antibodies, Cre mice show a homogeneous distribution of Cre (A), 
Cre activity respectively (C) in mammary tissue, while wildtype mice are Cre negative (B, D). 400 X magnification.
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